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“It takes a village to raise a child,” is a common colloquialism 
referring to the immense amount of time and support required to 
develop a contributing member of society. In residency education, 
it takes collaboration amongst multiple individuals to run a 
program, educate within the standard of graded responsibility, and 
mentor residents with differing needs and interests. This village 
of educators (Residency Leadership and Core Faculty), allows 
for exposure to different ways of thinking, approaches to patient 
care, and methods of teaching, creating a rich environment for 
the exponential growth of learners. It is the responsibility of these 
individuals to assure excellence in education, inside and outside 
the clinical setting, to develop high quality emergency physician 
(EP) graduates for our society.  
Until 2019, the Emergency Medicine ACGME 
(Accreditation Council for Graduate Medical Education) program 
requirements stated that institutions were required to provide 
protected non-clinical time for core faculty. Specifically, core 
faculty could not be required to generate clinical or other income 
to support that protection. These core faculty could not average 
more than 28 clinical hours per week, or 1344 clinical hours per 
year. In the new proposed program requirements, the requirement 
to ensure this non-clinical time has been removed. This will 
undoubtedly have a negative effect on the quality of resident 
education and the physician wellness of the faculty.  
While we can certainly understand the ACGME’s 
desire to create uniformity in processes among training in all 
specialties, there are unique qualities of each specialty that 
merit individualization. Specifically, EM has shift scheduling 
challenges, increasing patient volumes with frequent emergency 
department (ED) crowding, and an increased burden of clerical 
work. These factors pose unique challenges in educating and 
training EM residents that will create serious consequences 
without the provision for protected time for clinician-educators.  
Additionally, changes in other specialties and decreased 
availability of specialists has led to increased workload on EPs, 
and increased need for education in areas that were previously not 
in the purview of our specialty.
The ED is open and available 168 hours per week, all 
weekends and all holidays. An EP’s work is compounded when 
other specialists are less or not available at all. It has been 
demonstrated that when EDs are busy, EPs need to be able 
to distribute the work of procedures to admitting services to 
continue to serve the patients.1 Current ED trends demonstrate 
increasing volumes and complexity each year, which further 
challenge EM educators to teach during clinical shifts.2
Several changes in other specialty requirements have been 
focused on controlling the learning environment to comply with 
ACGME rules. These, have, in turn, negatively impacted EM 
residents by increasing workload. Patient capping (limits for 
inpatient residents to accept further patients for care), decrease in 
non-EM specialty procedural requirements (creating need for EM 
residents to perform procedures prior to admission), and changes 
in rotational requirements (removing off-service residents from 
ED rotations) have all impacted the ED. The effect of capping 
patient volumes to admitting services has increased ED crowding, 
which increases the cognitive load on EPs.3 When other specialties 
decrease their scope of practice, the EP’s must necessarily 
expand, increasing the workload and complexity of the learning 
environment.  As an example, the removal from the ACGME 
requirement for nephrology fellows to be trained to  place dialysis 
catheters has shifted that responsibility to critical care or ED 
teams.  With the decrease in other specialties rotating through 
the ED, the understanding of the ED environment by consultants 
and admitting teams declines as well. This lack of exposure and 
understanding can lead residents to delay writing admitting orders 
until it is either convenient, or the patient has been seen by more 
senior residents and supervisors, or even other possible admitting 
services. This leads to delay in patient care, increased cognitive 
load on the EP, and patient dissatisfaction.  Additional stress 
may decrease EP empathy, the faculty’s ability to educate, and 
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residents’ openness to learning.4  
The scope of EM practice is very broad. One of the critical 
aspects of EM training is preparing learners for low frequency, 
high stakes clinical scenarios and procedures. As the scope of 
practice for procedures done in the ED continues to expand, the 
burden of education that occurs outside the clinical environment 
increases. Peri-mortem c-sections, emergent cricothyrotomies, 
acute resuscitations of massive gastrointestinal bleeds, and 
ruptured ectopic pregnancies are not very common scenarios, 
but an excellent EM resident must be prepared and competent to 
perform these rare clinical cases. What allows training residents 
to achieve competence is the increased use of high and low 
fidelity simulators and task trainers. Proper preparation of learners 
for these cases requires innovative teaching strategies that 
leverage technology, simulation, blended learning, and traditional 
teaching. To guarantee exposure of all residents, procedural 
experiences and other teaching must be scheduled outside of the 
ED clinical environment. EM education  “beyond the shift” has 
been identified as a best practice, given common ED crowding, 
which limits  time available to  teach due to immediate patient 
care needs.5  Suggestions include that faculty send articles after 
shifts and create teaching files outside the shifts to best educate 
EM residents. For procedural training, simulation is increasingly 
necessary to ensure patient safety and a standardized training 
environment. The number of procedures done and self-report of 
comfort does not equate to procedural competence.6 “Rigorous 
simulation-based education is a natural fit with the ACGME 
milestone framework because it provides standardization, 
deliberate practice, feedback, translation of outcomes to improved 
patient care, and reliable formative evaluation until a mastery 
standard is met.”6
While EM faculty are committed to providing these blended 
teaching methods and experiential learning environments, they 
require protected non-clinical time for preparation and teaching. 
Such examples from EM educational faculty in ultrasound and 
simulation demonstrate the time commitment of these training 
modalities outside of the clinical environment. 
• Benchmarking surveys performed by The Society 
for Clinical Ultrasound Fellowships determined that 
clinical ultrasound faculty spend, on average, 590 
hours per year on ultrasound activities, with 288 hours 
spent on ultrasound education alone. This translates 
to more than 6 hours per week per faculty member. 
An additional 124 hours per year is spent on quality 
assurance of ultrasound examinations performed by 
residents, fellows, and faculty as part of the education 
mission.  
• Data from the Society for Academic Emergency 
Medicine’s Simulation Academy demonstrates that, 
on average, 300 hours of simulation are taught every 
year to students, EM residents, and fellows by each 
EM simulation faculty. This survey also demonstrated 
that most programs are using simulation to educate EM 
residents with up to 30% of curriculum being taught via 
simulation and faculty report spending up to 50 hours 
per month on simulation education. 
EM has been on the forefront of innovative teaching 
solutions using sound andragogical theory. Without clear 
delineation of protected educational time for faculty, we will 
necessarily decrease educational innovation and effort in order to 
accommodate increased clinical expectations. This will degrade 
the educational experience for the residents and adversely affect  
patient safety and the clinical learning environment. The quality 
of the training environment impacts patient outcomes during 
training, and this effect remains stable after graduation.7  ,Without 
the explicit requirement of protected time for EM faculty to teach, 
this time will be lost due to the market forces described below. It 
is clear that the inability to train EM residents for rare, but high-
risk clinical situations will have a profound negative impact on  
training, and will be transmitted to the public, as the population of 
inadequately-prepared residents grows.
We must also consider how the proposed rule changes will 
impact physician burnout.   According to Medscape’s Annual 
National Burnout and Depression Report 2018, 8 EM has one 
of the highest burnout rates. A study published in Archives of 
Internal Medicine in 2012 reported that EM physicians were 
three times more likely to develop burnout than the average 
physician.9  The following factors have been identified as 
drivers of burnout and decreased engagement: workload/job 
demands, efficiency/resources, meaning in work, culture/values, 
control/flexibility, social support/community work, and work-
life integration.10  The changes in  support for faculty time in 
academic settings will have significant impact on the workload/
job demands and meaning in work categories. Increasing ED 
volumes, charting demands, and emphasis on throughput metrics 
have negatively impacted the teaching environment.11 Faculty 
at institutions with residency programs consider it part of their 
mission to educate the next generation of EM physicians. If the 
balance of clinical service and education is shifted by increasing 
workload and decreasing time to educate, there will be a negative 
impact on faculty physician wellness and an increase in burnout. 
Additionally,  EM practice is becoming ever-more privatized 
and consolidated into large contracted medical groups (CMG).  
These corporations are large, for-profit companies that are 
incentivized to have their employees (EM physicians) see patients 
and generate revenue rather than spend time on educational or 
academic pursuits. This market pressure will begin to force CMGs 
that wish to remain lean and competitive to disincentivize academic 
and education time. This will absolutely and inevitably degrade 
the high standards to which EM educators hold their learners,  and 
endanger patients both at those training sites and beyond.7  
Results from a recent internal CORD survey queried 
Program Directors, Assistant Program Directors, and Core 
Faculty in US EM training programs. With almost 200 
respondents, 95% reported that removal or decrease of core 
faculty protected time would be “job threatening” or “career 
threatening.” Likewise, over 96% of respondents reported that a 
loss of protected time would impede their ability to perform their 
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academic duties to a large extent. Additionally, more than 99% 
of core faculty responding felt there would be a distinct negative 
impact from the loss of academic protected time.  
With increasing volumes and charting demands, greater 
range of responsibilities, and no protected non-clinical time to 
teach outside of the clinical setting for Core Faculty, education 
outside of the clinical setting will be left solely to Program 
Directors and Associate/Assistant Program Directors without 
provisions for additional protected time for them. This will 
further erode resident education as well as Core Faculty and 
Program Director wellness.  Additionally, it will have a negative 
impact on academic scholarship, when that is no longer seen as 
something worth time to cultivate. 
Changes in requirements of dedicated non-clinical time 
for EM education faculty will lead to decreased scholarship, 
diminished exposure of residents to varied ways of thinking and 
practice, and a workforce of EPsthat are only incentivized by 
how fast patients can be moved through an ED.  While external 
forces have decreased the amount of time available to teach 
during clinical shifts, removing protected time for Core Faculty 
to engage in education away from the bedside will diminish 
the amount and quality of that education.  We need to protect 
our village to innovate and continue to advance EM education, 
creating the leaders of the future.  
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Introduction: Advanced practice providers (APP), including physicians’ assistants and nurse 
practitioners, have been increasingly incorporated into emergency department (ED) staffing over the past 
decade. There is scant literature examining resource utilization and the cost benefit of having APPs in 
the ED. The objectives of this study were to compare resource utilization in EDs that use APPs in their 
staffing model with those that do not and to estimate costs associated with the utilized resources.
Methods: In this five-year retrospective secondary data analysis of the Emergency Department 
Benchmarking Alliance (EDBA), we compared resource utilization rates in EDs with and without 
APPs in non-academic EDs. Primary outcomes were hospital admission and use of computed 
tomography (CT), radiography, ultrasound, and magnetic resonance imaging (MRI). Costs were 
estimated using the 2014 physician fee schedule and inpatient payments from the Centers for 
Medicare and Medicaid Services. We measured outcomes as rates per 100 visits. Data were 
analyzed using a mixed linear model with repeated measures, adjusted for annual volume, patient 
acuity, and attending hours. We used the adjusted net difference to project utilization costs between 
the two groups per 1000 visits. 
Results: Of the 1054 EDs included in this study, 79% employed APPs. Relative to EDs without 
APPs, EDs staffing APPs had higher resource utilization rates (use per 100 visits): 3.0 more 
admissions (95% confidence interval [CI], 2.0–4.1), 1.7 more CTs (95% CI, 0.2–3.1), 4.5 more 
radiographs (95% CI, 2.2–6.9), and 1.0 more ultrasound (95% CI, 0.3–1.7) but comparable MRI 
use 0.1 (95% CI, -0.2–0.3). Projected costs of these differences varied among the resource utilized. 
Compared to EDs without APPs, EDs with APPs were estimated to have 30.4 more admissions per 
1000 visits, which could accrue $414,717 in utilization costs.
Conclusion: EDs staffing APPs were associated with modest increases in resource utilization as 
measured by admissions and imaging studies. [West J Emerg Med. 2019;20(4)541-548.] 
INTRODUCTION
Advanced practice providers (APP), including physicians’ 
assistants (PA) and nurse practitioners (NP), have been 
increasingly incorporated into emergency department (ED) 
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staffing over the past decade. According to the Emergency 
Department Benchmarking Alliance (EDBA), ED APP 
staffing increased from 23% of EDs in 2010 to 62% in 2016.1 
This rise is in response to increased ED visits, a shortage 
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Population Health Research Capsule
What do we already know about this issue?
Emergency departments (ED) with advanced 
practice providers (APP) have increased 
from 23% in 2010 to 62% in 2016, but little 
is known about resource use as measured by 
admissions and imaging studies.
What was the research question?
Does resource use differ in EDs staffed with 
attending physicians only vs EDs with APPs 
in the staffing mix?
What was the major finding of the study?
Non-academic EDs staffing APPs were 
associated with modest increases in 
admissions and imaging studies.
How does this improve population health?
Optimizing resources is essential for 
population health. Better understanding of 
resource utilization can help ED staffing 
decisions and health system costs.
of emergency medicine (EM)-trained physicians,2 and cost 
constraints. In addition to providing direct ED patient care, 
APPs serve as transitional providers between the ED and 
inpatient units as patients wait for beds to become available.3 
About 10.5% of PAs identify EM as their primary specialty.4,5 
Another 10% specialize in urgent care medicine, according 
to a North Carolina study.3 Proficiency with procedural skills 
such as laceration repairs and abscess drainage make APPs 
particularly suitable to ED and urgent care practice.6 
Data have demonstrated the cost effectiveness of APPs. 
Their involvement in urgent care settings decreases costs 
and waiting room time.7 APPs on trauma services have 
been associated with significantly decreased intensive care 
unit length of stay.8 One of the benefits APPs are thought to 
provide to the overall staffing structure is the ability to free 
emergency physicians to see higher acuity patients. Phillips 
and colleagues found that over 90% of APPs see low-acuity 
patients defined as Emergency Severity Index (ESI) levels 3-5 
while 36% of APPs report caring for high acuity (ESI levels 
1 and 2) patients.9 The variation in ESI levels seen by APPs 
might be due to differing physician supervision requirements 
across states that can also influence diagnostic study and 
admission ordering privileges. 
Importance
There is scant literature examining resource utilization 
and the cost-benefit of APPs in the ED setting. In a cross-
sectional study surveying American College of Emergency 
Physician council members, NPs were perceived as using 
significantly more resources than their PA counterparts. In 
addition, the survey revealed concern for over-testing by all 
APPs, which abated with experience.9 Despite these concerns, 
APP use in EDs is increasing incrementally over time.1 
Goals of This Investigation
The objectives of this study were twofold: 1) to compare 
resource utilization in EDs that use APPs in their staffing 
model with those that do not; and 2) to estimate costs 
associated with the utilized resources.
METHODS
Study Design and Setting 
We conducted a five-year retrospective secondary data 
analysis of non-academic EDs that reported data to the EDBA. 
EDBA is a national, non-profit ED-level database of member 
organizations that was created to collate and monitor trends 
of ED performance metrics on an annual basis.10,11 The EDBA 
contains data from more than 1100 EDs in the United States, 
representing over 40 million patient visits.12 The data is 
accessible to member institutions that voluntarily submit their 
ED demographics and performance metrics to the organization. 
Member organizations use the data to benchmark performance 
against similar EDs, identify best practices, conduct research, 
and collaborate to improve quality. EDBA contains annual 
ED aggregate data including hospital demographics, annual 
visit volumes, provider hours, patient acuity, length of stay, 
hospital admissions, computed tomography (CT), radiographs, 
ultrasounds, and magnetic resonance imaging (MRI). 
Definitions of metrics in the report are standardized by the 
EDBA Board of Directors. Data are blinded at the hospital 
level but clustered by state. EDBA data is completely free 
from commercial influence and solely reported for purposes 
of benchmarking quality. The database has been used for 
numerous studies published in peer-reviewed journals.13-17 
We compared resource utilization in EDs that included 
APPs in their staffing mix with EDs that did not. We then 
analyzed the cost implications of those differences using the 
2014 Centers for Medicare and Medicaid Services (CMS) 
physician fee schedule and inpatient Diagnoses Related 
Group (DRG) payments to estimate utilization cost. The term 
cost is used strictly to represent CMS average admission and 
prospective resource utilization payments. The University of 
Maryland institutional review board (IRB) exempted this study 
from IRB review since only de-identified data were examined.
The study included patient encounters that occurred 
between 2012 and 2016 in 1092 EDs located in 44 states 
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and the District of Columbia. Because data reporting was 
voluntary, reporting compliance varied among EDs: some 
reported data for the entire five-year study period while 
others reported one, two, three, or four years. The use of APP 
staffing was unchanged for most EDs during the study period 
as departments either used or did not use APPs in the staffing 
matrix. This consistency facilitated a two-group comparative 
panel in which EDs staffing APPs constituted the comparison 
group while EDs without APPs became the control group. 
All EDs reporting data to the EDBA were examined for 
inclusion in the study. Inclusion criteria were non-teaching 
general and adult EDs. We excluded EDs classified as 
“academic” or “teaching” because they have different resource 
utilization patterns than non-teaching facilities. EM resident 
physicians have been shown to increase the hospitalization 
percentage and use of imaging studies relative to attending 
physicians practicing alone.18,19 Similar utilization patterns 
were observed during our data screening leading to exclusion 
of academic EDs or EDs with residents. We also excluded 
EDs classified as free-standing, urgent care, or pediatric, as the 
former two lack admission capabilities while the latter focuses 
on a pediatric population, which differs in practice from 
EDs that treat adults. Thirty-eight EDs changed their staffing 
patterns from one year to the next, adding or eliminating APPs 
from their staffing matrix. To avoid biasing the findings by the 
38 EDs that would appear in both study arms, we excluded 
these facilities. We used a first-percentile Winsorization 
approach20 for the primary outcomes to identify the highest 
and lowest outcome outliers, which were flagged and removed 
from the analysis.
Outcome Measures
The primary outcome variables used to reflect resource 
utilization were hospital admission, CT, radiography, 
ultrasound, and MRI. All outcome variables were reported 
as rates (number of uses per 100 ED visits). Of the 1054 
EDs included in the study, 144 reported zero use of MRI 
and 11 reported zero use of ultrasound for an entire year. 
We converted zero values to missing because we could not 
discern if “zero” meant lack of use, lack of equipment, or 
lack of accurate reporting. EDBA defines ED volume as the 
total number of annual patient visits; it defines high acuity 
as the percentage of total visits assigned Current Procedural 
Terminology (CPT) code levels (four, five, or critical care), 
and defines provider hours as the number of staffed hours 
in an average day. These three potential confounders—
annual ED volume, high acuity, and attending hours—that 
could influence resource utilization were also examined and 
included in our analytical models. 
Cost estimates were obtained from two CMS sources: 
inpatient admission charge data and Physician Fee Schedule 
payments. First, we used the inpatient charge data for fiscal 
year 2014 to compute the average admission cost. The charge 
file lists average total payments for each Medicare Severity 
Diagnosis Related Group (MS-DRG). We summed the total 
payments for all MS-DRGs and averaged them to obtain a 
grand overall mean for admission cost. The average admission 
cost was inflation adjusted by 3.5%21 to account for rising 
healthcare costs. Second, we used the CMS Physician Fee 
Schedule to estimate resource utilization payments. Because 
these payments vary according to CPT codes, we estimated 
usage cost by averaging payment for common radiology CPT 
codes of each imaging study. The supplemental eTable 1 lists 
the CPT codes that we used with their prospective payments 
as derived from the CMS Physician Fee Schedule and includes 
the summed total and average resource payments. 
We calculated the estimated resource utilization cost 
as follows: the utilization difference between EDs with and 
without APPs was projected per 1000 patients, which was 
then multiplied by the average resource payment to reflect the 
estimated resource cost per 1000 patients. For example, if CT 
use was increased, hypothetically, by 10 scans per 1000 visits 
in EDs with APPs compared with those without APPS, and if 
the average payment of one CT is $276, then the total cost for 
the extra CTs per 1000 patients would be $2,760 (10 x $276). 
The supplemental eFigure 1 presents a condensed graphical 
summary of the average cost per single use and the estimated 
utilization difference.
Data Analysis
Descriptive statistics are presented as overall means and 
standard deviations. Mean comparisons using Student’s t-test 
were employed to compare resource utilization in EDs with 
and without APPs. The number of EDs reporting data for each 
variable was also recorded to reflect variations in reporting 
patterns. We generated adjusted estimates for each outcome 
using a linear mixed regression with repeated measures. The 
multivariable model results were presented as means and 95% 
confidence intervals (CI) adjusted for ED volume, high acuity, 
and attending hours. All tests were two sided, with a p-value 
<0.05 considered statistically significant. We performed all 
analyses with SAS 9.4 statistical package (SAS Institute Inc., 
Cary, North Carolina).
RESULTS
Characteristics of Study Population
The five-year study period contained 6033 total ED records, 
of which 4631 were for non-academic ED records. After applying 
our exclusion criteria, the final working sample consisted of 2699 
ED records representing 1054 unique EDs (Figure 1).
Of the 1054 distinct EDs, 79% (n=830) had APPs on staff 
and 21% (n=224) did not. Resource utilization rates by APP 
status are shown in Table 1. EDs with APPs had higher crude 
resource utilization rates in all assessed measures compared 
with EDs without APPs (p < 0.05). EDs with APPs also had a 
higher prevalence of high-acuity visits (66.6% vs 61.3%) and 
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4,631 Non-academic ED records
Excluded
• Free standing, pediatric, 
special, urgent care records, 
n=372
• Foreign EDs, n=9
• Illegible volume ED, n=1
• Academic/residents, n=1,020
Excluded
• Missing APP value, n=1,764
• Winsorization, n= 23
• APP mixed staffing EDs, n=145
2,699 Records with eligible APP entry
(distinct ED n=1,054)
422 Records without APPs
(unique ED n=244)
2,277 Records with APPs
(Unique ED n=830)
Figure 1. Study population. 
ED, emergency department; AAP, advanced practice provider.
6,033 
Total ED records, 2012-2016
more average attending hours (39.3 vs 28.0 per day) than EDs 
without APPs.
Adjusted regression estimates comparing resource 
utilization between EDs with and without APPs are displayed 
in Table 2. Relative to EDs without APPs, resource utilization 
increased by 3.04 per 100 visits (95% CI, 2.0‒4.1) for 
admission, by 1.7 per 100 (95% CI, 0.2‒3.1) for CT, by 4.5 
per 100 (95% CI, 2.2‒6.9) for radiography, and by 1.0 per 
100 (95% CI, 0.3‒1.7) for ultrasound in EDs with APPs. 
There was no statistical difference in MRI utilization between 
the two study groups (1.0 vs 0.9 per 100 visits [p=0.58]). 
The supplemental eTable 2 provides the adjusted coefficient 
outputs and regression estimates of the controlled covariates 
for each model.
Figure 2 presents the projected costs associated with 
increases in resource utilization in EDs with APPs based 
on 1000 patient visits. The average inflation-adjusted costs 
were $13,642 for a single hospital admission, $276 for a CT, 
$82 for a radiograph, $214 for an ultrasound, and $486 for 
an MRI. EDs with APPs were estimated to have 30.4 more 
admissions per 1000 patients, which would accrue $414,717 
(30.4 x $13,642. While not as substantial, the approximated 
costs per 1000 for CT, radiography, ultrasound, and MRI were 
$4692, $3690, $2140, and $486, respectively. 
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All EDs
(n=1,054)
EDs With APPs
(n=830) 
EDs without APPs 
(n=224)
Resource n Mean (SD) n Mean (SD) n Mean (SD) p value
Hospital admission 1021 15.4 ±(7.0) 809 16.5 ±(6.7) 212 11.3 ±(6.6) <0.01
CT scan 762 20.7 ±(7.7) 615 21.4 ±(7.7) 147 17.8 ±(7.0) <0.01
Radiography 784 45 ±(12.3) 635 46.2 ±(12.3) 149 40.1 ±(11.5) <0.01
Ultrasound 450 4.8 ±(3.1) 366 5.2 ±(3.1) 84 3.1 ±(2.5) <0.01
MRI 610 1.1 ±(1.1) 531 1.1 ±(1.1) 79 0.8 ±(1.0) 0.03
High acuity 938 65.6 ±(11.2) 763 66.6 ±(10.8) 175 61.3 ±(11.6) <0.01
Attending hours 1053 36.9 ±(17.3) 830 39.3 ±(17.8) 223 28 ±(11.7) <0.01
Volume 1054 35052 ±(21281) 830 40285 ±(19908) 224 15661 ±(13616) <0.01
Table 1. Descriptive statistics of emergency departments (ED) by advanced practice provider (APP) status (per 100 patient visits), 
EDBA 2012‒2016.1
1Data presented are overall (distinct ED) means and standard deviation (SD); attending hours are average hours on an average day; 
volume is average per year.
EDBA, Emergency Department Benchmarking Alliance; CT, computed tomography; MRI, magnetic resonance imaging.
DISCUSSION
APPs are providing increasing numbers of hours to cover 
ED shortages in the United States. Using EDBA data, Augustine 
noted that 39% of hours were worked by PAs or NPs in 2016.1 
We believe that our study is the first examining the potential 
impact of this change by comparing resource utilization and 
cost in the ED setting. Our findings do not conclude that APPs 
are causing the increase in resource utilizations. We found that 
EDs staffing APPs were associated with increased resource 
utilization, as measured by hospital admissions and the use of 
CT, radiography, and ultrasound studies. Although our study 
could not directly compare ED attendings to ED APPs due to 
data limitations, our aggregate analysis demonstrated correlation 
between APP ED setting and modest increases in utilization. This 
comparison can be a starting point for future discussions and a 
call for more robust research on this important topic. 
In past studies, other practices outside the ED have shown 
increased utilization among APPs compared to physicians as well. 
Studies done in primary care practices demonstrated increased 
utilization of resources when comparing physician practice with 
that of APPs. Everett et al. found that patients whose usual primary 
care provider was an APP had 2.4-3 times the odds of having five 
or more annual primary care visits (compared with the typical 2-4 
visits) if seen primarily by a physician.22 In an office-based setting, 
another study found that new and established patients seen by 
APPs were significantly more likely to have more imaging studies 
ordered than those seen by primary care physicians.23 Additionally, 
studies examining quality of care and comparing resource-ordering 
patterns between APPs and physicians for patients with diabetes or 
cardiovascular disease found that APPs ordered slightly more tests, 
imaging studies, and referrals.24-26 
In our study, ultrasound and MRI studies had the smallest 
adjusted differences, 1 and 0.1 per 100 visits respectively. To 
evaluate if converting the zero values for 144 MRI and 11 
ultrasound records to “missing” biased our model estimates, 
we included these zero records, re-estimated the models, and 
compared the findings. We found no sizeable differences 
between the two models when zero value records were 
included. Including zero values caused the adjusted differences 
for ED with APPs to be marginally larger (1.0 vs 1.2 per 100 
visits) for ultrasound, and (0.1 vs 0.2 per 100 visits) for MRI, 
with no change in statistical significance. 
Although our findings demonstrate correlation between 
EDs staffing APPs and increased resource utilization and cost, 
we cannot assume causation. Our results simply demonstrate 
that average resource utilization rates increased in EDs with 
APPs of comparable volume, acuity, and doctor hours relative to 
EDs without APPs. A valid argument is that resource utilization 
increases are caused by increases in volume and acuity in EDs 
staffing APPs. We adjusted for the effect of acuity and volume 
in our models, and we separately examined if volume or acuity 
moderated the effect seen on hospital admission. The interaction 
between acuity and APPs was not statistically significant, which 
means that EDs with APPs had higher hospital admission rates 
regardless of acuity levels. On the other hand, patient volume 
showed a partial moderation effect on hospital admission in 
that hospital admission differences between EDs with vs those 
without APPs were larger at EDs with smaller annual volume 
(<40,000) but the utilization differences were smaller in EDs with 
larger volume. The direct effect of EDs with APPs was still about 
three more admissions per 100 visits for EDs with APPs even if 
the interaction term was adjusted for in the model. 
Even with modest differences, the financial impact on the 
healthcare system can be large. Hospital admission is one of the 
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most prominent factors driving cost. An increase in the rate by 
30.4 admissions per 1000 visits in a single hospital could have a 
projected cost of $414,717. CT, radiography, and ultrasound have 
projected increases in cost as well, but certainly not as large as 
hospital admission.
In light of the study limitations, we cannot conclude that 
APPs are causing the noted increases in resource utilization 
because multiple factors can influence utilization patterns. 
Among those factors are clinical experience, medical judgment, 
and APP scope of practice. Studies examining resource utilization 
demonstrated that ordering patterns varied among emergency 
physicians.27,28 Physicians who ordered more radiography, 
CTs, ultrasounds, and MRIs were more likely to have higher 
admission rates than physicians with lower resource utilization 
rates.28 Hence, utilization variations might be due to physician 
heterogeneity between the two comparative groups. 
Scope of practice is another complex factor that can influence 
resource utilization. While NPs mostly function independently, 
physician supervision is required for PAs in 43 states.29 The level 
of APPs’ practice is specified by the practice site, which can vary 
greatly even within the same state. Hence, privileges to order 
imaging studies or admission independently are diverse among 
APPs. Some practice sites require co-signature of a physician,29 
while others do not allow APPs to write admission orders. Our 
study did not consider the level of attending supervision19 in our 
analysis of resource utilization in EDs staffed with APPs. 
This study did not assess quality or patient safety. We do 
not know if increased utilization represents over-utilization of 
resources in EDs that staffed APPs or under-utilization in EDs 
that do not. Further work is needed to delineate and track ordering 
practices in EDs with and without APPs as well as examine the 
value of increased testing and hospitalization.
LIMITATIONS
This study has several limitations. First, it was a retrospective 
observational study of aggregate data. Control of confounders was 
limited to aggregate variables available in the data, which included 
high acuity, annual volume, and average attending hours. The data 
lacked patient-level (demographic) factors that could influence 
resource utilization, such as age and comorbidity. ED-specific 
factors were also limited to those used in the model. Second, we 
could determine neither the provider who ordered imaging studies 
or hospitalization, nor the type of APP-physician supervision. 
Hence, our findings reflect only the overall association between 
these resources and EDs with APPs. Finally, the CMS cost 
figures are estimates; actual costs would depend on the specific 
geographic location and payer mix of the ED patient population. 
CONCLUSION
Within the context of this study’s limitations, we found 
that EDs staffing APPs are associated with modest increases in 
resource utilization, as measured by admissions and imaging 
studies. Studies are needed to track resource utilization 
prospectively in a more granular ED sample and to incorporate a 
broader spectrum of diagnoses. 
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Resource With APPs Without APPs Difference p value
Hospital admission 16.5 (16.1‒16.9) 13.5 (12.5‒14.4) 3.04 (2.0‒4.1) <0.01
CT scan 20.8 (20.2‒21.4) 19.1 (17.8‒20.5) 1.7 (0.2‒3.1) 0.03
Radiography 45.5 (44.6‒46.4) 40.9 (38.8‒43.1) 4.5 (2.2‒6.9) <0.01
Ultrasound 4.9 (4.6‒5.2) 3.9 (3.2‒4.5) 1.0 (0.3‒1.7) 0.01
MRI 1.0 (0.9‒1.1) 0.9 (0.7‒1.1) 0.1 (-0.2‒0.3) 0.58
Table 2. Adjusted resource utilization rates (number of uses per 100 patient visits) for emergency departments (ED) with and without 
advanced practice providers (APP), EDBA 2012‒2016.1
1Data are means and 95% confidence intervals adjusted for high acuity, volume, and attending hours.
EDBA, Emergency Department Benchmarking Alliance; CT, computed tomography; MRI, magnetic resonance imaging.
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Figure 2. Projected additional costs of emergency departments (ED) with advanced practice providers per 1000 visits, Emergency 
Department Benchmarking Alliance 2012‒2016.
CT, computed tomography; MRI, magnetic resonance imaging.
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It started slowly. On February 12, 2013, James Flavy 
Coy Brown arrived in downtown Sacramento after being 
placed on a three-day Greyhound ride on discharge from a 
Nevada psychiatric hospital. Less than three months later the 
story was exposed by the Sacramento Bee1 and ultimately 
led to a class action lawsuit on behalf of the patients, and a 
Pulitzer nomination for the paper. The following year 
brought a lawsuit against a hospital in Los Angeles for 
discharging a patient to a local shelter. In late 2016, an 
outbreak of Hepatitis A in San Diego’s homeless population 
again highlighted the poor health conditions of California’s 
growing homeless population. The following years brought a 
flood of news stories highlighting the plight of California’s 
homeless populations, culminating in a general sense that 
something should be done. 
On February 14, 2018, we learned what that something 
was. California Senate Bill (SB) 1152 was introduced by 
Senator Ed Hernandez, an optometrist representing the San 
Gabriel Valley. At the time, while he was serving the final 
year of his Senate term, he was still the powerful chair of the 
Senate Health Committee and he was running for lieutenant 
governor. With the support of powerful state unions, the bill 
proposed limits on both hospital and emergency department 
(ED) homeless patient discharges. 
As introduced, the bill essentially prohibited discharging 
homeless patients from hospitals and EDs. Homeless 
patients could not be discharged at night, or into inclement 
weather. Homeless patients could only be released to a care 
facility or social services agency that had agreed in writing 
to accept that patient. Prior to discharge, homeless patients 
were to receive a meal, appropriate clothing, a 30-day 
supply of all medications, all necessary durable medical 
equipment, infectious disease screening, all appropriate 
vaccinations, a source of regular follow-up care, a 
psychiatric evaluation, and transportation to any place of 
their choosing. Remember this was not a guideline or a 
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California
California American College of Emergency Physicians, Sacramento, California 
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recommendation for best practice. There was no room for 
clinical decision-making or variation in practice patterns; it 
would be a crime not to comply. Yes, it was intended to 
include patients seen only in the ED.
The fundamental challenge is that our policymakers and 
legislators do not share our understanding or experiences. 
Their contact with emergency medicine (EM) is as a patient 
and family member, or through news stories of sympathetic 
patients. The concept of the Emergency Medicine Treatment 
and Active Labor Act (EMTALA) which is so embedded into 
our daily practice and fundamental to our mission as a 
specialty, is poorly understood by policymakers. Those of us 
on the frontlines inherently understood that SB 1152 would 
decimate California EDs’ ability to treat patients. But from 
the outside it looks like basic human decency, backed by the 
most powerful players in California politics. 
California’s Chapter of the American College of 
Emergency Physicians (ACEP) is almost as old as ACEP 
itself. At 47, the California chapter has a track record of 
fighting for our specialty and our patients. California ACEP 
is the voice of EM in the California State Capitol. The 
chapter has invested in our state policymakers for years. The 
work of explaining the unique challenges of an ED and 
building champions has to begin long before there is a need. 
Relationships and trust must also be built with other 
stakeholders in the political process, not just with legislators 
. It’s the years of building relationships and a reputation as a 
patient advocate that gives California ACEP influence. 
California ACEP’s opposition letter to SB 1152 outlined 
the bill’s impact on crowding and patient care in the ED. 
Throughout the remainder of the spring, the California 
Chapter continued to meet with legislators to educate them 
on the impact on our ED patients. The first stop for SB 1152 
was the Senate Health Committee chaired by its author 
Senator Hernandez. 
We relied on the background work educating legislators 
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that happens every year when our members go to Sacramento 
for lobby day and take policymakers on ED tours in their 
communities. We also worked with the sponsors of the bill to 
help them understand the unintended consequences of their 
proposal and to make changes to the bill. 
Lobbying against a bill always begins with the author 
and their staff in the hopes that, if you can provide a better 
understanding of the policy and its potential impact, they 
will be willing to make modifications. If that doesn’t work, 
or they aren’t willing to make enough changes, the next step 
is to lobby the committee chair and the committee consultant 
– the staff person assigned to analyze the bill.  The chair of 
each committee has tremendous power to reshape legislation 
that is heard in his or her committee. And while each 
committee has many members, they often defer to the chair, 
and they are certainly reluctant to oppose the chair.  
Unfortunately for us, in this instance the chair was also the 
author, so we weren’t going to be able to rely on the 
committee making changes for us. We lobbied each of the 
nine members of the committee, and many of them raised 
questions and gave voice to our concerns during the 
committee hearing. However, they ultimately voted for the 
bill. It passed out of committee with all seven Democrats 
voting in favor, one Republican voting no, and the other 
Republican abstaining.
The Chapter reached out to the California Medical 
Association, the California Hospital Association, and our 
public hospital partners to keep up pressure on our state 
legislators to negotiate the provisions of the bill. Throughout 
this process there was a continual back-and-forth 
conversation of potential changes and amendments. 
California ACEP worked hard to get to a place that we felt 
could provide for the needs of the homeless population, 
while allowing EDs the space and resources to continue to 
provide emergency care. 
Usually bills that have a potential cost to the state are 
referred to the Appropriations Committee in each house for 
a fiscal analysis. Costs to the state are estimated for each 
bill, and those with a cost of more than $150,000 are placed 
on the “suspense file” to be considered at the end of the 
fiscal committee deadline. This is meant to be a thoughtful, 
deliberative process to maintain fiscal accountability, while 
various new programs/initiatives are considered each year. 
However, this process is often also used as a political tool to 
kill a bill without voting it down. It is not a stretch to 
estimate SB 1152 would increase costs to the state through 
the Medi-Cal program and increase costs to public and 
University of California hospitals. However, with a senator 
as its author and powerful political winds behind SB 1152, it 
bypassed the Senate Appropriations Committee process 
entirely and went straight to the Senate floor to be voted on 
by all senators. 
It passed out of the Senate on a straight party line vote: 
all 26 Democrats voted in favor and all 13 Republicans voted 
against. After passing the California Senate a bill goes 
through a mirror process in the California Assembly before 
going to the Governor. The Assembly gave us another 
opportunity to express our concerns with lawmakers and 
seek amendments. Since we had a more objective committee 
chair in the Assembly, and because the bill was sent to the 
Appropriations Committee in the Assembly, there were more 
opportunities for our lobbying to be fruitful. It was in this 
process that we were able to impact the outcome of the bill. 
As a result of California ACEP’s work, six sets of 
amendments were made to SB 1152, each lessening the 
impact on care provided to all patients in the ED. For 
example, homeless patients could be discharged when 
clinically appropriate, and the rest of the bill’s mandates 
could take place in an area of the hospital that does not 
provide clinical care. Homeless patients could be given 
transportation to a place of their choosing, rather than only to 
social service providers that may or may not exist or have 
available capacity. On August 28, SB 1152 passed out of the 
Senate and landed on Governor Jerry Brown’s desk. 
Governor Brown was always a wild card in this debate. 
His passion has always been for California’s infrastructure and 
climate change, rather than healthcare. Also at play was 
Governor Brown’s style of governing. While not anti-
government, he has been thoughtful and judicious when 
considering imposing new state requirements. While more 
unpredictable than most governors, he was more likely to veto 
legislation that places mandates on private businesses and 
local governments than most Democratic governors. He often 
said he saw the unintended consequences of the mandates he 
signed during his first gubernatorial terms from 1975-1983 
both as a private citizen and then as mayor of Oakland.  
Again, we mobilized, this time calling upon our 
members who sent over 700 messages to the Governor 
urging him to veto the bill. 
Yet late in the evening on Sunday September 29, 2018, 
just hours before his deadline to act, Governor Brown signed 
SB 1152 into law. At the time it felt like a crushing defeat. 
However, looking back at the original bill, the efforts of 
California ACEP are clear. Even in defeat, I am reminded 
how important it is for every emergency physician to stay 
engaged for the health of our specialty and our patients. 
Recall that the original bill did not allow discharge of a 
homeless patient in inclement weather. Another of the many 
requirements was that a homeless patient be “permitted to 
remain in the facility for the time necessary to ensure that he 
or she is released during daytime hours where the receiving 
social services or other agency is open and available to 
receive the patient.” The final version of the bill requires the 
hospital to identify a post-discharge destination, which could 
include a patient’s “home.” As far as the requirements on the 
treating physicians before patient discharge, there were only 
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three in the final bill, and none of them are substantially 
different from what we already do. They are as follows:
• The treating physician has provided a medical 
screening examination and evaluation. If the treating 
physician determines that the results of the medical 
screening examination and evaluation indicate that 
follow-up behavioral healthcare is needed, the 
homeless patient shall be treated or referred to an 
appropriate provider.
• The treating physician has determined the homeless 
patient’s clinical stability for discharge, including, but 
not limited to, an assessment as to whether the patient 
is alert and oriented to person, place, and time, and 
the physician or designee has communicated post-
discharge medical needs to the homeless patient.
• The homeless patient has been provided with a 
prescription if needed, and for a hospital with an 
onsite pharmacy licensed and staffed to dispense 
outpatient medication and an appropriate supply of all 
necessary medication, if available.  
Thousands of bills are introduced each year in the state 
legislature. In 2018 the California state legislature 
considered over 2,000 bills. California ACEP takes a broad 
look for any potential impact on our patients and our 
healthcare system. Each of the bills are reviewed by 
California ACEP staff. Several hundred bills are reviewed by 
California ACEP’s Government Affairs Committee and 
selected for either support, oppose or “watch” positions. 
Many bills are written poorly, and we must try to seek 
amendments to them to avoid unintended consequences. This 
process, while seemingly simple, is very resource-intensive. 
Additionally, California ACEP carefully watches hundreds of 
relevant bills during the process in case one is amended in a 
harmful way for our patients or practice. Well-intentioned 
ideas can be unworkable in the busy 24/7 pace of EM. One 
example is the requirement for prescribers in California to 
check the state Prescription Drug Monitoring Program prior 
to prescribing controlled substances. In recognition of our 
practice environment, California ACEP successfully lobbied 
for an exemption for prescriptions for less than seven days 
duration, saving untold hours of precious practice time, 
while protecting patients in pain. 
In addition, each year, critical issues for our patients and 
our practice lead to chapter-sponsored bills. Currently 
California ACEP is sponsoring an effort to support ED 
patient navigators for substance use and behavioral health 
disorders, as well as legislation to allow emergency 
physicians to continue to operate as independent contractors 
despite a Supreme Court ruling that threatens this long-term 
practice. The Chapter typically sponsors four bills each year. 
Some take multiple attempts over several years to be 
enacted, while others are successful on the first try.  We have 
sponsored at least one bill each year for the last several years 
to improve our ability to care for patients with mental illness. 
While that has been a consistent theme, our sponsored 
legislation has covered a wide variety of practice topics. For 
example, we sponsored and successfully enacted legislation 
that allows health information technology such as the 
Emergency Department Information Exchange to access 
information from the CURES (Controlled Substance 
Utilization Review and Evaluation System) database. Prior 
to our bill, this was prohibited by California law. 
While we do not have a perfect track record, our record 
defeating, fixing, supporting, and sponsoring legislation is 
stellar. This is even more true when you consider the 
resources available to us. In 2017, the Sacramento Bee 
published a list of the top 500 lobbyist employer spenders. 
The California Hospital Association ranked sixth, the 
California Medical Association ranked 19th, the Service 
Employees International Union (the sponsors of SB 1152) 
ranked third, and California ACEP ranked 215th.  Much like 
the emergency physicians we represent, California ACEP is 
adept at doing more with less and producing impressive 
outcomes. We owe much of it to the passionate voices of our 
members working across the state. We hope you will join us 
and add your voice to the fight.
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Introduction: Safe firearm storage is associated with a lower risk of firearm-related injury and death. 
Although providing firearm locking devices is a key component of firearm safety interventions, little is 
known about the types and characteristics of devices preferred by firearm users or others who make 
decisions about firearm storage. The aim of this study was to describe preferences for firearm locking 
devices and device features among firearm safety event participants.
Methods: We conducted a cross-sectional survey in the State of Washington in 2016 that assessed 
participants’ preferences for five firearm locking devices (eg, trigger lock) and seven device features 
(eg, quick access). We categorized respondents (n=401) as adults in households with 1) all firearms 
locked, 2) at least one unlocked firearm, and 3) no firearms. We analyzed data in 2017.
Results: Device ownership and feature preferences varied substantially but were similar across 
the three household categories. Of those residing with unlocked firearms, 84% reported they would 
consider using or definitely use a lock box, whereas 11% reported they would never use a trigger lock. 
Additionally, of those residing with unlocked firearms, 80% and 89% reported that the ability to lock a 
firearm while loaded and unlock it quickly were, respectively, “very important” or “absolutely essential.”
Conclusion: Participants had differing preferences for firearm locking devices and device features, 
although preferences were largely similar across households with locked, unlocked, or no firearms. At 
least eight in ten participants reported “great importance” regarding the ability to lock a firearm while 
loaded and unlock it quickly, which is likely related to perceptions about the utility of safely stored 
firearms for household protection. Designing firearm safety interventions to match the needs and 
preferences of those who make firearm storage decisions may improve their effectiveness. [West J 
Emerg Med. 2019;20(4)552-556.] 
INTRODUCTION
Safe firearm storage (i.e., storing firearms locked and 
unloaded) is associated with a lower risk of firearm-related 
suicide as well as firearm-related unintentional injury 
and death.1-3 Several interventions have been shown to be 
effective in promoting safe firearm storage.4,5 The provision 
of firearm locking devices appears to be a key component 
of successful interventions.4 However, little is known about 
preferences for different, commercially-available locking 
devices, including external locking mechanisms (e.g., 
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trigger, cable, and Life Jacket™ locks) or storage containers 
in which firearms can be secured (e.g., firearm safes, lock 
boxes) (Appendix A). A recent community-based firearm 
safety intervention found that 96% of participants elected 
to receive a free firearm lock box rather than a trigger 
lock.6 This finding is consistent with a small study among 
rural Alaskan households in which participants preferred 
firearm safes instead of trigger locks and were much less 
likely at follow-up to use trigger locks than safes to store 
their firearms.7
These findings are concerning given that most 
interventions have relied on distributing cable or trigger 
locks to promote changes in firearm storage behaviors, 
largely due to their relatively low cost and ease of 
distribution.4,5 Such a “one size fits all” approach may 
be ineffective in promoting population-level changes in 
storage practices given the diversity in characteristics 
of firearm owners, types of firearms owned, and firearm 
uses.8-10 A majority of firearm owners in the U.S. report 
that protection is a primary reason for their firearm 
ownership.8,10 Storage preferences (e.g., ease of access) 
may differ among those owning firearms for hunting or 
target shooting rather than protection. Aligning intervention 
characteristics with the needs and preferences of those 
who make decisions on firearm storage practices is 
necessary. The aims of this study were to provide a detailed 
description of preferences for multiple, available firearm 
locking devices and the first description of preferences 
for locking device features among firearm safety event 
participants.
METHODS
Study Design
We conducted a cross-sectional survey among 
participants in two community-based, firearm safety 
events in the State of Washington in 2016. We included 
participants who were 18 years or older, spoke English 
or Spanish, signed a legal release form necessary for 
event participation, and returned a completed survey. 
This evaluation was exempted from review by the human 
subjects divisions of the University of Washington and 
Seattle Children’s Hospital. We analyzed the data in 2017.
Firearm Safety Event and Survey Procedure
Events were held at community retail locations where 
participants received a brief safety message and their 
choice of a free firearm trigger lock or lock box. Additional 
details have been published previously.6 Prior to event 
participation, participants completed a voluntary, 23-item 
survey assessing firearm storage practices, reported and 
considered use of specific firearm storage devices, and 
perceived importance of specific device features. Pictures 
of specific storage devices and their approximate costs were 
presented to participants using a visual placard that showed 
a trigger lock ($5-15), cable lock ($5-15), Life Jacket™ 
($20-30), lock box ($20-100), and a firearm cabinet/safe 
($100 or more) (Appendix A).
Statistical Analysis
We classified respondents into three categories, namely 
those who reported the following: 1) all household firearms 
were stored locked; 2) at least one household firearm was 
unlocked; and 3) no firearms were kept in their homes. We 
described device ownership and use across these groups 
and compared device feature preferences between them 
using chi-squared tests.
RESULTS
Of 583 participants, 401 returned completed surveys 
(68.8% response proportion). Demographic characteristics 
and storage practices are shown in the supplemental table. 
Prevalence of device ownership and reported device use 
or consideration of use was similar across the three groups 
(Table 1). A greater proportion of respondents within each 
household category reported that they would never use a 
trigger lock (4.2-8.9%), cable lock (7.7-11.4%), or Life 
Jacket™ (7.6-14.4%) compared to a lock box (0.6-2.8%) 
or firearm safe (0-4.3%). Large proportions within each 
household category reported they would consider using, or 
definitely use, each of the devices if they owned it (51.9-
85.5%). Those reporting at least one unlocked household 
firearm were most likely to report that they would consider 
using, or definitely use, a lock box if owned (84.0%), 
followed by the Life Jacket™ (82.4%), trigger lock 
(78.6%), firearm safe (76.5%), and cable lock (68.9%).
Preferences for device features were generally similar 
across the three groups (Table 2). Eighty percent and 89% 
reported that the ability to lock a firearm while loaded and 
to unlock it quickly, respectively, was “very important” 
or “absolutely essential,” whereas 12% and 26% reported 
that device appearance and device cost of less than $15, 
respectively, was “very important” or “absolutely essential.” 
Of those who responded to the survey, 80-90.2% reported that 
ease of transfer between vehicle and home, ability to use the 
device on both handguns and long guns, and recommendation 
of the device by a law enforcement agency or firearm 
advocacy group were at least “moderately important.”
DISCUSSION
In this study we found that firearm safety event 
participants had differing preferences for firearm locking 
devices and device features, although preferences were 
largely similar among households with locked, unlocked, or 
no firearms. To our knowledge, no prior work has assessed 
preferences for firearm locking devices or device features in 
such detail.
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These findings have important implications for safe 
firearm storage interventions. Most interventions have 
focused on distributing single devices (usually cable or 
trigger locks).4,5 Having only offered trigger locks during 
these events would not have addressed the 8% of those in 
firearm households who reported they would never use this 
device and the 4% who already owned but did not use them. 
There are many variations in what storage options might 
work best for gun owners given the variety of firearms 
available and reasons for ownership and use. Participant-
centered interventions designed to address this variation are 
likely to be more effective.
At least eight in ten participants reported “great 
importance” regarding the ability to lock a firearm while 
loaded and unlock it quickly. This is likely related to 
the fact that two-thirds of firearm owners keep firearms 
for protection and perceptions that the time required to 
unlock a firearm may interfere with that purpose.8,10 Such 
strong preferences should be considered in deciding 
what types of devices are distributed in safety device 
promotion interventions. However, those who develop 
interventions with the aim of preventing firearm suicides 
must also consider that delaying access to a firearm during 
an emotional crisis is precisely one of the purposes of the 
locking device. In this scenario, there may be a role for 
developing communication strategies to be incorporated 
into firearm safety interventions that address risk 
misperceptions (e.g., balancing the risk of harm to oneself 
and household members vs harm from others).
Firearm-owning household, 
all firearms locked
Firearm-owning household, 
at least one unlocked firearm
Non-firearm owning household
n=185 n=141 n=75
Would 
never 
use if 
owned
Would 
con-
sider 
using if 
owned
Would 
definite-
ly use if 
owned
Owns 
and 
uses
Owns 
but 
does 
not use
Would 
never 
use if 
owned
Would 
con-
sider 
using if 
owned
Would 
definite-
ly use if 
owned
Owns 
and 
uses
Owns 
but 
does 
not use
Would 
never 
use if 
owned
Would 
con-
sider 
using if 
owned
Would 
definite-
ly use if 
owned
Owns 
and 
uses
Owns 
but 
does 
not use
Trigger 
lock
13 
(7.2%)
19 
(10.5%)
100 
(55.3%)
39 
(21.6%)
10 
(5.5%)
12 
(8.9%)
38 
(28.2%)
68 
(50.4%)
14 
(10.4%)
3 
(2.2%)
3 
(4.2%)
10 
(13.9%)
49 
(68.1%)
7 
(9.7%)
3 
(4.2%)
Cable 
lock
14 
(7.7%)
33 
(18.2%)
79 
(43.7%)
43 
(23.8%)
12 
(6.6%)
15 
(11.1%)
35 
(25.9%)
58 
(43.0%)
18 
(13.3%)
9 
(6.7%)
8 
(11.4%)
13 
(18.6%)
40 
(57.1%)
6 
(8.6%)
3 
(4.3%)
Life 
Jacket™
13 
(7.6%)
60 
(34.9%)
87 
(50.6%)
10 
(5.8%)
2 
(1.2%)
18 
(14.4%)
39 
(31.2%)
64 
(51.2%)
4 
(3.2%)
0 
(0%)
8 
(11.6%)
13 
(18.8%)
45 
(65.2%)
2 
(2.9%)
1 
(1.5%)
Lock 
box
1 
(0.6%)
11 
(6.0%)
112 
(61.5%)
40 
(22.0%)
18 
(9.9%)
3 
(2.2%)
9 
(6.5%)
107 
(77.5%)
12 
(8.7%)
7 
(5.1%)
2 
(2.8%)
5 
(6.9%)
54 
(75.0%)
7 
(9.7%)
4 
(5.6%)
Firearm 
safe
0 
(0%)
11 
(6.0%)
84 
(45.9%)
61 
(33.3%)
27 
(14.8%)
3 
(2.2%)
9 
(6.6%)
95 
(69.9%)
22 
(16.2%)
7 
(5.2%)
3 
(4.3%)
5 
(7.1%)
50 
(71.4%)
9 
(12.9%)
3 
(4.3%)
Table 1. Device use and considered use by household firearm ownership and storage practices (n=401)*^
* Cell data are frequencies and corresponding row percentages. Row frequencies may not sum to totals due to missing data.
^ Participants were able to report ownership of more than one device.
LIMITATIONS
This study was conducted among event participants in 
the State of Washington, and specific findings on device 
preferences may not apply elsewhere. What is generalizable, 
however, is that gun owners have preferences that must be 
addressed if they are to be expected to use a product – a 
concept that has yet to be applied broadly to firearm safety 
interventions. A small proportion who identified themselves 
as living in non-firearm owning households also reported 
owning and using firearm safety devices. This finding can 
be explained if respondents were reluctant to report firearm 
ownership, completed this item in error, used devices on 
firearms stored outside the home, if devices were used to 
store non-firearm items (e.g., valuables stored in locked 
safe), or if they intended to give the storage device to 
someone else.
CONCLUSION
This study provides the first detailed insights into preferences 
for firearm safety devices among adults in both firearm and 
non-firearm owning households. Determining whether the 
consideration of these preferences in the design of firearm safety 
interventions improves their effectiveness is warranted.
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Total Firearm-owning 
household, all 
firearms locked
Firearm-owning 
household, at least 
one unlocked firearm
Non-firearm 
owning household
p value
n=401 n=185 n=141 n=75
Can unlock the device quickly 0.67
Not at all/little importance 9 
(2.3%)
3 (1.6%) 5 (3.6%) 1 (1.3%)
Moderate importance 34 
(8.5%)
14 (7.6%) 12 (8.6%) 8 (10.7%)
Very important 150 
(37.5%)
66 (35.7%) 54 (38.6%) 30 (40.0%)
Absolutely essential 207 
(51.8%)
102 (55.1%) 69 (49.3%) 36 (48.0%)
Device costs less than 15 United States dollars 0.09
Not at all/little importance 164 
(41.4%)
81 (44.3%) 55 (39.6%) 28 (37.8%)
Moderate importance 128 
(32.3%)
56 (30.6%) 51 (36.7%) 21 (28.4%)
Very important 69 
(17.4%)
24 (13.1%) 25 (18.0%) 20 (27.0%)
Absolutely essential 35 (8.8% 22 (12.0%) 8 (5.8%) 5 (6.8%)
Can lock firearm while it is loaded 0.52
Not at all/little importance 28 
(7.0%)
15 (8.2%) 8 (5.7%) 5 (6.8%)
Moderate importance 51 
(12.8%)
27 (14.7%) 15 (10.7%) 9 (12.2%)
Very important 131 
(32.9%)
51 (27.7%) 57 (40.7%) 23 (31.1%)
Absolutely essential 188 
(47.2%)
91 (49.5%) 60 (42.9%) 37 (50.0%)
Appearance of locking device 0.03
Not at all/little importance 283 
(71.1%)
137 (74.9%) 105 (75.0%) 41 (54.7%)
Moderate importance 67 
(16.8%)
30 (16.4%) 20 (14.3%) 17 (22.7%)
Very important 32 
(8.0%)
9 (4.9%) 10 (7.1%) 13 (17.3%)
Absolutely essential 16 
(4.0%)
7 (3.8%) 5 (3.6%) 4 (5.3%)
Easy transfer between vehicle and home 0.66
Not at all/little importance 39 
(9.8%)
21 (11.4%) 14 (10.0%) 4 (5.3%)
Moderate importance 94 
(23.6%)
38 (20.7%) 33 (23.6%) 23 (30.7%)
Very important 156 
(39.1%)
70 (38.0%) 57 (40.7%) 29 (38.7%)
Absolutely essential 110 
(27.6%)
55 (29.9%) 36 (25.7%) 19 (25.3%)
Table 2. Importance of specific firearm locking device features by household firearm ownership and storage practices (n=401).*
Question stem: “Please tell us how important each of these features is to you in a gun locking device.
*Rows may not sum up to total population due to missing data.
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Total Firearm-owning 
household, all 
firearms locked
Firearm-owning 
household, at least 
one unlocked firearm
Non-firearm 
owning household
p value
n=401 n=185 n=141 n=75
Can use on both long guns and handguns 0.18
Not at all/little importance 79 
(19.8%)
29 (15.7%) 37 (26.4%) 13 (17.3%)
Moderate importance 126 
(31.5%)
61 (33.0%) 46 (32.9%) 19 (25.3%)
Very important 114 
(28.5%)
52 (28.1%) 37 (26.4%) 25 (33.3%)
Absolutely essential 81 
(20.3%)
43 (23.2%) 20 (14.3%) 18 (24.0%)
Device recommended by law enforcement 
agency or firearm advocacy group
0.24
Not at all / little importance 50 
(12.5%)
16 (8.7%) 24 (17.3%) 10 (13.3%)
Moderate importance 105 
(26.3%)
49 (26.5%) 38 (27.3%) 18 (24.0%)
Very important 143 
(35.8%)
63 (34.1%) 50 (36.0%) 30 (40.0%)
Absolutely essential 101 
(25.3%)
57 (30.8%) 27 (19.4%) 17 (22.7%)
*Rows may not sum up to total population due to missing data.
Table 2. Continued.
Question stem: “Please tell us how important each of these features is to you in a gun locking device.
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Cannabis legalization has led to significant health consequences, particularly to patients in 
emergency departments and hospitals in Colorado. The most concerning include psychosis, 
suicide, and other substance abuse. Deleterious effects on the brain include decrements in 
complex decision-making, which may not be reversible with abstinence. Increases in fatal motor 
vehicle collisions, adverse effects on cardiovascular and pulmonary systems, inadvertent pediatric 
exposures, cannabis contaminants exposing users to infectious agents, heavy metals, and 
pesticides, and hash-oil burn injuries in preparation of drug concentrates have been documented. 
Cannabis dispensary workers (“budtenders”) without medical training are giving medical advice that 
may be harmful to patients. Cannabis research may offer novel treatment of seizures, spasticity 
from multiple sclerosis, nausea and vomiting from chemotherapy, chronic pain, improvements in 
cardiovascular outcomes, and sleep disorders. Progress has been slow due to absent standards 
for chemical composition of cannabis products and limitations on research imposed by federal 
classification of cannabis as illegal. Given these factors and the Colorado experience, other states 
should carefully evaluate whether and how to decriminalize or legalize non-medical cannabis use. 
[West J Emerg Med. 2019;20(4)557–572.]
INTRODUCTION
As of January 2018 in the United States, nine states 
have legalized cannabis for recreational use, with another 29 
legalizing it for medical use. These policy changes have created 
broad interest in understanding the effects on public health and 
the healthcare system. 
The Colorado Department of Public Safety report, “Impacts 
of Marijuana Legalization in Colorado: A Report Pursuant 
to Senate Bill 13-283,” includes a timeline for marijuana 
legalization in Colorado with five distinct periods in both 
the legal status and commercial availability of marijuana in 
Colorado.1 These include the following:
•	 Prior to 2000: It is illegal to possess or grow marijuana.
•	 2000-2009: Amendment 20 is approved and medical 
marijuana is legalized. The Colorado Department of 
Public Health and Environment (CDPHE) issues registry 
identification cards to individuals who have received 
recommendations from a doctor that marijuana will help a 
debilitating medical condition. No regulated market exists. 
Individual grow operations or caregiver grow operations 
University of New Mexico, Department of Emergency Medicine, Albuquerque, New Mexico
Partner, Southern Colorado Emergency Medicine Associates, Pueblo, Colorado
limited to five patients are allowed.
•	 2010-2012: Medical marijuana is commercialized and 
regulated with licensed dispensaries, grow operations, 
and product manufacturers open in jurisdictions allowing 
these types of businesses. This corresponded with the 
Ogden memorandum issued in October 2009, which 
instructed U.S. Attorneys not to “focus federal resources 
in your States on individuals whose actions are in clear 
and unambiguous compliance with existing state laws 
providing for the medical use of marijuana.”2 The 
commercialization of medical marijuana followed and 
the number of patients registered with CDPHE increased 
dramatically from about 5000 in 2009 to almost 119,000 
in 2011. 
•	 2013: Amendment 64 takes effect. Personal possession and 
grow limits for recreational marijuana are in place but sales 
are not commercialized. Medical continues as a regulated, 
commercial market. 
•	 2014 to present: Recreational and medical marijuana 
is fully regulated and commercialized. Licensed retail 
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Population Health Research Capsule
What do we already know about this issue?
Legalized cannabis has led to increased 
cannabis related presentations to emergency 
departments (ED).
What was the focus of this review?
The negative impacts to EDs, particularly 
in the state of Colorado, following cannabis 
legalization.
What was the conclusion of this review?
Cannabis legalization has been correlated with 
multiple adverse outcomes that impact EDs.
How does this improve population health?
Healthcare policy makers may take 
the adverse outcomes described into 
consideration when considering if and/or how 
to legalize cannabis.
stores open January 1, 2014. This corresponded with 
the Cole memorandum, which gave further guidance 
to U.S. Attorneys: “[I]n jurisdictions that have enacted 
laws legalizing marijuana in some form and that have 
also implemented strong and effective regulatory 
and enforcement systems to control the cultivation, 
distribution, sale, and possession of marijuana, conduct in 
compliance with those laws and regulations is less likely 
to threaten federal priorities… [E]nforcement of state law 
by state and local law enforcement and regulatory bodies 
should remain the primary means of addressing marijuana-
related activity.”3 This memorandum was widely 
interpreted to mean that the federal government would not 
interfere with state marijuana laws;4 however, in January 
2018 the Cole memorandum was rescinded by then U.S. 
Attorney General Jeff Sessions.4 
Changes in past-month cannabis use by year and age group 
for Colorado and Kansas (non-legalized state) are shown in 
Figures 1 and 2. (Kansas was chosen for proximity; other non-
legalized states in proximity, including Wyoming and Idaho, had 
similar graphs to Kansas.)5
Over this time span cannabis potency has increased. Current 
commercialized cannabis is near 20% tetrahydrocannabinol 
(THC), the primary psychoactive constituent of cannabis, while 
in the 1980s concentration was <2%. This 10-fold increase in 
potency does not include other formulations such as oils, waxes, 
and dabs, which can reach 80-90% THC.6 
This general increase in cannabis use and increase in 
cannabis potency has led to cannabis-related presentations to 
emergency departments (ED) and hospitalizations across the 
state. This review will focus on negative health and safety 
effects Colorado has experienced with inclusion of relevant peer-
reviewed literature. It will conclude with a short review of the 
medicinal use of cannabis products.
Cannabis Effects on Healthcare Resources in Colorado
ED visits and hospitalizations with marijuana-related 
billing codes have increased following legalization. Mental 
Figure 1. Marijuana use in the past month in Colorado, by age group.
Reproduced from Substance Abuse and Mental Health Services Administration National Survey on Drug Use and Health: State 
Estimates. Available at: https://pdas.samhsa.gov/saes/state. Accessed November 2018.
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illness represents a concerningly large number of marijuana-
related visits. A retrospective review by Wang et al. reported 
Colorado Hospital Association hospitalizations and ED visits 
with marijuana-related billing codes. Between 2000 and 2015, 
hospitalization rates increased 116% from 274 to 593 per 100,000 
hospitalizations. For primary diagnosis categories, the prevalence 
of mental illness was five-fold higher (5.07; 95% confidence 
interval [CI], 4.96 - 5.09) for ED visits and nine-fold higher 
(9.67; 95% CI, 9.59 - 9.74) for hospital admissions for patients 
with marijuana-related billing codes compared to those without.7 
This data compared diagnostic categories between patients with a 
marijuana-related diagnostic code and those without.
Subsequent data by the CDPHE show significant increases 
in hospitalizations in each phase of marijuana legalization, 
increasing from 575 per 100,000 hospitalizations in 2000 to 2413 
in the 2014–June 2015 period, as displayed in Figure 3.8 There 
are differences in incidence between the Wang study and the 
CDPHE report because the Wang study only included a patient’s 
healthcare event if a marijuana code was among the first three 
diagnostic codes, while the CDPHE study included marijuana 
diagnostic codes within the top 30. 
ED and urgent care (UC) visits with cannabis-associated 
International Classification of Diseases (ICD) codes or positive 
urine drug screens for teenagers and young adults have increased 
since legalization, and the majority require behavioral health 
evaluation. A subsequent retrospective review by Wang et al. 
from 2005-2015 identified 4202 such visits for patients 13 to < 21 
years old to a tertiary-care children’s hospital system. Behavioral 
health evaluation was obtained for 2813 (67%) and a psychiatric 
diagnosis was made for the majority (71%) of the visits. ED/
UC visits with cannabis-associated ICD codes or positive urine 
drug screens of all types increased 2.7-fold from 1.8 per 1000 in 
2009 to 4.9 per 1000 in 2015 (N = 161 in 2005 to 777 in 2015). 
Behavioral health consultations increased 2.7-fold from 1.2 per 
1000 in 2009 to 3.2 per 1000 in 2015 ( N = 84 in 2005 to 500 
in 2015). These data indicate that despite national survey data 
suggesting the rate of adolescent marijuana use is flat, there 
has been a significant increase in adolescent ED/UC visits with 
cannabis-associated ICD codes or positive urine drug screens.9 
Figure 4 displays these visits by year.
Cannabis Effects on Mental Health
Psychosis and Schizophrenia
Previous studies, including large reviews by the World 
Health Organization (WHO) and the National Academies of 
Sciences, Engineering, and Medicine (NASEM), have found 
substantial evidence of a statistical association between cannabis 
use and the development of schizophrenia or other psychoses, 
with the highest risk among the most frequent users.6,10 In a 
study of 45,570 Swedish men drafted into the military, the 
authors found that the men who had tried cannabis by age 18 
were 2.4 times (95% CI, 1.8-3.3) more likely to be diagnosed 
with schizophrenia over the next 15 years than those who had 
not.11 A follow-up study found a dose-response relationship 
between frequency of cannabis use at the age of 18 and the 
risk of schizophrenia. This effect persisted after controlling for 
confounding factors such as psychiatric diagnosis at enlistment, 
IQ score, personality variables concerned with interpersonal 
relationships, place of upbringing, paternal age, cigarette 
smoking, disturbed behaviors in childhood, history of alcohol 
misuse, family history of psychiatric illness, financial situation 
of the family, and father’s occupation. (The enlistment procedure 
Figure 2. Marijuana use in the past month in Kansas, by age group. 
Reproduced from Substance Abuse and Mental Health Services Administration National Survey on Drug Use and Health: State 
Estimates. Available at: https://pdas.samhsa.gov/saes/state. Accessed November 2018.
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included intelligence tests and non-anonymous, self-reported 
questionnaires on family, social background, behavior during 
adolescence, and substance use – including first drug used, drug 
most commonly used, frequency of use, and direct questions 
regarding use of a list of specified drugs.) The researchers 
estimated that 13% of cases of schizophrenia could have been 
averted if no one in the cohort had used cannabis.12 These findings 
have been reproduced repeatedly and across the world.13-20 
Depression, Anxiety, and Suicide
Cannabis use is associated with increased rates of depression, 
anxiety, and suicide. The NASEM found that there is a moderate 
statistical association between cannabis use and an increased risk 
for the development of depressive disorders (odds ratio [OR] 
= 1.17; 95% CI, 1.05-1.30) and this increases with increased 
frequency of use (OR = 1.62; 95% CI, 1.21-2.16).10,21 There 
was also moderate evidence of a statistical association between 
regular cannabis use and increased incidence of social anxiety 
disorder (OR = 1.28; 95% CI, 1.06–1.54).10,22 The NAESM found 
that there was moderate evidence of a statistical association 
between cannabis use and the incidence of suicidal ideation (OR 
= 1.43; 95% CI, 1.13-1.83 with any cannabis use, OR = 2.53; 
95% CI, 1.00-6.39 with heavy cannabis use) and suicide attempts 
(OR = 2.23; 95% CI, 1.24-4.00 for any cannabis use, OR = 3.20; 
95% CI, 1.72–5.94 with heavy cannabis use), and increased 
incidence of suicide completion (OR = 2.56; 95% CI, 1.25–5.27 
for any cannabis use).10,23 
The NASEM reviewed multiple studies to come to the 
summary conclusions, and the odds ratios represent the most 
compelling systematic review for the conclusions. However, there 
were many more studies used to reach the stated conclusions. 
The data reviewed by the World Health Organization also 
demonstrate similar results for depression, anxiety, and suicide.6 
Both the NASEM and the WHO reviews acknowledge that 
reverse causation and shared risk factors cannot be ruled out as 
explanations of these statistical associations and acknowledge 
that further research is needed.
In the most recent data on Colorado adolescent suicides, 
marijuana was the most common substance present for ages 
10-19 in 2016. Of 62 suicides with toxicology data available, 
marijuana was present in 30.6% (n = 19) compared to 9.7% (n = 
6) for alcohol.24 This trend has been increasing since liberalization 
of marijuana policy in 2010. This is more concerning as 
suicide is currently the leading cause of death of adolescents 
in Colorado.25 For all age groups in Colorado, in the five-year 
period from 2004-2009 there were 4822 suicides and 7.1% (n 
Figure 3. Rates of hospitalizations (HD) and emergency department (ED) visits per year with possible marijuana exposures, diagnoses, 
or billing codes per 100,000 HD and ED visits, by legalization eras in Colorado.
Reproduced from Marijuana Legalization in Colorado: Early Findings. A Report Pursuant to Senate Bill 13-283. Colorado Department of  
Public Safety. 2016. Available at: http://cdpsdocs.state.co.us/ors/docs/reports/2016-SB13-283-Rpt.pdf. Accessed March 2018.
NA, Data not available.
Data provided by Colorado Hospital Association with analysis provided by Colorado Department of Public Health and Environment.
Note: Data for 2015 covers January 1, 2015 – June 30, 2015. An individual can be represented more than once in the data; therefore, the rate 
is HD or ED visits with marijuana codes per 100,000 total HD or ED visits. 
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= 303) of those were marijuana positive on toxicology analysis 
(538 did not have toxicology data available). In the subsequent 
five-year period of marijuana legalization, 2010-2015, there were 
5880 total suicides (22% increase), and 12.6% had a positive 
toxicology for marijuana (n = 601; 1,120 did not have toxicology 
data available). This represents a statistically significant 77.5% 
increase in the proportion of suicide victims with toxicology 
positive for marijuana (an absolute difference of 5.5%) for which 
toxicology data were reported (chi square 77.2884, p<0.0001). 
Suicides with marijuana toxicology by year and overall suicide 
by year data are displayed in Figure 5.
Social Outcomes
Cannabis has been associated with adverse social outcomes 
which may impact EDs and patient health. The large (N = 
49,321) cohort study of Swedish men drafted at age 18-20 and 
followed to age 40 showed increased risk of unemployment 
and need for welfare assistance in those using cannabis greater 
than 50 times (risk ratio [RR] = 1.26; 95% CI, 1.04–1.53 for 
unemployment), (RR = 1.38; 95% CI, 1.19–1.62 for welfare 
assistance).26 These results were repeated in a longitudinal birth 
cohort study in New Zealand to 25 years old, which found high 
levels of cannabis use correlated with statistical significance to 
poorer educational outcomes, lower income, greater welfare 
dependence and unemployment, and lower relationship and life 
satisfaction. This cohort was classified into six levels of cannabis 
use, and found that as cannabis use increased, the odds ratio of 
adverse outcome increased.27,28 Both of these studies adjusted for 
confounding factors including socioeconomic background of the 
family, family functioning and exposure to adversity, exposure 
to child sexual and physical abuse, childhood and adolescent 
adjustment, academic achievement in early adolescence, 
comorbid mental health disorders, and other substance use. 
A prospective cohort study from upstate New York (N = 548) 
found that, compared with cannabis nonusers or minimal users (a 
few times a year or less), chronic users and users who began use 
in early adulthood and then tapered off use into later adulthood, 
had a significantly higher likelihood of unemployment at mean 
age 43 (adjusted OR = 3.51; 95% CI, 1.13–10.91), even after 
controlling for covariates.29 The NASEM review stated that there 
was a limited level of evidence of impaired academic achievement 
and education outcomes, increased rates of unemployment and/
or low income, and impaired social functioning or engagement in 
developmentally appropriate social roles.10 The report stated that 
although there was evidence to suggest these outcomes, it was 
difficult to document a direct link between cannabis use and these 
outcomes because other variables played a role. Social outcome 
data for cannabis users specifically in Colorado are currently 
unavailable and could be an area for further research.
Structural, Functional, and Chemical Brain Changes in 
Cannabis Users
A number of review articles on cannabis have described 
adverse effects on brain imaging.6,30-33 These findings may help 
establish a mechanistic link between the epidemiological studies 
on the adverse effects of cannabis. Structural, functional, and 
chemical changes to the brain have been established. These 
include both the gray matter (neuronal cells) and white matter 
(nerve axons responsible for communication).34,35 Structural 
changes to the brain include reductions in the hippocampus34-38 
(12.1% in the left and 11.9% in the right, relative to controls)38 
and amygdala37,38 (6.0% in the left and 8.2% in the right, relative 
to controls)38 volumes in cannabis users. 
Several studies also identified reductions in volume of 
Figure 4. Number of emergency department (ED)/urgent care (UC) visits with cannabis-associated International Classification of Diseases 
codes or positive urine drug screens by adolescents aged 13 to < 21 to a tertiary-care children’s hospital system in Colorado by year.105
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specific areas of the prefrontal cortex,39-41 as well as functional 
magnetic resonance imaging (fMRI) studies demonstrating 
reduced functional connectivity in the prefrontal networks 
responsible for executive function (including inhibitory 
control) and the subcortical networks, which process 
habits and routines.30,42-25 Other fMRI studies show reduced 
connectivity in the fimbriae of the hippocampus and 
commissural fibers extending to the precuneus, and suggest 
that this disturbed brain connectivity in cannabis users may 
underlie cognitive impairment and vulnerability to psychosis, 
depression, and anxiety disorders.46 Multiple other areas of the 
brain have also been shown to demonstrate changes on fMRI 
studies in response to cannabis and include the orbitofrontal 
cortex, anterior cingulate cortex, striatum, amygdala, 
hippocampus, and cerebellum.37 In general, these changes on 
both structural and functional MRI studies corresponded with 
frequency of use and earlier age of onset of use (although 
several studies identified these changes in adult users as 
well).34,35 
Changes to neurotransmitters in the brain have also been 
well described in systematic reviews and include disruptions 
in glutamate,47 dopamine,48 N-acetylaspartate,49 myo-inositol,49 
choline,49 and γ-aminobutyric acid (GABA).33,49
Taken together, these changes may underlie the clinical 
features being observed in observational and epidemiological 
studies demonstrating increases in psychosis, impulsivity, 
depression, anxiety, suicidality, decreases in cognition, IQ, and 
executive function, abnormalities in habits, routines, decision-
Figure 5. Suicides with marijuana toxicology by year and total suicides by year in Colorado (A). Percent of suicides with marijuana 
present by year (B).24
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making capacity, and deficits in learning, memory, attention, 
and social interaction.6,30,31 
Link to Other Substance Abuse
Cannabis use has also been associated with abuse of other 
illicit substances. According to the NASEM report, there is a 
moderate level of evidence of a statistical association between 
cannabis use and the development of substance dependence 
and/or substance abuse disorder for alcohol, tobacco, and 
illicit drugs.10 Multiple cohort studies have demonstrated these 
results.50-52 Four separate discordant twin studies have found 
that the twin who used marijuana was more likely to use 
other substances even after controlling for environmental and 
genetic influences.53-56 Although some studies reported that 
medical cannabis has resulted in improvements in opiate-related 
deaths,57,58 Colorado has had an increase in poisoning and deaths 
from opiates and methamphetamines since 2010, with the 
highest in 2017. These rates have increased nationwide as well 
and the influence of cannabis in Colorado is difficult to discern. 
Nevertheless, the increase in overdose deaths in Colorado is 
alarming. These data are shown in Figure 6.25
Although animal studies do not consistently translate to 
human effects, rat studies can provide some mechanistic clues. 
After exposure to tetrahydrocannabinol (THC), rats have an 
increased behavioral sensitization response to not only THC 
but also opiates and nicotine.59-61 Studies also demonstrate 
that these behavioral changes in rats correspond to neuronal 
activity changes in mesolimbic dopamine neurons in the 
ventral tegmental area and nucleus accumbens and that cross-
tolerance results with exposure to morphine, amphetamines, and 
cocaine.61,62 Repeat morphine self-administration has been shown 
to be significantly lower in CB1 knockout mice (CB1 receptors are 
the among the most predominant G protein-coupled receptors in 
the brain and mediate most of the psychotropic effects of THC) 
and opiate withdrawal symptoms significantly less when the 
knockout mice are administered naloxone.63 
Cannabis Dependence/Withdrawal Symptoms
Cannabis use may result in dependence and cessation may 
result in withdrawal symptoms. Dependence rates are reported 
at one in 10 among those who ever use cannabis, one in six 
among adolescent users, and one in three among daily users.6,64-67 
Withdrawal symptoms may include anxiety, insomnia, appetite 
disturbance, and depression. These symptoms are sufficient to 
impair everyday functioning and are markedly attenuated by 
doses of an oral cannabis extract.6 
Other Relevant Physiological and Safety Concerns with 
Cannabis
Cannabinoid Hyperemesis Syndrome
Cannabinoid hyperemesis syndrome (CHS) has been 
well described in the literature.68-70 The symptoms of CHS 
include significant nausea, violent vomiting, and abdominal 
pain in the setting of chronic cannabis use. Cardinal diagnostic 
characteristics include regular cannabis use, cyclic nausea and 
vomiting, and compulsive hot baths or showers with resolution 
of symptoms after cessation of cannabis use.69 CHS patients 
present similarly to cyclic vomiting syndrome patients with the 
exception that cannabis use is required to make the diagnosis.69 
Following legalization, the prevalence of cyclic vomiting 
presentations to Denver Health and the University of Colorado 
Hospital increased 1.92-fold (95% CI, 1.33 to 2.79) from 41 per 
Figure 6. Drug poisoning/overdose deaths in Colorado by involvement of specific drug type: Colorado residents, 1999-2017.*
Reproduced from: Vital Statistics Program, Colorado Department of Public Health and Environment. Available at: https://drive.google.
com/file/d/1vfi4kL9eD9rib7aEboteiGw67gOxXFpf/view. 
*Drug categories are not mutually exclusive; a death involving more than one type of specific drug will be counted in each applicable 
category. “Fentanyl” is a subset of “prescription opioid.”
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113,262 ED visits from a year prior to marijuana liberalization 
(November 1, 2008–October 31, 2009) to 87 per 125,095 
ED visits a year following marijuana liberalization (June 1, 
2010–May 31, 2011). Patients with cyclic vomiting in the 
post-liberalization period were more likely to have marijuana 
use documented than patients in the pre-liberalization period 
(OR = 3.59; 95% CI, 1.44 to 9.00).71 These patients often are 
evaluated with multiple imaging studies, lab work, endoscopies, 
and admissions to the hospital as well as antiemetic treatment. 
These studies are often non-diagnostic and treatment is often 
ineffective. This may also influence ED crowding.68,72 
Motor Vehicle Collisions
Traffic fatalities with blood or urine drug screens positive 
for cannabinoids have sharply risen across Colorado.73,74 Total 
fatal motor vehicle collisions (MVC) in Colorado had been 
decreasing from a high of 677 in 2002 to a low of 407 in 2011 but 
then began increasing each year since then to 600 in 2017. Total 
MVCs mirror this trend. The NASEM review found substantial 
evidence of a statistical association between cannabis use and 
increased risk of MVCs.10 CDPHE found substantial evidence 
that recent marijuana use by a driver increases his or her risk of a 
MVC and that the higher the blood THC level, the higher the risk 
of MVC. The use of alcohol and marijuana together increases risk 
of impairment and MVC more than either substance alone. For 
less-than-weekly marijuana users, using marijuana containing 10 
milligrams (mg) of THC is likely to impair the ability to safely 
drive, bike, or perform other safety-sensitive activities. A typical 
marijuana cigarette, or joint, contains 60-115 mg of THC.75 
A systematic review of observational studies and meta-
analysis for acute cannabis consumption and MVC risk found 
that driving under the influence of cannabis was associated with a 
significantly increased risk of MVCs compared with unimpaired 
driving (OR = 1.92; 95% CI, 1.35 to 2.73), especially for fatal 
collisions (OR = 2.10; 95% CI, 1.31 to 3.36).76 However, a 
recent study of crash fatality rates after recreational marijuana 
legalization in Washington and Colorado found changes in motor 
vehicle crash fatality rates were not statistically different from 
those in similar states without recreational marijuana legalization. 
This was, however, only after further statistical regression 
analysis (for population, gender, spending on road construction 
and maintenance, annual gross domestic product, per capita 
income, unemployment rate, per capita alcohol consumption, 
seatbelt laws, road density, traffic density, and rurality). Initial 
data demonstrated that after legalization, motor vehicle crash 
fatality rates increased by a mean of +0.1 (± 0.4) fatalities per 
billion vehicle miles traveled in Washington and Colorado, and 
decreased by a mean of -0.5 (± 0.9) fatalities per billion vehicle 
miles traveled in the control states each year.77 
Cardiovascular Effects
The effect of cannabinoids on the cardiovascular system 
is complex and an area of ongoing research.78 Of concern to 
practicing emergency physicians is ST-segment elevation 
myocardial infarctions and acute stroke presentations with a 
close temporal relationship with cannabis use, which have been 
documented in multiple case reports in otherwise young, healthy, 
male patients.79-82 The NASEM summary found there was a 
limited level of evidence of a statistical association between 
acute cannabis use and triggering an acute myocardial infarction 
(AMI), ischemic stroke, or subarachnoid hemorrhage.10 The 
WHO review states: “There is evidence that cannabis use can 
trigger coronary events. Recent case reports and case series 
suggest that cannabis smoking may increase cardiovascular 
disease risk in younger cannabis smokers who are otherwise at 
relatively low risk.”6 
CDPHE found moderate evidence that marijuana use 
increases risk of ischemic stroke in individuals younger than 
55 years of age and limited evidence that acute marijuana use 
increases risk of myocardial infarction.75 The main case crossover 
study cited for the AMI findings demonstrated that the risk for 
AMI associated with cannabis use during the hour preceding 
symptoms of AMI was elevated 4.8 times over baseline (95% CI,  
2.9-9.5). This risk was substantially reduced following that hour.83
A review of nationwide inpatient sample data from 2010 
to 2014 demonstrated a 32% increase in inpatient admissions 
for primary diagnosis of myocardial infarction and secondary 
diagnosis of cannabis use disorder (increasing from 2198 to 2900 
cases). The overall mean age of patients was 41 years old. These 
patients also had longer lengths of stay, higher hospitalization 
costs, and higher levels of morbidity due to AMI following 
hospitalization than non-cannabis users.84 
In a study reviewing secondhand marijuana smoke exposure, 
the authors found that one minute of exposure substantially 
impaired endothelial function in rats for at least 90 minutes, 
considerably longer than comparable impairment by tobacco 
secondhand smoke.85
The pathophysiological basis of these events is not 
fully understood and a full discussion is beyond the scope 
of this review. In short summary, it may encompass a 
complex interaction between exogenous cannabinoids and 
the endocannabinoid system, autonomic nervous system, 
oxidative stress, direct cellular effects on the endothelium, and 
pro-coagulant effects.86 Exposure to THC causes activation 
of the sympathetic nervous system and inhibition of the 
parasympathetic nervous system.87 These effects include 
elevated heart rate, serum norepinephrine levels, elevated 
supine blood pressure, and increases in left ventricular 
systolic function87-89 Smoking results in decreasing oxygen 
delivery to the heart and other vital organs and may be further 
compromised by increasing carboxyhemoglobin levels.90 
The impaired myocardial oxygen demand-to-supply ratio 
following cannabis smoking has been shown to reduce the 
time to onset of symptoms during exercise in patients with 
stable angina.91 
Direct effects of cannabis on blood vessels are complex 
due to the differing compounds in cannabis and the functional 
properties of the blood vessels examined.92 Studies are 
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inconsistent regarding the effects on vasoconstriction and 
dilation. Cannabis has been consistently shown to produce 
vasodilation with resultant orthostatic hypotension,92,93 
but it has also been implicated in vasoconstrictive arteritis 
mechanisms.94,95 A large review article suggested that there 
are three phases in cardiovascular parameters affected by 
the endocannabinoid system and that different chemical 
constituents of the cannabis plant have varying effects 
at different target organs, which may account for the 
differences.93 Transient vasospasm and reduction in cerebral 
blood flow are well described and may underlie changes in 
coronary, cerebral, and peripheral arterial systems leading to 
end organ ischemia.86,96,97 Myocardial blood flow has been 
shown to correlate inversely with circulating plasma levels of 
endocannabinoids.86,98 Cannabis has also been shown to be a 
potent source of cellular oxidative stress through formation of 
reactive oxygen species, and this may contribute to endothelial 
dysfunction and promote regional arterial vasospasm.86,99 
THC has also recently shown a dose-dependent pro-
coagulant effect.100 This ex vivo observation has been 
supported by reports of thrombotic coronary artery occlusion 
in young individuals without underlying atherosclerosis.86 
There are also cannabinoid receptors on the surface of 
platelets and THC has been shown to increase the surface 
expression of glycoprotein IIb–IIIa and P selectin in a 
concentration-dependent manner resulting in platelet 
activation.86,101 Figure 7 summarizes these effects.
Respiratory Effects
Marijuana smoking leads to adverse pulmonary 
outcomes. The NASEM, CDPHE, and WHO reports state 
there is substantial evidence of a statistical association 
between marijuana smoking and worse respiratory symptoms 
and more frequent chronic bronchitis episodes.6,10,75 These 
data were based primarily on a systematic review by 
Tetrault et al. from 14 studies that assessed the association 
between long-term cannabis smoking respiratory symptoms 
including chronic cough (OR = 1.7–2.0), increased sputum 
production (OR = 1.5–1.9), and wheezing (OR = 2.0–3.0).102 
There is also evidence of a statistical association between 
the cessation of cannabis smoking and improvements in 
respiratory symptoms.10 Cannabis smoking may also lead 
to increased rates of pneumonia and upper respiratory 
infections. On histology, this is associated with a reduction 
in ciliated cells and increase in mucus secretion from the 
larger number of mucus-secreting cells.6,30,103
Exposures to Children
Reported exposures to children less than age 10 have 
sharply increased in Colorado following recreational marijuana 
legalization. A retrospective cohort study of hospital admissions 
and regional poison control center (RPC) cases between January 
1, 2009–December 31, 2015 at a tertiary-care children’s hospital 
found that the mean rate of marijuana-related visits to the 
children’s hospital (ages 0-9) increased from 1.2 per 100,000 
population in the two years prior to legalization to 2.3 per 
Figure 7. Flow diagram demonstrating pathophysiologic pathways to common major adverse cardiovascular events reported in users of 
cannabis and related chemicals.86
AMI, acute myocardial infarction; CBR1, cannabinoid receptor 1; CVA, cerebrovascular accident; MVO2 myocardial oxygen consumption 
(demand); O2, oxygen; ROS, reactive oxygen species.
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100,000 after (P = .02). The median age of exposure was 2.4 
years. The majority were exposure to an infused edible product 
(48%, n = 30); 65% (n = 40) were observed in the ED or UC; 
21% (n = 13) were admitted to an inpatient ward; and 15% (n 
= 9) were admitted to the intensive care unit. Two of these 
children required respiratory support. The median length of 
stay for all patients was 11 hours, and the median length of 
stay for admitted patients was 26 hours. 
Annual RPC pediatric marijuana cases increased more 
than five-fold from 2009 (nine cases) to 2015 (47 cases).104 
Colorado had an average increase in RPC cases of 34% 
(P < .001) per year while the remainder of the United States 
had an increase of 19% (P < .001).104 In a follow-up study in 
October 2018, the same author found that despite multiple 
public health interventions in legislation after 2014 (child-
resistant packaging, dose limitations, opaque packaging, 
limiting marketing campaigns, and banning specific edibles), 
the incidence of children’s hospital visits and RPC calls has 
continued to rise in Colorado with an observed doubling of 
children’s hospital visits in 2017 compared to 2016105 (Figure 
8). Edibles are sold as cookies, candies, and sodas with 
advertising that appeals to children.104,106
Cannabis Contaminants, Cannabis Concentrates, and Hash-oil 
Burns
Varying cultivation techniques and end-product 
alterations further complicate the understanding of the 
physiological effects of cannabis. Cannabis plants can be 
altered to achieve higher growth rates, changes in potency, 
and increased bud production. These techniques can include 
use of varying soil types, fertilizers, and pesticides that 
can result in physiological effects. These changes may 
also result in exposures to possible fungal agents such as 
powdery mildew and botrytis; budworm or mite infestations 
have been reported in the literature. Historically, there have 
been reports of bacterial contamination with salmonella, 
enterobacter, streptococcus, and klebsiella, as well as case 
reports of fungal spore contaminants, including mycotoxin‐
producing strains of aspergillus.107 
There are three pathways through which cannabis may 
be contaminated with heavy metal substances. Firstly, 
cannabis is able to remove heavy metals from substrate 
soils and deposit these in its tissues by virtue of its 
bioaccumulative capacity. Secondly, cross‐contamination 
may occur during processing (eg, during drying). Thirdly, 
post‐processing adulteration may occur, whereby metals may 
be added to the preparation to increase weight and thereby 
appreciate its street value. There are case reports of lead 
and arsenic poisoning from cannabis.107 Pesticides are also 
commonly used in cannabis cultivation. In a report from 
Washington State, laboratory analysis revealed that 84.6% 
(N = 26 samples) of legalized cannabis products contained 
significant quantities of pesticides including insecticides, 
fungicides, miticides, and herbicides. These comprised a 
wide array of different substances and encompassed proven 
carcinogens (carbaryl, diuron, ethoprophos, permethrin, and 
propargite), endocrine disruptors, as well as a variety of 
developmental, reproductive, and neurological toxins. 107,108 
There are also changes in end-product concentrations 
through post-processing of the plant. These changes include 
creation of oils, waxes/shatter, and dabs. Oils are created by 
removing the hydrophobic components such as THC with a 
heated butane solvent. THC concentrations may reach up to 
55.7%.109 Waxes and shatter are concentrated and solidified 
oil with THC concentration reaching up to 90% THC. 110,111 
Dabs are composed of heated wax and are inhaled off of an 
Figure 8: Colorado pediatric marijuana exposures (ages 0-9) to a tertiary-care children’s hospital, and regional poison control center 
cases by year.105
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object such as a nail, which even further concentrates THC 
content over 90%.112 
Preparation of these concentrated products has also led 
to fires and explosion injuries in amateur production attempts 
in garages, tool sheds, and vacant homes.113,114 In Colorado 
29 patients with butane hash-oil burns were admitted to the 
University of Colorado Burn Center from 2008-2014. Zero 
cases presented prior to medical liberalization, 19 during 
medical liberalization (October 2009–December 2013), and 
12 from January–June 2014 at the study’s conclusion. (Two 
patients had four total visits.) The median total body surface area 
(TBSA) burn size was 10% (TBSA range 1-90%). Median length 
of hospital admission was 10 days. Six required intubation for 
airway protection while 19 required skin grafting.115 
Marijuana Shop Employees Providing Medical Advice
Marijuana shop employees not trained in medicine 
or pharmacology are giving medical advice that may be 
harmful to patients. A recent study in Colorado found that 
employees are giving medical advice 70% of the time 
to use cannabis for treatment of nausea and vomiting in 
pregnancy and few dispensaries encouraged discussion 
with a healthcare provider without prompting.116 The author 
has personally had patients bring in products recommended 
by dispensary workers with a recommended potency and 
frequency of use and report being advised to stop their 
usual medications and use the cannabis product instead. 
Cannabis dispensaries provide medical advice and offer 
treatment without medical training even when this may 
harm the patient.
Potential Medicinal Uses of Cannabis
There are potential therapeutic intervention targets for 
cannabinoids. In general, these therapeutic targets require 
a high ratio of cannabidiol compounds (CBD- cited to 
decrease or eliminate the psychoactive effects of THC), and 
are from products that significantly differ from those found 
in commercial dispensaries. The NASEM report found 
substantial evidence that cannabis or cannabinoids are 
effective for the treatment of chronic pain in adults, as an 
antiemetic for chemotherapy-induced nausea and vomiting, 
and for improving patient-reported multiple sclerosis 
spasticity symptoms. They also found moderate evidence 
that cannabis or cannabinoids are effective for improving 
short-term sleep outcomes associated with obstructive sleep 
apnea, fibromyalgia, chronic pain, and multiple sclerosis.10 
Studies have also demonstrated that cannabinoids may 
improve cardiovascular outcomes.92,117 
Likely the most significant treatment implication has 
been in patients with refractory epilepsy, most commonly 
in patients with Dravet’s syndrome and Lennox-Gestault 
syndrome, but also in other patients. This has led to the 
U.S. Food and Drug Administration approving Epidiolex 
(a high concentration CBD cannabinoid treatment) in 
June 2018 for the treatment of Dravet’s syndrome and 
Lennox-Gestault syndrome.118-120 Despite these potential 
medicinal uses, current Colorado legal distribution of 
cannabis products goes through an intermediary budtender 
before making it to the patient which may not consistently 
promote therapeutic benefit; there is insufficient training of 
dispensary staff to serve this purpose.
Variations in Potency, Bias in Studies, and Conflicting 
Laws Confuse Consumers and Impair Research
The potential positive health effects of cannabis rest on 
which of the multiple species and hybrids are studied and 
their specific chemical composition. One of the difficulties 
in determining the physiological effects of cannabis is that 
“marijuana,” or “cannabis,” can refer to multiple species 
of plants with widely varying chemical compounds and 
corresponding variable physiological effects. The cannabis 
genus includes multiple species, most commonly Cannabis 
sativa and Cannabis indica, and within those are hybrids 
specifically developed by growers to achieve a specific 
effect. For example, the commonly used term, hemp, refers 
to a variety of Cannabis sativa that is fast growing and 
can be spun into usable fiber for paper, textiles, clothing, 
biofuel, animal feed, and other industrial uses. Hemp has 
low concentrations of THC (less than 0.3%) and higher 
concentrations of CBD. 
The differences in composition offer different potential 
treatment effects. For example, the effect for pain control 
cited in the NASEM review was primarily found with 
nabiximols (Sativex), a cannabis extract mouth spray that 
delivers a dose of 2.7 mg of THC and 2.5 mg of CBD.121 
For comparison, a typical marijuana cigarette or joint 
contains 0.5 g of marijuana and THC content ranges from 
12-23%; therefore, a typical joint contains 60-115 mg 
of THC, 20-40 times the medicinal dose. The NASEM 
cautioned that many of the cannabis products sold in state-
regulated markets bear little resemblance to those available 
for research at the federal level in the U.S.10 This is further 
complicated in that commonly sold cannabis products are 
often mislabeled for CBD and THC content. One study 
showed only 17% of dispensary products were accurately 
labeled. 122,123 Scientific studies, particularly for treatment 
of pain, have been limited by a substantial bias, and results 
have varied.124,125 Some demonstrate improvement in pain10 
with coinciding decreases in opiate abuse,10,57,126 while 
others show the opposite.123,125,127,128 
The conflict between federal and state laws on the 
medical use of cannabis products, the lack of consistency 
among state laws, and the availability of artisanal products 
in dispensaries, with high variability between composition 
of products, have caused significant confusion for 
researchers and limited the ability to fully and accurately 
research the true effects of commonly available dispensary 
cannabis products.129 
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LIMITATIONS
This was not a systematic review of the literature but 
rather a summary of selected research including several large 
reviews from the NASEM, the WHO, and the CDPHE. There 
is undoubtedly much literature, some of it conflicting, not 
cited here. However, as other states and countries wrestle with 
decriminalization and legalization of cannabis for personal 
use and sale, it is crucial to report the Colorado experience 
as a cautionary tale. This review summarizes a large body 
of research for practicing emergency physicians who are 
increasingly confronted with questions and patients who 
use cannabis. Although the author practices in Colorado, the 
information is likely generalizable. This review clearly reflects 
the author’s biases, yet its composition was motivated by 
alarming experience in everyday practice.
Discussions of cannabis’ effects are relevant not only to 
the healthcare system, but to legal, business, environmental, 
legislative, and other branches within a public health 
framework. This article does not address those other facets. 
Neither have numerous other physiological effects of cannabis 
been reviewed here. Many of the previous research studies 
have focused on cannabis with a much lower THC level 
limiting applicability to cannabis sold at dispensaries today. 
Finally, the words “marijuana” and “cannabis” were used 
interchangeably throughout the article. This was done to 
maintain the wording from the studies cited consistent with 
their original language. No difference should be implied with 
the alternating use of these terms. 
CONCLUSION
Cannabis legalization has led to significant health 
consequences, particularly to EDs and hospitals in Colorado. The 
most concerning include psychosis, suicide, and other substance 
abuse. There are deleterious effects on the brain and some of 
these may not be reversible with abstinence. Other significant 
health effects include increases in fatal motor vehicle collisions, 
adverse effects on cardiovascular and pulmonary systems, 
inadvertent pediatric exposures, cannabis contaminants exposing 
users to infectious agents, heavy metals, and pesticides, and 
hash-oil burn injuries due to preparation of concentrates. Finally, 
cannabis dispensary workers not trained in medicine are giving 
medical advice that could be harmful to patients. 
Cannabis research may offer opportunities for novel 
treatment of seizures, spasticity from multiple sclerosis, 
nausea and vomiting from chemotherapy, chronic pain, 
improvements in cardiovascular outcomes, and sleep 
disorders. However, progress has been difficult due to absent 
standardization of the chemical composition of cannabis 
products and limitations on research secondary to federal 
classification of cannabis. Given these factors and the 
Colorado experience, other states should carefully evaluate 
whether and how to decriminalize or legalize non-medical 
cannabis use.
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Introduction: Routine interventions in the practice of medicine often lack definitive evidence or 
are based on evidence that is either not high quality or of only modest-to-marginal effect sizes. 
An abnormal urinalysis in an elderly patient presenting to the emergency department (ED) with 
non-specific symptoms represents one condition that requires an evidence-informed approach 
to diagnosis and management of either asymptomatic bacteriuria or urinary tract infection (UTI). 
The emergency provider often will not have access to urine cultures, and the risks associated with 
antibiotic use in the elderly are not without potentially significant side effects.
Methods: We performed a historical and clinical review of the growing body of literature 
suggesting measurable differences in the systemic immune response manifest among patients with 
asymptomatic pyuria and UTI, including increases in the pro-inflammatory cytokine interleukin-6 and 
the acute phase reactant procalcitonin. 
Results: Serum procalcitonin, a peptide that undergoes proteolysis into calcitonin, has been 
demonstrated to quickly and reliably rise in patients with severe bacterial infections, and may serve 
as a potentially sensitive and specific marker for identification of bacterial illness. 
Conclusion: In the absence of validated risk scores for diagnosing UTI in elderly patients presenting 
to the ED, there may be a role for the use of procalcitonin in this patient population. [West J Emerg 
Med. 2019;20(4)573-577.]
INTRODUCTION
Evidence-Based to Evidence-Informed Practice: The 
Clinical Reality 
The evolution from eminence-based to evidence-
based care has come to define bedside emergency medicine 
(EM), with rigorous skepticism and scholarly consideration 
accelerated by the power of global connectivity.1 Where 
anecdote and opinion once drove therapy, clinicians now 
approach clinical conundrums with deliberate reflection, 
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expecting – and at times demanding – ever-higher proof of 
perfection prior to implementing or incorporating therapies, 
tests, or approaches into their own practice. Such cogitation 
ensures excellence and safety and avoids pitfalls of over-
adoption or confounding. Sackett originally defined this 
approach as evidence-based medicine, or the “use of current 
best evidence in making decisions about the care of individual 
patients...integrating individual clinical expertise” and 
honoring patients’ values and preferences.2 Unfortunately, 
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many of our daily decisions are made in a space devoid of 
definitive data.3-8 
We thus are required to transition from the ideals of 
evidence-based medicine into the real and pragmatic world of 
evidence-informed medicine. It is at this precipice of real-world 
practice—where often studies and statistics do not exist, are not 
of high quality, or are of modest-to-marginal effect sizes—that 
we change, where we push forward the boundaries of care, and 
develop not only experience but the very questions that will 
define the next advances in EM. With this in mind, we sought to 
explore the clinical realities of the assessment and treatment of 
abnormal urinalyses in the elderly patient presenting with non-
specific symptoms to the emergency department (ED).
METHODS
We performed a historical and clinical review of the current 
literature on urinary tract infection (UTI) focusing on identifying 
and summarizing key trends relevant to the diagnosis of abnormal 
urinalyses in elderly patients with non-specific symptoms with a 
specific emphasis on the biomarker procalcitonin.
RESULTS
Asymptomatic Bacteriuria: Historical Perspective
Asymptomatic bacteriuria was first identified in the mid-
1950s, when a series of autopsy reports identified chronic 
pyelonephritis as a common cause of renal failure, despite the fact 
that none of the deceased individuals had been diagnosed with a 
urinary tract infection while alive.9 Such findings led researchers 
to declare, “there is now clear evidence that bacteriuria is one 
of the commonest human infections, that it may be chronic and 
persistent, that it may influence structure and function outside 
of the urinary tract, and that it plays an important role in disease 
from the cradle to the grave—from prematurity to hypertension 
and renal failure.”10 Since these observations, decades of 
antibiotics have been administered with frequency through 
the mouths, veins, and bladders of asymptomatic patients, all 
while several studies conclusively demonstrated that treatment 
of asymptomatic bacteriuria not only lacks benefit, but likely 
increases the short-term risk of pyelonephritis.11 
Asymptomatic Bacteriuria: Clinical Pearls in the 
Emergency Department
Asymptomatic bacteriuria is a microbiologic diagnosis 
defined as >105 colony-forming units per milliliter (cfu/mL) 
bacteria identified in two consecutive voided urine specimens 
(only one specimen needed for males).12 It is incredibly common, 
affecting greater than 20% of healthy, elderly, community-
dwelling women, and reaching a prevalence as high as 50% 
in institutionalized elderly females, and 100% in patients with 
indwelling catheters.13 In the ED, without access to culture 
information, emergency providers are thus not confronted with 
asymptomatic bacteriuria, but rather asymptomatic pyuria, an 
even more prevalent and low-yield urinalysis usurper. 
The clinical conundrum of the abnormal urinalysis in 
an elderly patient presenting with non-specific symptoms is 
a common occurrence.14 While it is well-known that UTIs 
can cause malaise and mental status changes in elderly 
populations,15 consistent clinical data suggest that the 
overwhelming percentage of “positive” urinalyses (UA) 
represent asymptomatic bacteriuria, and are neither truly 
indicative of UTI nor related to the patient’s non-specific 
complaints.16 Additionally, fixating on the “positive” UA can 
often cause clinicians to reach premature diagnostic closure 
and stop further investigations. Unfortunately, determining 
which UAs represent constitution-influencing infection and 
which are simple asymptomatic presentations is a difficult task 
in the ED, particularly when the patient lacks the cognitive 
or physical ability to relay typical symptoms such as dysuria, 
urinary frequency, or hesitancy. 
Knowing that antibiotic treatment is of no value in non-
pregnant patients with simple asymptomatic bacteriuria,11,12 
we strive to limit such unnecessary antimicrobials, which also 
bring risk of allergic reaction, increased antibiotic resistance, 
and iatrogenic injury ranging from Clostridium difficile colitis 
to renal injury. 
Despite compelling data that treatment of asymptomatic 
bacteriuria lacks benefit, and growing evidence that non-
specific symptoms in the elderly are generally not caused by 
UTIs,16 these patients are overwhelmingly exposed to broad 
spectrum agents initiated in the ED or upon admission to the 
hospital.17,18 It can be difficult for the emergency provider to 
avoid incorporating into the diagnostic framework the need 
for antibiotic stewardship with the real concerns of disease 
progression or missed infection treatment metrics. Even when 
restraint wins out in the ED, diagnostic equipoise often drives 
inpatient teams to start antibiotics. Strikingly, well-done surveys 
demonstrate that nearly half of physician respondents prescribe 
antibiotics for asymptomatic bacteriuria despite knowing a UA 
demonstrates asymptomatic bacteriuria and not true infection.19 
When clinicians are unable to elicit information on lower 
urinary tract symptoms from elderly patients with dementia, 
advanced cerebrovascular disease, or other impairments 
resulting in communication barriers, they are likely to initiate 
antimicrobial therapy in a well-intentioned effort to prevent 
progression and worsening infectious outcomes with anecdote 
of improvement perpetuating such practice.20
Systemic Immune Response
Recognizing the difficulty in distinguishing true infection 
from asymptomatic bacteriuria, multiple authors have 
attempted to investigate differences in systemic immune 
response among these cohorts. In 2011, a group of researchers 
compared the levels of various inflammatory markers in 
urine samples before and after inoculation with Escherichia 
coli, noting a substantial increase in both white blood cells 
and polymorphonuclear neutrophils, a not uncommon 
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phenomenon in lab results seen in the ED.21 Interestingly, 
however, levels of interleukin-6 (IL-6), a pro-inflammatory 
cytokine that is not only an acute phase reactant but also one 
of the major regulators of acute phase protein synthesis,22,23 
remained unchanged in this study.21 The authors suggested that 
these findings support the hypothesis that a less-robust host 
immune response occurs among patients with asymptomatic 
bacteriuria compared to those with symptomatic infection.
A subsequent study exploring the role of IL-6 and 
heparin binding-protein (HBP), a protein released from 
activated neutrophils during infection24 and previously shown 
to be associated with UTIs,25 a 2016 investigation enrolled 
asymptomatic, elderly, nursing home residents and matched 
them with patients living in the community or at nursing 
homes with symptomatic UTI.26 In this study, urinary IL-6, but 
not HBP, reliably distinguished between patients with cystitis 
or asymptomatic bacteriuria, adding further to the growing 
observational literature that there is a fundamental and 
measurable difference in the body’s immune reaction in cases 
of true infection compared to colonization.26 
Procalcitonin and Urinary Tract Infection
Perhaps one of the most hotly debated acute phase reactants, 
procalcitonin, is the latest diagnostic darling in inpatient circles. 
Procalcitonin (the biologic precursor to calcitonin) reaches 
measurable serum concentrations quickly and reliably in the 
setting of bacterial infection.27-29 Dozens of trials have reliably 
demonstrated procalcitonin’s strong performance in decision 
support for antibiotic initiation or cessation; however, in the 
most salient ED investigation—the Procalcitonin Consensus 
Trial (ProACT) —procalcitonin failed miserably in limiting 
unnecessary antibiotic use.30 Notably, however, such failure 
seemed more a function of clinician fears of untreated infection 
rather than a shortcoming of the test itself, an idiosyncrasy noted 
many times over in a myriad of editorials following publication 
of ProACT. The recently published HI-TEMP trial, however, 
applied PCT across a heterogeneous population and found no 
benefit in decreasing antibiotic use or significantly decreasing 
patient-oriented endpoints.31 As many respondents to ProACT 
argued, though – and the trial authors seemed to agree with – the 
combination of this reassuring objective test with a concerted 
effort to limit unnecessary antibiotic use, or an antibiotic 
stewardship program, could be more effective in harnessing the 
diagnostic value of procalcitonin.32-34 
DISCUSSION
We suggest that a considered and nuanced synthesis of 
this inflammatory marker in a well-defined clinical context 
is supported by a vibrant body of literature suggesting a role 
for procalcitonin in the diagnosis of true UTI. In one bench 
study, procalcitonin reliably increased with worsening urinary 
tract disease.35 Additionally, one comprehensive review found 
procalcitonin to be a “key marker” in children with UTI.36 When 
operationalized, serum procalcitonin was a good predictor of 
disease severity in a meta-analysis of prospective pediatric 
clinical trials of UTIs.37 More recently, a randomized controlled 
trial (RCT) out of Switzerland randomized patients presenting to 
the ED with a UTI to a procalcitonin-pyuria-based (PCT-pyuria) 
algorithm or current guidelines (control group) for initiation and 
duration of antibiotic therapy.38 In the intention-to-treat analysis, 
cumulative 90-day exposure to antibiotics was shorter in the 
PCT-pyuria group compared to the control, although with no 
changes in mortality and reinfections. In a 2015 Cochrane review 
assessing procalcitonin for diagnosing acute pyelonephritis in 
pediatric patients,39 there were limited studies at the time of 
the review and marked heterogeneity of the included studies 
to recommend it for daily practice, although procalcitonin 
performed significantly better for ruling-in pyelonephritis 
compared to erythrocyte sedimentation rate or C-reactive protein. 
It is important to note that procalcitonin can be elevated in 
any acute infectious circumstance and is not specific to a UTI. 
Therefore, an elevated procalcitonin level should not be equated 
to UTI and does not clinch the diagnosis of UTI. Pyuria in the 
setting of an elevated procalcitonin level may still represent 
asymptomatic bacteriuria with an alternate infectious process 
(i.e., meningitis, bacteremia, etc.). Clinicians should be cautious 
to avoid premature diagnostic closure in this circumstance. 
Furthermore, it should be noted that PCT levels may not rise 
with localized infections (septic arthritis, localized abscess, etc.), 
steroid use, and atypical bacteria,40,41 and decisions regarding 
antimicrobial therapy should not be based solely on procalcitonin 
serum concentrations.
Procalcitonin for Urinary Tract Infection in the 
Emergency Department
The management morass of abnormal urinalyses in the 
elderly patient with nonspecific symptoms may represent an 
excellent opportunity for utilization of procalcitonin testing 
using an evidence-informed approach, ie, efforts undertaken in 
the absence of strict guiding data but supported and shepherded 
by complementary knowledge. Given the ambiguity of 
asymptomatic bacteriuria, a de-facto antibiotic stewardship 
effort is already underway in every hospital across the country, 
as well-meaning physicians strive to separate true infection from 
asymptomatic distractors. Where clinical complacency exists—
an afebrile, non-toxic-appearing patient in whom the desire to 
spare unnecessary antibiotic use conflicts with the compulsion 
to not allow an indolent infection run rampant—a procalcitonin-
augmented strategy might satisfy both imperatives.
This recommended strategy is not novel. As recently 
reported in the American Journal of Emergency Medicine, 
one retrospective analysis of UTIs found a negative predictive 
value of 91% for a low procalcitonin further bolstering 
the argument in favor of its use as an adjunct in the non-
initiation of empiric antibiotics.42 Even more compelling, a 
RCT of nearly 200 ED patients found that a procalcitonin-
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based algorithm reduced antibiotic exposure by 30% without 
negative effects on clinical outcomes.38 The introduction of 
procalcitonin in these departments served as a reliable and 
objective diagnostic marker and limited costly, harmful, and 
unnecessary exposure to antibiotics.
LIMITATIONS
The use of procalcitonin in the work-up of UTI in elderly 
patients with an abnormal urinalysis presenting with non-
specific symptoms requires further investigation ideally 
through a multicenter, RCT. Furthermore, this historical and 
clinical review was not systematic in its goal to describe the 
entirety of the use of procalcitonin; however, the purpose of 
this paper was to provide a succinct, narrative update of the 
latest research related to the use of biomarkers for diagnosing 
UTI for this patient population in the ED setting. 
CONCLUSION
Where definitive studies are lacking, nuance and rational 
integration of the literature is not only an option, but an 
imperative. The application of evidence-based medicine is at its 
easiest after large RCTs and rigorous analyses are popularized 
and widely disseminated. A true test of bedside Bayesianism, 
however, comes when the clinician is presented with clinical 
conundrums not yet thoroughly vetted and extensively analyzed. 
When no clear answer exists in the literature, we are forced 
to faithfully apply the best available knowledge to answer 
critical questions in real time in an ongoing attempt to correct 
shortcomings and pursue better care. No current rigorous trial 
has yet examined procalcitonin’s performance in this narrow and 
nuanced framework, but the collated and considered information 
available suggests that adding this simple test likely provides a 
much-needed diagnostic beacon and can safely lead to better care 
in real-world applications.
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Introduction: There is no widely used method for communicating the possible need for surgical 
intervention in patients with traumatic brain injury (TBI). This study describes a scoring system 
designed to communicate the potential need for surgical decompression in TBI patients. The scoring 
system, named the Surgical Intervention for Traumatic Injury (SITI), was designed to be objective and 
easy to use.  
Methods: The SITI scale uses radiographic and clinical findings, including the Glasgow Coma Scale 
Score, pupil examination, and findings noted on computed tomography. To examine the scale, we used 
the patient database for the Progesterone for the Treatment of Traumatic Brain Injury III (ProTECT III) 
trial, and retrospectively applied the SITI scale to these patients.  
Results: Of the 871 patients reviewed, 164 (18.8%) underwent craniotomy or craniectomy, and 
707 (81.2%) were treated nonoperatively. The mean SITI score was 5.1 for patients who underwent 
surgery and 2.5 for patients treated nonoperatively (P<0.001). The area under the receiver operating 
characteristic curve was 0.887.
Conclusion: The SITI scale was designed to be a simple, objective, clinical decision tool regarding 
the potential need for surgical decompression after TBI. Application of the SITI scale to the ProTECT III 
database demonstrated that a score of 3 or more was well associated with a perceived need for surgical 
decompression. These results further demonstrate the potential utility of the SITI scale in clinical practice. 
[West J Emerg Med. 2019;20(4)578–584.]
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INTRODUCTION
In the United States, traumatic brain injury (TBI) leads to 
significant morbidity and mortality with recent data showing 
that patients reaching a hospital with TBI account for more 
than 250,000 hospital admissions and more than 50,000 
deaths.1 While there are no approved pharmacotherapeutic 
agents for the treatment of TBI, timely management at an 
appropriate institution may improve outcomes.2 One method 
for potentially facilitating communication and management of 
this patient population is the use of a clinical decision tool.
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Population Health Research Capsule
What do we already know about this issue?
The Glasgow Coma Scale is widely used to 
classify severity of traumatic brain injury 
(TBI). It does not measure potential need for 
surgery in patients with TBI.
What was the research question?
Does the Surgical Intervention for Traumatic 
Injury [SITI] scoring system correlate with the 
decision to perform a craniotomy for TBI?
What was the major finding of the study?
When applied to the database of ProTECT 
III (a clinical trial of progesterone to treat 
TBI), scores on the SITI scale correlated with 
a perceived need for craniotomy
How does this improve population health?
While our results need prospective evaluation, 
the SITI scale may be a clinical decision tool 
that can efficiently communicate potential 
surgical urgency in TBI patients.
When designed and used appropriately, clinical decision 
tools have been shown to improve clinical practice.3 Currently, 
there are no widespread clinical decision tools for the evaluation 
and surgical treatment of TBI. The Glasgow Coma Scale 
(GCS) has been extensively used to classify TBI patients by 
injury severity and is a well-defined and reproducible system;4 
however, this scale does not provide information to indicate 
whether a surgical intervention is necessary.5 We previously 
described the Surgical Intervention for Traumatic Injury 
(SITI) scale as a possible clinical decision tool for evaluating a 
patient’s potential need for surgical decompression (craniotomy 
or craniectomy) for treatment of TBI.6 
Our currently presented findings expand on that original 
study by using the database from a recent multicenter study 
for TBI. The Progesterone for Traumatic Brain Injury, 
Experimental Clinical Treatment (ProTECT III) trial was 
a prospective, randomized clinical trial that examined the 
effect of treatment with intravenous progesterone vs placebo 
in patients with nonpenetrating, moderate or severe TBI.7 
We used the emergency department (ED) admission data, 
head computed tomography (CT) findings at presentation, 
and the surgical treatment data from the ProTECT III trial to 
determine if the patient’s score on the SITI scale correlated 
with whether they received a surgical decompression 
within the first 24 hours of admission. Our hypothesis was 
that the SITI score, at the time of admission, would be 
significantly higher in patients who went on to have surgical 
decompression.
METHODS
The ProTECT III trial met institutional requirements for 
the conduct of human subjects research and was registered 
on http://www.ClinicalTrials.gov (identifier, NCT00822900). 
The currently presented study used de-identified data from the 
ProTECT III database; nonetheless, we sought approval by 
the institutional review board (IRB). The IRB determined that 
review was not necessary.
Patient Data
This was a retrospective study that used an existing 
database from the ProTECT III trial.7 The ProTECT III 
trial was a phase III, multicenter, double-blind, clinical trial 
examining the efficacy of progesterone for the treatment of 
TBI. Inclusion criteria for the ProTECT III trial were adults 
with blunt force TBI and an initial GCS combined score of 
4-12 who were able to initiate treatment within four hours 
of injury. Exclusion criteria included the following: an 
injury deemed nonsurvivable; a clinical exam demonstrating 
bilateral dilated and unresponsive pupils; clinical evidence 
of hypoxemia, hypotension, spinal cord injury, or status 
epilepticus; a history of cardiopulmonary resuscitation 
following the injury; a current pregnancy; a history of 
reproductive cancer or a blood clotting disorder; a current 
diagnosis of active myocardial infarction, ischemic stroke, 
pulmonary embolism, or deep vein thrombosis; allergy to 
either progesterone or the pharmacological delivery vehicle; 
severe alcohol intoxication (defined as having an ethanol 
level greater than 249 milligrams per deciliter); or being a 
ward of the state (e.g., a prisoner). In addition, for analysis 
for the current study, patients were removed if they presented 
with intraparenchymal hemorrhage in the posterior fossa or 
if surgical intervention was not considered (eg, the family 
decided to withdraw care, or surgery was excluded as an 
option by the treating physicians).  
We reviewed the patient report forms from the ProTECT 
III trial to ensure that the data collected would be sufficient 
for calculating the SITI score. The variables needed to 
determine the SITI score were mapped to the data elements 
from the original ProTECT III public-use data set, and a 
single database was created using SPSS (IBM, Armonk, 
New York). Specifically, the data used for this study included 
demographic information, mechanism of injury, timing from 
injury to arrival to the ED, the combined GCS score on 
arrival, pupillary response on arrival, data obtained from the 
radiologist’s interpretation of the admission head CT, and 
information regarding surgical interventions. All patients 
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included and randomized to the ProTECT III study had a 
calculated GCS performed in the ED. For intubated patients, 
the verbal response was graded 1T. None of the patients 
included in the ProTECT III trial were found to have a history 
of prior eye surgery that would have prevented performance of 
a pupillary light reflex. 
For patients with midline shifts that were not clear from the 
ProTECT III database, a radiologist (Jason W. Allen) blinded 
to the patient’s background information determined the degree 
of midline shift. In cases where the patient’s operative status 
was unclear (ie, whether the patient had an operation in the 
first 24 hours after admission), individual case reviews were 
performed to determine whether the patient received surgical 
intervention. We defined patients as “operative patients” if they 
had craniotomies or craniectomies within 24 hours of arrival 
to the hospital. In ProTECT III, craniectomy and craniotomy 
were considered third-tier therapy. Surgeons were advised to 
perform surgical intervention, at their discretion, for refractory 
intracranial pressure and were referred to the most recent 
surgical guidelines.5
SITI Scale 
The SITI scale was previously described (Table 1),6 and 
its design was influenced by published surgical guidelines.5 
Briefly, the scale has five components: the combined GCS 
score on initial evaluation in the ED; eye findings; midline shift 
on head CT; presence of blood within or near the temporal lobe 
on head CT; and presence of an epidural hematoma on head CT. 
To calculate the SITI score, we obtained the GCS combined 
score from the patient’s initial evaluation in the ED, Patients 
with total GCS scores of 9-12 received 1 point, and patients 
with total GCS scores of <9 received 2 points. On the initial 
eye exam, a unilateral enlarged pupil added 2 points. (Bilateral 
enlarged and/or unreactive pupils did not add points.)  Findings 
on head CT were also used: we measured midline shift of 
the septum pellucidum (measured at the level of the foramen 
of Monro), and patients received 2 points for midline shift 
measuring 5-10 millimeters (mm) and 4 points for midline 
shift >10 mm. Pathology (defined as hemorrhage or edema) 
localized to the middle cranial fossa added 1 point. An epidural 
hematoma with a width ≥ 10 mm added 2 points. The minimum 
score was zero, and the maximum possible score was 11.
Statistical Analysis
The statistical analyses were performed by a statistician 
(Junxin Shi), and the software Statistical Analysis System 9.3 
(SAS Institute, Cary, North Carolina) was used. We compared 
operative and nonoperative patient groups using t-tests for 
means and chi-squared tests for percentages (statistical 
significance was defined as P<0.05). We built logistic models 
to examine the odds of surgery with varied combinations of 
the five SITI score components as independent variables. 
For each of these models, we constructed area under the 
receiver operating curves (AUC) to evaluate the SITI scale’s 
performance.8 For the final chosen model, using all five SITI 
score components, we report sensitivity, specificity, positive 
predictive value, and negative predictive value.
RESULTS
Characteristics of Study Subjects
Of the 882 patients enrolled in the ProTECT III trial, 871 
patients were assessed. Eleven patients were not assessed 
for this retrospective analysis: six of the patients had care 
withdrawn; two had a posterior fossa hemorrhage; and three 
were deemed medically unfit for surgery by their treating 
physician (Figure 1). Patient characteristics were examined 
by univariate analysis (Table 2). Comparing the operative 
and nonoperative patients, we found no difference in gender 
or intubation status. Operative patients were, on average, 
six years older than nonoperative patients (P<0.001), and 
operative patients were transported from the location where 
the injury took place to the admitting hospital, on average, 
eight minutes earlier than nonoperative patients (P<0.001). 
For the components of the SITI score, operative patients had a 
slightly higher GCS combined score (P= 0.047), a higher rate 
of a unilateral enlarged pupil on initial exam (P=0.015), and 
higher rates of midline shift, temporal pathology, and epidural 
hematoma (P<0.001, for each variable).  Treatment with 
progesterone for the ProTECT study was similar between the 
two groups (P=0.82).
Main Results
Comparing the percentages of patients who had certain 
Feature Finding Points
GCS >12 0
9-12 1
<9 2
Eyes
Unilateral enlarged pupil yes 2
no 0
Head CT <5 mm 0
Midline shift 5-10 mm 2
>10 mm 4
Temporal blood yes 1
no 0
Epidural hematoma >10 mm yes 2
no 0
Table 1. Components of the Surgical Intervention for Traumatic 
Injury Scale.6
GCS, Glasgow Coma Scale; CT, computed tomography; mm, 
millimeter.
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SITI scores, approximately 66.5% of the nonoperative patients 
had SITI scores between of 0 and 2, as compared with 6.7% 
of the operative patients (Figure 2). To determine the potential 
usefulness of setting the threshold of a positive SITI score at 3 
or above, we performed retrospective analysis. The sensitivity 
for the SITI score with the decision to perform a craniotomy 
or craniectomy was 0.93, and the specificity was 0.66 (Table 
3). The positive predictive value was 0.39, and the negative 
predictive value was 0.97 (Table 3). The AUC was also 
examined and was found to be 0.89 (Figure 3).
DISCUSSION
As was shown in the initial publication describing 
the SITI score,6 our results indicate that there is a strong 
association between the SITI score and a neurosurgeon’s 
perceived need to perform a craniotomy or craniectomy for 
treatment of TBI. Our work represents an initial effort to 
create such a tool, and there is no gold standard to use for 
comparison. To further examine the SITI score,we used AUC 
analysis, which is a well-recognized method of evaluating a 
diagnostic test.9  
The AUC for the SITI score was found to be 0.89, 
indicating that higher SITI scores were associated with patient 
presentations that neurosurgeons perceived as requiring 
surgical intervention.10 For comparison, in a multicenter 
study the commonly used Acute Physiology, Age, Chronic 
Health Evaluation (APACHE III) methodology was found to 
have an AUC of 0.89 for prediction of mortality in trauma 
patients admitted to the intensive care unit.1 In addition, 
the SITI score had a high sensitivity and a high negative 
predictive value, suggesting that it would have a higher 
tendency to identify patients who potentially need surgery 
and would have a lower tendency to mislabel potentially 
operative patients as nonoperative.
Total number of patients from the 
ProTECT III data base (n=882)
Total excluded patients (n=11)
Care was withdrawn (n=6)
Posterior fossa hemorrhage (n=2)
Deemed medically unfit for surgery (n=3)
Included in analysis of the SITI 
Scale (n=871)
Figure 1. Flowchart of retrospective patient selection from the ProTECT III database. 
ProTECT III, Progesterone for the Treatment of Traumatic Brain Injury III Trial; SITI, Surgical Intervention for Traumatic Injury. 
Nonoperative Operative
Total number of patients, n 707 164
Mean age, years‡ 37.8 44.2
Female patients, na 184 (26.0) 44 (26.8)
Mechanism, na‡
MVC/ATV/Scooter 425 (60.1) 62 (37.8)
Fall 101 (14.3) 33 (20.1)
Assault 38 (5.4) 16 (9.8)
Bicycle 38 (5.4) 8 (4.9)
Other/unknown 23 (3.2) 13 (7.9)
Pedestrian struck by vehicle 82 (11.6) 32 (19.5)
Mean time from injury to ED 
intake (minutes)‡
55.1 47.2
Intubation, na‡ 169 (23.9) 41 (25)
Mean GCS† 7.6 8.1
Enlarged pupul, na‡ 94 (13.2) 34 (20.7)
Midline shift, na‡
0-5 millimeters 688 (97.3) 61 (37.2)
5-10 millimeters 19 (2.7) 68 (41.5) 
> 10 millimeters 0 35 (21.3)
Temporal pathology, na‡ 245 (34.7) 143 (87.2)
Epidural hematoma, na‡ 56 (7.9) 49 (29.8)
Treatment with progesterone, na‡ 352 (49.8) 80 (48.7)
MVC, motor vehicle collision; ATV, all-terrain vehicle, ED, emergency 
department; GCS, Glasgow Coma Scale score.
aParentheses indicate percentage of total
†Indicates difference between the non-operative and operative 
groups is P<0.05
‡Indicates difference between the non-operative and operative 
groups is P<0.001
Table 2. Patient characteristics.
Western Journal of Emergency Medicine 582 Volume 20, no. 4: July 2019
The SITI Scale: A Clinical Tool for Traumatic Brain Injury Sribnick et al.
Figure 2. The Surgical Intervention for Traumatic Injury (SITI) score at admission for operative and nonoperative patients. 
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Table 3. Using a threshold of 3 for the SITI (Surgical Intervention for 
Traumatic Injury) score, the sensitivity, specificity, positive predictive 
value (PPV), and negative predictive value (NPV) are shown.
Operative 
patients
Nonoperative 
patients
SITI Score > 3 152 327 PPV 0.39
SITI Score < 3 12 470 NPV 0.97
Sensitivity Specificity
0.93 0.66
The clinical implications of such a scale are several-fold. 
A validated numerical scale could promote clear and efficient 
communication between clinicians in the manner similar to 
how the GCS is used to rapidly communicate a neurological 
assessment.12 The SITI score could be used in interdepartmental 
communication (e.g., between the ED and the neurosurgery 
consultant) or for hospital-to-hospital transfer (e.g., between a 
referring hospital and an accepting trauma center). Increasing 
efficiency in communication for patient transfers may translate 
into improved outcomes, as earlier operative intervention may 
improve functional outcome.13  
The current study advances our research of the SITI scale 
as a clinical tool. Our initial retrospective study6 did show a 
possible association between the SITI score and the surgeon’s 
decision to perform a surgical decompression, but that study 
had several limitations, including that it was limited to a single-
center, retrospective design, a limited number of patients, 
and had a high potential for observer bias. While the current 
study was also retrospective, the data were from a Phase III, 
multicenter trial where TBI patient treatment and outcome data 
were collected for a completely separate purpose; thus, observer 
bias was not likely introduced. Nonetheless, future work on the 
SITI scale will need to include prospective analysis.  
Figure 3. The area under the receiver operating characteristic 
(ROC) curve using a Surgical Intervention for Traumatic Injury 
(SITI) score of 3 as the threshold. 
Area under the curve = 0.8866.
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Determining the utility of the SITI score in clinical 
practice will require prospective testing and, ultimately, 
clinician acceptance. Nonetheless, prior research has identified 
several aspects of a clinical decision tool that were predictive 
of usefulness: the SITI scoring system is automated; it 
provides information at the time of clinical decision making; 
and it provides a recommendation that can result in a 
clinical intervention.3  The SITI scoring system is based on 
information that should already have been gathered for the 
TBI patient. It would easily lend itself to a handheld device 
(e.g., tablet or smartphone). Additionally, the information 
provided by the score would arrive at the time a decision 
needs to be made and would support a clinical action.
For a scoring system to be effective, it must define a 
specific clinical scenario and population to be addressed. For 
instance, the commonly used Subaxial Cervical Spine Injury 
Classification (SLIC) is not applicable to the entire cervical 
spine, as injuries involving the atlas, axis, and craniocervical 
junction are distinct injuries that do not lend themselves to 
the SLIC scale.14 Finally, a clinical scale should be used to 
suggest a clinical response, not to dictate it. The over-riding 
point of the scale is not to replace clinical judgment but to 
highlight a patient population in which timely surgical action 
may be warranted.
LIMITATIONS
A limitation to the SITI scale is that it is not intended 
to be used for all forms of TBI. It only covers closed head 
injury; skull fractures do not factor into the score, and 
it does not address posterior fossa injuries.  Guidelines 
for the surgical management of penetrating head injury15 
and depressed skull fracture16 exist and have additional 
considerations, such as infection prevention, that also 
must be taken into account when deciding on surgical 
management. Injuries to the posterior fossa have their own 
indications and are rare.17-19 The current study uses data 
obtained from the ProTECT III trial; thus, any exclusion 
criteria from that study (e.g., severe alcohol intoxication) 
influenced the present study and limit its applicability. Future 
work will need to be more inclusive to demonstrate the 
utility of this clinical tool.
CONCLUSION
In summary, this study used the multicenter ProTECT III 
database to examine whether the previously described SITI 
scoring system correlates with TBI patients who received 
surgical intervention for their injury. Our findings show 
a strong association between a SITI score of 3 or greater 
and the treating neurosurgeon’s perceived need to perform 
an operative intervention. Our findings potentially have 
significant clinical implications. Utility of the SITI score in 
clinical practice and future clinician acceptance require further 
prospective evaluation.
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INTRODUCTION
Prior studies have reported that during the period of Daylight 
Saving Time (DST) adjustment, there are a greater number of 
motor vehicle collisions.1-3 These studies noted that the increase 
in collisions occurs mainly on the following Monday after the 
time change. We hypothesize that changes in sleep patterns 
may be one of the reasons for this increase. Although the 
number of fatal accidents increases, it is unclear whether there 
is an increased need for hospital-based trauma services. We 
hypothesized that there may be an increased number of trauma 
activations during DST changes that may indicate a need for 
increased resources.
METHODS
We performed a retrospective chart review at an academic, 
tertiary care hospital identified as a Level 1 trauma center. 
This hospital serves multiple counties and has an emergency 
department annual census of 83,000 patients. There are no other 
trauma centers in the primary county. Data, including dates and 
total number of trauma activations for those respective dates, 
were extracted from the hospital’s trauma registry. We compared 
the number of trauma activations occurring on the Mondays of 
DST change to those occurring on the Mondays one week before 
and one week after the DST changes, over a 20-year span. Mann-
Whitney U tests were employed for all analyses. 
RESULTS
At the start of DST, the median number of trauma activations 
(N = 40) on the Mondays of DST (median = 2, range = 7) did not 
differ significantly (U = 190.5; p = 0.41) from the Mondays one 
week before (median = 2.5, range = 7), nor did it significantly 
differ (U = 184; p = 0.34) from the Mondays one week after 
(median = 2.5, range = 7). Likewise, at the end of DST, the 
median number of total trauma activations for the Mondays of 
DST (median = 2, range = 7) did not differ significantly (U = 167; 
p = 0.19) from the Mondays one week before (median = 3, range 
= 7), nor did it significantly differ (U = 161.5; p = 0.15) from the 
Mondays one week after (median = 2, range = 7).
WellSpan York Hospital, Department of Emergency Medicine, York, Pennsylvania *
DISCUSSION
We did not identify an increase in the number of trauma 
activations associated with DST changes during the study period. 
Our hospital is located in the Mid-Atlantic area of the United 
States and our data might differ from other sites by experiencing 
greater lighting changes during DST. Furthermore, with a 
relatively low sample size of trauma activations per day, there 
may not be enough variability to detect changes associated with 
DST. Although this site provides care to multiple counties with 
the nearest Level 1 trauma center over 20 miles away, we did not 
find a significant increase in activations. Currently, there are no 
indications for increasing trauma services during DST changes at 
our single site.
Median Number 
of Activations Range P
Mondays 1 week before start of DST 2.5 7 0.41
Mondays of start of DST 2.0 7
Mondays 1 week after start of DST 2.5 7 0.34
Mondays 1 week before end of DST 3.0 7 0.19
Mondays at end of DST 2.0 7
Mondays 1 week after end of DST 2.0 7 0.15
Table 1. Trauma activations on Mondays.
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Angioedema is defined by non-dependent, non-pitting edema that affects several different sites and 
is potentially life-threatening due to laryngeal edema. This narrative review provides emergency 
physicians with a focused overview of the evaluation and management of angioedema. Two primary 
forms include histamine-mediated and bradykinin-mediated angioedema. Histamine-mediated forms 
present similarly to anaphylaxis, while bradykinin-mediated angioedema presents with greater face 
and oropharyngeal involvement and higher risk of progression. Initial evaluation and management 
should focus on evaluation of the airway, followed by obtaining relevant historical features, including 
family history, medications, and prior episodes. Histamine-mediated angioedema should be treated 
with epinephrine intramuscularly, antihistaminergic medications, and steroids. These medications are 
not effective for bradykinin-mediated forms. Other medications include C1-INH protein replacement, 
kallikrein inhibitor, and bradykinin receptor antagonists. Evidence is controversial concerning the 
efficacy of these medications in an acute episode, and airway management is the most important 
intervention when indicated. Airway intervention may require fiberoptic or video laryngoscopy, with 
preparation for cricothyrotomy. Disposition is dependent on patient’s airway and respiratory status, 
as well as the sites involved. [West J Emerg Med. 2019;20(4)587-600.]
INTRODUCTION
Angioedema is a condition defined by non-dependent, 
non-pitting, transient edema lasting up to seven days due to 
the accumulation of vasoactive substances.1-5 These substances 
increase vascular permeability, resulting in swelling in the deep 
dermal, submucosal, and subcutaneous tissues of the face, 
lips, neck, extremities, and gastrointestinal (GI) system.1,2,6-9 
Urticaria may be present in up to 50% of cases, depending on the 
underlying process.1,2,6-9
Angioedema accounts for 80,000 to 112,000 emergency 
department (ED) visits per year, with a hospitalization rate of 
4.0 per 100,000 population.10-12 For patients taking angiotensin-
converting enzyme inhibitors (ACEi), the incidence of 
angioedema ranges from 0.1-0.7% over a patient’s lifetime, 
while the prevalence of hereditary angioedema (HAE) ranges 
from 1 in 10,000 to 1 in 50,000 persons.6,10-15  Over 50% of 
patients with HAE require ED management, with over half of 
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patients admitted to the hospital.1-3 ACEi-mediated angioedema 
accounts for 30% of angioedema cases. Of the cases of ACEi-
mediated angioedema, one study found 18% of patients were 
admitted to observation, 12% to the inpatient setting, and 11% 
to the intensive care unit.1,16 Due to risk of airway involvement 
and death, the emergency physician (EP) plays a key role in 
assessment and management of angioedema.1,2,17,18
METHODS
We searched PubMed and Google Scholar for articles 
in English from 1966 to October 2018 using a combination 
of the keyword and medical subject heading “angioedema” 
for production of this narrative review. Our search included 
case reports and series, retrospective and prospective studies, 
systematic reviews and meta-analyses, narrative reviews, and 
clinical guidelines. Two authors decided by consensus which 
studies to include for the review. Initial literature search revealed 
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Population Health Research Capsule
What do we already know about this issue?
Angioedema is defined by non-dependent, non-pitting 
edema that affects several different sites and is 
potentially life-threatening due to laryngeal edema.
What was the research question?
This narrative review evaluates the pathophysiology, 
evaluation, and management of angioedema.
What was the major finding of the study?
There are two forms of angioedema. Management 
must focus on the airway, although several 
medications are promising.
How does this improve population health?
Evidence is controversial for the efficacy of several 
medications, and airway management is the most 
vital intervention if indicated. Disposition depends 
upon airway and respiratory status.
over 500 articles, of which 185 were selected for inclusion, 
focusing on ED evaluation and management.
DISCUSSION
Etiology
Angioedema can be defined as either hereditary 
(bradykinin) or acquired (bradykinin or histamine) (Table 1).1-
5,7,15,19-24 The underlying pathophysiology (ie, bradykinin- vs 
histamine-mediated) influences the clinical presentation and 
treatment recommendations.1,2,7,8 Bradykinin-mediated forms are 
generally more severe, longer lasting, and frequently involve the 
upper airway and gastrointestinal (GI) system.1,20-24 
Histamine-mediated
Histamine-mediated angioedema is the most common 
form, accounting for 40-70% of all cases, and is associated 
with immunoglobulin E resulting in degranulation of mast 
cells and basophils.1-5 H1 and H2 receptors are primarily 
responsible for the swelling that leads to angioedema.1,4,5 
Histamine-mediated angioedema, such as anaphylaxis, occurs 
rapidly after an allergen exposure (type I hypersensitivity 
reaction).5,25-30 Histamine-mediated angioedema and 
anaphylaxis present similarly, as they are along the same 
clinical spectrum, although diagnosis of anaphylaxis requires 
specific clinical criteria.1-5 Importantly, therapy for histamine-
mediated angioedema and anaphylaxis is the same, which 
will be discussed later. Histamine-mediated angioedema 
typically resolves within 24-48 hours. This form can result 
from food allergens, medications, exercise, bites, stings, or 
latex exposure.31-33  There is also a form of physically-induced 
angioedema from cold exposure, heat pressure, physical 
activity, ultraviolet radiation, and vibration, which is most 
likely due to histamine release.34-36 
Bradykinin-mediated
Bradykinin-mediated pathways involve this vasoactive 
nonapeptide that activates endothelial cells.5,14,37 Several systems 
regulate bradykinin, including the coagulation, complement, and 
contact pathways.4,38 Excess bradykinin is due to  production, 
release, or inhibition of its breakdown.39-41 This form comprises 
drug-induced angioedema (ie, ACEi-mediated), HAE 
Types Characteristics
Histamine-mediated 
(with urticaria)
- Allergy to food, venom, latex, medication
- Acute or chronic spontaneous urticaria
- Urticaria/angioedema associated with cold urticaria, vasculitis, exercise, episodic angioedema, 
vibration-induced, drug reactionp
Bradykinin-mediated 
(without urticaria)
- Type I HAE: defective C1-INH level/function
- Type II HAE: defective C1-INH function
- Type III HAE: normal C1-INH 
-Acquired C1-INH deficiency: Type I associated with increased catabolism of C1-INH 
(lymphoproliferative disorder, autoimmune disease); Type II associated with autoantibody to C1-INH
- ACEi-mediated angioedema
- Medication associated: dipeptidyl peptidase-IV inhibitor (gliptins for diabetes mellitus), angiotensin II 
receptor blockers, recombinant tissue plasminogen activator, sirolimus, tacrolimus, everolimusd
Idiopathic 
(unknown etiology)
- Histaminergic
- Nonhistaminergic
HAE, hereditary angioedema; C1-INH, C1 inhibitor; ACEi, angiotensin-converting enzyme inhibitor.
Table 1. Types of angioedema.
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types I and II, and several forms of acquired and idiopathic 
angioedema.13,20,42,43 
ACEi-mediated angioedema accounts for up to 30% of 
ED visits for angioedema of all types.16,21,44-49 ACEis prevent 
the conversion of angiotensin I to angiotensin II and reduce 
bradykinin metabolism, which increases the risk of angioedema. 
Most cases are localized to the lips and tongue.14,15 Patients at 
greatest risk for developing ACEi-mediated angioedema include 
African Americans and those taking immunosuppressants 
or dipeptidyl peptidase-IV inhibitors (a class of diabetic 
medications) in addition to the ACEi.14,15,49  The rate of 
angioedema is highest within the first 30 days of starting an 
ACEi, although the risk of angioedema remains for the duration 
of the ACEi use, with cases of ACEi-mediated angioedema 
documented in patients with prolonged courses of multiple 
years.50-52 If a patient continues taking an ACEi after developing 
ACEi-mediated angioedema, the average time to recurrence is 
approximately 10 months.50,53 Angiotensin II receptor blockers 
(ARB) and renin antagonists can also cause angioedema, but this 
is not due to bradykinin.1-5 If angioedema develops in a patient 
on an ACEi, the ACEi should be discontinued and a different 
antihypertensive class used.
HAE is thought to be autosomal dominant with abnormal 
C1-INH amounts and/or function. HAE affects approximately 
1 in 10,000–50,000 people.1,2,54,55 Type 1 is due to decreased 
and defective C1-INH and is the most common (85%) form of 
HAE, followed by type II which is caused by dysfunctional C1-
INH.13,55-59 A third form of HAE with normal C1-INH has also 
been described.60-62 Most patients present by age 10 with recurrent 
episodes of edema.1-4,58  HAE is often associated with prodromal 
symptoms, such as erythema marginatum, but not urticaria.1,4,16,61,63 
HAE occurs more commonly in females and causes more severe 
swelling with significant face and tongue involvement when 
compared with males.1-5,13 Estrogen-containing medications and 
pregnancy increase the attack frequency in female patients.7,61,64 
Acquired angioedema appears similar to HAE with C1-
INH deficiency, but this is not hereditary and more commonly 
affects those > 40 years.1,65-71 This form is most commonly due 
to catabolism of C1-INH, although some patients may have a 
lymphoproliferative or autoimmune disorder.1,65-71  
A less common cause of non-histaminergic angioedema 
is associated with medications, including nonsteroidal anti-
inflammatory drugs (NSAID), antibiotics, and ARB.72-75 
NSAID-associated angioedema results from inhibition of 
cyclooxygenase and accumulation of leukotriene mediators, 
and occurs in 0.1-0.3% of patients taking an NSAID.56 
Exposure to recombinant tissue plasminogen activator therapy 
in acute ischemic stroke is also associated with angioedema, 
occurring in 1.2-5.1% of patients, with increased risk in 
patients taking an ACEi.76-80 Most of these cases are mild and 
resolve in 24 hours.1,2,7,8
Idiopathic
Idiopathic angioedema is diagnosed by failure to determine 
the etiology with > 3 attacks in a 6-12 month period.2,5,81-83 
Most patients with idiopathic angioedema will demonstrate a 
response to standard therapies for anaphylaxis (eg, epinephrine, 
antihistamines, steroids), although a small group will not 
improve with these therapies.1-4,84 This latter group is more 
commonly bradykinin-associated.1-4,84   
Presentation, History, and Physical Examination
Initial evaluation requires assessing vital signs, airway, and 
cardiovascular systems. Asphyxiation is the leading cause of 
mortality in these patients, necessitating airway evaluation.17,18,85 
At least one episode of laryngeal edema occurs in over half of 
all patients with HAE and accounts for over 30% of deaths in 
HAE.17,18  Emergency physicians (EP) must inquire about lip 
swelling, tongue swelling, and GI symptoms (nausea, vomiting, 
diarrhea, and pain).  Additional information to gather includes 
prior personal or family history of angioedema, medications, 
and related symptoms (eg, pruritis, dyspnea, syncope, 
lightheadedness).85-93 Patients with a known history of HAE 
should also be asked about recent trauma, which can trigger an 
episode.1-5 Most patients with HAE report prodromal symptoms 
prior to swelling, such as fatigue and rash.94 
The presentation can vary depending upon the subtype 
but is primarily dependent upon whether the etiology is 
histaminergic or non-histaminergic (Table 2).1-5,13 The most 
commonly involved areas include the head and neck (eg, 
eyelids, lips, tongue, larynx), extremities (eg, hands and feet), 
external urogenital system, and abdomen.1-5,9,13,28 However, 
involvement of these sites is often non-contiguous, with no 
specific pattern.1-5,7,8 Histaminergic forms display faster onset, 
while HAE and acquired forms have a slower, progressive 
onset occurring over several hours.1,2,7,8  GI tract submucosal 
involvement occurs in up to 93% of patients with HAE and 
can cause symptoms that mimic bowel obstruction.13,55,90,91 
Non-pitting edema is present in both histaminergic and non-
histaminergic forms.1,4,7,8 Pruritic, localized, urticarial lesions 
may be present in histamine-mediated forms with involvement 
Features Histaminergic Non-histaminergic
Onset Minutes Hours
Duration 12-24 hours 48-72 hours
Hypotension Common Atypical
Urticaria Common Atypical
Bronchospasm; wheez-
ing
Common Atypical
Laryngeal edema Possible Possible
Abdominal pain Possible Possible
Therapy with epinephrine, 
antihistamines, steroids
Effective Not effective
Table 2. Comparison of features between non-histaminergic and 
histaminergic angioedema.
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of the deep dermis, but these are rare in non-histaminergic 
forms.13,95,96 Urticaria occurs in approximately 50% of patients 
with histamine-mediated angioedema.13,95,96 
Findings suggestive of the need for a definitive airway 
include stridor, hoarseness, dyspnea, and voice changes.86-92 
The patient should be asked to phonate “E” with a high pitch, 
as a patient able to complete this maneuver is unlikely to have 
laryngeal edema.1,7,8  Auscultation of the lungs to determine the 
presence of wheezing is recommended.
Differentiating histamine and bradykinin-mediated 
angioedema can be difficult. One retrospective study evaluated 
188 patients, with one point assigned to age > 65 years, dyspnea, 
no itching or erythema, laryngeal involvement, and intake of 
ACEi/AT-II antagonist, and two points assigned if there was 
no response to steroid therapy.97 If the score was > 3 points, the 
patient was treated with C1-INH or B2 receptor antagonist for 
suspicion of bradykinin-mediated angioedema. This resulted 
in a sensitivity of 96% and specificity of 84% for the diagnosis 
of bradykinin-mediated angioedema.97 While this tool can 
help to differentiate the underlying etiology, it requires further 
validation before routine use. 
Diagnostic Testing
Angioedema is a clinical diagnosis, with no required testing 
in the ED.1,2,4  Leukocyte counts cannot reliably differentiate if 
an infection is present, as leukocytosis over 30,000 per cubic 
millimeter has been observed.98 C-reactive protein may be 
elevated in ACEi-mediated angioedema.1,4 Determining the 
specific type of angioedema involves specialized laboratory 
testing not available in the ED, including tryptase, C4, and C1-
INH.1-4 These tests can be obtained in the outpatient setting and 
should not be routinely obtained in the ED, as they do not guide 
management. Histamine-mediated forms can display elevated 
tryptase levels during attacks, while patients with HAE will 
display normal tryptase levels.3 C4 levels serve as a sensitive 
screening test for C1-INH deficiency.1,3 Serum C4 levels will 
typically be < 30% of normal in acute episodes of angioedema 
from HAE types I and II, although the laboratory values may 
be normal between attacks.23,100,101 Type I HAE often involves 
low C1-INH levels and decreased function, while type II HAE 
includes normal levels but decreased function.13,19,102  C1q 
levels, a component of the complement system, can be used to 
differentiate acquired and hereditary forms, as C1q is decreased 
in acquired angioedema and normal in HAE.1,3,4,100,103 Type III 
HAE has normal levels and function of C1-INH but is usually 
identified by a positive family history.1-4,7,8 No tests can confirm 
ACEi-mediated angioedema.1,7,19,23 
Patients with abdominal symptoms may demonstrate 
segmental bowel wall edema, straightening of intestinal 
segments, and ascites on computed tomography (CT).4,104,105  
Ultrasound may similarly reveal bowel wall thickening or 
ascites.106 Ultrasound can be used to evaluate for laryngeal 
edema, although this requires further study.4 Chest radiography, 
if obtained, is typically normal. Neck radiographs and CT of 
the neck with intravenous (IV) contrast can evaluate for mimics 
of angioedema, but they should not be ordered routinely for 
patients with suspected angioedema.104 Fiberoptic visualization 
of laryngeal and airway structures is recommended if concern for 
laryngeal or airway involvement is present.
Management
The primary focus of ED management is assessment 
of the airway and evaluation for anaphylaxis, which is the 
most common mimic.1-4,7,8 Figure 1 depicts an algorithm for 
management. Vital signs should not be relied upon in isolation to 
determine the need for airway intervention.  
Airway Management
Patients with angioedema involving the tongue or larynx 
require consideration of definitive airway management. 
Angioedema can progress rapidly within hours, and 
airway obstruction occurs in up to 15% of patients with 
angioedema.1,4,17,18 For patients with angioedema who require a 
definitive airway, cricothyrotomy or tracheostomy is needed in 
up to 50% of cases.17,87,105 Prior history of intubation or severe 
angioedema should raise the concern for a difficult airway which 
may require early airway intervention.1,4,107 Evidence of upper 
airway involvement on examination includes stridor, change in 
patient voice, and hoarseness. If physical examination reveals 
swelling of the tongue, floor of the mouth, or soft palate, directly 
visualize the tongue base and airway with fiberoptics. The 
presence of epiglottic, aryepiglottic, or laryngeal edema suggests 
need for definitive airway.1,2 If the angioedema exclusively 
involves structures anterior to the teeth such as the lips, intubation 
is generally not needed.85-92
Noninvasive positive pressure ventilation can also assist 
with temporization; however, this is not a definitive therapy for 
patients with airway involvement. Supraglottic and extraglottic 
airway devices are common rescue devices; however, they are 
not recommended in patients with angioedema, as the device will 
remain above the site of airway obstruction.1,4,7,8,85 If placed, these 
devices may also worsen edema due to the associated trauma 
with placement. 
Physical manipulation of the airway may worsen edema, 
especially in bradykinin-mediated angioedema.1,4,7,8 In 
patients with history or evidence on examination of a difficult 
airway, video laryngoscopy or fiberoptic awake intubation is 
recommended, as this allows the patient to maintain his/her 
airway reflexes during airway visualization and the intubation 
attempt.1,4,107-109 Topical anesthetics and ketamine are optimal 
agents for awake intubation. Severe edema may prohibit 
passage of an endotracheal tube through the glottis, even with 
the use of fiberoptic or video laryngoscopy guidance. Thus, the 
resuscitation team must prepare for cricothyrotomy before an 
attempt at intubation is started, known as a double setup.1-5 If the 
patient does not require immediate airway intervention, transfer 
to the operating room may be beneficial with anesthesia and 
otolaryngology consultation, similar to pediatric epiglottitis. 
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Figure 1. Algorithm for angioedema management. 
IV, intravenous; IM, intramuscular; ACEi, angiotensin converting enzyme inhibitor; FFP, fresh frozen plasma; ICU, intensive care unit.
*ACEi-mediated, Hereditary, or Acquired Angioedma only.
**Hereditary or Acquired Angioedema only.
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Medications
Medication management focuses on three aspects: acute 
episode management, short-term prophylaxis, and long-term 
prophylaxis, with ED management focusing on the acute 
episode.1,4,7,8 If the suspected etiology is drug- or allergic-induced, 
the trigger must be removed.1-5 In histamine-mediated forms of 
angioedema, standard therapy for anaphylaxis is recommended. 
However, in other forms of angioedema including bradykinin-
mediated forms, standard therapies for anaphylaxis should not be 
effective.110,111  
Patients with evidence of histaminergic forms of angioedema 
and concern for airway involvement should receive epinephrine, 
steroids, antihistamines, and IV fluids.1-5,7,8,112 If there is any 
suspicion of anaphylaxis, urticaria-associated angioedema, or 
if the exact underlying cause of the angioedema is unknown, 
histamine-mediated edema should be assumed. Epinephrine 
should be administered via the intramuscular route into the 
anterolateral middle third of the thigh, with initial dose 0.3-
0.5 milliliter (mL) (0.3-0.5 milligram [mg]) of 1:1000 dilution 
(1 mg/mL), which can be repeated every 5-20 minutes.1,4 
Subcutaneous administration is not recommended.112-114 IV 
epinephrine should be considered in patients requiring multiple 
doses of intramuscular epinephrine and should begin at doses of 
1-4 micrograms (mcg) per minute.112,115,116  Epinephrine can be 
administered peripherally by injecting 1 mg of epinephrine into 
1 L of normal saline, resulting in a final concentration of 1 mcg/
mL. If administered wide-open through an 18-gauge IV, this 
provides 20-30 mL/minute (20-30 mcg/minute) of epinephrine. 
Adjunctive therapies for histamine-mediated angioedema 
include antihistamines and steroids.1-5,7,8,112 Antihistamines have a 
slower onset of action and should only be used as an adjunctive 
therapy.1-5,7,8,112,117 Diphenhydramine is an H1 antagonist that 
can be used in doses of 25-50 mg IV to reduce swelling in 
combination with a second- or third-generation antihistamine 
agent (eg, cetirizine, loratadine, fexofenadine, levocetirizine, 
desloratadine).1-5,112,117-127 The addition of an H2 antagonist is 
beneficial in decreasing urticaria, as 15% of cutaneous histamine 
receptors are H2.117-128 Steroids such as methylprednisolone 125 
mg IV decrease inflammatory mediators in histamine-mediated 
angioedema and anaphylaxis but, similar to other medications, 
there is little to no evidence for their use in non-histaminergic 
angioedema.1,4,7,8,112 The onset of action after administration is 
delayed, typically requiring 4-6 hours to take effect.1-5,7,8,14,15 
Fresh frozen plasma (FFP) has been recommended for use in 
angioedema based on case reports demonstrating improvement 
in HAE and ACEi-mediated angioedema,129-133 as FFP contains 
varying amounts of C1-INH.1-4,7,8,14,15,134-136 Several of the first 
case reports suggested FFP can be used as prophylaxis for HAE 
in patients undergoing dental procedures.129,135,137 A retrospective 
study suggests efficacy in decreased intubation frequency and 
intensive care unit (ICU) length of stay.137 However, type II HAE 
may worsen with FFP due to the presence of an autoantibody 
responsible for decreased C1-INH.134 Limited literature has 
described FFP in ACEi-mediated angioedema, primarily case 
reports and series demonstrating improved symptoms at four 
hours.132,133,136,138-145 Its use in acquired forms has not demonstrated 
efficacy, and a major limitation is the need to thaw FFP for 
use. The literature is inconsistent with regard to preferred 
dosing, with most studies giving 1-4 units (250–1000 cubic 
centimeters).1-5,135,136 FFP requires close to 50 times the volume of 
other medications with C1INH to obtain the same serum levels of 
enzyme.135 Risks include potential volume overload, transmission 
of bloodborne infection, and hypersensitivity reaction.1-4,7,8,136 FFP 
also contains substrates such as kallikrein and kininogen that may 
paradoxically worsen angioedema.1-4,7,8,14 Despite this theoretical 
effect, worsening of angioedema with FFP administration has not 
been found in cases of ACEi-mediated angioedema.1,4,134-136 There 
is no support for FFP in other acquired forms of angioedema.1-4,135 
Prothrombin complex concentrate (PCC) has also been 
used for ACEi-mediated angioedema.1,4,146 However, the data is 
limited to one case report in which 1500 units were administered. 
Symptoms began to improve in 20 minutes, with resolution in 
eight hours.146 Four-factor PCC contains C1-INH, which may 
explain the improved symptoms. 
Targeted Therapies for Bradykinin-mediated Angioedema
Bradykinin-mediated forms of angioedema are typically 
resistant to therapies effective in histamine-mediated 
reactions.1,4,7,8,13,135,136,147 At the time of construction for this 
review, several medications have been FDA approved for 
treatment of acute bradykinin-mediated angioedema: three C1-
INH concentrates (two plasma-derived and one recombinant), 
one kallikrein inhibitor, and one bradykinin-2-receptor 
antagonist (Table 3).1,4,7,8,13,135,136  
C1 Inhibitor Concentrate
C1-INH concentrate for HAE episodes was first described 
in 1973, and there are two plasma-derived formulations currently 
available (Berinert and Cinryze), as well as one recombinant form 
(Ruconest), all administered intravenously.1-5,7,8,135,136,148 They are 
currently approved for acute HAE, although these medications 
have been used for ACEi-mediated forms.1-5,7,8,135,136,148 Berinert 
and Cinryze provide native plasma protein that regulates 
kallikrein and Factor XII activity, reducing bradykinin 
production. Bork et al. published a study based on 18 patients 
with 193 episodes of HAE, finding that the mean time to 
reversal was 42.2 minutes.149 The IMPACT trials (funded by 
CSL Behring, manufacturer of Berinert) evaluated Berinert vs 
placebo for acute episodes of HAE. IMPACT-1 found 20 units 
per kilogram (kg) improved time to symptom relief (0.5 hours 
vs 1.5 hours), but 10 units/kg did not.150,151 IMPACT-2 evaluated 
1085 episodes of HAE in 57 patients, with a median time to 
symptom relief of 0.46 hours in patients receiving open-label 
Berinert.151 Cinryze has also been evaluated in HAE, with a 
double-blind placebo-controlled trial of 68 patients finding no 
statistically significant improvement in time to relief, although a 
double-blind crossover trial of 21 patients demonstrated decrease 
in attack number, duration, and severity.4,136,152 A study that was 
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not placebo controlled found 68% of patients had improvement 
at one hour, while 87% experienced relief at four hours.153 Other 
trials evaluating Berinert and Cinryze for HAE and ACEi-
mediated angioedema have found that the time to symptom 
improvement from administration varies from 0.5-5 hours, with 
complete resolution occurring within 1-10 hours.136 Ruconest is 
a recombinant form of C1INH. One open-label study with no 
placebo control found time to symptom relief of 30 minutes.154 
A double-blind, placebo-controlled trial found time to symptom 
relief of 66 minutes in patients receiving 100 units/kg, vs 495 
minutes in controls.155 Another randomized trial found time to 
symptom relief of 75 minutes in treated patients vs 303 minutes 
in patients receiving placebo.156 
Kallikrein Inhibitor
Ecallantide (Kalbitor) is a recombinant plasma inhibitor 
of kallikrein provided subcutaneously and approved for use 
in HAE.1,4,7,8,136 This agent reduces bradykinin synthesis by 
preventing the cleavage of kininogen.1,4,7,8,136 It is associated with 
up to a 3% risk of anaphylaxis, necessitating close observation 
during administration and for up to one hour after.1,4,7,8 The 
EDEMA trials evaluated ecallantide for HAE.157-160 The 
EDEMA1 trial evaluated ecallantide at various doses vs placebo, 
finding the 40 mg/m2 dose improved symptoms at four hours, 
although other doses did not.157 The phase 2 EDEMA2 trial found 
subcutaneous dosing had improved outcomes vs IV dosing.158 
EDEMA3 was an open label and double-blind phase 3 trial 
evaluating ecallantide vs placebo, with improvement in treatment 
score at four hours in patients receiving ecallantide.159 EDEMA4 
found improved symptom scores vs placebo.160 A triple-blind 
phase 2 randomized controlled trial compared ecallantide at three 
different subcutaneous doses with placebo for ACEi-mediated 
angioedema and found no difference in patients meeting criteria 
for discharge.161 Lewis et al. conducted a double-blind phase 2 
study with patients randomized to placebo or ecallantide.162 Most 
patients received therapy for histamine-mediated angioedema as 
well. The study found no difference in patients meeting criteria 
for discharge within six hours with ecallantide administration.162 
Bradykinin B2 Receptor Antagonist
Icatibant acetate (Firazyr) is a selective and competitive 
bradykinin B2 receptor antagonist.1,4,7,8,136 Icatibant was evaluated 
in three clinical trials: FAST-1, FAST-2, and FAST-3.136,163,164 
FAST-1 was a double-blind, placebo-controlled trial that 
demonstrated faster symptom relief (0.8 vs 16.9 hours) but no 
difference in the degree of symptom relief.4,163 The FAST-2 study 
demonstrated improved time to symptom relief in a double-
blind study comparing icatibant to oral tranexamic acid (onset of 
symptom improvement 0.9 vs 7.8 hours).4,163 FAST-3 was a phase 
3 double-blind, randomized, placebo-controlled trial that found 
a decrease in the time to primary symptom relief (2.0 vs 19.8 
hours) and complete symptom relief (median 8.0 vs 36 hours).4,164 
The literature suggests that the time to symptom improvement 
ranges from several minutes up to seven hours for icatibant. Of 
studies reporting improvement, approximately half of patients 
improve within 30 minutes, while time to complete symptom 
resolution ranges from 0.5-16 hours.136,165-174 Importantly, 40% of 
cases have complete resolution under four hours.136,165-173   A phase 
2 multicenter, randomized controlled trial by Bas et al. evaluated 
icatibant vs steroids plus antihistamines, finding a shorter time 
to symptom relief with icatibant (2 hours vs 11.7 hours).174 More 
patients receiving icatibant also demonstrated resolution of edema 
at four hours. However, there was no difference in the degree of 
patient-reported symptom relief.4,136 
Medication (trade name) Mechanism Route Dose Time to onset Minor side effects Serious side effects
Plasma derived C1-INH 
(Berinert, Cinryze)
C1-INH protein 
replacement
IV Berinert 
20 units/
kg; Cinryze 
1000 units
Median 30-48 
minutes
Dysgeusia Hypersensitivity, 
thrombosis, blood-
borne infection
Recombinant C1-INH 
(Ruconest)
C1-INH protein 
replacement
IV 50 units/kg Median 90 
minutes
Pruritis, rash, 
sinusitis
Hypersensitivity, 
anaphylaxis
Ecallantide (Kalbitor) Kallikrein inhibitor SQ 30 mg Median 67 
minutes
Headache, injection 
site reactions, 
nausea, fever
Hypersensitivity, 
anaphylaxis
Icatibant acetate 
(Firazyr)
Bradykinin 
B2 receptor 
antagonist
SQ 30 mg Median 2 
hours
Elevated LFTs, 
injection reaction, 
dizziness, headache, 
nausea, fever
Theoretical worsening 
of an ongoing ischemic 
event
Fresh frozen plasma C1-INH protein 
replacement 
(various amounts)
IV 15 mg/kg Minutes to 
hours
Hypersensitivity, 
worsening angioedema, 
transfusion infection
Table 3. Angioedema medications.
C1-INH, C1 inhibitor; IV, intravenous; SQ, subcutaneous; LFTs, liver function tests; mg, milligram; kg, kilogram.
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A systematic review published in 2017 evaluating medication 
use in ACEi-mediated angioedema concluded icatibant possessed 
the highest level of evidence due to better study quality, while 
FFP has limited evidence demonstrating benefit and inconsistent 
dosing strategies for ACEi-mediated angioedema.136 This 
systematic review incorporated case reports, case series, a 
prospective observational study, and one randomized controlled 
trial. However, the recommendations were limited by low 
quality evidence and significant heterogeneity with respect to 
the severity of angioedema and clinical outcomes.175 Most of the 
included studies evaluated time to discharge and time to symptom 
relief, rather than the need for definitive airway, peak symptoms 
severity, duration of mechanical ventilation, and hospital/
ICU admission.136,175 Publication bias was also severe, limiting 
conclusions. Studies following the publication of this systematic 
review from 2017 suggest no difference in time to discharge 
with icatibant.175 Sinert et al. evaluated icatibant vs placebo in 
a phase III, double-blind clinical trial.176 Time to discharge was 
four hours in both groups, with similar time of symptom relief.176 
A second prospective, randomized study published by Straka 
et al. compared icatibant and placebo, finding no difference in 
symptom severity or duration.177 
The current literature evaluating targeted therapy for 
bradykinin-mediated angioedema suffers from several limitations, 
including significant heterogeneity in patient selection, outcomes, 
comparators, dosing, and study design, as well as low numbers 
of included patients and high risk of bias.1,4,136,175 Medication 
efficacy is controversial with delayed onset of action, variable 
relief of symptoms, and limited availability depending on the 
institution.136,175 Rather than primarily focus on administering 
medications that may or may not improve symptoms in 
bradykinin-mediated forms of angioedema, EPs should focus on 
managing the patient’s airway.1,4,175
Disposition
Disposition is mainly determined by airway involvement. 
Several studies have sought to predict airway compromise in 
patients with acute angioedema.1-5,85,178 Ishoo et al. performed 
a retrospective study of 80 patients with 93 acute episodes 
of angioedema.85 Wheezing, voice change, hoarseness, and 
stridor predicted the need for airway intervention. This 
study categorized patients based on the anatomic location of 
angioedema (Table 4).85 A subsequent study published one 
year later found the same factors predict need for definitive 
airway.178 Importantly, these factors require further validation 
and laryngeal visualization for staging. 
Patients with respiratory or airway distress require ICU 
admission, as well as those with stage III and IV edema due 
to risk of progression.1-5,7,8,89 Patients with stable or improving 
stage I or II edema of the face, lip, or soft palate should be 
monitored for several hours to evaluate for worsening of the 
angioedema.1-5,7,8,89,102 Patients with stage I angioedema can be 
discharged with follow-up after evaluation for progression. 
Patients with stage II angioedema are often discharged home 
within 24 hours, and ED observation units provide an optimal 
setting for monitoring of these patients.1,4 However, if edema 
involves > 3 sites (lips, tongue, mouth floor, soft palate, and 
larynx), admission is recommended due to greater risk of 
airway involvement.89 
Patients with acute and recurrent angioedema may benefit 
from consultation with allergy/immunology specialists to discuss 
laboratory testing and arrange follow-up, particularly in patients 
with HAE.1-5,7,8,102 Patients with a first episode of angioedema, 
no response to anaphylaxis treatment, or family history of HAE 
require follow-up with an allergy/immunology specialist. These 
specialists can help diagnose a specific cause, evaluate and 
educate the patient concerning triggers, and provide prophylactic 
medications, which may prevent the need for ED care.1,4,179,180 
Patients with known HAE and a recurrent attack may present 
with an action plan and recommended therapies, which should be 
followed when possible.102,181,182
Patients discharged from the ED with histamine-mediated 
angioedema and those with unclear etiology or first-time episode 
should be prescribed epinephrine autoinjectors and educated on 
potential triggers.69,102 Family and friends should also be educated 
on these factors. Patients with respiratory distress or airway 
swelling after discharge should use the epinephrine autoinjector 
and immediately return to the ED. The patient with ACEi-
mediated angioedema must discontinue his or her medication, 
and an alternative agent should be discussed with the patient’s 
primary care provider.1-5,7,8,102  Most patients can use calcium 
channel blockers or angiotensin receptor blockers without 
developing a recurrence of their angioedema.1,183,184 The literature 
suggests the incidence of angioedema with ARB is 0.11%, which 
is not statistically different than placebo.185 
Stage Site Frequency Discharge Inpatient ICU Intervention
I Face, lip 31% 48% 52% 0% 0%
II Soft palate 5% 60% 40% 0% 0%
III Tongue 32% 26% 7% 67% 7%
IV Larynx 31% 0% 0% 100% 24%
Table 4. Predicting airway compromise based on anatomic location of angioedema.85 
ICU, intensive care unit.
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CONCLUSION
Angioedema is non-dependent, non-pitting edema at a 
variety of sites. Its forms can be divided into histamine-mediated 
and bradykinin-mediated types. Histamine-mediated forms can 
present similarly to anaphylaxis, while bradykinin-mediated 
angioedema is slower in onset, presents with greater face and 
oropharyngeal involvement, and has higher risk of progression. 
Initial evaluation and management should focus on the airway, 
followed by an evaluation for family history, medications, and 
prior episodes. Histamine-mediated angioedema is treated like 
anaphylaxis with epinephrine, antihistamines, and steroids. 
These medications are not effective for the bradykinin-mediated 
forms, although they can be attempted in the absence of effective 
therapy. Other medications include C1-INH protein replacement, 
kallikrein inhibitor, and bradykinin receptor antagonists. Several 
studies have evaluated these for angioedema, but the evidence is 
lacking for efficacy. The focus should be on airway management 
rather than medications in bradykinin-mediated angioedema. This 
may require fiberoptic or video laryngoscopy, with preparation 
for cricothyrotomy. Disposition depends on patient’s airway and 
respiratory status, as well as the involved sites. 
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Introduction: Airway management is a fundamental skill of emergency medicine (EM) practice, 
and suboptimal management leads to poor outcomes. Endotracheal intubation (ETI) is a procedure 
that is specifically taught in residency, but little is known how best to maintain proficiency in this 
skill throughout the practitioner’s career. The goal of this study was to identify how the frequency of 
intubation correlated with measured performance. 
Methods: We assessed 44 emergency physicians for proficiency at ETI by direct laryngoscopy on 
a simulator. The electronic health record was then queried to obtain their average number of annual 
ETIs and the time since their last ETI, supervised and individually performed, over a two-year period. 
We evaluated the strength of correlation between these factors and assessment scores, and then 
conducted a receiver operator characteristic (ROC) curve analysis to identify factors that predicted 
proficient performance.
Results: The mean score was 81% (95% confidence interval, 76% - 86%). Scores correlated well 
with the mean number of ETIs performed annually and with the mean number supervised annually 
(r = 0.6, p = 0.001 for both). ROC curve analysis identified that physicians would obtain a proficient 
score if they had performed an average of at least three ETIs annually (sensitivity = 90%, specificity 
= 64%, AUC = 0.87, p = 0.001) or supervised an average of at least five ETIs annually (sensitivity = 
90%, specificity = 59%, AUC = 0.81, p = 0.006) over the previous two years.
Conclusion: Performing at least three or supervising at least five ETIs annually, averaged over 
a two-year period, predicted proficient performance on a simulation-based skills assessment. 
We advocate for proactive maintenance and enhancement of skills, particularly for those who 
infrequently perform this procedure. [West J Emerg Med. 2019;20(4)601-609]
INTRODUCTION
Endotracheal intubation (ETI) is a high-stakes, life-saving, 
procedural skill. However, little is understood regarding 
maintenance of proficiency for this procedure. Although airway 
skills are known to decline without continuous practice,1,2 factors 
influencing the maintenance of proficiency for this procedure 
are poorly understood. Patients requiring ETI for impending 
respiratory failure are at high risk of death or permanent cognitive 
impairment when the procedure is improperly performed. Prior 
Maimonides Medical Center, Department of Emergency Medicine, Brooklyn, New York
studies demonstrate that patients undergoing multiple attempts at 
intubation (three or more) have significantly higher adverse event 
rates as compared with patients undergoing fewer attempts.3,4
The Accreditation Council of Graduate Medical Education 
(ACGME) mandates that resident physicians, prior to 
graduation, perform a specific number of intubations, which 
varies across specialties, in order to achieve proficiency for 
this skill.5 However, once acquired, the best way to maintain 
this skill is unclear,6,7 and evidence is lacking regarding the 
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minimum experience needed to maintain proficiency. Pusic 
et al. suggested that there is a rate for both gaining and losing 
skills, and that deliberate practice was the method of choice for 
avoiding losses.8
The Agency for Healthcare Research and Quality, The Joint 
Commission, and the American Board of Medical Specialties 
(ABMS) have increased efforts on quality improvement 
initiatives that facilitate the maintenance of proficiency and 
adherence to evidence-based standards. In 2004, the American 
Board of Emergency Medicine (ABEM) implemented a 
maintenance of certification (MOC) program to improve the 
quality of care delivered by emergency physicians.9 It consists 
of the four components proposed by ABMS: 1) lifelong learning 
and self-assessment; 2) improvement in medical practice; 3) the 
ConCert examination (assessment of knowledge, judgment and 
skills); and 4) professionalism and professional standing. Despite 
these efforts, there is no evidence-based guideline for maintaining 
proficiency in procedural skills such as ETI.
The purpose of this study was to identify factors relating to 
intubation frequency that correlate with proficiency for ETI. 
 
METHODS
Study Design
This was a cross-sectional study to determine factors 
related to intubation frequency that correlated with assessed 
skill of ETI via direct laryngoscopy (DL) on an airway 
simulator. We performed a subsequent analysis on factors with 
good correlation to identify intubation frequencies that could 
predict assessment scores below a defined proficiency level. 
The study was classified as “exempt” by the local institutional 
review board.
Study Setting and Sample
The study was conducted at a private urban hospital in 
the Northeast with an annual emergency department census 
of 115,000 patients, and an associated emergency medicine 
(EM) residency program. Subjects assessed for ETI proficiency 
included a convenience sample of all employed full-time 
attending physicians over a three- month time period. All 
participants were board certified or board eligible in EM, 
pediatric EM, or both. Participation was mandated as part of a 
departmental skills advancement initiative conducted between 
November 2011 and January 2012. 
Measurements
The primary outcome measures were the strength of 
correlation between DL ETI assessment scores and the 
following: 1) the time since last performing an intubation; 2) the 
time since last supervising an intubation; 3) the mean number 
of intubations performed annually; and 4) the mean number 
of intubations supervised annually. The secondary outcome 
measure was the identification of intubation frequencies that 
predict a physician score below the established proficiency 
score on the airway assessment. We performed a post hoc 
analysis to measure the strength of correlation with years of 
experience and ETI assessment score.
ETI Assessment - Score Calculation
Each attending physician was individually administered 
a skills assessment of ETI by DL on a TruCorp Airsim 
Advance mannequin, which was a model replicating the 
airway from DICOM library images of an actual patient’s 
computed tomography. We assessed physicians for successful 
completion of 11 checklist items (Table 1), as well as their 
overall psychomotor adeptness using a rating scale of 0-10, 
Population Health Research Capsule
What do we already know about this issue?
Intubation skill is associated with frequency of 
performance and deliberate practice, not years of 
experience. Formal skill assessment after residency is 
uncommon.
What was the research question?
How does the frequency of endotracheal intubation 
correlate with measured performance in attending 
physicians?
What was the major finding of the study?
Performing at least three or supervising at least five 
intubations annually predicted proficient skill.
How does this improve population health?
Evidence-based guidelines regarding intubation 
frequency help inform the need for proactive training 
to maintain proficiency in this critical skill.
Assembly of equipment:
□ Suction
□ Correct-sized endotracheal tube and blade
□ Back-up tube and blade
□ Rescue device
□ Stylet
□ Confirmation device (EDD, EtCO2 detector, etc.)
Discrete actions:
□ Evaluates airway anatomy and mobility
□ Positions appropriately
□ Articulates RSI meds
□ Does not rock laryngoscope handle backwards on insertion
□ Inserts tube to correct depth
Table 1. 11-item intubation checklist. 
EDD, esophageal detector device; EtCO2, end-tidal carbon dioxide; 
RSI, rapid sequence intubation.
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with 0 representing significant “struggle” and 10 representing 
“no struggle.” The construct of “struggle” was defined by 
characteristics such as coordination, grace, dexterity, and 
timing. Of note, time itself was not discretely measured as 
we aimed for the assessment to reward quality over speed. At 
least two of three pre-trained raters were present during each 
evaluation, and performance scores were recorded by consensus 
on a standardized evaluation form. Successful performance for 
each checklist item was grounded in common best practices. 
For example, the item “inserts tube to correct depth” would 
be considered acceptable if a 7.5 tube was placed at a level 
anywhere from 21-24 cm at the lips. Regarding tube and blade 
size, a variety of common options available in the clinical 
space were provided, and any reasonable choice appropriate to 
the size of the airway simulator was deemed acceptable. The 
binary evaluation for procedural step completion and the overall 
psychomotor adeptness scale were similarly weighted such that 
the total assessment had a maximal potential score of 21 points. 
The total score was ultimately represented as a percentage of the 
total possible points (ie, 18/21 would be 86%).
ETI Assessment - Instrument Validity 
There is no well-established, validated tool for measuring 
ETI skill via the DL approach for experienced providers who 
served as our population group. Furthermore, few previously 
published tools provide validity evidence in accordance with 
its contemporary conceptualization embodied by the current 
Standards of Educational and Psychological Testing.10 Thus, 
the authors chose to develop a novel assessment tool. Content 
validity of the tool is supported in that checklist items were 
crafted after triangulation of multiple sources for best practices 
in EM and anesthesiology textbooks and discussion with 
experienced emergency physicians.11,12 
Due to the inherent limitations in an assessment rooted 
purely in checklist items,13 we also used a psychomotor scale 
to evaluate other characteristics of procedural skill such as 
coordination, grace, dexterity, and timing. Checklists alone 
have been criticized for rewarding thoroughness rather than 
competence,14 and do not differentiate the novice who performs 
all steps (poorly) from the expert. They do add an objective 
component to the evaluation that allows assessors a standardized 
report of critical actions. Global rating scales may be more 
appropriate for assessment on performance-based evaluations,15 
and have been shown to have good psychometric characteristics 
when used in conjunction with a checklist.16,17 
Response process was supported in that all three raters 
(authors BG, DS, and AA) were involved in developing the 
instrument and had come to consensus on how to employ the tool 
a priori. Raters also familiarized themselves with equipment and 
testing conditions in advance of assessments, and they deliberated 
upon ratings for each step, with disagreements discussed in real 
time until there was consensus. As the scores were shared with 
the department chair as part of Ongoing Professional Practice 
Evaluations, care was taken to ensure that scores were an accurate 
representation of performance on the simulator. This was made 
explicitly transparent to participants, thus providing an impetus 
to make their best attempt at intubating as if it were a real patient. 
Further consequences validity evidence was provided in that 
low assessment scores resulted in protected time to attend an 
airway skills refresher course at the expense of the department, 
additional mannequin training in the simulation center, and repeat 
assessment (with improved results). Validity evidence based on 
internal structure of the tool was supported by demonstration 
of good internal consistency between checklist items and 
psychomotor adeptness (Cronbach’s α = 0.8). 
 
ETI Assessment - Proficiency Cut Score
We used a borderline methods approach to determine a 
cut score for proficient skill performance.18 The construct of 
proficient performance was defined as a physician demonstrating 
requisite skill such that he or she is likely to successfully 
intubate patients via DL in the emergent setting, consistent with 
the definition of proficiency as provided by Dreyfus.19 After 
participants completed their assessment, each rater independently 
identified attendings whose performance was not clearly 
proficient or clearly not proficient, ie, on the borderline. We used 
the median score from this cohort as the cut off for proficient skill 
performance. 
Data Analysis
We presented assessment scores and intubation frequencies 
with descriptive statistics and 95% confidence intervals (CI). 
Intubation frequencies were obtained by querying the electronic 
health record over the previous two years, concluding on 
the date of each physician’s assessment. Factors relating to 
intubation frequency were 1) the time interval between a 
physician’s assessment and their last performance of an ETI; 2) 
the time interval between a physician’s assessment and their last 
supervision of an ETI; 3) the total number of ETIs performed; 
and 4) the total number of ETIs supervised. We performed a post 
hoc analysis to measure the strength of correlation with years of 
experience and ETI assessment score.
The strength of correlation between assessment scores and 
each of these factors was calculated using Pearson’s correlation 
coefficient. Factors that demonstrated good correlation with 
assessment scores (r ≥ 0.6) were plotted on a receiver operating 
characteristic (ROC) curve to identify specific values that 
would predict ETI assessments below the proficiency cut score. 
We evaluated internal consistency of the assessment tool with 
Cronbach’s alpha for its two overarching aspects, psychomotor 
adeptness and completion of procedural steps. Data was analyzed 
with SPSS version 20 (IBM, Armonk, New York).
RESULTS
We assessed all full-time employed EM attending physicians 
(n = 44, 33 general EM trained and pediatric EM (PEM) trained). 
From this initial cohort, 12 were excluded as they were not 
present for the entirety of the two-year, look-back period, 
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leaving 24 EM-trained and 8 PEM-trained physicians (n = 32). 
The mean years of professional practice for the physician group, 
defined as years practiced since graduating from residency, was 
10.3 years (95% CI, 7.4-13.3) (Table 2). 
General emergency physicians on staff during the look-
back period performed an average of 4.2 intubations per year 
(95% CI, 2.8-5.6) and supervised an average of 5.3 per year 
(95% CI, 4.4-6.2). PEM physicians on staff during the two-year, 
look-back period performed an average of 0.2 intubations per 
year (95% CI, 0-0.4) and supervised an average of 0.3 per year 
(95% CI, 0.1-0.6). There was significant heterogeneity between 
physicians regarding the number of days elapsed between 
taking the assessment and last performing an intubation 
(mean = 405, median = 74, standard deviation = 687) or last 
supervising an intubation (mean = 83, median = 35, standard 
deviation = 144). A summary of EM and PEM assessment 
scores is provided in Table 3.
We identified 14 participants as borderline performers (10 
EM and 4 PEM) relating to the construct of clearly evident 
proficient performance. The median assessment score for the 
borderline group was 79% (lower quartile = 75%; upper quartile 
= 86%,; interquartile range = 11%). 
Scores correlated well with the average number of 
intubations performed per year (r = 0.6, p < 0.001) and with the 
average number of intubations supervised per year (r = 0.6, p 
= 0.001). Scores did not correlate as well with the time passed 
since last supervising or performing an intubation, or with years 
of experience (r = -0.5, p = 0.002; r = -0.3, p = 0.07; and r = 
-0.4, p = 0.004; respectively).
ROC analysis identified, with good accuracy, that physicians 
Practice setting Faculty specialty Physician Total supervised Total performed Years post-residency
Academic urban General EM 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
11
16
18
6
7
10
8
10
16
5
5
10
6
16
20
10
4
7
8
15
8
13
13
12
14
16
20
10
6
12
0
2
21
0
9
13
1
7
23
8
6
2
1
7
1
5
13
4
4.5
4.5
3.5
0.5
8.5
8.5
8.5
10.5
3.5
30.5
0.5
16.5
12.5
5.5
4.5
2.5
2.5
6.5
9.5
7.5
15.5
3.5
2.5
4.5
Pediatric EM 25
26
27
28
29
30
31
32
1
1
0
1
0
2
0
0
0
0
0
2
0
0
1
0
3.5
17.5
12.5
3.5
33.5
3.5
7.5
10.5
Total precepted Total performed Years post-residency
General EM mean (n=24) 10.6 8.4 7.4
Pediatric EM mean (n=8) 0.6 0.4 11.5
Total mean (n=32) 8.1 6.0 8.4
EM, emergency medicine.
Table 2. Summary of practice setting and provider characteristics.
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would score at or above the proficiency cut score if they 
performed an average of at least three intubations annually 
(sensitivity = 90%, specificity = 64%, area under the curve 
[AUC] = .87, p = .001) or supervise an average of at least five 
intubations annually (sensitivity = 90%, specificity = 59%, AUC 
= .81, p = .006) over a period of two years (Figures 1 and 2). 
DISCUSSION
It is the public trust that gives physicians their status as 
professionals. When polled, 95% of respondents rated MOC for 
physicians as “important,” with a majority stating that regular 
testing to assess physician medical knowledge and periodically 
testing clinical performance and quality of care as being “very 
important.”20 Leach described skill acquisition and competence 
as a process, not a destination, with professional development 
needing to be a lifelong habit.21 This is because skill decay (the 
loss or degradation of acquired skills after periods of non-use) is a 
well-known phenomenon.  
We ultimately identified two factors that correlated well with 
ETI performance– the number of intubations performed and the 
number of intubations supervised (on average per year for both). 
Specifically, physicians were at risk to fall below proficiency if 
they performed fewer than three or supervised fewer than five 
intubations per year on average. The ROC analysis allowed 
us to establish an optimal cut point for intubation frequency to 
predict proficient performance on the assessment. We chose 
cut points with higher sensitivity to avoid misclassification 
of “true positives,” ie, those who actually scored below the 
proficiency cut score on the assessment. We were unable to 
parse out the relative importance of performing vs supervising 
intubations as these metrics were exceedingly interconnected. 
It is unclear exactly how supervising intubations contributes 
to maintaining proficiency in the actual performance of ETI. 
However, neuroscience research on mirror neurons does suggest 
a physiologic basis for this phenomenon.22,23 
Several studies have shown decay of critical cognitive and 
psychomotor skills in managing cardiopulmonary arrest.24,25,26 
Major factors that influence the rate of decay are length of 
retention interval; degree of overlearning; task characteristics 
(closed loop vs open loop, cognitive vs physical, speed vs 
accuracy); methods of testing for original learning and retention; 
conditions of retrieval; instructional strategies or training 
methods; and individual differences in abilities.27 Historically, 
ETI was taught in the same place it needed to be performed – on 
patients in the clinical setting. While this method may positively 
influence some of the listed factors (original learning methods 
and conditions of retrieval), it is unlikely to provide the kind of 
experience that will lead to overlearning. 
Ericsson et al. demonstrated that deliberate practice (rigorous 
practice with assessment and feedback) is the method of choice 
to gain expertise and avoid decay of a skill.28 For ETI, this would 
be most easily accomplished and assessed with simulation. 
Simulation-based assessments are increasingly integrated into 
medical education and have been proposed as the modality of 
choice to develop and assess procedural skill acquisition.29 Our 
study demonstrates replicable methodology using an airway 
simulator to assess performance. Obviously, simulation is 
not “real life”; however, it is the ethical alternative in which 
patient safety is not at risk and where confounding variables 
may be tightly controlled. Additionally, a simulation-based 
assessment carries greater face validity than the current practice 
of no assessment at all for this procedure. That said, the strong 
correlation between assessment scores and intubation experience 
suggests further construct validity of the assessment platform 
used in this study.
Similar to other sites,30 the PEM physicians in our cohort 
averaged less than one intubation per year, which is well below 
the threshold identified in our study. Not surprisingly, a prior 
survey of PEM directors revealed that 62% felt the number 
of ETIs  performed were inadequate to maintain competency, 
and nearly half (48%) of the respondents reported that they use 
simulation to remediate or maintain competency.31 Ultimately, we 
chose not to exclude the PEM attendings, just as we chose not to 
exclude other cohorts that intubate less frequently (eg, physician 
administrators, researchers, or those working predominantly 
in less- acute zones), since the population of providers that 
infrequently perform ETI was specifically the group we were 
most concerned with regarding potential skill decay.
Board-certified EM and PEM physicians are expected to 
be able to perform airway management in adult and pediatric 
patients with requisite skill. Furthermore, the ACGME mandates 
the development of such skill as part of program requirements. 
ETI Assessment Score Mean Median IQR Standard Deviation Range (min) Range (max)
All EM Attendings
(n=44)
81% 86% 76-91% 16% 33% 100%
Adult EM Attendings 
(n=33)
85% 86% 81-95% 14% 33% 100%
PEM Attendings
(n=11)
69% 76% 60-79% 17% 33% 86%
ETI, endotracheal intubation; IQR, interquartile range; EM, emergency medicine; PEM, pediatric emergency medicine.
Table 3. Comparison of emergency medicine and pediatric emergency medicine providers’ assessment scores in intubation skills.
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Thus, we chose to include all providers who might be expected 
to perform an intubation on a patient with an adult-sized airway. 
Most dedicated pediatric emergency physicians treat patients with 
an upper age range from 18-25. We felt it would be inconsistent 
with the public trust placed in EDs for us to remove PEM 
providers from our cohort because they less frequently perform 
intubations. There is no published data showing PEM attendings 
have explicitly been assessed for procedural skill, and no data 
comparing their skill to general EM attendings. That said, in our 
cohort EM and PEM providers performed at both ends of the 
spectrum with a similar distribution of borderline performers to 
the overall cohort. Furthermore, in support of competency-based 
education, the expectation of educators is to train to a set standard 
regardless of subspecialty.32
Procedural re-credentialing is essentially automatic in our 
specialty, typically in two-year intervals, which is why we chose a 
two-year interval to analyze. Given the high-stakes nature of ETI, 
the results of this study may be used to help identify physicians 
Intubations performed per year (n=32) ROC curve with cutoff at 3 ETIs performed per year
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Figure 1. Sensitivity and specificity for various cut points represented as the number of endotracheal intubations performed annually.
ROC, receiver operator characteristic; ETI, endotracheal intubation; AUC, area under the curve.
Intubations performed per year (n=32) ROC curve with cutoff at 5 ETIs performed per year
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Figure 2. Sensitivity and specificity for various cut points represented as the number of ETIs supervised annually and the ROC curve for a cut 
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ROC, receiver operator characteristic; ETI, endotracheal intubation; AUC, area under the curve.
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who may benefit from refresher training in conjunction with 
re-credentialing. In our department, attendings who performed 
poorly were required to complete an airway refresher course 
at the department’s expense as well as local, simulation-based 
training. This approach was well received, and when re-assessed 
their scores dramatically improved.
It is well accepted that psychomotor skill acquisition 
and maintenance requires repetition. The surgical literature 
demonstrates this principle. Patient outcomes after surgical 
procedures have a clear association with the number of times 
that the surgeon has performed the procedure.33-35 Even when 
attempts to control for other factors have been considered, the 
number of times that a surgeon has performed a procedure 
remains strongly correlated to outcomes. This stands to reason: 
practice makes perfect.
Experience in years alone, however, does not predict a 
higher level of functioning. Our study showed a weak negative 
correlation between years of experience and assessed skill. 
Multiple previous studies have also shown that provider 
experience has an inverse relationship to many measures of 
clinical performance,36 and specifically in complex airway 
management.37 This implies that skills must be practiced with 
some minimal frequency. We cannot ethically dictate how many 
of our patients will need ETI, and so alternative methods of 
experience must be sought. Computer screen-based simulation 
may be an acceptable method for teaching some skills, but high-
fidelity simulation has shown to assist in the retention of complex 
airway skills for up to one year.38
It is possible that the level of skill demonstrated by 
physicians on the airway simulator used in this study does not 
translate to a similar level of competence in the clinical arena. 
The use of simulation requires a “suspension of disbelief,” and 
there has been some concern raised that task trainers do not 
accurately replicate human anatomy.39-41 Using simulation for the 
assessment of competence needs to be authentic if it is to imply 
that the practitioner would perform similarly with real patients.42 
However, research demonstrates that assessment in simulated 
environments can be reliable and valid.43,44 Specifically in airway 
management, studies have shown that assessment of competence 
corresponds to operational performance in the clinical setting.45,46 
In addition, there is evidence supporting the use of mannequins 
for training, assessment, and maintaining competency.47,48
While faculty development may be ubiquitous in training 
institutions, generally it is focused on the domains relevant 
to career advancement such as teaching, administration, and 
research. The focus of developing more generalized knowledge, 
skills, and attitudes is limited to resident trainees. In our 
department, this initiative led to the formalization of an ongoing, 
robust, simulation-based faculty skills advancement curriculum 
that encompasses procedural (both novel and established), 
clinical, and cognitive skills. This has been well received by our 
faculty,49,50 and we hope this skills advancement curriculum will 
serve as a model for other organizations.
 
LIMITATIONS
We abstracted intubation data from the electronic health 
record, making it possible that uncharted intubations may have 
been missed. Assessors and participants were both employed by 
the same department. This meant that although the assessors had 
no prior access to each provider’s intubation record, absolute 
blinding was impossible. It is unknown if this contributed to 
unconscious bias. Additionally, for ethical reasons assessments 
were conducted on an airway simulator as opposed to live 
patients. However, the strong correlation observed between 
physicians’ assessment scores and their average numbers of 
annual intubations suggests construct validity for this assessment, 
and internal consistency for the tool was very good.
Although general EM and PEM providers are expected to 
be able to intubate both adult and pediatric patients, we only 
tested providers on the adult-equivalent manikin. This study was 
performed at a single center with a small sample size and may 
reflect factors not found at other institutions. Lastly, the study was 
conducted at an academic ED, where the majority of intubations 
are supervised rather than performed by attending physicians. 
As such, there was significant variance among physicians with 
regard to the time between last performing an intubation and 
taking the assessment. This likely relates to why the assessment 
scores correlated particularly poorly with the time interval since 
last performing an intubation at our institution.
 
CONCLUSION
Performing at least three or supervising at least five ETIs per 
year correlated with proficient performance on a skills assessment 
in our cohort. Our methodology is easily replicable and can be 
extrapolated across a wide range of procedures in future studies. 
Since simulation training has become widely available, we 
advocate for this modality as a platform for active maintenance 
and advancement of procedural skills. This approach was well 
received in our department. 
Address for Correspondence: David Saloum, MD, MACM, 
Maimonides Medical Center, Department of Emergency Medicine, 
965 48th Street, Brooklyn, NY 11219. Email: dsaloum@
maimonidesmed.org.
Conflicts of Interest: By the WestJEM article submission 
agreement, all authors are required to disclose all affiliations, 
funding sources and financial or management relationships that 
could be perceived as potential sources of bias. No author has 
professional or financial relationships with any companies that are 
relevant to this study. There are no conflicts of interest or sources 
of funding to declare.
Copyright: © 2019 Gillett et al. This is an open access article 
distributed in accordance with the terms of the Creative Commons 
Attribution (CC BY 4.0) License. See: http://creativecommons.org/
licenses/by/4.0/
Western Journal of Emergency Medicine 608 Volume 20, no. 4: July 2019
Skill Proficiency Predicted by Intubation Frequency of EM Attendings Gillett et al.
REFERENCES
1. Kovacs G, Bullock G, Ackroyd-Stolarz S, Cain E, Petrie D. A 
randomized controlled trial on the effect of educational interventions 
in promoting airway management skill maintenance. Ann Emerg Med. 
2000;36(4):301-9.
2. Youngquist ST, Henderson DP, Gausche-Hill M, Goodrich SM, Poore 
PD, Lewis RJ. Paramedic self-efficacy and skill retention in pediatric 
airway management. Acad Emerg Med. 2008;15(12):1295-303.
3. Hasegawa K, Shigemitsu K, Hagiwara Y, et al. Association between 
repeated intubation attempts and adverse events in emergency 
departments: an analysis of a multicenter prospective observational 
study. Ann Emerg Med. 2012;60(6):749-54.
4. Sakles JC, Chiu S, Mosier J, Walker C, Stolz U. The importance of first 
pass success when performing orotracheal intubation in the emergency 
department. Acad Emerg Med. 2013;20(1):71-8
5. Emergency medicine defined key index procedure minimums. 
Accreditation Council for Graduate Medical Education website. 
2017. Available at: https://www.acgme.org/Portals/0/PFAssets/
ProgramResources/EM_Key_Index_Procedure_Minimums_103117.
pdf?ver=2017-11-10-130003-693. Accessed Sept 7, 2018.
6. Nolan J, Clancy M. Airway management in the emergency department. 
Br J Anaesth. 2002;88(1):9-11.
7. Graham CA. Advanced airway management in the emergency 
department: What are the training and skills maintenance needs for UK 
emergency physicians? EMJ. 2004;21(1):14-9.
8. Pusic MV, Kessler D, Szyld D, Kalet A, Pecaric M, Boutis K. Experience 
curves as an organizing framework for deliberate practice in emergency 
medicine learning. Acad Emerg Med. 2012;19(12):1476-80.
9. MOC overview. American Board of Emergency Medicine website. 
Available at: https://www.abem.org/public/stay-certified. Accessed 
August 31, 2018
10. Validity.1999. In: American Educational Research Association, American 
Psychological Association, National Council on Measurement in 
Education. Standards for Educational and Psychological Testing. Amer 
Educational Research Assn.
11. Brown CA, Walls RM. Airway. In: Marx JA, Hockberger RS, Walls RM, 
eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 7th 
ed. Philadelphia: Mosby/Elsevier; 2010:3-22
12. Hagberg, CA, Artime, CA. 2015. Airway Management in the Adult. In 
Miller RD (Ed.), Miller’s Anesthesia, 8th ed. (1647-1683). Philadelphia, 
Pennsylvania: Saunders/Elsevier.
13. Streiner DL, Norman GR, Cairney J. 2015. Validity. In Streiner DL, 
Norman GR, Cairney J. Health Measurement Scales: A Practical Guide 
to Their Development and Use, 5th ed. (227-253). Oxford, United 
Kingdom: University Press.
14. Norman G. Editorial - Checklists vs. ratings, the illusion of objectivity, the 
demise of skills and the debasement of evidence. Adv Health Sci Educ 
Theory Pract. 2005;10(1):1-3.
15. Regehr G, MacRae H, Reznick RK, Szalay D. Comparing the 
psychometric properties of checklists and global rating scales for 
assessing performance on an OSCE-format examination. Acad Med. 
1998;73(9):993-7.
16. Martin JA, Regehr G, Reznick R, et al. Objective structured 
assessment of technical skill (OSATS) for surgical residents. Br J Surg. 
1997;84(2):273-8.
17. Cohen R, Rothman AI, Poldre P, Ross J. Validity and generalizability of 
global ratings in an objective structured clinical examination. Acad Med. 
1991;66(9):545-8.
18. Streiner DL, Norman GR, Cairney J. 2015. From items to scales. In 
Streiner DL, Norman GR, Cairney J. Health Measurement Scales: 
A Practical Guide to Their Development and Use. 5th ed. (131-158). 
Oxford, United Kingdom: University Press.
19. Dreyfus SE. The five-stage model of adult skill acquisition. Bull. Sci. 
Technol. Soc. 2004;24(3):177-81.
20. Facts about the ABMS consumer survey: Lifelong learning and other 
qualities in choosing a doctor. 2011. American Board of Medical 
Specialties website. Available at: https://www.abms.org/media/1319/
abms_2010_consumer_survey_fact_sheet.pdf. Accessed August 
31,2018.
21. Leach DC. Competence is a habit. JAMA. 2002;287(2):243-4.
22. Keysers C, Gazzola V. Social neuroscience: mirror neurons recorded in 
humans. Curr Biol. 2010;20(8):R353-R354
23. Keysers C. Mirror neurons. Curr Biol. 2009;19(21):R971-R973.
24. Stross JK. Maintaining competency in advanced cardiac life support 
skills. JAMA. 1983;249(24):3339-41.
25. Palese A, Trenti G, Sbrojavacca R. Effectiveness of retraining after basic 
cardiopulmonary resuscitation courses: A literature review. Assist Inferm 
Ric. 2003;22:68-75.
26. Kaye W, Wynne G, Marteau T, et al. An advanced resuscitation training 
course for preregistration house officers. Clin Med (Lond).1990;24(1):51-
54.
27. Arthur W, Bennett W, Stanush PL, McNelly TL. Factors that influence 
skill decay and retention: a quantitative review and analysis. Human 
Performance. 1998;11(1):57-101.
28. Ericsson KA. Deliberate practice and the acquisition and maintenance 
of expert performance in medicine and related domains. Acad Med. 
2004;79(10):S70-S81
29. Wang EE, Quinones J, Fitch MT, et al. Developing technical expertise 
in emergency medicine - the role of simulation in procedural skill 
acquisition. Acad Emerg Med. 2008;15(11):1046-57.
30. Mittiga MR, Geis GL, Kerrey BT, Rinderknecht AS. The spectrum and 
frequency of critical procedures performed in a pediatric emergency 
department: implications of a provider-level view. Ann Emerg Med. 
2013;61(3):263-70.
31. Losek JD, Olson LR, Dobson JV, Glaeser PW. Tracheal intubation 
practice and maintaining skill competency - survey of pediatric 
emergency department medical directors. Pediatr Emerg Care. 
2008;24(5):294-9.
32. McGaghie WC, Siddal VJ, Mazmanian PE, et al. Lessons for continuing 
medical education from simulation research in undergraduate and 
graduate medical education: effectiveness of continuing medical 
education: American College of Chest Physicians Evidence-Based 
Educational Guidelines. Chest. 2009;135(3):62S-68S.
33. Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital 
Volume 20, no. 4: July 2019 609 Western Journal of Emergency Medicine
Gillett et al. Skill Proficiency Predicted by Intubation Frequency of EM Attendings
volume and surgical mortality in the United States. N Engl J Med. 
2002;346(15):1128-37.
34. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, 
Lucas FL. Surgeon volume and operative mortality in the United States. 
N Engl J Med. 2003;349(22):2117-27.
35. Hannan EL, Kilburn H, Racz M, Shields E, Chassin MR. Improving the 
outcomes of coronary artery bypass surgery in New York State. JAMA. 
1994;271(10):761-6.
36. Siu LW, Boet S, Borges BCR, et al. High-fidelity simulation demonstrates 
the influence of anesthesiologists’ age and years from residency on 
emergency cricothyroidotomy skills. Anesth Analg. 2010;111(4):955-60.
37. Nyssen AS, Larbuisson R, Janssens M, Pendeville P, Mayne A. A 
comparison of the training value of two types of anesthesia simulators: 
computer screen-based and mannequin-based simulators. Anesth 
Analg. 2002;94(6):1560-5.
38. Boet S, Borges BCR, Naik VN, et al. Complex procedural skills are 
retained for a minimum of 1 yr after a single high-fidelity simulation 
training session. Br J Anaesth. 2011;107(4):533-9.
39. Schebesta K, Hupfl M, Rossler B, Ringl H, Muller MP, Kimberger 
O. Degrees of reality airway anatomy of high-fidelity human patient 
simulators and airway trainers. Anesthesiology. 2012;116(6):1204-9.
40. Klock PA. Airway simulators and mannequins: a case of high infidelity? 
Anesthesiology. 2012;116(6):1179-80.
41. Schebesta K, Hupfl M, Ringl H, Machata AM, Chiari A, Kimberger O. A 
comparison of paediatric airway anatomy with the SimBaby high-fidelity 
patient simulator. Resuscitation. 2011;82(4):468-72.
42. Ker J, Bradley P. Simulation in medical education. In: Swanwick T, ed. 
Understanding Medical Education: Evidence, Theory, and Practice. 
Chichester, United Kingdom: Wiley-Blackwell; 2010:164-80.
43. Newble D. Techniques for measuring clinical competence: objective 
structured clinical examinations. Med Educ. 2004;38(2):199-203.
44. Nishisaki A, Keren R, Nadkarni V. Does simulation improve patient 
safety? Self-efficacy, competence, operational performance, and patient 
safety. Anesthesiology Clinics. 2007;25:225-36.
45. Mayo PH, Hackney JE, Mueck JT, Ribaudo V, Schneider RF. Achieving 
house staff competence in emergency airway management: Results of 
a teaching program using a computerized patient simulator. Crit Care 
Med. 2004;32(12):2422-7.
46. Overly FL, Sudikoff SN, Shapiro MJ. High-fidelity medical simulation as 
an assessment tool for pediatric residents’ airway management skills. 
Pediatr Emerg Care. 2007;23(1):11-5.
47. Friedman Z, You-Ten KE, Bould MD, Naik V. Teaching lifesaving 
procedures: the impact of model fidelity on acquisition and transfer 
of cricothyrotomy skills to performance on cadavers. Anesth Analg. 
2008;107(5):1663-9.
48. Chandra DB, Savoldelli GL, Joo HS, Weiss ID, Naik VN. Fiberoptic oral 
intubation: the effect of model fidelity on training for transfer to patient 
care. Anesthesiology. 2008;109(6):1007-13.
49. Saloum D, Gillett B, Aghera A et al. A mechanism to promote 
faculty involvement in nonclinical activities. Ann Emerg Med. 
2013;62(5):S174-S175
50. Saloum D, Aghera A, Gillett B. A simulation-based video laryngoscopy 
course for maintenance of board certification. Ann Emerg Med. 
2013;62(5):S179.
Western Journal of Emergency Medicine 610 Volume 20, no. 4: July 2019
original rEsEarch
 
Improvement in the Safety of Rapid Sequence Intubation 
in the Emergency Department with the Use of an Airway 
Continuous Quality Improvement Program
 
John C. Sakles, MD*
Cassidy C. Augustinovich, MS1†
Asad E. Patanwala, PharmD‡
Garrett S. Pacheco, MD*
Jarrod M. Mosier, MD*¶
Section Editor: Matthew Prekker, MD, MPH           
Submission history: Submitted January 14, 2019; Revision received April 6, 2019; Accepted April 20, 2019  
Electronically published June 3, 2019   
Full text available through open access at http://escholarship.org/uc/uciem_westjem    
DOI: 10.5811/westjem.2019.4.42343
Introduction: Airway management in the critically ill is associated with a high prevalence of failed first 
attempts and adverse events which negatively impacts patient care. The purpose of this investigation is 
to describe an airway continuous quality improvement (CQI) program and its effect on the safety of rapid 
sequence intubation (RSI) in the emergency department (ED) over a 10-year period.
Methods: An airway CQI program with an ongoing airway registry was initiated in our ED on July 1, 2007 
(Academic Year 1) and continued through June 30, 2017 (Academic Year 10). Data were prospectively 
collected on all patients intubated in the ED during this period using a structured airway data collection 
form. Key data points included method of intubation, drugs and devices used for intubation, operator 
specialty and level of training, number of intubation attempts, and adverse events. Adult patients who 
underwent RSI in the ED with an initial intubation attempt by emergency medicine (EM) resident were 
included in the analysis. The primary outcome was first pass success which was defined as successful 
tracheal intubation with a single laryngoscope insertion. The secondary outcome was the prevalence 
of adverse events associated with intubation. Educational and clinical interventions were introduced 
throughout the study period with the goal of optimizing these outcomes. Data were analyzed by academic 
year and are reported descriptively with 95% confidence intervals (CI) of the difference of means.
Results: EM residents performed RSI on 342 adult patients during Academic Year 1 and on 445 
adult patients during Academic Year 10. Over the 10-year study period, first pass success increased 
from 73.1% to 92.4% (difference = 19.3%, 95% CI 14.0% to 24.6%). The percentage of patients who 
experienced an adverse event associated with intubation decreased from 22.5% to 14.4% (difference = 
-7.9%, 95% CI -13.4% to -2.4%). The percentage of patients with first pass success without an adverse 
event increased from 64.0% to 80.9% (difference = 16.9%, 95% CI 10.6% to 23.1%). 
Conclusion: The use of an airway CQI program with an ongoing airway registry resulted in a substantial 
improvement in the overall safety of RSI in the ED as evidenced by an increase in first pass success and 
a decrease in adverse events. [West J Emerg Med. 2019;20(4)610–618.]
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Population Health Research Capsule
What do we already know about this issue?
Airway management is frequently performed 
in the emergency department (ED) and 
is associated with a high prevalence of 
adverse events.
What was the research question?
Could monitoring of airway performance in 
conjunction with an airway continuous quality 
improvement (CQI) program improve the safety 
of rapid sequence intubation in the ED? 
What was the major finding of the study?
Over a 10-year period the airway CQI 
program was associated with a 19.3% 
absolute increase in first pass success and a 
7.9% absolute decrease in adverse events.
How does this improve population health?
By monitoring airway management practices 
in the ED and making iterative clinical 
adjustments, the safety of this high-risk 
procedure can be improved.
INTRODUCTION
Critically ill patients frequently require airway 
management in the emergency department (ED) and this is 
usually accomplished with rapid sequence intubation (RSI).1 
Emergency airway management has been shown to be 
associated with a high prevalence of failed first attempts and 
adverse events, both of which can negatively affect patient 
care.2,3,4,5,6,7,8,9,10,11 Multiple intubation attempts are associated 
with an increase in adverse events, many of which can be 
life-threatening.3,12,13 When adverse events occur during 
emergency intubation, the effect on patient outcomes are much 
more severe compared to elective intubation.9,14 To maximize 
the safety of intubation in the ED, the goal should be to 
achieve first pass success without any adverse events. Without 
measuring important outcomes like first pass success and 
adverse events, it is difficult to improve patient care with 
emergency airway management. In our ED we developed an 
airway continuous quality improvement (CQI) program that 
incorporated an ongoing airway registry with the aim of 
improving the safety of emergency airway management. This 
study describes our airway CQI program and its associated 
effect on the safety of airway management in our ED. 
METHODS
Study Design and Setting
This study was conducted at an urban academic ED with a 
Level 1 trauma center and includes data over the 10-year period 
from July 1, 2007 (Academic Year 1) to June 30, 2017 
(Academic Year 10). Since this project was a CQI initiative it 
was granted an exemption by the University of Arizona 
Institutional Review Board.
This institution serves as the training site for two 
Accreditation Council for Graduate Medical Education 
(ACGME) accredited three-year emergency medicine (EM) 
residency programs, one of which is a university hospital-based 
program and the other which is a community-hospital based 
program. In addition, the institution supports a five-year 
combined emergency medicine/pediatrics (EM/PEDS) residency 
program. There are currently a total of 79 residents in these three 
training programs. Intubations in this ED are performed primarily 
by the EM and EM/PEDS residents under direct supervision by 
the EM attending.
Throughout the study period, multiple airway devices were 
stocked in the ED, with clinical availability of the devices varying 
somewhat. The availability of these devices were based on 
hospital considerations and manufacturer issues and were not the 
result of the CQI program. The direct laryngoscope (DL) with 
Macintosh and Miller blades was available in the ED throughout 
entire study period. One or more video laryngoscopes (VL) were 
also available throughout the study period. The hyperangulated 
GlideScope® was available from Academic Year 1 continuously 
through the second month of Academic Year 10, and the standard 
geometry GlideScope® (MAC T3 and T4) was available from 
Academic Year 8 continuously through the second month of 
Academic Year 10. The standard geometry C-MAC® was 
available from the eighth month in Academic Year 3 continuously 
through Academic Year 10 and the hyperangulated C-MAC® 
(D-blade) was available from the tenth month in Academic Year 4 
continuously through Academic Year 10. Other VLs such as the 
McGrath®, the Pentax Airway Scope® and the Res-Q-Scope® 
were available sporadically on a trial basis for brief periods of 
time. Rescue devices available during the study period included a 
supraglottic device (LMA Fastrach®) and a commercially 
available surgical airway kit (Cook Universal Emergency 
Cricothyrotomy Catheter Set®).
This study included all adult patients 18 years of age and 
older that underwent RSI in the ED by an EM resident as the 
first operator.
Airway CQI Program and Airway Registry
The airway CQI program and airway registry was started on 
July 1, 2007. A single page (double sided) paper-based airway 
data collection form was developed to capture important clinical 
information regarding intubations in the ED (Appendix: https://
escholarship.org/uc/item/8tv7v5nz#supplemental). The form was 
Western Journal of Emergency Medicine 612 Volume 20, no. 4: July 2019
Improvement in Safety of Rapid Sequence Intubation in the ED with Airway CQI Program Sakles et al.
housed in the physician charting area of the ED. After each 
intubation the resident was expected to fill out the airway form. 
The senior investigator reviewed all airway forms on a weekly 
basis and cross-referenced them with the electronic medical 
record and the hospital admission log. If any intubations were 
identified without a corresponding airway form, a blank form was 
given to the resident for completion. If any of the airway forms 
had incomplete or contradictory information, the resident was 
interviewed by the senior author and the form updated as 
appropriate. Timeliness of completion of the airway forms was 
recorded during the last two years of the study period. 70% of the 
forms were filled out on the day of the intubation, 86% were 
filled out within two days of the intubation, and 94% were filled 
out within seven days of the intubation. Ultimately, 100% of 
airway forms were completed.
The airway form was designed to capture important 
information about the patient, the operator and the characteristics 
of the procedure. This included data such as patient age and sex, 
diagnosis, operator post-graduate year (PGY), operator specialty, 
reason for intubation, method of intubation, difficult airway 
characteristics, drugs used for intubation, device used on each 
attempt, outcome of each attempt, and adverse events associated 
with intubation. Adverse events and their definitions are presented 
in Table 1. An intubation attempt was defined as the insertion of 
the laryngoscope blade into the mouth of the patient, regardless 
of whether an attempt was made to insert a tracheal tube. First 
pass success was defined as successful tracheal intubation on a 
single laryngoscope insertion. First pass success without an 
adverse event was defined as successful tracheal intubation on the 
first attempt without the occurrence of any adverse events.
The airway training program for the EM and EM/PEDS 
residents consisted of multiple educational components. 
Residents in the university-based EM and EM/PEDS program 
complete a four-week rotation on the anesthesia service to learn 
fundamental aspects of airway management. Residents in the 
community-based EM program do not participate in an anesthesia 
rotation. During the intern year there is a full day airway 
orientation that includes three hours of didactics and three hours 
of hands-on experience in the simulation laboratory. Each year 
there is a difficult airway lab in the simulation lab. The difficult 
airway lab has been expanded over the study period and currently 
includes the following six hands-on stations: 1. Rigid 
laryngoscopy including both DL and VL, 2. Flexible 
laryngoscopy, 3. Face mask ventilation and supraglottic insertion, 
4. Surgical airway techniques, 5. Pediatrics, and 6. Ultrasound 
assessment of the airway and hemodynamics. Airway lectures 
and cases are presented on an ongoing basis at the regularly 
scheduled conference time throughout the academic year. Based 
upon ongoing data analysis from the airway registry, these 
educational programs have been modified and expanded to 
address varying clinical concerns. For example, use of a VL for 
the initial attempt has been increasingly promoted over the entire 
study period due to the beneficial effects observed with the CQI 
program. Even if DL was the primary approach to be performed, 
use of a standard geometry VL was strongly encouraged.15 In the 
last four years of the study, heavy emphasis was placed on the 
importance of physiologic optimization prior to intubation.16 
Appropriate preoxygenation strategies were emphasized and 
non-invasive ventilation (NIV) for hypoxemic patients with shunt 
physiology was encouraged.17 The use of apneic oxygenation and 
high flow nasal oxygen (HFNO) was also encouraged for patients 
at high risk of oxygen desaturation. Hemodynamic optimization 
before intubation, with crystalloids, blood products, vasopressors 
or inotropes, as clinically indicated, was also strongly 
emphasized. Pre-intubation point-of-care cardiovascular 
ultrasonography was promoted as a means to identify patients at 
risk of hemodynamic collapse and to allow proactive 
management with appropriate resuscitation strategies. Operators 
Adverse event Definition
Aspiration Presence of vomit at the glottic inlet visualized during intubation in a previously clear airway
Cardiac arrest Pulseless dysrhythmia occurring during intubation
Cuff leak Air leak around a cuffed ETT requiring replacement of the ETT
Dental trauma Fracture or avulsion of tooth during intubation
Dysrhythmia Bradycardia or any ventricular dysrhythmia during intubation
Esophageal intubation Inadvertent placement of the ETT in the esophagus requiring removal and reintubation
Extubation Accidental removal of the ETT requiring reintubation
Hypotension Decrease in systolic blood pressure to <90 mmHg
Hypoxemia A decrease in oxygen saturation below 90%
Laryngospasm Adduction of vocal cords preventing passage of the ETT through the glottic inlet
Mainstem intubation Radiographic identification of the tip of the ETT in a mainstem bronchus
Table 1. Definitions of adverse events.
ETT, endotracheal tube; mmHg, millimeters of mercury. 
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were encouraged to use their assessment of cardiac function and 
evaluation of the inferior vena cava (IVC) to determine the need 
for intravenous fluids or vasoactive drugs in the peri-intubation 
period.
Outcome Measures
The primary outcome measure was first pass success. The 
secondary outcome measure was the number of patients who 
experienced an intubation associated adverse event. Other 
important variables such as first pass success without an adverse 
event and procedural characteristics are reported as well.
Data Analysis
Data from the collected paper forms was entered into Excel® 
for Windows 2013 (Microsoft, Redmond, Washington) and 
transferred in to STATA 13® (StataCorp, College Station, Texas) 
for analysis. Data was analyzed by academic year (July 1, 
2007–June 30, 2017). The first year of the study was the academic 
year 2007-2008 (Academic Year 1), and the last year of the study 
was academic year 2016-2017 (Academic Year 10). Data are 
reported descriptively with 95% confidence intervals (CIs) or the 
95% CI of the difference of the means, as appropriate.
RESULTS
Characteristics of Study Subjects
There were 5,229 total intubations performed in the ED 
over the 10-year study period. Of these, 4,362 were performed 
using an RSI technique. The number of adult patients who 
underwent RSI by an EM resident was 3,763, and these were 
included in this analysis. The mean age in years of patients 
intubated was 46.1 (range 18-98). 1,307 (34.7%) were women 
and 1,431 (38.0%) were trauma patients.
 
First Pass Success
First pass success by academic year is listed in Table 2. 
Over the 10-year period, first pass success increased from 
73.1% to 92.4% (difference = 19.3%, 95% CI 14.0% to 
24.6%). Intubation was successful within two attempts in 
88.6% of patients in Academic Year 1 and 99.3% of patients in 
Academic Year 10. Intubation was successful within three 
attempts in 94.7% of patients in Academic Year 1 and in 100% 
of patients in Academic Year 10. 
Adverse Events
The number of patients who experienced an adverse event 
are listed in Table 3. Over the 10-year period, the percentage of 
patients who experienced an adverse event decreased from 22.5% 
to 14.6% (difference = -7.9%, 95% CI -13.4% to -2.4%). 
Specific adverse events are listed in Table 4. Hypoxemia 
(SpO2<90%) was the most common adverse event and occurred 
in 76.6% (59/77) of the patients with adverse events in Academic 
Year 1 and in 76.9% (50/65) of the patients with adverse events in 
Academic Year 10. The percentage of patients who had 
hypoxemia decreased from 17.3% to 11.2% (difference = -6.0%, 
95% CI -11.0% to -1.1%). 
Complete oxygen saturation data was available in 73.4% 
(251/342) of patients in Academic Year 1 and in 86.3% (384/445) 
of patients in Academic Year 10. Oxygen desaturation to <80% 
occurred in 8.8% of patients in Academic Year 1 and in 3.6% of 
patients in Academic Year 10 (difference = -5.2%, 96% CI -8.7% 
to -1.7%). Oxygen desaturation to <70% occurred in 5.0% of 
patients in Academic Year 1 and in 1.6% of patients in Academic 
Year 10 (difference = -3.4%, 95% CI -6.0% to -0.8%).
The percentage of patients who had a recognized esophageal 
intubation decreased from 4.4% in Academic Year 1 to 0% in 
Academic Year 10 (difference = -4.4%, 95% CI -6.4% to -2.2%).
First Pass Success without an Adverse Event
First pass success without an adverse event increased over 
the 10-year period from 64.0% to 80.9% (difference = 16.9%, 
95% CI 10.6% to 23.1%). 
Procedural Characteristics
Procedural characteristics are listed in Table 5. VL use on 
the initial attempt increased from 44.7% to 97.8% (difference 
= 53.0%, 95% CI 47.6% to 58.5%) over the 10-year period. 
GlideScope ® use decreased from 86.9% in Academic Year 1 
to 5.5% in Academic Year 10 and C-MAC® use increased in 
Academic Year
First Pass Success
% (n) 95% CI
1
(2007-2008)  73.1% (250/342) 68.2% to 77.5%
2
(2008-2009)  73.9% (260/352) 69.0% to 78.2%
3
(2009-2010)  75.3% (220/292) 70.1% to 79.9% 
4
(2010-2011)  79.8% (257/322) 75.1% to 83.9% 
5
(2011-2012)  82.5% (320/388) 78.4% to 86.0%
6
(2012-2013)  85.2% (351/412)  81.4% to 88.3%
7
(2013-2014)  86.2% (367/426) 82.5% to 89.1%
8
(2014-2015)  89.1% (352/395) 85.6% to 91.8%
9
(2015-2016)  92.1% (348/378) 88.9% to 94.4% 
10
(2016-2017)  92.4% (410/445) 89.5% to 94.5%
Table 2. First pass success by year over the 10-year period.
CI, confidence interval.
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Academic Year
Patients with 
Adverse Events
% (n) 95% CI
1
(2007-2008)  22.5% (77/342) 18.4% to 27.2% 
2
(2008-2009)  29.3% (103/352) 24.8% to 34.2%
3
(2009-2010) 25.0% (73/292) 20.4% to 30.3% 
4
(2010-2011)  22.9% (74/322) 18.7% to 27.9%
5
(2011-2012)  23.5% (91/388) 19.5% to 27.9% 
6
(2012-2013)  20.6% (85/412) 17.0% to 24.8%
7
(2013-2014)  22.8% (97/426) 19.0% to 27.0%
8
(2014-2015)  15.4% (61/395) 12.2% to 19.4%
9
(2015-2016)  15.3% (58/378) 12.0% to 19.3%
10
(2016-2017)  14.6% (65/445) 11.4% to 18.0%
Table 3. Patients with adverse intubation events by year over the 
10-year period.
CI, confidence interval.
Academic Year 1 from 0% to 94.5% in Academic Year 10, 
reflecting clinical availability of the two devices. In Academic 
Year 9, when the GlideScope® and C-MAC® were both 
available, clinical use was very similar (GlideScope® 48.6% 
and C-MAC® 51.4%). 
Use of succinylcholine increased from 40.4% to 53.9% 
(difference = 13.6%, 95% CI 6.6% to 20.5%) and use of 
ketamine increased from 2.0% to 14.6% (difference = 12.6%, 
95% CI 9.0% to 16.2%). Senior residents (PGY ≥3) performed 
43.6% of the intubations in Academic Year 1 and 51.2% in 
Academic Year 10 (difference = 7.7%, 95% CI 6.6% to 
14.7%). The need for a device switch after a failed intubation 
attempt decreased from 17.8% to 0.5% (difference = -17.4%, 
95% CI -21.5% to -13.3%), and the need for an EM attending 
to rescue an EM resident decreased from 5.8% to 0.2% 
(difference = -5.6%, 95% CI -8.1% to -3.1%).  
Over the entire study period there were 6 adult patients 
(0.16%) with a failed RSI by an EM resident that ultimately 
went on to receive a surgical airway (one in Academic Year 2, 
one in Academic Year 5, two in Academic Year 6, one in 
Academic Year 7, and one in Academic Year 9).
DISCUSSION
Airway management in the critically ill is known to be 
associated with a high prevalence of failed intubation attempts 
and serious adverse events, which can negatively impact patient 
care. To maximize patient safety, the goal of airway 
management in the ED should be first pass success without 
adverse events. Just over a decade ago we developed an airway 
CQI program with an ongoing airway registry to monitor our 
airway performance in the ED. We found over the 10-year 
period that first pass success increased from 73% to 92% and 
adverse events decreased from 23% to 15%. Patients that had 
first pass success without an adverse event increased by 17%. 
While it is difficult to say exactly which components of our 
program were responsible for this improvement, we believe 
there were a couple of key factors. One is the adoption of near 
universal VL use for initial intubation attempts. Over the 
10-year period VL use increased from 45% to 98%. Since the 
operators in this study were EM residents, they had variable and 
limited experience with intubation. When using a DL, the 
supervising attending had virtually no ability to assist the 
resident with laryngoscopy and identification of the airway, thus 
increasing the risk of a failed intubation attempt or esophageal 
intubation. On the other hand, when using a VL, the EM 
attending could see everything the resident was seeing during 
laryngoscopy and thus could assist with navigation to and 
identification of the airway. This would have the effect of 
improving first pass success and avoiding inadvertent misplaced 
tubes in the esophagus. This notion is supported by the fact that 
with essentially universal VL use, the esophageal intubation rate 
fell to 0% and the need for the EM attending to rescue the 
resident fell to 0.2%. The CQI program allowed us to realize the 
beneficial effect of VL in our ED and thus was largely 
responsible for the promotion of increased VL use.
The other factor that we believe played an important role 
in the improvement we observed was greater emphasis on 
pre-intubation physiologic optimization during the latter half 
of the study period.16 Greater attention was given to 
optimization of preoxygenation and hemodynamics before 
intubation. Appropriate preoxygenation methods were 
emphasized to maximize oxygen stores before RSI.17 NIV was 
encouraged for preoxygenation in patients with shunt 
physiology who remained hypoxemic with conventional 
preoxygenation techniques.18 The use of apneic oxygenation 
and HFNO was encouraged for patients at great risk of oxygen 
desaturation. Point-of-care ultrasound was encouraged prior to 
intubation to evaluate cardiovascular function and to guide 
decision making for appropriate hemodynamic support in the 
peri-intubation period.
There were some minor changes in procedural characteristics 
over the 10-year period. There was a small increase (8%) in the 
number of intubations performed by senior residents. This may 
also have contributed to the increase in first pass success observed 
in the study, as previous work in our ED has demonstrated an 
increase in first pass success with VL with increasing post-
graduate level.19 Other notable differences over the study period 
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involved the use of pharmacologic agents for RSI. 
Succinylcholine use increased by 14%, likely representing a shift 
away from the use of long acting neuromuscular blocking agents 
in trauma patients with traumatic brain injuries to allow ongoing 
neurologic assessment. Ketamine use increased by 13%, likely 
reflecting an increased awareness of ketamine’s safety in head 
injured patients and its beneficial hemodynamic profile in 
shocked patients. Based on previous studies it is unlikely that any 
of these pharmacologic changes we observed would have 
significantly affected first pass success.20,21
Many other programs have also attempted to improve the 
safety of emergency airway management with a variety of 
clinical interventions. In a university affiliated ED, Hwang 
and colleagues reported on their experience with an airway 
CQI initiative over a three-year period.22 With procedural 
standardization, airway education and equipment preparation 
they found that they were able to increase their first pass 
success from 68% to 79%. They also observed a decrease in 
adverse events from 16% to 8%. It is of interest that in their 
study, they also had a significant increase in VL use for first 
intubation attempts, from 9% in year 1 to 60% in year 3. In an 
academic pediatric ED, Kerrey and colleagues instituted a 
CQI program with the goal of reducing the prevalence of 
oxygen desaturation during emergency intubation.23 With the 
use of an RSI checklist, the use of VL, and the restriction of 
intubation to specific providers, they observed a reduction of 
intubation associated hypoxemia from a historical control of 
33% to 16%. In the intensive care unit (ICU) setting, Jaber 
and colleagues instituted an intubation bundle in an attempt to 
decrease complications associated with emergency 
intubation.24 Their intubation bundle had 10 components and 
included such things as pre-intubation fluid loading, early 
vasopressor use, and NIV for preoxygenation. They found a 
reduction in life-threatening complications from 34% to 21% 
in the six-month period after the introduction of this bundle. 
Mayo and colleagues reported on their results from a CQI 
program in their intensive care unit (ICU), where emergency 
intubations were performed by pulmonary/critical care 
fellows.25 Their CQI program incorporated a combined team 
approach, mandatory checklist use, crew resource 
management techniques and scenario-based training using 
computerized patient simulators. Over a three-year period, 
they observed a first pass success of 62%. Of note, their 
standard approach for emergency intubation was not RSI, but 
rather sedative only intubation. In the prehospital setting, 
Olvera and colleagues reported on their experience with the 
introduction of a CQI program in a large aeromedical transport 
service.26 They implemented an elaborate CQI program across 
160 helicopter bases and over a three-year period found an 
improvement in first pass success from 85% to 95%. First pass 
success without desaturation was found to increase from 84% 
to 94%. In another prehospital study, Jarvis and colleagues 
described their experience with an intubation bundle designed 
to reduce the occurrence of peri-intubation hypoxemia.27 Their 
Specific Adverse Events
Academic Year 1
 (2007-2008)
%, (n = 342)
Academic Year 10 
(2016-2017)
%, (n = 445) % Difference (95% CI)
Aspiration 1.8% (6) 0% (0) -1.8% (-3.1% to -0.4%)
Cardiac arrest 0.6% (2) 0% (0) -0.6% (-1.4% to 0.2%)
Cuff leak 0.6% (2) 0% (0) -0.6% (-1.4% to 0.2%)
Dental injury 0.3% (0) 0% (0) -0.3% (0.9% to 0.3%)
Dysrhythmia 0.3% (1) 0.2% (1) -0.07% (-0.8% to 0.7%)
Esophageal intubation 4.4% (15) 0% (0) -4.4% (6.6% to 2.2%)
Extubation 0.6% (2) 0.7% (3) 0.1% (-1.0% to 1.1%)
Hypoxemia 17.3% (59) 11.2% (50) -6.0% (-11.0% to -1.1%)
Hypotension 0% (0) 2.9% (13) 2.9% (1.4% to 4.5%)
Laryngospasm 0% (0) 0.45% (2) 0.5% (-0.2% to 1.1%)
Mainstem intubation 2.6% (9) 0.9% (4) -1.7% (-3.6% to 0.2%)
Total patients with adverse events 22.5% (77) 14.6% (65) -7.9% (-13.4% to -2.4%)
Patients with 1 adverse event 17.5% (60) 12.8% (57) -4.7% (-9.8% to 0.4%)
Patients with 2 adverse events 3.5% (12) 1.8% (8) -1.7% (-4.0% to 0.6%)
Patients with ≥3 adverse events 1.5% (5) 0% (0) -1.5% (-2.7% to 0.2%)
Table 4. Adverse intubation events in Academic Year 1 versus Academic Year 10.
CI, confidence interval.
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Procedural characteristic
Academic Year 1
 (2007-2008)
%, (n = 342)
Academic Year 10 
(2016-2017)
%, (n = 445) % Difference (95% CI)
Device used
Direct laryngoscope 52.6% (180) 2.0% (9) -50.6% (-56.1% to -45.2%)
Video laryngoscope 44.7% (153) 97.8% (435) 53.0% (47.6% to 58.5%)
 Hyperangulated VL 100% (153/153)  7.4% (32/435) -92.6% (-95.1% to -90.2%)
 Standard Geometry VL 0% (0/153) 92.6% (403/435) 92.6% (90.2% to 95.1%)
 GlideScope® 86.9% (133/153) 5.5% (24/435) -81.4% (-87.2% to -75.7%)
 C-MAC® 0% (0/153) 94.5% (411/435) 94.5% (92.3% to 96.6%)
 Other VL 13.1% (20/153) 0% (0/435) -13.1% (-18.4% to -7.7%)
Paralytic used
Succinylcholine 40.3% (138) 54.0% (240) 13.6% (6.6% to 20.5%)
Rocuronium 59.1% (202) 45.8% (204) -13.2% (-20.2% to -6.3%)
Sedative used
Etomidate 90.4% (309) 81.6% (363) -8.8% (-13.5% to -4.0%)
Ketamine 2.0% (7) 14.6% (65) 12.6% (9.0% to 16.2%)
Propofol  2.6% (9) 2.2% (10) -0.4% (-2.6% to 1.8%)
Operator PGY
PGY 1 17.3% (59) 13.7% (61) -3.5% (-8.7% to 1.6%)
PGY 2 39.2% (134) 35.0% (156) -4.1% (-10.9% to 2.7%)
PGY ≥3 43.6% (149) 51.2% (228) 7.7% (0.7% to 14.7%)
Rescue maneuvers
Device switch 17.8% (61) 0.5% (2) -17.4% (-21.5% to -13.3%)
Resident rescue 3.2% (11) 0.9% (4) -2.3% (-4.4% to -0.3%)
Attending rescue 5.8% (20) 0.2% (1) -5.6% (-8.1% to -3.1%)
SGD rescue 1.2% (4) 0% (0) -1.2% (-2.3% to 0%)
CRIC rescue 0% (0) 0% (0) 0%
Table 5. Procedural characteristics in Academic Year 1 versus Academic Year 10.
Other VL=McGrath®, Pentax Airway Scope®, Res-Q-Scope®.
CI, confidence interval; VL, video laryngoscope; SGD, supraglottic device; CRIC, cricothyrotomy; PGY, postgraduate year.
intubation bundle included goal directed preoxygenation, 
apneic oxygenation, and the use of delayed sequence 
intubation. They found that implementation of this bundle in 
their ground ambulance service resulted in a decrease in 
intubation associated hypoxemia from 44% to 3.5%. As a 
whole, the results of these studies consistently show a 
temporal relationship between monitoring airway performance 
with iterative clinical adjustments and improved procedural 
safety.
Limitations
There are several important limitations in this study. First, 
this is single center observational study at an academic center 
where EM residents perform most of intubations in the ED, so 
these results might not be generalizable to EDs with fully 
trained practitioners at non-teaching hospitals. In particular, the 
value of VL may be overstated when extrapolated to these 
clinicians and environments. Second, the data collected was all 
self-reported by the operator and collected at varying times after 
the intubation. It is thus highly subject to recall bias. Studies on 
emergency airway management have demonstrated that 
operators tend to over-report first pass success and under-report 
adverse events in the chart compared to what is found on 
recorded videos of the intubation.28,29 In one study it was found 
that intubation associated desaturation events were only 
documented in the chart in 16% of the cases, when video review 
of those same cases identified a 33% prevalence of oxygen 
desaturation.29  While video review of ED intubations would be 
ideal to obtain the highest quality data, this was not possible 
given the structure of our ED. Additionally, video review is 
Volume 20, no. 4: July 2019 617 Western Journal of Emergency Medicine
Sakles et al. Improvement in Safety of Rapid Sequence Intubation in the ED with Airway CQI Program
expensive and very labor intensive, and while important for 
research projects, it is simply impractical for widespread 
adoption of airway CQI programs in the ED. Third, the 
definitions used for adverse events in our study were not very 
specific and could be subject to varying interpretation by the 
operators. For example, if hypotension or a cardiac arrest 
occurred shortly after intubation, the operator may not believe 
or document this as a complication of the procedure. Finally, 
numerous educational and clinical changes were made 
throughout the 10-year study period, so it is impossible to 
ascertain which of these interventions were responsible for the 
clinical improvements we observed. While increased use of 
VL and greater emphasis on physiologic optimization appear 
to be associated with the improvement we have observed, this 
is not evidence of causation. 
CONCLUSION
To maximize the safety of airway management in the ED, 
the goal should be first pass success without adverse events. We 
developed an airway CQI program in our ED that incorporated 
an ongoing airway registry to monitor and improve the safety of 
emergency intubation. With this approach we were able to 
substantially increase first pass success and decrease adverse 
events associated with intubation. We recommend that all EDs 
monitor their airway performance and attempt to improve upon 
it so that patent safety can be maximized.
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Introduction: Warfarin is a potent anticoagulant used for the prevention and treatment of venous and arterial 
thrombosis. Occasionally, patients require emergent warfarin reversal due to active bleeding, supratherapeutic 
international normalized ratio, or emergent diagnostic or therapeutic interventions. Various agents can be 
used for emergent warfarin reversal, including fresh frozen plasma (FFP) and 4-factor prothrombin complex 
concentrate (4F-PCC). Both FFP and 4F-PCC are generally considered safe; however, both agents contain 
coagulation factors and have the potential to provoke a thromboembolic event. Although clinical trials have 
compared the efficacy and safety of FFP and 4F-PCC, data are limited comparing the risk of thromboembolism 
between the two agents.  
Methods: A retrospective chart review was performed at a single, urban, academic medical center comparing 
the incidence of thromboembolism with FFP or 4F-PCC for warfarin reversal during a three-year period in the 
emergency department (ED) at Massachusetts General Hospital. Patients were included in the study if they 
were at least 18 years of age and were on warfarin per electronic health records. Patients were excluded if 
they had received both FFP and 4F-PCC during the same visit. The primary outcome was the frequency of 
thromboembolism within 30 days of 4F-PCC or FFP. Secondary outcomes included time to thromboembolic 
event and in-hospital mortality.
 
Results: Three hundred and thirty-six patients met the inclusion criteria. Thromboembolic events within 30 days 
of therapy occurred in seven patients (2.7%) in the FFP group and 14 patients (17.7%) in the 4F-PCC group 
(p=<0.001). Death occurred in 39 patients (15.2%) who received FFP and 18 patients (22.8%) who received 
4F-PCC (p=0.115). Since the 4F-PCC group was treated disproportionately for central nervous system (CNS) 
bleeding, a subgroup analysis was performed including patients requiring reversal due to CNS bleeds that 
received vitamin K. The primary outcome remained statistically significant, occurring in four patients (4.1%) in 
the FFP group and nine patients (14.1%) in the 4F-PCC group (p=0.02). 
Conclusion: Our study found a significantly higher risk of thromboembolic events in patients receiving 4F-PCC 
compared to FFP for urgent warfarin reversal. This difference remained statistically significant when controlled for 
CNS bleeds and administration of vitamin K. [West J Emerg Med. 2019;20(4)619-625.]
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Population Health Research Capsule
What do we already know about this issue?
Despite clinical trials of fresh frozen plasma 
(FFP) vs. 4-factor prothrombin complex 
concentrate (4F-PCC), few data compare 
thromboembolism risk for warfarin reversal.
What was the research question?
What is the incidence of thromboembolism 
using FFP compared to 4F-PCC for urgent 
warfarin reversal?
What was the major finding of the study?
There was a higher risk of thromboembolic 
events in patients receiving 4F-PCC compared 
to FFP for urgent warfarin reversal. 
How does this improve population health?
While 4F-PCC is the preferred agent for 
warfarin reversal, providers must weigh the 
risks and benefits when using it in patients 
already at high risk of thromboembolism.
INTRODUCTION
Warfarin is a potent anticoagulant used for the 
prevention and treatment of venous and arterial thrombosis. 
As a vitamin K antagonist, warfarin prevents the post-
translational carboxylation of coagulation factors II, 
VII, IX, and X, along with protein C and S, by 30-50%.1 
Warfarin is one of the top medications implicated in 
emergency department (ED) visits due to bleeding events. 
Annually, bleeding complications associated with over-
anticoagulation with warfarin occur in 15-20% of patients, 
with fatal bleeds accounting for 1-3%.2
Occasionally, patients require emergent warfarin 
reversal due to life-threatening bleeds or the need for 
emergency diagnostic or therapeutic intervention. The risk 
of bleeding is directly related to the degree of international 
normalized ratio (INR) elevation.3 It is important to note, 
however, that half of all major bleeding episodes associated 
with warfarin occur when the INR is less than 4.0.4 The 
degree and rapidity of reversal are dependent upon not 
only the absolute value of the INR, but also the clinical 
indication for reversal. Prior to the approval of 4-factor-
prothrombin complex concentrate (4F-PCC) in 2013, fresh 
frozen plasma (FFP) was the preferred therapy for reversing 
warfarin in the United States. However, 4F-PCC reduces 
the INR more quickly and is now preferred as a first-line 
agent for warfarin reversal in intracranial hemorrhage, 
the most disabling form of major bleeding.5,6,7,8,9 Both FFP 
and 4F-PCC are generally considered safe; however, both 
agents contain coagulation factors and have the potential to 
provoke a thromboembolic event. Although clinical trials 
have compared the efficacy and safety of FFP and 4F-PCC, 
there is sparse data comparing the risk of thromboembolism 
between the two agents outside the clinical trial setting, 
using “real world” data. 6,7,10,11,12,13,14
The primary objective of this study was to assess the 
incidence of thromboembolic events in patients who received 
either 4F-PCC or FFP for emergent warfarin reversal. 
METHODS
We performed a retrospective chart review at a single, 
urban, academic medical center. Consecutive patients 
receiving 4F-PCC in the ED between April 20, 2016 – 
October 28, 2017, or FFP in the ED between January 1, 
2010 – January 30, 2011, were identified from the electronic 
health record (EHR). During the FFP period, 4F-PCC was 
not available for use at our institution, and FFP was used 
for all emergent warfarin reversal. In April 2013, 4F-PCC 
became available for warfarin reversal, although its use was 
restricted to patients with central nervous system (CNS) and 
intrapulmonary bleeds on warfarin. Any other indications 
required hematology approval. A report from the hospital’s 
EHR identified patients who received an order for FFP or 
4F-PCC while in the ED. 
Patients were included in the current study if they 
were at least 18 years of age and were on warfarin as 
per EHR, including outpatient medication lists, previous 
prescriptions, and prescriber notes. We excluded patients if 
they had received both FFP and 4F-PCC during the same 
visit. Collected data included initial INR on presentation 
to the ED, indication for warfarin, indication for warfarin 
reversal, administration and dose of FFP or 4F-PCC, 
administration of vitamin K, thromboembolic events, 
and mortality. Age, gender, and race were also collected 
for demographic purposes. Thromboembolic events 
were identified by reviewing provider notes, discharge 
summaries, follow-up notes, imaging, and medication 
administration records. 
We used the search function of the EHR to ensure 
that no thromboembolic events occurring at our hospital 
were overlooked. This search function identifies the 
searched term in the EHR, as well as any other medically 
related terms. For example, when searching for the term 
“clot,” similar search terms such as thromboembolism and 
thrombus are also identified. Patients in the FFP group were 
originally collected for a separate analysis of pulmonary 
complication rates after FFP administration and time to 
INR reversal.15 
Abstractors were trained in clinical research and quality 
assurance. There was an initial review of study variables, 
standard operating procedures for data abstraction, 
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and the data abstraction form (which was electronic, 
using REDCap). Each abstractor then reviewed a set of 
practice records, with variables verified for accuracy and 
discrepancies adjudicated. After training, regular meetings 
occurred to review data collection and address questions 
and discrepancies.
The primary outcome was the frequency of 
thromboembolism within 30 days of 4F-PCC or FFP 
administration. Secondary outcomes included time to 
thromboembolic event and in-hospital mortality. 
Statistical Analysis
This study was approved by the institutional review board. 
We collected and analyzed data using RedCap and Excel. We 
used chi-square tests to compare the rate of thromboembolic 
events and mortality between patients who received 4F-PCC 
and FFP. The method by Cohen was used to determine power 
since there were no previous studies on which to base our 
power analysis.16 In order to detect a medium effect size 
difference (d = 0.5 where d = (meana-meanb)/α) and α = 
0.05), it was estimated that 64 patients would be required for 
each group. We also calculated Cohen’s kappa to assess for 
inter-rater reliability. This number was based on 10% of our 
data chosen at random to be reabstracted by an independent 
reviewer for our primary endpoint. 
RESULTS
Table 1 shows patients’ baseline characteristics. The 
most common reason for patients to receive 4F-PCC was 
CNS bleed (82.3%), while the indications for FFP were 
more varied, including CNS bleed (38.1%), urgent surgery 
(25.7%), and gastrointestinal bleed (19.8%). The median 
amount of FFP administered was 3 units (interquartile 
range [IQR] 1-3) with the average dose being 9.4 milliliters 
per kilogram (mL/kg). The mean dose of 4F-PCC 
administered was 2168 units (standard deviation [SD] 723 
units). All patients included in the 4F-PCC group received 
a dose within 10% of their calculated dose based on their 
initial INR and weight, consistent with U.S. Food and Drug 
Administration (FDA)-approved dosing. Inclusion and 
exclusion criteria are described in Figure 1. 
The primary outcome, thromboembolic events within 30 
days, occurred in seven patients (2.7%) in the FFP group and 
14 patients (17.7%) in the 4F-PCC group (p=<0.001). We 
calculated a Cohen’s kappa score of 0.84 based on 10% of the 
data reabstracted by an independent reviewer. The mean time to 
thromboembolic event was 4.1 days (SD 5.4) in the FFP group 
and 8.9 days (SD 8.7) in the 4F-PCC group (p=0.20). We also 
evaluated thromboembolic events based on type and indications 
for warfarin use, as seen in Tables 2 and 3. Two patients in 
the FFP group and four patients in the 4F-PCC group had 
superficial clots, all of which were cephalic vein thromboses. 
When these less dangerous and non-life-threatening clots were 
removed from the analysis, the difference in thromboembolic 
events remained statistically significant (p=<0.001) between the 
two groups. 
Vitamin K was administered in 209 of 257 (81.3%) patients 
in the FFP group and 78 of 79 (98.7%) patients in the 4F-PCC 
group (p=0.0002). Death occurred in 39 patients (15.2%) who 
received FFP and 18 patients (22.8%) who received 4F-PCC 
(p=0.115). Cause of death in the FFP group was attributed to 
a bleeding event in 20 patients and thromboembolic event in 
two patients, while 17 patients had other, non-related or unclear 
causes of death. In the 4F-PCC group, death was attributed to 
a bleeding event in 10 patients and thromboembolic event in 
two patients, while six patients had other, non-related or unclear 
causes of death. All bleeding events resulting in death were 
attributed to the presenting event. 
As the 4F-PCC group was treated disproportionately 
for CNS bleeding (due to the hospital guideline restricting 
4F-PCC use to high-risk conditions such as this), we 
performed a subgroup analysis including only patients 
requiring warfarin reversal due to CNS bleeds and those that 
received vitamin K in the ED. There were 98 patients included 
in the FFP group and 65 patients included in the 4F-PCC 
group. The median amount of FFP administered was 4 units 
(IQR 1-3), while the mean dose of 4F-PCC administered 
was 2148 units (SD 698 units). The primary outcome, 
thromboembolic events within 30 days, remained statistically 
significant occurring in four patients (4.1%) in the FFP group 
and nine patients (14.1%) in the 4F-PCC group (p=0.02). 
Death occurred in 30 patients (30.6%) who received FFP and 
17 patients (26.2%) who received 4F-PCC (p=0.54). 
DISCUSSION
According to the American College of Cardiology 
(ACC) and the Neurocritical Care Society guidelines on 
anticoagulation reversal, 4F-PCC is currently recommended 
as the preferred method for emergency warfarin reversal.8,9 
Although patients receiving warfarin have pre-existing 
thromboembolic risk factors that may be unmasked with 
reversal, it is not clear whether different warfarin reversal 
options carry different thromboembolic risks. Phase 2 and 
3 clinical trials evaluating thromboembolic events between 
FFP and 4F-PCC for vitamin K antagonist reversal found 
no difference between these options.5,6,7,17 However, our 
study of real-world data suggests the thromboembolic 
risk of 4F-PCC may be higher than FFP. Importantly, the 
thromboembolic events in the 4F-PCC group, on average, 
occurred much later in the clinical course and therefore 
may be less related to the initial reversal administered. 
Although this difference was not statistically significant, it 
could have clinically significant implications. 
Several factors may have contributed to the difference 
in thromboembolic risk in our study, the first of which 
is the differences in baseline characteristics. Patients 
who received 4F-PCC had a significantly higher rate of 
atrial fibrillation requiring warfarin therapy, while more 
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4F-PCC (n=79) FFP (n=257) p-value 
Sex
Male 59.5% 59.1% 0.96
Female 40.5% 40.9% 0.96
Age (years) 75.2 73.0 0.09
Race
Hispanic/Latino 2 (2.5%) 4 (1.6%) 0.57
Not Hispanic/Latino 76 (96.2%) 252 (98.0%) 0.35
Unavailable 1 (1.3%) 1 (0.4%) 0.38
Weight (kg) 78.3 79.8 0.26
Baseline INR 3.65 3.86 0.37
Indication for Warfarin*
Atrial fibrillation 60 (75.9%) 162 (63.0%) 0.03
Mitral valve replacement 4 (5.1%) 7 (2.7%) 0.31
Aortic valve replacement 6 (7.6%) 13 (5.1%) 0.39
Deep vein thrombosis 7 (8.8%) 41 (15.9%) 0.12
Pulmonary embolism 4 (5.1%) 36 (14.0%) 0.03
Hypercoagulable state 5 (6.3%) 11 (4.3%) 0.45
Other 3 (3.8%) 57 (22.1%) <0.001
Indication for Warfarin reversal*
CNS bleed 65 (82.3%) 98 (38.1%) <0.001
GI bleed 5 (6.3%) 51 (19.8%) 0.005
Musculoskeletal bleed 3 (3.8%) 2 (0.8%) 0.05
Intra-abdominal bleed 0 (0%) 10 (3.9%) 0.13
Hematuria 0 (0%) 4 (1.6%) 0.58
Hemoptysis 0 (0%) 3 (1.2%) 1.0
Epistaxis 0 (0%) 2 (0.8%) 1.0
Hematoma 4 (5.1%) 4 (1.6%) 0.07
Hemothorax 0 (0%) 1 (0.4%) 1.0
Other bleeding** 0 (0%) 7 (2.7%) 0.21
Surgery 4 (5.1%) 66 (25.7%) <0.001
Other indications for reversal 0 (0%) 7 (2.7%) 0.21
Average dose 28 IU/kg 9.4 mL/kg
Concomitant vitamin K 78 (98.7%) 209 (81.3%) <0.001
Table 1. Baseline characteristics.
*Numbers do not add up to 100% as some patients had more than one indication for warfarin or warfarin reversal. 
**Other bleeding includes vaginal bleeding, catheter site bleeding, arteriovenous fistula, hemorrhagic ovarian cyst, hemorrhagic goiter, 
bleeding associated with multi-trauma, and hemathrosis. 
FFP, fresh frozen plasma; 4F-PCC, 4-factor prothrombin complex concentrate; kg, kilogram; INR, international normalized ratio; CNS, 
central nervous system; GI, gastrointestinal; mL/kg, milliliters per kilogram; IU/kg, international unit per kilogram.
FFP patients were under treatment for thromboembolic 
disorders such as pulmonary emboli. Patients in the FFP 
group had an overall higher risk of venous thromboemboli, 
potentially putting them at higher risk of thromboembolic 
events with warfarin reversal. Our results demonstrated the 
opposite, suggesting that the patients in the 4F-PCC group 
may have an increased risk of thromboembolic events 
despite their indication for warfarin.
The dose of FFP administered and differences in 
vitamin K administration may also have contributed. 
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When using FFP for the emergency reversal of warfarin, 
10-15mL/kg is recommended.9 Most adults will need an 
average dose of 3-6 units to replace enough coagulation 
factors to reverse warfarin. In our study, the median 
amount of FFP given was 3 units, with the group having 
a mean weight of 79.8 kg. On average, patients in our 
study received a subtherapeutic dose of FFP at 9.4 mL/
kg, while all patients in the 4F-PCC group received the 
recommended dose based on their weight and INR. For 
comparison, the FFP arms of clinical trials include doses 
that are substantially higher than those used in our center 
during the study period;6,7,17 therefore, our FFP patients may 
have been exposed to lower thromboembolic risk. Although the 
average FFP dose administered in our study was subtherapeutic 
according to the guidelines, it was within 10% of the lower limit 
of the recommended dose of 10 mL/kg, which suggests that the 
lower end of the dosing range may be safer. 
The difference in Vitamin K administration might also have 
contributed to the difference in thromboembolic events. The 
FFP group received vitamin K significantly less often than 
the 4F-PCC group (81% vs.99%, respectively; p = <0.001), a 
difference that was not seen in most other studies.5,6,7
Another difference identified between the two groups 
was the number of CNS bleeds. Our hospital guideline allows 
4F-PCC to be ordered without specialist approval for patients 
with CNS bleeds; however, most other uses require hematology 
approval. To control for this, we performed a subgroup analysis 
examining only those with CNS bleeds who received vitamin 
K. The thromboembolic event rate remained higher in the 
4F-PCC group. However, there was no difference in mortality. 
It remains possible that providers selected more severely injured 
patients for 4F-PCC.18 
Several studies examined the difference between 
thromboembolic events as a secondary outcome, but only a few 
have looked at this occurrence as a primary outcome.5,6,7,17 A post 
Excluded (n=78)
Did not receive FFP (n=6)
Not actively on warfarin (n=72)
Excluded (n=35)
Did not receive 4F-PCC (n=3)
Received both FFP and 
4F-PCC (n=28)
Not actively on warfarin (n=4)
Assessed for eligibility (n=449)
FFP group 
(n=335)
4F-PCC group
(n=114)
Patients included in the 
FFP analysis (n=257)
Patients included in the 
4F-PCC analysis (n=79)
Figure 1. Study inclusion and exclusion. 
FFP, fresh frozen plasma; 4F-PCC, 4-factor prothrombin complex concentrate.
4F-PCC (14) FFP (7) p-value 
Myocardial infarction 0 (0%) 1 (14.3%) 0.33
Cerebral vascular 
accident
2 (14.3%) 0 (0%) 0.53
Pulmonary embolism 2 (14.3%) 1 (14.3%) 1
Deep venous 
thrombosis
4 (28.6%) 3 (42.9%) 0.64
Superficial thrombosis* 4 (28.6%) 2 (28.6%) 1
Other** thromboembolic 
event
2 (14.3%) 0 (0%) 0.53
Table 2. Thromboembolic events within 30 days of warfarin reversal.
*Superficial thrombosis includes cephalic vein thrombus.
**Other events include left ventricular thrombus and right atrial 
thrombus. 
FFP, fresh frozen plasma; 4F-PCC, 4-factor prothrombin complex 
concentrate.
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hoc exploratory analysis of two randomized controlled trials 
found that most thromboembolic events in the 4F-PCC group 
occurred >7 days after reversal, clustering around the two-week 
mark while thromboembolic events in the FFP group occurred 
within seven days of reversal, with nearly 50% occurring within 
the same day. This difference may be due to the increased 
amount of vitamin K and non-vitamin K dependent coagulation 
factors being loaded over a short period but also raises the 
question of whether the thromboembolic events were caused by 
the administration of 4F-PCC or a consequence of prolonged 
hospitalizations and delayed anticoagulation initiation after a 
major bleeding event. 
The ACC published an expert consensus on the management 
of bleeding in patients on oral anticoagulants, in which they 
recommend the use of either variable dosing of 4F-PCC 
based on INR and weight or fixed dose.9 There are few data to 
suggest that the rate of thromboembolic events with 4F-PCC 
is dose dependent. However, giving a fixed dose of 1000-
1500 international units may theoretically reduce the risk of 
thromboembolic events. Since our study used the variable FDA 
dosing of 4F-PCC based on INR and weight, further studies are 
needed to determine if the risk of thromboembolic events would 
remain significant between FFP and 4F-PCC when using fixed 
dose 4F-PCC.  
LIMITATIONS
Limitations of this study include its retrospective, single-
center design, which only included patients seen and followed up 
at our hospital. Although we were able to identify all patients that 
followed up at hospitals within our healthcare system, patients 
may have been missed if they had thromboembolic events or 
Thromboembolic event
Warfarin Indication*
4F-PCC FFP
Cerebral vascular accident (n=1 in 4F-PCC) Atrial fibrillation (n=1)
Cerebral vascular accident (n=1)
None
Myocardial infarction (n=1) None Atrial fibrillation (n=1)
Pulmonary embolism (n=2 in 4F-PCC and 1 in FFP) Atrial fibrillation (n=2)
Deep venous thrombosis (n=1)
Deep venous thrombosis (n=1)
Hypercoagulable state (n=1)
Deep venous thrombosis (n=4 in 4F-PCC and 4 in FFP) Atrial fibrillation (n=4)
Deep venous thrombosis (n=1)
Factor V Leiden (n=1)
Atrial Fibrillation (n=3)
Deep venous thrombosis (n=1)
Hypercoagulable state (n=2)
Superficial thrombosis (n= 4 in 4F-PCC and 2 in FFP) Mechanical valve (n=2)
Atrial fibrillation (n=3)
Pulmonary embolism (n=1)
Deep venous thrombosis (n=1) 
Hypercoagulable state (n=1)
Other thromboembolic event (n=2 in 4F-PCC) Atrial fibrillation (n=1)
Mechanical valve (n=1)
Deep venous thrombosis (n=1)
None
Table 3. Warfarin indications for patients with thromboembolic events after reversal with 4-factor prothrombin complex concentrate (4F-PCC) 
or fresh frozen plasma (FFP).
*Warfarin indications were not mutually exclusive.
FFP, fresh frozen plasma; 4F-PCC, 4-factor prothrombin complex concentrate.
died at hospitals outside of our system. Another limitation is the 
difference in time periods in which the data were collected and 
the difference in baseline characteristics between the two groups. 
Although 4F-PCC was FDA approved in 2013, its distribution 
was managed by the blood bank at our institution until 2016, 
when it was transferred to the pharmacy department.18 Due to 
this timing, we were unable to obtain any data for 4F-PCC use 
before this time. To ensure inter-rater reliability an independent 
abstractor conducted quality assurance using the Cohen’s 
kappa score by reabstracting 10% of the data. Despite the 
difference in abstractors and time periods, a kappa score of 0.84 
suggested almost perfect agreement between the abstractors. 
In addition, clinical care of patients requiring warfarin reversal 
may have changed during the study period, and data capture 
for thromboembolic events may have improved, artificially 
increasing the frequency of thromboembolism over time. Lastly, 
we are unable to comment on the long-term morbidity and 
mortality between the two groups as this study only analyzed data 
up to 30 days after patients received 4F-PCC and FFP.
CONCLUSION
Our study found a higher risk of thromboembolic events in 
patients receiving FDA-approved doses of 4F-PCC compared 
to FFP for urgent warfarin reversal. This difference remained 
when controlled for CNS bleeds and administration of vitamin 
K. Thromboembolic events, on average, developed several 
days later in the 4F-PCC group compared to the FFP group. 
Although 4F-PCC is the preferred agent for emergent warfarin 
reversal, it is important for providers to weigh the risks and 
benefits when using this agent in patients already at high risk of 
thromboembolic events. 
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Introduction: In many hospitals, off-hours emergency department (ED) radiographs are not read by 
a radiologist until the following morning and are instead interpreted by the emergency physician (EP) 
at the time of service. Studies have found conflicting results regarding the radiographic interpretation 
discrepancies between EPs and trained radiologists. The aim of this study was to identify the number 
of radiologic interpretation discrepancies between EPs and radiologists in a community ED setting. 
Methods: Using a pre-existing logbook of radiologic discrepancies as well as our institution’s picture 
archiving and communication system, all off-hours interpretation discrepancies between January 
2012 and January 2015 were reviewed and recorded in a de-identified fashion. We recorded the 
type of radiograph obtained for each patient. Discrepancy grades were recorded based on a pre-
existing 1-4 scale defined in the institution’s protocol logbook as Grade 1 (no further action needed); 
Grade 2 (call to the patient or pharmacy); Grade 3 (return to ED for further treatment, e.g., fracture 
not splinted); Grade 4 (return to ED for serious risk, e.g., pneumothorax, bowel obstruction). We also 
recorded the total number of radiographs formally interpreted by EPs during the prescribed time-
frame to determine overall agreement between EPs and radiologists.
Results: There were 1044 discrepancies out of 16,111 EP reads, indicating 93.5% agreement.  Patients 
averaged 48.4 ± 25.0 years of age and 53.3% were female; 25.1% were over-calls by EPs. The majority 
of discrepancies were minor with 75.8% Grade 1 and 22.3% Grade 2. Only 1.7% were Grade 3, which 
required return to the ED for further treatment. A small number of discrepancies, 0.2%, were Grade 
4. Grade 4 discrepancies accounted for two of the 16,111 total reads, equivalent to 0.01%. A slight 
disagreement in finding between EP and radiologist accounted for 8.3% of discrepancies. 
Conclusion: Results suggest that plain radiographic studies can be interpreted by EPs with a very low 
incidence of clinically significant discrepancies when compared to the radiologist interpretation. Due to 
rare though significant discrepancies, radiologist interpretation should be performed when available. 
Further studies are needed to determine the generalizability of this study to EDs with differing volume, 
patient population, acuity, and physician training. [West J Emerg Med. 2019;20(4)626-632.]
INTRODUCTION
In many emergency departments (ED) across the United 
States and throughout the world, plain radiographic studies 
are initially interpreted by an emergency physician (EP) 
without the immediate interpretation of a trained radiologist. 
While EP interpretation aids in ED flow and prompt treatment, 
interpretation errors can potentially place a patient at 
unnecessary risk of adverse outcome and the treating physician 
at risk for litigation.1,2 Studies in the literature have suggested 
that immediate radiology interpretation has potential to reduce 
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Population Health Research Capsule
What do we already know about this issue?
Existing studies have found conflicting 
agreement rates between emergency 
physicians (EP) and radiologists regarding 
plain radiograph interpretations.
What was the research question?
Can EPs accurately interpret plain 
radiographs without the immediate aid of 
a radiologist?
What was the major finding of the study?
EPs can accurately interpret commonly 
obtained radiographs with a very low rate 
of treatment-changing misses.
How does this improve population health?
While EPs interpret common films 
well, this study can improve emergency 
department care by stimulating EPs to be 
more cautious interpreting pediatric and 
less common radiographs.
errors that would require call-back to the ED.3,4 
Several studies have examined radiologic interpretation 
discrepancies between EPs and radiologists.5-18 These studies 
report a wide range of agreement between the two specialties in 
regard to plain radiograph interpretation in the ED. Two existing 
studies found agreement rates as high as 97-99% between 
EPs and radiologists.15,16 In contrast, other studies have found 
agreement rates as low as 52-66%.5,7 The large variability in 
the reported range of radiographic interpretation discrepancies 
suggests the need for further study in relation to this clinically 
relevant topic encountered on a day-to-day basis in many EDs 
without 24-hour radiologist coverage.
The aim of this study was to identify the number of 
radiologic interpretation discrepancies between EPs and 
radiologists in a community ED setting. We also sought to 
determine the frequency and nature of treatment- changing 
discrepancies to determine whether plain radiographs can 
be safely interpreted by EPs without immediate radiologist 
interpretation. A secondary aim was to examine the agreement 
in radiology reads based on age as well as the specific body 
area imaged. We hypothesized that radiographs interpreted by 
EPs would have a high level of agreement with final radiologist 
interpretation. Furthermore, we hypothesized that discrepancies 
presenting serious risk to the patient would be rare.
METHODS
The setting for this study was a community hospital 
ED with an emergency medicine (EM) residency program 
in which “off-hours,” plain radiographs are not read by a 
radiologist until the following morning. These off-hours are 
generally 5-6 PM to 6:30 AM. The number of hours without 
radiologist coverage of plain radiographic reads varies per 
day based on the radiologist shift schedule, which generally 
ranges from 8-12 hours without coverage of radiograph 
interpretation. During times without radiologist coverage, 
initial interpretations, determined by the attending, board-
certified EP, are logged into our picture archiving and 
communication system (PACS) and a board-certified general 
radiologist provides final interpretations in the morning. 
Radiographic discrepancies are charted in the morning 
after radiology read in a discrepancy logbook by the day-shift 
attending EP. The degree of discrepancy, as explained below, 
is also determined and documented by the attending physician. 
Necessary callbacks are made by nursing based on the clinical 
judgment of the documenting, not interpreting, EP. No formal 
training is specifically given to the EP on discrepancy grading, 
although the grading follows straightforward guidelines. If 
in the clinical judgment of the documenting EP, a callback or 
return to ED was warranted this was directly reflected in the 
discrepancy grading. 
Degree of discrepancy is graded on a 1-4 scale. Grade 1 is 
a minor discrepancy with no additional action needed, eg, an 
infiltrate read on radiologist interpretation of chest radiograph 
(CXR) but not seen overnight by the EP even though the 
patient was started on an antibiotic at the time of service. 
Minor “over-calls” by the EP that were not appreciated in 
the final radiology interpretation would also be considered 
Grade 1. For example, an EP interprets, “questionable 
fracture,” and instructs the patient to follow-up although 
the radiologist interprets, “no fracture.” Grade 2 is a minor 
discrepancy in which the patient was contacted and did not 
require return to the ED. For example, a radiologist interprets 
infiltrate on CXR, not appreciated on overnight read, which 
required an antibiotic to be called in to the pharmacy. An 
additional example would be informing a patient via phone 
call regarding a pulmonary nodule that was appreciated by 
the radiologist, which requires primary care follow-up. Grade 
3 is a major discrepancy in which the patient was required to 
return to the ED for further treatment. An example would be 
calling a patient back to the ED to splint a fracture that was 
not appreciated on overnight EP read. Grade 4 discrepancies 
are major discrepancies that risk serious harm to the patient. 
Examples are a missed pneumothorax, free air under the 
diaphragm, small bowel obstruction, etc.
Following institutional review board approval, we 
retrospectively reviewed all radiologic discrepancies 
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recorded in our logbook and PACS between January 1, 
2012 and January 1, 2015, regardless of patient age, gender, 
or presenting complaint. No discrepancies were excluded. 
Age and gender of the patient were documented. We also 
recorded the initial diagnosis, final diagnosis, body area 
of radiographic study, nature of discrepancy, grade of 
discrepancy, modified treatment, and disposition. The total 
number of EP radiographic reads during the time period 
studied were obtained from our PACS to determine overall EP 
and radiologist agreement. In addition, we queried our PACS 
and categorized EP reads by body area to determine if certain 
types of radiographs had a higher or lower level of agreement 
in interpretation. Radiographs were separated into groups as 
follows: chest, abdomen, lower extremity, upper extremity, 
cervical spine, thoracic-lumbar-sacral-coccygeal spine, pelvis, 
soft tissue neck, or other. Upper extremity included any 
radiograph performed at the level of the shoulder or distal 
to the shoulder. Lower extremity included any radiograph 
at the level of the hip or distal to the hip. The category of 
“other” included radiographs of the scapula, clavicle, sternum, 
nose, face, orbits, mandible, and ribs. We further categorized 
patients into the age groups of 0-6 years, 7-12 years, 12-17 
years, and 18 years or greater to determine if discrepancy rates 
were higher in a particular age group.
Data were entered into, organized, and analyzed with 
PASW statistics (version 17.0, SPSS Inc., Chicago, IL). We 
determined frequency counts for all categorical variables, 
and measures of central tendency and dispersion were 
performed on continuous variables. Agreement percentages 
were calculated as 100 - [(number of discrepancies/ number of 
reads) x 100].
RESULTS
In our ED between January 2012 and January 2015, 
16,111 radiographs were interpreted by an EP without 
the aid of immediate radiologist interpretation. Of these 
interpretations, there were 1044 discrepancies indicating an 
overall 93.5% agreement rate between EP and radiologist. The 
average age of patients with radiographic discrepancies was 
48.4 ± 25.0 years, and 53.3% of patients were female. The 
age of patients with discrepancies ranged from 0.03 years to 
98.3 years. Of patients with radiographic discrepancies, 28.8% 
were admitted to the hospital from the ED.
The majority of discrepancies, 75.8%, were very minor 
and required no further action after radiologist interpretation. 
Grade 2 discrepancies, which required a phone call to the 
patient, patient’s physician, pharmacy, and/or to the hospital 
floor accounted for 22.3% of discrepancies. Less than 2% of 
discrepancies required the patient to return to the ED and/
or risked serious harm to the patient (Table 1). Based on the 
total number of EP radiology interpretations, discrepancies in 
radiograph interpretation led to 20 ED return visits, which is 
approximately 0.1% of the entire cohort studied. Based on the 
total 16,111 interpretations, Grade 1 discrepancies occurred in 
4.9%, Grade 2 in 1.4%, Grade 3 in 0.1%, and Grade 4 in 0.01%. 
Both of the Grade 4 discrepancies encountered in this 
study were small pneumothoraces. Patient 1 had a 3.5 
centimeter (cm) pneumothorax as well as a rib fracture 
interpreted on rib radiographs by the radiologist that were not 
appreciated by the EP. This patient was previously discharged 
from the ED and required callback for further treatment. 
No additional significant morbidity was encountered as a 
result of the missed pneumothorax based on review of the 
patient’s hospital course. Patient 2 had a CXR performed 
in the ED that was initially interpreted as “effusion” by the 
EP. On radiology interpretation in the morning, a 2.5 cm 
pneumothorax was appreciated. This patient was admitted 
following his ED course; therefore, the medicine team was 
contacted and prompt surgical consultation was initiated. This 
patient experienced no obvious significant morbidity due to 
the missed pneumothorax.
Of the 1044 discrepancies studied, 66.6% were attributed 
to findings that were not originally appreciated by the EP 
at the time of service. Over-calls by the EP accounted for 
25.1% of discrepancies, while 8.3% of discrepancies were 
based on a conflict in finding between the EP and radiologist 
(Table 1). For example, an EP interprets pneumonia on 
CXR while radiologist interprets vascular congestion or vice 
versa. CXRs accounted for 45.1% of the total number of 
radiographs interpreted by an EP, followed by 20.9% lower 
extremity, 17.7% upper extremity, and 6.2% abdominal. 
The remainder of body areas accounted for 10% of the total 
number of radiographs interpreted. Analysis of the various 
body areas revealed greater than 90% agreement in all types 
of radiographs except for those grouped into the category 
“other.” Only 31 radiographs were interpreted in this “other” 
category, with an agreement rate of only 35.5% (Table 2) .
Of the 695 abnormalities not appreciated by the EP, the most 
common were the following, in descending order: 22.9% 
Not appreciated by EP (%) 66.6
Over-call by EP (%) 25.1
Conflict in read (%) 8.3
Discrepancy grade (%)
Grade 1 75.8
Grade 2 22.3
Grade 3 1.7
Grade 4 0.2
Table 1. Discrepancies in radiograph read (n=1044).
EP, emergency physician. 
Grade 1 - No action needed; Grade 2 - Call to patient or 
pharmacy; Grade 3 - Major discrepancy, return to ED; Grade 4 - 
Major discrepancy, serious risk to patient.
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infiltrate; 16.5% fracture; 15.7% pulmonary nodule; 10.9% 
extremity finding other than fracture; 9.9% nonspecific lung 
density. In terms of possible or definite missed fractures, 
they were well distributed throughout the body areas with 
the highest percentages found in the forefoot including fifth 
metatarsal (13.0%), scaphoid (8.7%), rib (7.8%), triquetral 
(6.1%), ankle (6.1%), and thoracic or lumbar fractures (6.1%). 
Of the 262 findings that were over-called by the EP, the most 
common were as follows, in descending order: 35.5% fracture; 
33.6% infiltrate; 9.2% pulmonary vascular congestion; 
7.3% other lung finding; 5.3% extremity finding other than 
fracture. In terms of the over-called fractures, they were well 
distributed with the most frequent being forefoot (15.1%), 
ankle (10.8%), distal radius (9.7%), metacarpals/phalanges 
(6.5%), and rib (6.5%).
In subgroup analysis based on categorized age, 
radiographs of patients 0-6 years of age had an agreement 
rate of 70.8%. Radiographs of patients 7-12 years had an 
agreement rate of 92.1%, patients 13-17 years 89.4%, and 
those aged 18 or greater had an agreement rate of 94.1% 
(Table 3). Of the discrepancies in patients aged 0-6 years, 
60% were EP misses and 35.7% were EP over-calls, with the 
remainder being a conflict in read. Of the EP misses in those 
0-6 years, 64.3% were possible or definite infiltrates. Of the 
EP over-calls, 72.0% were possible or definite infiltrates.
DISCUSSION
In this study we sought to examine discrepancies in plain 
radiographic reads between EPs and radiologists over a three-
year period in our community hospital ED. While similar 
studies have been performed, data adding to the existing body 
of evidence are necessary as there are conflicting reports in the 
literature with agreement rates as low as 52%7 and as high as 
97%-99%.15,16 We hypothesized that agreement would be high 
between the specialties. Our results support this hypothesis 
as we found a 93.5% agreement rate out of 16,111 total 
radiographic reads. We also hypothesized that discrepancies 
that place a patient at significant risk would be rare. Again, 
our results support this hypothesis, as only 0.01% of the total 
16,111 reads were deemed to place a patient at serious risk. In 
total, only 0.1% of the total reads were determined to require 
return to the ED for further treatment.
Similar studies at academic institutions have found 
results comparable to ours. In a 1996 study performed at 
two academic EDs, Nitowski et al. performed an analysis 
of 14,046 radiographic studies interpreted by EP attending 
and radiologist and found a 0.95% disagreement rate with 
only 0.2% of the total being of clinical significance.15 
While our overall disagreement rate was higher at 6.5% 
we found a similar rate of serious discrepancies: 2/16,111 
in our study, compared to 3/14,046 in Nitowski et al.15 In 
a 1990 study performed by Gratton et al. at an emergency 
medicine residency program, the radiographic error rate 
between various EPs, including residents, with radiologist 
interpretation was reported as 3.4% overall with 2.8% of the 
total being of clinical significance.10 A 2011 study also found 
a very low rate of major discrepancies requiring emergent 
treatment, 85/151,693 (0.056%). In total, the authors found 
4605 discrepant studies out of 151,693 radiographs.16 
The findings of these studies, in combination with our data, 
Type of radiograph read by EP % of total interpretations
Chest 45.1
Lower extremity 20.9
Upper extremity 17.7
Abdominal 6.2
TLS spine 5.2
Pelvis 2.5
Cervical spine 1.7
Soft tissue neck 0.4
Other 0.2
Discrepancy by 
radiograph type
# discrepancies/ # reads 
(% Agreement)
Chest 616/7261 (91.5)
Lower extremity 165/3371 (95.1)
Upper extremity 135/2858 (95.3)
Abdominal 50/999 (95.0)
TLS spine 19/844 (97.8)
Pelvis 25/400 (93.7)
Cervical spine 8/278 (97.1)
Soft tissue neck 6/69 (91.3)
Other 20/31 (35.5)
Table 2. Radiographs and discrepancies by body area (n=16111).
EP, emergency physician; TLS, thoracic, lumbar, and/or 
sacrum coccyx; #, number.
Other includes scapula, clavicle, sternum, nasal, facial, orbital, 
mandible, ribs.
Table 3. Radiographic discrepancies by patient age (n=16111).
Age categorized
# discrepancies/ # reads 
(% Agreement)
0 to 6 years 70/240 (70.8)
7 to 12 years 37/467 (92.1)
13 to 17 years 51/479 (89.4)
18 years and greater 886/14925 (94.1)
#, number.
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suggest that plain radiographs can be interpreted by EPs with a 
very low occurrence of discrepancies that would place a patient 
at serious risk. A potential caveat is that two of the above-
mentioned studies are over 20 years old and were performed 
in a time period with lesser technology in relation to electronic 
PACS. A more recent study performed in Iran in 2014 studied 
105 trauma CXRs and found identical interpretation between 
EPs and radiologists in 89.5% of cases.18 The authors reported 
subcategories for differing traumatic injuries and found that EPs 
and radiologists had an agreement rate of 99% for hemothorax 
and 98.1% for pneumothorax.18
On the contrary, other studies have found conflicting 
results with much higher discrepancy rates than reported 
in our study. In a 2009 study by Al Aseri, 312 CXRs were 
studied and a 34% disagreement rate was reported between 
EPs and radiologists.5 In a 2005 study examining the 
agreement in pneumonia diagnosis on CXR between EPs and 
radiologists, the authors reported only a 52.3% agreement rate 
when combining reads of pneumonia or possible pneumonia.7 
Of the 817 CXRs the EP read as pneumonia or possible 
pneumonia, the radiologist read normal in 21.2%, and 26.5% 
were interpreted as a process different from pneumonia. 
The authors explicitly mentioned that neither the EP nor the 
radiologist was held to blame as CXR is prone to significant 
inter- and intra-observer variability, even among radiologists. 
The authors also noted that EPs have the benefit of making a 
diagnosis on clinical grounds rather than just a static image 
and, therefore, the EP treatment may have been appropriate.7 
In a 2018 study performed in Switzerland the authors 
examined discrepancies in interpretations for various imaging 
modalities, and in subgroup analysis of radiographs they 
found a discrepancy rate of 17.9% with a clinically significant 
disagreement rate of 5.67%.13 
In conflict with the above studies, our data suggest 
that discrepancy rates in EDs may be much lower than the 
rather high discrepancy rates reported by these three studies. 
Regardless, data reported by these studies should alert an EP that 
discrepancies do in fact occur; and to minimize risk to a patient, 
an EP must not discount the value of radiologist interpretation.
While we reported discrepancies for all types of 
radiographs, the majority were CXRs and musculoskeletal 
extremity films. Facial, sternal, clavicular, orbital, nasal, and 
rib radiographs are obtained much less frequently in our ED; 
only 31 total as a group were interpreted first by an EP and the 
overall interpretation agreement was extremely low at 35.5%. 
This is in stark contrast to the greater than 90% agreement 
for films of frequently encountered body areas. Gratton et 
al. found a 9% disagreement rate when looking specifically 
at facial films, while they found lower rates of disagreement 
in more frequently encountered radiographs.10 Despite the 
low subgroup sample size we believe this suggests that 
EPs must exercise caution when interpreting films in which 
experience is lacking as this may lead to an increasing number 
of interpretive errors. In addition, while extremities films and 
CXRs are commonly encountered by the EP, our results may 
suggest the need for a more broad radiographic education 
for EPs as additional imaging modalities may not always be 
available to the EP.
In adult EDs, pediatric radiographs are generally 
encountered less frequently than those of older teenagers and 
adults. In our study only 1186/16,111 radiographs were in 
patients 17 years and younger. Furthermore, only 1.5% of the 
16,111 radiographs were in patients six years and younger. 
Given the fact that radiographs of the very young are a small 
subset of day-to-day practice in an adult ED, experience 
can play a factor in radiographic interpretative error. Our 
agreement rate for those six years and younger was 70.8%, 
which is approximately 20% less than any other age group 
studied. In addition, the vast majority of misses and over-
interpretations in this age group were infiltrates on CXRs. This 
common finding in our study could suggest the need for better 
education regarding interpretation of pediatric CXRs. 
In a 2010 study, Johnson and Kline studied the intra- and 
inter-observer reliability of radiologists, senior pediatric EPs, 
and junior pediatric EPs in interpreting pediatric CXRs in 
patients aged 1-4 years.. Even in these pediatric-trained EPs, 
interpretative variability was considerably higher than among 
pediatric radiologists.19 Our subgroup analysis indicates that 
adult EPs must be vigilant when interpreting radiographs in 
the very young patient as interpretative discrepancies are more 
likely to occur than in adults presenting to a non-pediatric ED.
LIMITATIONS
This was a single-site study in a community hospital ED 
with a limited number of practicing EPs and radiologists. This 
could negatively influence the overall generalizability of the 
study to sites with a greater or lesser number of physicians 
with differing levels of experience and/or training. Also, we 
were unable to determine whether an EP’s or radiologist’s 
number of years in practice had any correlation with 
interpretation accuracy. While all EPs interpreting radiographs 
in this study were board-certified, this is an area that warrants 
future research with well-designed prospective studies. In 
addition, we were unable to obtain an accurate gauge of the 
total number of radiographs with serious pathology such as 
abdominal free air, pneumothorax, bowel obstruction, etc. 
that were correctly interpreted by the EP over the studied time 
period. While our ED evaluates patients with pneumothorax, 
perforated viscus, and small bowel obstructions on a regular 
basis, we were unable to ascertain whether or not the 
percentage of treatment-changing discrepancies would be 
influenced if a higher incidence of serious pathology were 
encountered during off-hours. 
The retrospective nature of this study did lead to 
weaknesses that should be addressed in future studies. Based 
on the documentation method used in our logbook as well 
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as in our PACS, we were unable to determine the number of 
true-positives vs true-negatives. Agreements were simply 
documented as no deficiency whether they were a positive 
or negative study. As such, more robust measures of inter-
rater reliability such as the kappa coefficient could not be 
calculated. Also as mentioned above, we were unable to 
determine the influence of the raters’ experience due to 
the method in which the deficiencies were documented. 
Prospective studies comparing the interpretation of more than 
one EP with more than one radiologist could account for these 
limitations. Despite this, our findings as well as our limitations 
suggest that despite the study of this topic in the past, more 
research is needed.
While we used the radiologist interpretation as the gold 
standard of diagnosis, it should be mentioned that there are 
potential issues with this design. There was more than one 
radiologist interpreting images in this study and radiologists 
can differ in their opinion or interpretation. It has been found 
that overall error rates between experienced radiologists is 
potentially around 3-9% in a mixture of negative and positive 
plain radiograph studies.20-23 Studies have abstracted from 
these data that if normal studies were excluded, error rates 
between radiologists could be as high as 30% in a grouping 
of abnormal studies.20 While this could have influenced our 
discrepancy percentage in a positive or negative direction, we 
feel it is unlikely to have skewed the results by more than a 
few percentage points based on the potential 3-9% radiologist 
disagreement rate reported above. In addition, the EP is more 
likely to have clinical clues, eg, pinpoint tenderness over the 
distal radius leading to an EP over-call of “possible fracture” 
while a radiologist is only provided a small history without 
aid of physical examination. This can introduce bias, mainly 
in regard to discrepancies in which an EP over-calls a specific 
radiographic study. While this may contribute to patient safety 
in a positive manner, it could potentially lead to overtreatment 
with antibiotics, immobilization, etc. 
Finally, radiologists at our institution are not blinded to 
the overnight EP interpretation, and therefore this potentially 
introduces bias to the radiologist interpretation. Unfortunately 
in our PACS, the EP interpretation appears immediately 
when a radiologist opens the radiographic study. In general, 
radiologists at our institution do attempt to formulate their 
own interpretation of a study before fully reviewing the EP 
interpretation to determine if there are any conflicts. A project 
with blinding of the radiologist to the EP interpretation 
warrants further study in the future to determine if the 
radiologist interpretation is actually influenced by EP read. 
CONCLUSION
We found that plain radiographic studies can be 
interpreted by EPs with a low incidence of clinically 
significant discrepancies when compared to the final 
radiologist interpretation. While conflicting reports exist 
regarding disagreement in plain radiographic reads between 
EPs and radiologists, our study suggests that discrepancy 
rates are most consistent with studies reporting lower rather 
than higher discrepancy rates. Although serious discrepancies 
were rare in our study, radiologist interpretation should 
be performed immediately when available to limit the 
small number of treatment-changing discrepancies that 
could potentially place patients at risk of adverse outcome. 
Furthermore, while we found greater than 90% agreement 
in the most commonly obtained radiographs in the ED, 
infrequently obtained radiographs such as facial and rib films 
had a very poor agreement rate among EPs and radiologists. 
Increasing discrepancy rates were also found in patients 
aged six and younger when compared to adults and older 
pediatric patients. In the best interest of patient care, an EP 
should be hesitant to make treatment decisions based on their 
interpretation of infrequently obtained radiographs as well as 
in the very young if immediate radiologist interpretation is not 
available. Future prospective studies are needed to determine 
the generalizability of this study to EDs with differing volume, 
patient population, acuity, and physician training.
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INTRODUCTION
Over 15% of the visits to emergency departments (EDs) 
can be attributed to patients older than 65 years in the United 
States.1 Compared to younger patients, this population has a 
higher risk of death or development of a functional decline 
leading to institutionalization.2,3 Moreover, atypical symptoms 
in prevalent diseases are common, and older patients often 
present with nonspecific complaints (NSC), such as weakness 
or acute functional decline.4,5 Previous studies showed that 
patients presenting with NSCs have a 30-day mortality reaching 
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Introduction: Older patients frequently present to the emergency department (ED) with nonspecific 
complaints (NSC), such as generalized weakness. They are at risk of adverse outcomes, and early 
risk stratification is crucial. Triage using Emergency Severity Index (ESI) is reliable and valid, but 
older patients are prone to undertriage, most often at decision point D. The aim of this study was to 
assess the predictive power of additional clinical parameters in NSC patients.
Methods: Baseline demographics, vital signs, and deterioration of activity of daily living (ADL) in 
patients with NSC were prospectively assessed at four EDs. Physicians scored the coherence 
of history and their first impression. For prediction of 30-day mortality, we combined vital signs at 
decision point D (heart rate, respiratory rate, oxygen saturation) as “ESI vital,” and added “ADL 
deterioration,” “incoherence of history,” or “first impression,” using logistic regression models.
Results: We included 948 patients with a median age of 81 years, 62% of whom were female. The 
baseline parameters at decision point D (ESI vital) showed an area under the curve (AUC) of 0.64 
for predicting 30-day mortality in NSC patients. AUCs increased to 0.67 by adding ADL deterioration 
to 0.66 by adding incoherence of history, and to 0.71 by adding first impression. Maximal AUC was 
0.73, combining all parameters. 
Conclusion: Adding the physicians’ first impressions to vital signs at decision point D increases 
predictive power of 30-day mortality significantly. Therefore, a modified ESI could improve predictive 
power of triage in older patients presenting with NSCs. [West J Emerg Med. 2019;20(4)633-640.] 
6%–13%.6,7 However, individual prediction of mortality is 
difficult due to the broad differential diagnosis including a 
wide span of reasons ranging from lack of social support to 
acute life-threatening disease.4,8 Therefore, disease-specific risk 
scores (such as the HEART score) are not used at presentation; 
instead, general risk stratification tools to identify patients at 
risk should be developed. Although various parameters and 
clinical tools for the prediction of mortality in the general ED 
population exist,9 risk stratification tools for older patients with 
NCSs have not yet been developed. This is an unmet need in one 
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Population Health Research Capsule
What do we already know about this issue?
Patients presenting with nonspecific 
complaints (NSCs) in the emergency 
department (ED) are older than average and 
show an increased risk of adverse outcomes. 
What was the research question?
The aim was to assess the effectiveness of 
parameters for the prediction of 30-day 
mortality in NSCs patients.
What was the major finding of the study?
The parameters of respiratory rate and the 
physician’s “gesalt” are most efficient in 
predicting 30-day mortality. 
How does this improve population health?
The parameters can help improve the 
effectiveness of triaging patients according 
to their risk and assign the appropriate 
resources for each patient.
of the largest groups that requires several external resources during 
work-up presenting to the ED.10
The main tool used for the prediction of mortality in ED 
“all-comers” population is triage.11 Triage is the categorization 
of patients according to urgency and prognosis at presentation. 
A reliable and valid triage instrument is the Emergency Severity 
Index (ESI), which uses a five-level classification system.11,12 
ESI levels can be used to predict six-month and one-year 
mortality in an older ED population.13,14 Four decision points 
(A to D) are used to triage patients into the five ESI levels. 
Patients with ESI level 1 are in need of an immediate life-
saving intervention (decision point A). Stable patients in a 
high-risk situation are designated to ESI level 2 (decision point 
B). At decision point C, patients are assigned according to the 
expected use of resources, reaching from none (ESI 5) to more 
than one (ESI 3). To ultimately classify a patient as ESI level 
3, vital signs must be assessed. If they exceed defined limits, 
re-assignment to ESI level 2 is to be considered (decision point 
D).11,15 Obviously, vital sign assessment is important for the 
identification of patients with a poorer prognosis requiring 
urgent attention. 
One of the main problems of triage in older patients is 
undertriage.10 Undertriage describes a phenomenon where 
patients are misclassified into a lower urgency group. It occurs 
most commonly at decision point D separating ESI 3 from 
ESI 2.10 This highlights that decision point D may be crucial 
to avoiding undertriage and could, therefore, be a weakness of 
this triage tool. 
The aim of this study was to assess the effectiveness of 
vital sign assessments at decision point D (“ESI vital”) for the 
prediction of 30-day mortality in patients presenting with NSCs. 
We further evaluated the predictive power at decision point D 
with additional parameters such as the deterioration in activity of 
daily living (ADL) (“ESI A”), the incoherence of history (“ESI 
H”), and the first impression by the physician (“ESI F”). We 
focused on older patients with NSCs as a highly prevalent and 
vulnerable population. 
METHODS 
Study Design and Setting 
This study was part of a prospective, observational 
multicenter study with a 30-day follow-up. Data collection was 
conducted from May 24, 2007 to July 26, 2011. The study was 
performed at three EDs: a 700-bed tertiary care hospital, a 600-
bed tertiary care hospital, and a 400-bed secondary care hospital. 
The local ethics committee approved the study protocol. The 
study is registered at ClinicalTrials.gov. 
Selection of Participants
We used a validated German version of the Emergency 
Severity Index (ESI) for triage.11,16 All non-trauma patients older 
than 18 years with an ESI of 2 or 3, whose vital signs were not 
extremely out of range, (see Table 1) and who presented to 
the ED with NSCs were eligible for this study. Patients were 
included by the study team after recording of the patient’s 
medical history and focused clinical examination, but before 
laboratory results were available. Exclusion criteria are shown 
in Table 1. 
Screening for Nonspecific Complaints (NSCs)
NSCs are symptoms that are not part of the set of 
specific complaints. Patients with specific complaints or a 
clinical presentation suggestive of a working diagnosis can 
be managed using evidence‐based management protocols 
for emergency physicians. Patients for whom the physicians 
could name a specific complaint or a specific working 
diagnosis were excluded from the study. Any patients 
presenting with recent external laboratory results or specific 
electrocardiogram (ECG) changes on admission were not 
eligible.4 This definition for NSCs by exclusion has a major 
advantage, as there is not an endless list of nonspecific 
presenting complaints. Furthermore, patients with NSCs as 
defined above are comparable to patients with weakness and 
fatigue regarding demographics and outcomes.17
Measurements
Previously trained study physicians recorded the 
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following data shortly after ED presentation: demographic 
(age, sex); ESI level; vital signs (heart rate, blood pressure, 
oxygen saturation, and body temperature); ECG; ADL 
deterioration within the prior two weeks; evaluation of the 
coherence of the patient’s history; and the physician’s first 
impression of the patient. The mode of presentation was 
extracted from the patient’s electronic health records (EHR) 
and included two modes: “ambulance transport” (including 
hospital transfer) or “walk-in.” 
To assess the parameter “ADL deterioration,” the study 
physician asked the patient about a decline of independence 
in the prior two weeks regarding “bathing,” “dressing,” 
“mobility,” “feeding,” “toilet hygiene,” and “incontinence.” 
For the parameter “coherence of history,” the study 
physicians provided a subjective judgment (yes/no), 
whether they considered the history given by the patient 
as coherent (no discrepancy to other information, such as 
health records or histories by proxies). For “first impression 
by the physician,” every physician assigned points to the 
question, “how ill does this patient look?,” using a scale 
ranging from 0 (patient looks very healthy) to 10 (patient 
looks critically ill). Mortality at 30 days was obtained 
from the EHR, the patient’s primary care physicians (by 
questionnaires), and from hospital discharge reports. 
Emergency Severity Index
Specifically trained triage nurses used the German version 
of the ESI.11 The first of the four decision points (decision 
point A) distinguishes patients in need of an immediate life-
saving intervention and allocates them to ESI level 1. ESI 
level 2 is assigned to patients who should not wait due to 
high-risk situations, such as new onset of confusion, lethargy, 
disorientation, and severe pain or distress (decision point B). 
ESI levels 5 to 3 are assigned according to the expected use 
of resources. Patients who need no resources are categorized 
as level ESI 5, while those who need one or more resources 
are classified as ESI 4 or ESI 3, respectively (decision point 
C). If patients are to be assigned to ESI level 3, vital signs 
must be assessed. If vital signs exceed the defined limits (heart 
rate higher than 100 beats per minute (min), respiratory rate 
higher than 20/min, or oxygen saturation lower than 92%), 
re-assignment to ESI level 2 should be considered (decision 
point D).11,15 
Additional Parameters Assessed at Decision Point D
For prediction of outcome, we compared the following 
predictors: all parameters in the set of vital signs at decision 
point D (heart rate, respiratory rate, and oxygen saturation 
[“ESI vital”]). Additional possible outcome predictors were 
a decline in ADL (“ESI A”), an incoherent medical history 
(“ESI H”), and the first impression by the physician of 9 
or higher (“ESI F”). Moreover, we added the additional 
parameters pairwise to obtain “ESI AH,” “ESI AF,” and “ESI 
HF,” as well as all additional parameters combined to obtain 
“ESI AHF” as an outcome predictor.
Statistical Analyses
We tested the following 12 parameters to predict 30-
day mortality in the NSCs population: age (years); sex 
(male); heart rate (per min); respiratory rate (per min); 
oxygen saturation (% on room air); systolic blood pressure 
(mmHg); low temperature (<35°C); ECG changes (all 
findings except tachycardia, bradycardia, and pacemaker 
rhythm); “ambulance transport” mode of presentation; 
“incoherence of history”; “ADL deterioration”; and “first 
impression by the physician.” In order to detect the effect 
of various parameters on the 30-day mortality, we used 
univariate logistic regression models. Results are expressed 
as odds ratios (OR) with corresponding 95% confidence 
intervals (CI) and p-values. Further, the AUC of a receiver 
operating characteristic (ROC) curve was calculated with 
corresponding 95% CIs for each parameter. 
To compare the different scores (eg, “ESI vital,” “ESI 
A,” etc.), AUCs of the different scores were calculated 
and compared pairwise using a non-parametric approach 
model.18 We computed descriptive statistics with 
frequencies or median and interquartile range (IQR). 
Overall p-values correspond to t-test (for means), Kruskall-
Criteria Examples
ESI 1, 4, or 5
Specific complaints Chest pain, dyspnea, 
abdominal pain
Clinical presentation 
suggestive of a working 
diagnosis to be managed by 
evidence based protocols
Jaundice
Vital signs markedly out of 
range
Systolic blood pressure < 90mmHg 
Heart rate > 120 beats/min
Tympanic body temperature > 
38.4°C or <35.6°C
Respiratory rate > 30 breaths/min
Oxygen saturation < 92%
Recent external laboratory 
results, or referral
Documented anemia
Specific electrocardiogram 
changes on ED presentation
ST-segment elevation
Moribund patients with 
terminal conditions
End-stage cancer
Incomplete data Missing values for activity of 
daily living (ADL)
Lack of informed consent
Table 1. Exclusion criteria in study assessing the predictive power 
of triage in older patients presenting with non-specific complaints.
ESI; emergency severity index; mmHg, millimeters of mercury; 
°C, degrees Celcius; min, minute.
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Wallis test (for median), and chi-square test or Fisher’s 
exact test if the expected frequencies were less than 5. 
A p-value <0.05 was considered significant. We did all 
analyses using R version 3.0.1 (The R Foundation for 
Statistical Computing, Vienna, Austria).
RESULTS
Characteristics of Study Subjects
A total of 1401 non-trauma patients who presented 
with NSCs to the ED were screened for eligibility. Of 
these, 1278 patients fulfilled the inclusion criteria. The 
data were retrospectively reviewed for completeness 
of all clinical parameters. In 330 patients one or more 
clinical parameters was missing, and these patients were 
subsequently excluded (Figure 1). To exclude selection 
bias, we compared the 948 patients with complete data 
and the 330 patients with incomplete data. The two groups 
were comparable with respect to age, sex, and vital signs 
(heart rate, respiratory rate, oxygen saturation, and systolic 
blood pressure), and regarding the occurrence of the 
parameters “ADL deterioration,” “incoherence of history,” 
“first impression by the physician,” and 30-day mortality 
(Supplementary Data 1).
Table 2 shows the baseline characteristics of all 948 
patients included. A total of 589 patients (62.1%) were 
female; the median age was 81 years with an IQR from 74-
87 years, and 835 (88.1%) patients were older than 65 years. 
A total of 57 (6.01%) patients were not alive 30 days after 
presentation to the ED.
Prediction of Mortality
To determine predictors of mortality, we analyzed the 
effectiveness of 12 clinical parameters including the vital sign 
parameters assessed at decision point D. We performed univariate 
logistic regression analysis for all parameters (Table 3). We 
found the following parameters to predict mortality: sex (male); 
respiratory rate; “ADL deterioration”; “incoherence of history”; 
and “first impression by the physician >8 points.” Of these, the 
physician’s first impression had the best predictive performance 
regarding 30-day mortality with an OR of 1.250 per 10% increase 
and an AUC of 0.67. The second most reliable parameter was 
respiratory rate with an OR of 2.667 and an AUC of 0.56. 
Respiratory rate is one of the vital signs assessed at decision point 
D. The other two vital signs recorded at decision point D (ie, heart 
rate and oxygen saturation had low predictive power) (Table 3).
To test the predictive power of vital signs at decision point 
D, we combined all three vital signs (respiratory rate, heart rate, 
and oxygen saturation) and calculated the “ESI vital” score. This 
score yielded an AUC of 0.64 for predicting the 30-day mortality 
in patients with NSCs. 
To further increase the predictive power of “ESI vital,” we 
added the three remaining best-performing parameters (accessory 
parameters) to the score: “ADL deterioration” for “ESI A”; 
“incoherence of history” for “ESI H”; and “first impression by 
Figure 1. Patient enrollment chart. 
ECG, electrocardiogram; STEMI; ST-elevation myocardial infarction.
Screening 
(n=1401)
Inclusion criteria fulfilled
(n=1278)
Exclusion criteria fulfilled
(n=123)
123 excluded
59 with specific symptoms
16 with vital signs out of range
2 with specific symptoms and vital sign out of range
11 who received surgery
7 with recent blood test results
2 specific ECG signs (STEMI)
3 referrals from other hospitals
18 missing data
4 lost in follow up
1 falsely excluded
Complete data
(n=948)
Incomplete data
(n=330)
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the physician >8 points” for “ESI F.” We calculated the 
predictive power of the different scores and compared it 
to the power of “ESI vital.” The AUC increased from 0.64 
to 0.67 for “ESI A” and to 0.66 for “ESI H.” A significant 
increase to 0.71 was observed for “ESI F” (p=0.004), if 
>8 points was chosen as cut-off. Figure 2 shows the ROC 
curves for 30-day mortality based on the scores “ESI 
vital,” “ESI A,” “ESI H,” and “ESI F.” This shows that the 
prediction of the 30-day mortality could be increased by 
adding the parameters “ADL deterioration,” “incoherence 
of history,” or “first impression by the physician” to the 
basic model “ESI vital.”
To further increase the predictive power, we added 
the additional parameters pairwise to “ESI vital”: “ADL 
deterioration” and “incoherence of history” for “ESI 
AH;” “incoherence of history” and “first impression by 
the physician” for “ESI HF”; and “ADL deterioration” 
and “first impression by the physician” for “ESI AF.” We 
compared the AUC of these scores with the AUCs of “ESI 
vital” and observed an increase in the predictive power, 
whereby “ESI AH” had an AUC of 0.68, “ESI HF” of 
0.72, and “ESI AF” of 0.72. Moreover, we added all three 
parameters to “ESI vital” (“ESI AHF”). By combining all 
three parameters, the predictive power further increased 
to an AUC of 0.73. This shows that the predictive power 
of “ESI vital” can be increased by addition of multiple 
accessory parameters, whereby the combination “ESI AHF” 
performed best, but not significantly better than ESI F.
DISCUSSION
We analyzed the parameters determined in ESI triage at 
decision point D separately and found that first, respiratory 
rate alone can efficiently predict 30-day mortality in patients 
presenting with NSCs. This result is in line with previous 
studies, showing that abnormal respiratory rate (<8/min and 
>30/min) can be used to predict in-hospital mortality.19,20 
Tachycardia and hypoxia, the other two parameters assessed 
at decision point D, were found previously to be associated 
with an increased risk of death in the ED.20 However, these 
two parameters alone were not useful for risk prediction 
in our population of elderly patients with NSCs. This 
discrepancy can be attributed to the a priori exclusion of 
patients with severe tachycardia and hypoxia (Table 1).
Second, the combination of all three vital sign 
parameters measured at decision point D (heart rate, 
respiratory rate, and oxygenation), predicted 30-day 
mortality moderately well. This result is also in line with 
previous studies.21,22 Yet undertriage occurs most often 
at decision point D.10 The reasons for this are probably 
multifactorial. However, it appears that vital sign assessment 
at decision point D is often performed incompletely, and this 
lack of adherence to the algorithm (e.g., lack of measurement 
of respiratory rate) contributes to the occurrence of 
undertriage.22 Hence, we have shown that vital signs are 
predictive for the patients’ outcomes, and our findings 
support the importance of a complete assessment of vital 
signs, including respiratory rate, to avoid undertriage. 
Older patients are particularly at risk of undertriage.10 
This might be explained by the age-related changes of 
vital signs in the elderly.23 Moreover, the measurement of 
vital signs tends to be less sensitive in patients with severe 
illness or injury who are older than 75 years. Thus, the use 
of age-adapted vital sign cut-offs at decision point D for the 
Variables Number
Total [n] 948
Sex
Male [n (%)] 359 (37.9%)
Female [n (%)] 589 (62.1%)
Age [median years (IQR)] 81 (74-87)
< 65 years [n (%)] 113 (11.9%)
> 65 years [n (%)] 835 (88.1%)
ESI Level at Triage
2 41 (4.7%)
3 836 (95.3%)
Mortality (30 days)
Non-survivors [n (%)] 57 (6.0%)
Living situation
Nursing home [n (%)] 81 (8.5%)
Vital signs at triage
Heart rate > 100/min [n (%)] 104 (11.0%)
Respiratory rate > 20/min / < 8/min [n (%)] 93 (9.8%)
O2 saturation < 92% [n (%)] 23 (2.4%)
Systolic blood pressure < 100 mmHg [n (%)] 38 (4.0%)
Other parameters at triage [n (%)]
Incoherence of history [n (%)] 436 (46.0%)
ADL deterioration [n (%)] 544 (57.4%)
First impression > 8 points [n (%)] 75 (7.9%)
Temperature < 36.5°C [n (%)] 6 (0.6%)
ECG changes [n (%)] 447 (47.2%)
Ambulance transport [n (%)] 615 (64.9%)
Table 2. Baseline and demographic variables. 
O2, oxygen; mmHg, millimeters of mercury; IQR, interquartile range; 
°C, degrees Celcius; min, minute; ESI, emergency severity index. 
Incoherence of history: physician’s judgment, whether he or she 
considered the patient’s history as coherent. Activity of daily 
living (ADL) deterioration: deterioration of any ADL within the 
prior two weeks. First impression: rating by the physician using 
a scale ranging from 0 (patient looks very healthy) to 10 (patient 
looks critically ill). Electrocardiogram (ECG) changes: all findings 
except tachycardia, bradycardia, and pacemaker rhythm and 
specific changes.
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Parameters AUC Lower Upper
Age (years) 0.54 0.47 0.62
Sex (male) 0.63 0.57 0.70
Vital signs at triage
Heart rate > 100/minute 0.57 0.48 0.66
Systolic blood pressure < 
100 mmHg
0.61 0.54 0.68
Respiratory rate > 20/minute 0.56 0.51 0.61
O2 saturation > 92% 0.50 0.42 0.57
Other parameters at triage
Incoherence of history 0.55 0.49 0.62
ADL deterioration 0.59 0.53 0.65
First impression > 8 points 0.67 0.60 0.74
Temperature < 36.5°C 0.56 0.48 0.65
ECG changes 0.55 0.48 0.61
Ambulance transport 0.50 0.44 0.56
Scores
“ESI vital” 0.64 0.56 0.73
“ESI A” 0.67 0.59 0.75
“ESI H” 0.66 0.58 0.74
“ESI F” 0.71 0.63 0.79
“ESI AH” 0.68 0.60 0.76
“ESI HF” 0.72 0.65 0.79
“ESI AF” 0.72 0.64 0.79
“ESI AHF” 0.73 0.65 0.80
mmHg, millimeters of mercury; O2, oxygen; °C, degrees Celcius; ESI, 
Emergency Severity Index; ESI A, decline in activity of daily living 
(ADL); ESI H, incoherence of history; ESI F, first impression of physi-
cian; ESI AH, decline in ADL plus incoherence of history; ESI AF, 
decline in ADL plus first impression of physician; ESI HF, incoherence 
of history plus first impression of physician; ESI AHF, decline in ADL 
plus incoherence of history plus first impression of physician.
Incoherence of history: physician’s judgment, whether he or she 
considered the patient’s history as coherent. Activity of daily living 
(ADL) deterioration: deterioration of any ADL within the prior two 
weeks. First impression: rating by the physician using a scale ranging 
from 0 (patient looks very healthy) to 10 (patient looks critically ill). 
Electrocardiogram (ECG) changes: all findings except tachycardia, 
bradycardia, and pacemaker rhythm and specific changes.
geriatric patient population has been suggested.24 Adapting 
vital sign cut-offs for specific age groups has been applied 
in the pediatric version of the ESI (e.g., heart rate > 140 
[3-8 years], respiratory rate > 30 [3-8 years]).25 Adapting 
cut-offs for vital signs in older patients may increase the 
power of mortality prediction, but has not been used for 
any triage tool as of yet.
Third, we could show that a further improvement of 
mortality prediction can be achieved by adding parameters 
to the baseline model of vital signs at ESI decision point 
D. The best-performing additional parameters were “ADL 
deterioration” and “first impression by the physician.” 
Consistent with this, adding these parameters to “ESI vital” 
increased the predictive power of the tool. The increased 
predictive power of “first impression by the physician” 
is consistent with the findings of a recent study, which 
showed that physicians may identify patients at risk 
of in-hospital mortality.26 Adding the parameter “ADL 
deterioration” also increased the prediction power over the 
baseline model of vital signs. This is in line with a previous 
study showing that the decrease of the ADL is a risk factor 
for in-hospital death in older patients.20 
The predictor analysis also showed an increased 
(yet not significant) risk of mortality for patients with an 
incoherent history (OR 1.53). This is in agreement with 
other studies which showed that an inaccurate medical 
history might lead to delayed or missed diagnoses.27,28 
ESI vital    
ESI A          
ESI H      
ESI F     
AUC: 0.64
AUC: 0.67
AUC: 0.66
AUC: 0.71
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Figure 2. Comparison of area under the receiver operating 
characteristic (ROC) curve of the different modifications of the 
emergency severity index (ESI) vital, ESI A, ESI H, and ESI F. The 
black continuous line shows the ESI vital including pulse, respiratory 
rate, and oxygen-saturation. The grey dotted line shows the ESI A 
including ESI vital and activity of daily living deterioration. The black 
dotted line shows ESI H including ESI vital and accuracy of medical 
history. The grey continuous line shows ESI F including ESI vital and 
the first impression by the physician.
AUC, area under the curve; ESI A, decline in activity of 
daily living (ADL); ESI H, incoherence of history; ESI F, first 
impression of physician.
Table 3. Odds ratios (OR) for all parameters tested for an 
association with 30-day mortality. 
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The combination of all three parameters improved the 
predictive power of “ESI vital.” However, the improvement 
was comparable to adding “first impression by the 
physician” only. Additionally adding so many variables 
into the ESI while testing may limit the external validity. 
Therefore, we believe that “ESI F” should be preferred over 
other modifications as it performs best while keeping triage 
using the ESI as fast and simple as possible. 
LIMITATIONS
Various parameters were needed for the calculation 
of the different scores. Since data were not available for 
all patients, 334 patients could not be included to the 
analysis. This, however, increases the risk of a selection 
bias. Nonetheless, both included and excluded populations 
are comparable regarding baseline demographics and 
regarding the prevalence of the parameters. Therefore, we 
assume that lack of data had most likely a random effect. 
Yet excluding patients with vital parameters extremely out 
of range in the first place could limit the performance of the 
different scores. Moreover, other tools such as the PARIS 
score, which is based on blood pressure, age, respiratory 
rate, loss of independence and oxygen saturation29 were not 
evaluated but could be tested in future studies.
Generally, mortality may not be the ideal outcome 
parameter in a population of patients with a median age 
of 82 years. In future studies, the performance of scores 
should be tested on other outcomes such as acute morbidity 
or institutionalization.
CONCLUSION
Patients with NSCs may need a triage system using 
additional information. At triage, it is important to use 
easily available parameters requiring no further equipment. 
We have shown that adding the first impression by the 
physician increased the prediction of mortality in patients 
presenting with NSC. Thus, in addition to vital signs out of 
the defined range, a score of 9 or 10 for “looking ill” may 
be considered for re-assignment to ESI level 2. With this 
modification, the use of “gestalt,” which was suggested 
in the original ESI score, could be specified concisely at 
decision point D. Improving the predictive power of triage 
in elderly patients presenting with nonspecific complaints 
is of importance due to their high vulnerability. This 
additional specification of decision point D should be 
prospectively validated in patients older than 65 years.
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Introduction: Each year residency programs expend considerable effort ranking applicants for the 
National Residency Matching Program (NRMP). We explored the relationship between residents’ 
NRMP rank list position as generated at our institution and their performance in residency and post-
graduation to determine whether such efforts are justified.
Methods: Faculty who were present for the 10 consecutive study years at an allopathic emergency 
medicine residency retrospectively evaluated residents on their overall performance, medical 
knowledge, and interpersonal skills. Residency graduates were surveyed regarding their current 
position, hours of clinical practice, academic, teaching and leadership roles, and publications. We 
compared match position to performance using graphical techniques as the primary form of analysis.
Results: Ten faculty evaluated the 107 residents who graduated from the program during these 
10 years by class year. Eighty-four residents responded to the survey. In general, we found little 
correlation between NRMP rank and faculty rank of resident performance. There was also little 
correlation between position in the NRMP rank list and the probability of having an academic career, 
publishing research, or having a teaching or leadership role. 
Conclusion: We found that the position on our NRMP rank list was of little value in predicting which 
residents would do best in residency or take on academic or leadership roles once graduated. 
Residencies should evaluate the processes they use to generate their rank list to determine whether 
the ranking process is sufficiently predictive to warrant the effort expended. [West J Emerg Med. 
2019;20(4)641-646.]
INTRODUCTION
Each year residencies across the United States participate 
in a time-intensive application process with three principal 
purposes: 1) to educate graduating medical student applicants 
about the residency program in a way that is both positive 
and realistic; 2) to identify applicants who would be a poor 
fit with the program and should not be ranked in the match; 
and 3) to differentiate highly desirable applicants from less 
desirable ones. While the first two objectives are necessary 
and feasible, the third objective poses a challenge and, in our 
experience, is very time intensive. Existing evidence suggests 
that programs are not particularly successful at determining 
which of their best performing medical student applicants will 
continue to be top performers in residency and ordering their 
rank lists accordingly.1-3 However, to our knowledge no study 
has explored the ability of the National Residency Matching 
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Population Health Research Capsule
What do we already know about this issue?
Residency programs expend considerable 
faculty time developing their National 
Residency Matching Program (NRMP) 
rank list. The value of fine tuning this list is 
unknown.
What was the research question?
Does NRMP rank order predict 
performance during residency or as a 
practicing physician?
What was the major finding of the study?
NRMP rank order did not predict 
performance during residency or career 
path in a meaningful way.
How does this improve population health?
This may motivate residencies to streamline 
their match list creation process.
Program (NRMP) rank to predict post-residency performance. 
Our goal was to determine whether the NRMP applicant 
ranking process correlated with resident clinical performance, 
which has been studied on a few occasions,1-7 and post-
graduation outcomes. This study was based on the ranking 
process currently conducted at a dual site emergency medicine 
(EM) residency program. We believe that if programs are 
unable to show that the energy expended ranking residents in 
a detailed manner produces important benefits to the program, 
then the faculty hours freed up by a less time-consuming 
method of ranking applicants could be redirected toward 
activities that improve the resident experience. 
METHODS
The overall design of our study was to compare the NRMP 
rank list generated for each class over a 10-year period to 
residency and post-graduation performance of the residents. This 
was achieved via the comparison of the rank-list position by class 
with attending evaluation and post-graduation survey data. 
Residency Recruitment Process
This two-part retrospective survey study took place in a 
dual site, four-year, allopathic EM residency program. The 
residency has been in place since 1978 with the mission of 
producing future leaders of EM in clinical research, academia, 
and public health administration. Our program has the luxury 
of having many more applicants (≈750) than positions (≈11 at 
the time of the study), so an applicant’s position on the rank list 
greatly influences his or her likelihood of joining our program. 
During the time of this study, our selection process began 
with a crude screening of applications using objective criteria 
such as medical school attended and United States Medical 
Licensing Exam test scores to reduce the pool to 300-400 
applicants. The residency recruitment committee reviewed 
these dossiers to identify the roughly 100 applicants who were 
offered an on-site interview. Each interviewee spent one of 10 
interview days at the program, participating in activities that 
included three, 30-minute interviews with faculty members. 
The interviews were used to assess characteristics difficult to 
ascertain from an application dossier including interpersonal 
and communication skills, ambition, commitment to a career in 
EM, and humanitarian beliefs. Interviewing faculty members 
completed a standardized scoring form that included a global 
assessment placing the applicant in a rank list quintile or “do 
not rank.” 
Additional faculty, residents, or staff (i.e., residency 
coordinators) who met the applicants during the interview day 
also submitted written comments. Based on the dossier, the 
interview ratings, and other comments, the program directors 
(PD) placed applicants in a tentative order. After each interview 
day they interdigitated additional applicants into the growing 
rank list. After concluding the interviews, PDs, faculty, and 
residents involved with recruitment reconsidered all applicants 
and held two full-day meetings to determine the final rank list 
submitted to the NRMP. 
Study Design
 In part 1 of this study, we obtained performance data for 10 
years of residents using an electronically administered survey 
to elicit the opinions of longstanding, full-time faculty members 
who were present for the entire residency experience of these 
classes. Each faculty member independently ranked all of the 
residents within a graduating class from highest to lowest on 
three distinct measures based on residency milestones –  overall 
performance, medical knowledge, and interpersonal skills – 
generating three rankings per resident per graduating class. The 
residents within a class were presented in random order, as were 
the classes, using software that allowed the faculty to move icons 
containing each resident’s name and photograph into the desired 
order. Ties were not permitted. 
In part 2 of this study, we electronically surveyed former 
residents in the 10 graduating classes regarding clinical, 
leadership, and academic outcomes post-residency (Appendix 1). 
This survey was designed to capture various pathways of career 
advancement in EM based on promotion guidelines at local 
academic and community institutions. This study was approved 
by the institutional review board (IRB) at our home institution. 
All participants read an IRB-approved description of the study; 
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their participation was deemed evidence of consent. 
Selection of Participants
All categorical EM residents who graduated from the 
program during 10 consecutive years were included. To maintain 
confidentiality of our participants, the specific years are not 
reported, but the 10-year period was within the time frame 1998-
2013. We excluded residents who participated in our combined 
EM/pediatrics or EM/internal medicine training programs. 
Faculty were eligible to participate if they were present for 
all years when these residents were in training, were not part 
of the study team, and were not involved in preparing the final 
NRMP rank order list, meaning that they were not a PD or an 
associate PD intimately involved in producing the final list. 
Faculty who interviewed applicants, met them at social events, or 
attended the rank meetings were eligible to participate provided 
they did not meet exclusion criteria. 
Outcome Measures and Analysis 
We defined our outcomes as follows:
1. Faculty rank: For each resident attribute (overall 
performance, medical knowledge, interpersonal skills), we 
created an overall rank order for each class using the mean of the 
faculty ranks. We broke ties using the mode and, if there were 
still ties, the median.
2. Assessment of self-reported, post-residency professional 
activities: Based on their responses to the survey, residency 
graduates were classified into the mutually exclusive categories 
“Major Academic,” “Minor Academic,” “Community Practice,” 
and “Out of Emergency Medicine” with those in “Community 
Practice” further divided into “Leader,” “Teacher,” “Leader and 
Teacher,” or “Clinical Practice Only” using rules described in 
Appendix 2. These categories have not been previously described 
but were intended to group graduates by their general type of 
involvement in EM and, as such, have face validity. 
Our independent variable was NRMP rank. Residents 
were assigned ranks first to Nth based on their position in 
the residency’s NRMP rank list relative to the other matched 
residents in their class. Residents taken outside the match were 
analyzed separately.
Our analysis was descriptive with the intention of visually 
depicting the degree of correlation between the NRMP rank 
order list, the faculty raters’ impression of each resident, and the 
graduates’ self-reported professional activities. Detailed graphics 
are used for this purpose as a method for visually assessing 
correlation. We examined the inter-rater reliability of the faculty 
rankings graphically, examining the distribution of deviations 
of each ranking from the average by rater and also examining 
the total squared deviations of each rater. We performed data 
management, analytics, and graph creation using Stata 14.2 (Stata 
Corp., College Station, Texas).
RESULTS
Of the 14 eligible faculty members, 10 agreed to participate. 
The 10 classes had 107 categorical EM residency graduates, 
95 of whom entered the residency through the match and had 
an NRMP rank. Class size varied from 9-12 residents over the 
10 years, primarily due to variations in the number of residents 
participating in our combined EM/pediatrics and EM/internal 
medicine programs. Eighty-four (79%) residency graduates 
completed the survey of post-residency activity, 77 of whom 
entered the program through the NRMP match. Residents 
entering the program outside the match did so when the size of 
the residency increased or to replace residents lost to attrition. 
There was general agreement among faculty raters when 
ranking residents. Figure 1 provides support for the notion that 
faculty were generally consistent in the ratings of the residents. 
For most classes there was more agreement about who were the 
lowest- and highest-performing residents in a class, as the leftward 
and rightward sections of the curves are parallel to the 45o (perfect 
agreement) line, and the middle section of the curve parallels the 
horizontal (no agreement) line. There was no evidence that raters 
were more consistent for more recent graduating classes (Figure 
1 and Supplementary Figure 1). While there was variation in 
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Figure 1. Faculty rating of residents’ mean rank vs ordinal rank 
by year. 
Lowest Middle Highest
Resident’s ordinal rank
This graph illustrates inter-rater reliability for the faculty with regard 
to the overall performance question by class. The x-axis indicates 
the resident’s overall rank (See text for explanation). The y-axis is 
the mean of that resident’s faculty rankings. For each class (colored/
numbered line), perfect agreement among faculty would result in a 
line that superimposes the 45o dashed line, as all faculty members 
would have ranked the overall highest ranked resident as 1, the next 
as 2, etc. Conversely, if there were perfect disagreement the lines 
would fall on the horizontal dashed gray line. Classes are labeled 
1=earliest to 10=most recent.
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rankings among the faculty, no faculty member was an obvious 
outlier (Figure 2 and Supplementary Figure 2). Together 
these analyses suggest that the faculty were able to rank resident 
performance within each class with sufficient reliability to make 
these rankings meaningful.
While there is some evidence that residents taken higher in 
the NRMP match received higher performance ratings from the 
faculty, the association was quite weak. Figure 3 shows that 
top faculty-rated residents came from all parts of the rank 
order list and from residents taken outside the match. The 
same is true for residents with low faculty ratings. While there 
is some evidence that being in the top half of the NRMP match 
predicts having an above-average faculty rating for overall 
performance and medical knowledge (top two panels of 
Figure 3), there appears to be no correlation between NRMP 
Figure 2. Deviation of faculty raters’ scores from average, by rater.
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Each histogram represents one faculty rater and shows the 
distribution of deviations between his or her rank and the mean rank 
of each of the 107 residents they ranked on overall performance. 
Raters are sorted from lowest (1) to highest (10) deviator, but there 
is no strong evidence that any raters were particularly better or 
worse than other raters. Histograms for the other questions are in 
the Appendix.
Figure 3. National Residency Matching Program (NRMP) rank 
and average faculty rank by resident, 1998-2013.
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This figure illustrates the NRMP rank order for each matched 
resident (black dot) and their average faculty rating (red dot) sorted 
by their NRMP rank. Faculty ratings for residents taken outside the 
match are shown on the far right. For each NRMP rank, the solid 
red bar segment represents the mean faculty rating of the residents 
who had that NRMP rank across all years, while the horizontal is the 
overal mean rank. The pink shading represents the divergence of the 
mean rating for the group of residents with that NRMP rank and the 
mean faculty mean rating for all residents.
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rank order and faculty rating of interpersonal skills. This is 
confirmed by analysis of the distribution of deviations of 
NRMP rank and faculty rank (Supplementary Figure 3). 
We observed a similar pattern when we compared self-
reported professional activity with NRMP rank order (Figure 
4). Over the 10 years included in the study, the program 
produced 36% academics (30 of the 84 graduates who 
responded to the survey), 33% of whom came from the top 
three positions in the NRMP rank order for their residency 
class. Interestingly, another 17% of academics came from 
residents taken outside of the match; 71% (5 of 7) of residents 
taken outside of the match went into academics. While the 
average NRMP rank of “major academics” was highest (4.0), 
the next highest average NRMP rank (4.6) was for those 
graduates who no longer play an active role in academics, 
teaching, or leadership (n=8) or are no longer practicing EM 
(n=1). Those in clinical teaching and leadership roles tended 
to come from the middle NRMP ranks. Academics came from 
all parts of the rank order list, as did those who appear to have 
minimal continuing involvement in the specialty. 
DISCUSSION
Despite our institution’s rigorous applicant evaluation 
process, this study demonstrates that the relative position 
of a resident on our NRMP rank list was not meaningfully 
predictive of clinical performance during residency and 
participation in professional activities post-residency (Figures 
3 and 4). While higher NRMP rank was somewhat predictive 
of a career in academics, this trend was not strong (Figure 4). 
Figure 4. Professional outcome of graduates by year and National Resident Matching Program (NRMP) rank. 
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Scatter plot of NRMP rank vs residency class based on post-graduation survey responses. Legend categories are defined in the text 
and Appendix 1. Following each category is the number in that category and the average rank in the NRMP match for that category.
Parentheses in rightward box denote average class rank (of 12 positions).
Our results reinforce the results of other investigations 
into the predictive value of the NRMP rank list. The 
majority of studies have shown that NRMP relative rank 
order correlates poorly with residency performance.1-3 Only 
one study found a positive correlation.7 Sklar and Tandberg 
(1996) demonstrated a positive correlation between NRMP 
relative rank order and faculty perception of 20 EM residents 
who graduated over a four-year period and found a positive 
correlation. Their results may differ from ours because they 
had smaller graduating classes (five per year) and ranked the 
four years of graduates together. Given the limited data and 
discrepant results, further investigation is warranted.
Many faculty hours are expended to determine the final rank 
order list. Given our findings, the time dedicated to a carefully 
ordered rank list appears to have low utility in predicting resident 
performance in residency and post-graduation, and less faculty-
intensive methods should be considered. 
LIMITATIONS
Our study had notable limitations. We used a resident’s 
relative order from the rank list and relative class performance 
ranking by faculty to assess the predictive value of the rank 
order list. It is possible that other methods of analyzing NRMP 
rank would produce different results. Faculty evaluations 
of resident clinical performance were retrospective and 
thus subject to recall bias and recency bias. Our method for 
categorizing post-residency professional outcomes has not 
been previously described and only captures gross categories of 
activity. Prior studies have focused on in-residency performance 
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and not categorized post-residency performance. 
Fortunately, or unfortunately, there is no absolute 
definition or measure of “success.” Furthermore, there 
was an error with our post-graduate survey that had non-
mutually exclusive choices (e.g., “0-5 publications” and 
“5-10 publications”), which would have been ambiguous for 
those with exactly five publications (Appendix 1). Finally, 
to protect anonymity, we did not take into account years 
since graduation with regard to publications; thus, residents 
from more recent graduating classes may not have the time 
to develop the criteria required to be considered a “major 
academic” or “leader.” 
This study only investigated the performance and 
professional outcomes of the applicants who matched with us. 
Since we start with an applicant pool of approximately 750, 
interview roughly 100, and fill our 12 positions by an average of 
50-60 on our rank list, we can only assess what the recruitment 
committee considered to be the top 8% of our applicants. We 
cannot address the utility of faculty time consumed determining 
who should be interviewed, nor the utility of time devoted to 
determining which applicants should be placed in the top vs the 
bottom half of our rank list, as we did not include those who 
were not matched at our program.
CONCLUSION
In summary, there was a lack of strong correlation between 
our NRMP rank order and clinical performance during an 
EM residency, a finding similar to the majority of literature 
on the topic. Correlation between NRMP rank order and post-
residency outcomes was also not strong. Given these findings, 
each residency will need to determine the appropriate amount of 
faculty labor used to formulate the NRMP rank order list while 
seeking ways to improve the predictive value of their rank lists 
and to identify and eliminate low-productivity faculty hours. We 
suspect that the process is insufficiently predictive to warrant 
current levels of expenditure of faculty time, which could be 
used more productively on other activities. 
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INTRODUCTION
As part of medical education’s shift toward competency-
based education (CBE), the Accreditation Council for 
Graduate Medical Education (ACGME) announced the 
Milestones Project in 2008 to create an outcomes-based model 
of competency development. The goal was to characterize 
specific accomplishments or behaviors demonstrated by 
physician trainees as they progressed toward independent 
practice. Since then, multiple specialties, with emergency 
medicine (EM) at the forefront, have developed and 
incorporated competency-based assessment of residents 
using specialty-specific Milestones. The development of 
EM Milestones by the Emergency Medicine Milestone 
Working Group (EMMWG) has been well-described.1 The 
EMMWG identified 23 subcompetencies within the six core 
competencies, and within each subcompetency, five different 
levels of proficiency. Each level has one or more Milestones 
of competency to mark the level of proficiency. As part of 
the Next Accreditation System (NAS) implemented by the 
ACGME in July 2013, each Milestone subcompetency has 
to be reported for every resident at six-month intervals by 
individual residency clinical competency committees (CCC).1 
While well-intended, methodically planned and developed, 
these standards have been met with various levels of 
exasperation and confusion by medical educators seeking to 
implement the new requirements.2 It is not my goal to push back 
against the Milestones approach, as it represents an iterative, 
dynamic process to continually advance medical education to 
provide safer and higher quality patient care. However, I aim 
to describe some frontline challenges for clinician educators 
attempting to implement these recommendations. 
Ankel et al. predicted that “the future of CBE will 
require significant changes in the learning environment, 
resident assessment frequency, and faculty development.”3 
Such changes have not happened in many programs, 
including my own. As a result, the sources of the trials and 
tribulations in the implementation of EM Milestones can 
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Emergency Medicine, Boston, Massachusetts
be similarly categorized into issues with the Milestones 
themselves, resident assessment, direct observation, 
educational infrastructure, and limited resources. 
The EM Milestones
The all-encompassing nature of EM Milestones, 
lacking specificity to any case, disease, or context, prevents 
educators from reaching consensus when evaluating and 
assigning Milestone rankings. I frequently notice one faculty 
describing a trainee performing well on a Milestone behavior, 
ranking them highly on a particular subcompetency, while 
another faculty might feel differently regarding the trainee’s 
performance on the same subcompetency or even the same 
Milestone. This is because skills and behaviors in one 
setting may not translate to another. Trainees’ performances 
on tests of general constructs are known to be highly case-
dependent.4-6 A resident might be fully capable of developing 
and narrowing down a differential diagnosis (PC4), ordering 
the right test (PC3), and choosing the optimal disposition 
(PC7) for a presentation that he or she is familiar with and 
be completely clueless without prior experience with such 
a case. Some have suggested the linking of Entrustable 
Professional Activities (EPA), defined as “units of physician 
practice in which the goal is unsupervised competent practice 
by a trainee” with EM Milestones.7 Because EPAs are based 
on clinical descriptions rather than individual physician 
descriptions, there may be less faculty development needed 
for Milestone subcompetency assessment.7 Often, EPAs 
are presentation or diagnosis specific, which may mitigate 
concerns regarding conflicting reports of trainee competency 
in different contexts. However, creation of EPAs for every 
single disease within the Model of the Clinical Practice of EM 
is likely too overwhelming to develop, evaluate, implement, 
and measure. Developers of EM Milestones would likely point 
out that the optimal solution is the use of multiple assessment 
tools to measure Milestone subcompetencies. And this leads 
us to my next point. 
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Resident Assessment
Beeson et al. accurately anticipated the need for EM to 
develop multiple, valid and reliable objective measures of 
Milestone competency assessments.1 However, our field has yet 
to meet this challenge raised by the developers of EM Milestones. 
The EM Milestones include suggested methods of 
evaluation that vary with subcompetency but may include 
direct observation, simulation, chart review, standardized 
patients, global ratings, multi-source feedback, and end-
of-shift evaluations. However, none has been sufficiently 
validated to effectively evaluate a trainee’s progression 
through the EM Milestones. In fact, EM Milestones have 
been shown to possess poor inter-rater reliability between 
various stakeholders, such as resident self-assessment, faculty, 
and CCC, in various clinical settings and in simulation.8-11 
Furthermore, EM Milestone ranking determined by CCC in 
this early stage of implementation is hardly a gold standard of 
comparison. Similarly, multiple assessment tools of Milestone 
competency failed to demonstrate significant utility.8,12 
Specifically, end-of-shift evaluations of EM Milestones resulted 
in grade inflation compared to CCC results.8 A multicenter, 
prospective, observational study to develop a direct observation 
assessment of Milestones in the form of the Critical Care Direct 
Observation Tool demonstrated low inter-rater reliability.12 
The authors expressed concerns for the reliability of other EM 
Milestone assessment tools that are currently in use.12 
Despite mandating the semiannual review and update 
of the progression of EM Milestones of every resident, the 
EMMWG never released specific guidelines on the ideal 
administration and format of a CCC. Therefore, the way each 
CCC is run differs between residency programs.13 Program 
directors and faculty are often left to their own devices in 
terms of what assessment tools to use and how to assign 
Milestone rankings. Even though my program’s CCC uses 
multiple assessment tools (shift evaluations, off-service 
evaluations, monthly EM rotation evaluations, in-service 
scores, procedure, ultrasound, and simulation logs), none 
have been shown to be valid in the assessment of Milestone 
subcompetencies. After diving deeply into all available 
assessment data, my colleagues and I in the CCC meet in 
person in an attempt to build consensus in assigning Milestone 
rankings. Despite our best efforts, my fellow faculty and I are 
still left with the best “educated guess” of where each resident 
lies on most subcompetencies.
 My department has trainees who are known to be less 
clinically competent but somehow consistently rank higher on 
EM Milestones year after year compared to their more capable 
peers. Much like a meta-analysis, the utility of the combined 
evidence depends on the strengths of the studies analyzed. 
The soundness and credibility of our CCC Milestone rankings 
leave much to be desired. My residents and faculty recognize 
the lack of reliability and validity in the assessment tools 
we use. This is demotivating to learners and educators alike, 
leading to less incentive for both parties to complete more 
assessments. The shortage of assessment data erodes faith in 
the Milestone evaluation process. This in turn feeds into the 
cycle of decreased validity and reliability of our Milestone 
ranking in the CCC, which further disincentivizes our 
residents and faculty to complete additional assessments. 
Direct Observation
The intention of using objective behaviors for EM 
Milestones requires direct observation to occur. Assessment 
of professional competence will need to be based on 
multiple assessment methods, each with a minimum of 8-10 
observations to ensure reliable inferences.3 This is unrealistic 
for many frontline EM educators who work with limited 
departmental and institutional resources for faculty time for 
direct observation. A previous report has suggested that the 
overall faculty-EM resident interaction time accounts for 
only 20% of a resident’s time spent on a clinical shift. Direct 
observation time of EM residents interacting with patients 
by faculty in the emergency department was only 3.6% of 
the time.14 This is exacerbated by our specialty’s distinct 
workflow, where trainees frequently work with multiple 
faculty on a single shift without opportunities for sustained 
contact and direct observation. A monthly EM Milestone 
evaluation is likely low-yield since sporadic short periods of 
observation by multiple faculty will not illuminate a consistent 
picture of trainee performance. Although video precepting can 
be a helpful adjunct to direct observation, it is not a panacea 
and can be time- and resource-intensive.15 The same could be 
said of simulation programs and standardized patients. 
Educational Infrastructure
One of the advantages of CBE is that the ability to 
progress is not based on time. Yet in graduate medical 
education (GME), no system exists that allows for the 
residents who attain Level 4 or 5 Milestone rankings to 
graduate early. There’s no reward for thinking critically or to 
excel.16 Level 5 “reach” Milestones are not important goals 
for trainees, as EM Milestones are no longer relevant for 
emergency physicians after residency graduation. Academic 
institutions have become overly dependent on trainees to 
provide patient care. Any change in the rate of progression for 
trainees can wreak havoc on the learners’ ability to meet their 
service requirements and therefore disrupt the current funding 
model for GME.2 After all, “the American public is both the 
consumer and the financier of the United States residency 
training system.”1 
Policymakers are demanding educational reform in 
light of healthcare inequality, cost pressures, the aging of 
populations, emerging diseases, and the advent of personalized 
medicine.2 Considering the need for public accountability, the 
main drive for the shift toward CBE has been described as 
political because it affects the way our government allocates 
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resources.16 Quality and patient safety is an example of an 
area where significant resources have been allotted. However, 
if Milestone data are to be used to provide assurance to the 
public, payers, and policymakers that residency programs are 
providing sufficient training in targeted areas of healthcare 
delivery as suggested by Beeson et al.,1 departmental and 
institutional resources have to be allocated for the proper 
implementation and assessment of EM Milestones. 
Limited Resources
However, despite mandating the implementation of 
EM Milestones, resources have not been made available 
to individual programs for execution or medical education 
research to support their use. None of my fellow CCC 
members have been given additional protected time or 
administrative support to dedicate to the observation, 
evaluation, discussion, and assignment of EM Milestone 
rankings. Beeson et al. warned against the potential threats 
to validity of EM Milestones in the form of too few 
observation and bias in rankings.1 Given the constraints 
imposed by finite time and resources, it will not be possible 
to reliably measure more than a minute fraction of all the 
behaviors and scenarios that would be required to effectively 
evaluate a trainee’s competence. Furthermore, resources for 
faculty development to “ensure consistent and appropriate 
evaluations” deemed as important by the developers of EM 
Milestones have yet to materialize.1,17 
Despite all this, residencies are still required by the 
ACGME to evaluate each resident using Milestones during 
CCC on a semiannual basis.18 The amount of time and energy, 
as well as faculty resources, may be inadvertently diverted 
away from other important educational interventions in order 
to facilitate this requirement. So far for my program, the 
efforts have not come to fruition. I hope that, through open 
discussion of my department’s barriers to implementation, I 
can encourage further dialogue to develop best practices to 
improve Milestone assessment and CCC administration, at my 
own and other programs. 
CONCLUSION
The Milestone Project is a noble, longitudinal endeavor 
in medical education reform that I hope will lead to improved 
patient outcomes. However, its implementation requires 
dedicated resources for research and execution at all levels. 
Unfortunately, those on the frontlines of EM resident 
education lack valid assessment tools, opportunities for direct 
observation, proper educational infrastructure and resources to 
fulfill the mandate effectively at a program level.
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Competency-based education (CBE) is a criterion-
referenced, outcomes-based framework used for curriculum 
design and assessment in medical education.1 The goals of 
CBE are to define and assess provider competence along a 
trajectory, from novice to expert, using objective performance 
measures.2
CBE requires five key design features to be successful.3 
(1) The first requirement is an outcomes-based competency 
framework. The Accreditation Council for Graduate 
Medical Education (ACGME) developed the ACGME 
Milestones Project to operationalize competency domains 
for postgraduate trainees.4 (2) The second expectation is that 
competencies and their developmental markers must support 
learner progression along a continuum. The Milestones 
represent just such a developmental model, with defined 
behavioral outcomes for residents as they progress through 
training. The remaining key features of CBE include (3) 
individually-tailored learning experiences within an authentic 
workplace environment that are sequenced or designed in 
response to each resident’s developmental trajectory; (4) 
coaching for individual resident growth and achievement; 
and (5) programmatic assessment using multiple methods of 
data collection. High-quality data is sourced from numerous 
assessors, at a high frequency, mapped to the chosen 
framework, and used for robust summative entrustment 
and promotion decision-making by a clinical competency 
committee (CCC).5-6 This approach to assessment is labor-
intensive but results in publicly-defensible decisions about the 
training and competence of our physician workforce.
The Challenges of Competency-based Education in 
Emergency Medicine
The ACGME Milestones can be operationalized to meet 
each of the CBE design features listed above. However, 
Sheng et al. identified significant challenges in their local 
implementation and utilization of this framework.7 The 
true intent of the ACGME Milestones is to represent the 
Stanford University School of Medicine, Department of Emergency Medicine, 
Palo Alto, California
developmental trajectory of a resident over time. The 
variability in faculty ratings, which may initially seem 
frustrating, are instead intentionally important to the process 
of monitoring development in our trainees. There is no perfect 
assessment tool and there will be variability in assessments. 
And that’s okay.
The attainment of competence is rarely a linear path for 
a resident, just as developmental progression is not the same 
for children.5,8 Residents learn at different rates, have different 
strengths, and different areas for improvement. These areas 
for improvement are rarely stable throughout three or four 
years of residency training. The lack of inter-rater consistency 
among faculty is normal and expected. The beauty of the 
Milestones is that the vast array of “dots” on the submission 
form – or assessment data points – will eventually provide 
a general understanding of each resident’s trajectory. The 
greater number of data points, the clearer the trajectory, 
especially if data points are sourced from a wide range of 
supervisory perspectives. 
“Does context matter?” The answer is clearly yes, for 
each separate data point. It is thus up to the trained group of 
faculty members who comprise the CCC to interpret those 
data and the context from which they arose. The Committee 
may then provide an educated decision about a trainee’s 
progress and propose an individually-tailored learning plan to 
address any areas of deficiency. An educated decision is not 
a random guess if the decision is based on adequate data; if 
there are inadequate data, then your CCC has simply identified 
an assessment gap for which the program needs to obtain 
more or better data.9
Optimizing this process is difficult without first changing 
our approach to obtaining Milestones data. Aggregate 
evaluations at the end of each rotation generally lack the 
necessary timeliness, granularity, or approachability to provide 
learners with truly actionable feedback.10 Residents often do 
not understand the Milestones themselves and simply look to 
any narrative comments on their evaluations to obtain insight 
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into their performance.11 We need to rethink our process of 
data collection and separate that process from decisions about 
the Milestones.
CBE is successful when there is a substantial emphasis on 
workplace-based assessment of trainees.5,12 True workplace-
based assessment requires at least some direct observation.5,11 
Unfortunately, there are abundant barriers to conducting 
planned observations in our workplaces. Emergency 
departments (ED) are fraught with interruptions, high volumes 
of patients, and competing priorities for faculty members’ 
attention. These practice realities can distract faculty members 
and trainees from seeking opportunities for lengthy, formal 
observations during a clinical shift. 
Failure to optimize workplace-based assessments in 
the ED is often blamed on the complexity of the Milestones 
rather than the workplace itself. We can design impressive 
assessments, but if our learning environments have barriers 
to performing observations or providing timely feedback, 
these assessments may be rendered useless to all stakeholders. 
The inability to obtain quality data about our learners may 
result from misalignment of our assessment methods and our 
workplaces. This lack of data ultimately impairs the work 
of the CCC, which leads to suboptimal group processes, 
uninformed promotion decisions, and a poor functional 
understanding of CBE by our residency core faculty members.
Strategies for Success
The ED can be deliberately designed to facilitate CBE. 
Emergency medicine faculty members make frequent 
subconscious decisions about entrustment and trainee 
supervision throughout each shift. We regularly allow 
residents to perform procedures with on-demand supervision, 
or we step back to observe senior residents as they direct 
a resuscitation team. Simply “recording” these moments 
and providing direct feedback to trainees operationalizes 
workplace-based assessment without necessitating the use 
of the Milestones in real time. It is the responsibility of the 
CCC to map the documentation of these assessments back to 
the Milestones for aggregate decision-making and reporting 
purposes. Such frontline documentation does not need to 
include any Milestones language. We do not need to train 
every faculty member to deeply understand the Milestones 
framework; rather we need to train our CCC members to 
interpret available data.13-14
Desired outcomes must drive assessments. If you want 
your senior residents to perform a tube thoracostomy with 
only indirect supervision, then you need to optimize the 
learning environment to ensure adequate opportunities for 
them to practice this task. Learning outcomes are workplace-
based tasks; outcomes are not the Milestones themselves. If 
your workplace environment does not support your current 
assessment methods, redesign the workplace or change the 
assessment method. Augment data collection with other 
modalities such as multisource feedback and simulation. Then 
design faculty development and resident training that follows 
your redesigned assessment process. 
Faculty development is one of the most frequently 
identified challenges to assessment, particularly as it relates to 
the Milestones.15 Many faculty development challenges may 
be ameliorated by simplifying frontline assessments to more 
intuitive forms that use task-based evaluations and supervisory 
language. Data from these forms can then be mapped back to 
the Milestones by the CCC. The Milestones were not designed 
to be copied onto evaluation forms directly as they are written; 
they were also not designed for use by frontline faculty.16,17 
By making workplace assessment tools more usable by 
the general faculty, you minimize your need for intensive 
faculty development. Use digital assessment tools rather than 
paper, if available; smartphone apps are more convenient 
than desktop portals for frontline evaluations. In addition, 
encourage residents to seek feedback using simply designed, 
self-assessment tools. These changes will reduce the burden of 
day-to-day assessment for faculty members, creating a shared 
responsibility to generate feedback for both faculty members 
and residents. 
The value of the CCC can be maximized through better 
group processes for summative decision-making. The guiding 
purpose of the CCC may in fact be twofold: to make decisions 
about each resident’s progress using the Milestones, and 
to critically appraise the assessment data available to the 
committee on a regular basis.18 Identify gaps in assessment 
that are preventing the CCC from making informed decisions 
about learner development and progression. Use available 
data to develop individualized learning plans and coach the 
residents accordingly.
To ensure that CCC decisions are defensible and accurate, 
there must be a structured format for committee meetings so 
that all stakeholder viewpoints are represented. This is often 
best accomplished by a having faculty “expert” for each 
postgraduate year (PGY) class.13,18 Involve each CCC member 
in the pre-review process of trainees in their assigned PGY 
class and allow them to lead the discussion of these trainees 
during the meetings. Provide CCC members with early 
access to high-quality assessment data and conduct regular 
training of the CCC members. Finally, stakeholder output is 
a key mandate of the CCC. While Milestone ratings are the 
necessary administrative outcome, individualized learning 
plans may be the more important CCC goal.18 These learning 
plans should document areas for improvement to be reviewed 
with trainees by their assigned faculty coaches. 
SUMMARY
Challenge your residency leadership and CCC to design 
a workplace that facilitates CBE. Create simpler frontline 
assessments that avoid the direct use of Milestone language 
and supplement with multisource feedback and simulation 
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to address assessment gaps. Map frontline assessment tools 
to the Milestones behind the scenes. Be deliberate about 
what you intend to assess, ensuring that assessment reflects 
key learning outcomes of the curriculum. Schedule time 
for direct observation of learners. Use faculty development 
and resident training to create a shared understanding of 
CBE and its application in your ED. Resolve any disconnect 
between obtaining data and using data. Empower residents 
to seek feedback during clinical shifts, to review self-
assessments with their faculty coaches, and to fully engage in 
the assessment process at your institution. Finally, focus the 
outcomes of CCC meetings not simply on the assignment of 
Milestones, but on the creation of individual learning plans 
that promote trainee development.
Address for Correspondence: Holly Caretta-Weyer, MD, Stanford 
University School of Medicine, Department of Emergency 
Medicine, 900 Welch Road Suite 350, Palo Alto, CA 94304. Email: 
hcweyer@stanford.edu.
Conflicts of Interest: By the WestJEM article submission 
agreement, all authors are required to disclose all affiliations, 
funding sources and financial or management relationships that 
could be perceived as potential sources of bias. No author has 
professional or financial relationships with any companies that are 
relevant to this study. There are no conflicts of interest or sources 
of funding to declare.
Copyright: © 2019 Caretta-Weyer et al. This is an open 
access article distributed in accordance with the terms of the 
Creative Commons Attribution (CC BY 4.0) License. See: http://
creativecommons.org/licenses/by/4.0/
icbme-site/five-core.html. Accessed March 16, 2019. 
4. Accreditation Council for Graduate Medical Education. Milestones. 
Available at: https://www.acgme.org/What-We-Do/Accreditation/
Milestones/Overview. Accessed March 16, 2019.
5. Ten Cate O, Hart D, Ankel F, et al. Entrustment decision making in 
clinical training. Acad Med. 2016;91(2):191-8.
6. van der Vleuten CP, Schuwirth LW, Driessen EW, et al. A model 
for programmatic assessment fit for purpose. Med Teach. 
2012;34(3):205-14. 
7. Sheng AY. Trials and Tribulations in the Implementation of the 
Emergency Medicine Milestones from the Frontlines. West J Emerg 
Med. 2019;20(4):
8. Ten Cate O. Entrustment as assessment: recognizing the ability, the 
right, and the duty to act. J Grad Med Educ. 2016;8(2):261-2.
9. Ten Cate O, Regehr G. The power of subjectivity in the assessment 
of medical trainees. Acad Med. 2019;94(3):333-7.
10. Gruppen LD, Ten Cate O, Lingard LA, et al. Enhanced requirements 
for assessment in a competency-based, time-variable medical 
education system. Acad Med. 2018;93(3S Competency-based, time-
variable education in the health professions):S17-21.
11. Holmboe ES, Sherbino J, Long DM, et al. The role of assessment in 
competency-based medical education. Med Teach. 2010;32(8):676-82.
12. Norcini J, Burch V. Workplace-based assessment as an educational 
tool. AMEE Guide No. 31. Med Teach. 2007;29(9):855-71. 
13. Hauer KE, Chesluk B, Iobst W, et al. Reviewing residents’ 
competence: a qualitative study of the role of clinical 
competency committees in performance assessment. Acad Med. 
2015;90(8):1084-92.
14. Hauer KE, Cate OT, Iobst W, et al. Ensuring resident competence: a 
narrative review of the literature on group decision making to inform 
the work of clinical competency committees. J Grad Med Educ. 
2016;8(2):156-64.
15. Hawkins RE, Welcher CM, Holmboe ES, et al. Implementation 
of competency-based medical education: Are we addressing the 
concerns and challenges? Med Educ. 2015;49(11):1086-102. 
16. Beeson MS. The emergency medicine Milestones: with experience 
comes uggestions to improve. Acad Emerg Med. 2016;23(12):1434-6.
17. Dehon E, Jones J, Puskarich M, et al. Use of emergency 
medicine Milestones as items on end-of-shift 
evaluations results in overestimates of residents› proficiency level. J 
Grad Med Educ. 2015;7(2):192-6.
18. Kinnear B, Warm EJ, Hauer KE. Twelve tips to maximize the value of 
a clinical competency committee in postgraduate medical education. 
Med Teach. 2018;40(11):1110-5. 
REFERENCES
1. Carraccio CL, Englander R. From Flexner to competencies: 
reflections on a decade and the journey ahead. Acad Med. 
2013;88(8):1067–73.
2. Frank JR, Snell LS, Cate OT, et al. Competency-based medical 
education: theory to practice. Med Teach. 2010;32(8):638–45.
3. International Competency-Based Medical Education Collaborators. 
Five Core Components of CBME. Available at: http://gocbme.org/
Western Journal of Emergency Medicine 654 Volume 20, no. 4: July 2019
Original research
 
SurgeCon: Priming a Community Emergency Department for 
Patient Flow Management
 
Christopher Patey, MD*†
Paul Norman, BNRN†
Mehdee Araee, PhD*
Shabnam Asghari, MD, PhD*
Thomas Heeley, MASP*
Sarah Boyd, MSc*
Oliver Hurley, MEnvSc*
Kris Aubrey-Bassler, MD*
Section Editor: Kenneth S. Whitlow, DO     
Submission history: Submitted January 10, 2019; Revision received May 21, 2019; Accepted May 17, 2019 
Electronically published July 5, 2019         
Full text available through open access at http://escholarship.org/uc/uciem_westjem   
DOI: 10.5811/westjem.2019.5.42027
Memorial University of Newfoundland, Discipline of Family Medicine, St. John’s, 
Newfoundland
Eastern Health, Carbonear Institute for Rural Research and Innovation by the Sea, 
Carbonear General Hospital, Carbonear, Newfoundland
*
†
Introduction: Canadian emergency departments (ED) are struggling to provide timely emergency 
care. Very few studies have assessed attempts to improve ED patient flow in the rural context. 
We assessed the impact of SurgeCon, an ED patient-management protocol, on total patient visits, 
patients who left without being seen (LWBS), length of stay for departed patients (LOSDep), and 
physician initial assessment time (PIA) in a rural community hospital ED. 
Methods: We implemented a set of commonly used methods for increasing ED efficiency with an 
innovative approach over 45 months. Our intervention involved seven parts comprised of an external 
review, Lean training, fast track implementation, patient-centeredness approach, door-to-doctor 
approach, performance reporting, and an action-based surge capacity protocol. We measured key 
performance indicators including total patient visits (count), PIA (minutes), LWBS (percentage), and 
LOSDep (minutes) before and after the SurgeCon intervention. We also performed an interrupted time 
series (ITS) analysis. 
Results: During the study period, 80,709 people visited the ED. PIA decreased from 104.3 (±9.9) 
minutes to 42.2 (±8.1) minutes, LOSDep decreased from 199.4 (±16.8) minutes to 134.4(±14.5) 
minutes, and LWBS decreased from 12.1% (±2.2) to 4.6% (±1.7) despite a 25.7% increase in patient 
volume between pre-intervention and post-intervention stages. The ITS analysis revealed a significant 
level change in PIA – 19.8 minutes (p<0.01), and LWBS – 3.8% (0.02), respectively. The change 
over time decreased by 2.7 minutes/month (p< 0.001), 3.0 minutes/month (p<0.001) and 0.4%/month 
(p<0.001) for PIA, LOSDep, and LWBS, after the intervention. 
Conclusion: SurgeCon improved the key wait-time metrics in a rural ED in a country where average 
wait times continue to rise. The SurgeCon platform has the potential to improve ED efficiency in 
community hospitals with limited resources. [West J Emerg Med. 2019;20(4)654-665.]
INTRODUCTION
Emergency department (ED) crowding is a perennial 
Canadian healthcare concern.1 Misdiagnosis, declining patient 
confidentiality and satisfaction, and bed-block (when all 
available beds are occupied and patients are left in corridors 
and ambulances) are only some of the resulting issues.1,2 
Amidst a perfect storm of recent Canadian Association of 
Emergency Physician national targets,1 increasing financial 
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Population Health Research Capsule
What do we already know about this issue?
Emergency department (ED) wait times 
continue to rise annually in Canada with a 
significant increase in crowding and cost to 
the healthcare system.
What was the research question?
How does the new initiative “SurgeCon” 
impact patient flow and wait times in a rural 
community ED?
What was the major finding of the study?
SurgeCon resulted in significant 
improvements in key wait-time metrics in a 
rural community ED.
How does this improve population health?
Decreasing wait times and crowding in the 
ED increases quality of care and improves 
patient health outcomes.
and resource pressures,3 loss of full-care community 
providers,4 and aging populations,5 Canadian EDs are 
grappling with some of the longest wait times compared 
to peer industrialized countries.6 The Newfoundland and 
Labrador (NL) Department of Health and Community 
Services has referred to EDs as the “front door” to the 
province’s healthcare system.7 After missing its own wait time 
benchmarks in 2016,8 NL’s Eastern Regional Health Authority 
joined the chorus of emergency care providers across Canada 
hunting for a solution to crowded ED care.7,9-13 Large-scale 
process improvement is effective at urban facilities,14,15 but 
NL is predominately rural16 with many small EDs facing 
crowding,17 increasing hospital occupancy rates,18 and 
restrictive department sizes.19 
A key problem with the literature related to ED quality 
improvement is the focus on urban tertiary/quaternary centers 
rather than smaller, rural EDs where the factors affecting patient 
flow may be different. In many rural communities, the ED is 
often the first and only choice to receive care.20,21 Our team from 
the rural NL community of Carbonear created SurgeCon as a way 
to counteract these challenges. Rural EDs are an ideal setting 
to implement innovative models since they are more agile and 
have the potential to improve healthcare delivery and patient 
outcomes for a considerable portion of the population.22 The 
ED in Carbonear represents a new frontier for the assessment 
of ED quality improvement interventions given the size of the 
communities it serves and the resources at its disposal, while 
facing the same challenges as larger centers.
SurgeCon is a pragmatic, ED management platform that 
includes a series of interventions acting together to improve 
ED efficiency and patient satisfaction. More specifically, 
the interventions target three key areas: 1) ED organization 
and workflow; 2) action-based ED management, and 3) the 
establishment of a patient-centric environment. SurgeCon is 
a term derived from the concepts of patient surge and defense 
readiness condition (DEFCON), which is a military escalation 
system. It is explicitly designed to address ED crowding by 
implementing commonly used methods for increasing ED 
efficiency in concert with technological innovation. The 
45-month, proof-of-concept investigation described in this 
paper assessed the impact of SurgeCon on key, patient-flow 
and wait-time indicators in a rural community ED strained 
by a large volume of lower acuity patients. Specifically, we 
examined 1) time until physician initial assessment (PIA), 
2) the proportion of patients who registered but left without 
being seen by a physician or his/her delegate (LWBS), and 3) 
mean length of stay for departed patients (LOSDep).
METHODS
Study Design and Time Period
We used a quasi-experimental research design to assess the 
impact of the SurgeCon intervention. The data used in this study 
considered a period of 15 months before the intervention (July 1, 
2013, to September 30, 2014, inclusive) and 30 months after the 
intervention (October 1, 2014, to March 31, 2017, inclusive). 
Study Setting
Carbonear General Hospital is an 80-bed hospital located 
on the southeastern coast of Newfoundland, the island portion of 
Canada’s easternmost province Newfoundland and Labrador.23 
Carbonear is located approximately 75 minutes (~100 kilometers) 
from the only two provincial, tertiary referral hospitals, which 
are located in the capital city of St. John’s. The community of 
Carbonear has a population of approximately 5,000, and the 
Carbonear Hospital provides services to a catchment population 
of approximately 40,000.24 There are four full-time and four part-
time emergency physicians (EP), one full-time nurse practitioner, 
two dedicated paramedics, and a maximum of three nurses at one 
time allocated to the ED. 
Data Collection and Integration
Routinely collected data provided by the Eastern Regional 
Health Authority included patient ED wait times from the point 
of registration to patient departure from the ED (eg, discharge, 
hospital admission). We used IBM Cognos Analytics (Armonk, 
New York), a business intelligence analytics platform, to 
provide monthly reviews from July 1, 2013, to March 31, 2017. 
A 45-month retrospective review of ED patient flow metrics 
was completed and compiled in May 2017. Values for each of 
these metrics were captured each month for 15 months prior 
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to initiation, 15 months in the early intervention period, and 15 
months in the late intervention period. This quality improvement 
initiative was conducted exclusively for ED improvement 
purposes and did not require ethics approval from the provincial 
Health Research Ethics Authority.
Intervention
Our intervention is composed of seven parts, which were 
implemented sequentially as described below.
1. Independent External Review: In October 2014 we 
contracted an ED quality improvement (QI) consulting 
firm to conduct a comprehensive assessment of the 
organization and function of the Carbonear ED. This 
review formally quantified performance, clarified key 
improvement issues, and prepared staff members to 
begin the improvement process. 
2. Lean25: Studies indicate that Lean strategies have been 
associated with improved ED performance and patient 
satisfaction.26,27 Frontline staff attended two days of Lean 
training to facilitate the implementation of improvement 
initiatives and encourage ED staff to become active 
participants in the improvement process. The course 
was formulated to directly improve the flow of patients 
at the frontline of operational EDs by using simulation 
exercises, innovative surge-management software tools, 
and inventive approaches to real-life ED flow problems.
3. Rapid Assessment “Fast Track” Zone: Fast-track areas 
staffed by midlevel providers can improve patient 
flow and reduce ED crowding, wait times, LOSDep, 
and LWBS rates without affecting quality of care.28-32 
We created a rapid assessment zone by re-designating 
an underused waiting area adjacent to the ED triage 
area, enabling a 20% increase in physical ED space. 
Adding two new short examination tables and a chair 
in this area and using it for patient assessment, blood 
tests, electrocardiograms, and other minor procedures, 
maximized accessibility and ambulatory patient 
throughput. By removing competition for assessment 
space, this area also doubled for early reassessments 
and discharges, and as an independent nurse 
practitioner area. 
4. Patient Centeredness: ED staff often believe that lower 
acuity patients should not seek care in an ED setting 
while also distinguishing patients based on “their 
legitimacy to be treated within the ED.”33 This belief 
system can create a culture of apathy and disregard 
toward patients who require primary and non-urgent 
care. Based on evidence that promoting a culture of 
patient “worthiness” improves patient satisfaction and 
ED efficiency,33,34 we initiated multiple 30-minute staff 
educational sessions reinforcing the following three 
main topics: 1) providing quality ED care to all patients 
regardless of urgency; (2) treating all patients with 
respect; and (3) always considering the patient’s visit 
to an ED to be necessary as they may have no other 
option. We also provided strategies to get the patient to 
the provider in a timelier manner (eg, physicians going 
to triage, moving patients from clinical assessment 
spaces back to waiting room/alternate waiting room, 
faster admitted patient extraction, efficient use of 
fast track areas, etc.). Patient-centeredness was also 
addressed through improving the ED environment, as 
a patient’s waiting environment is a better predictor 
of patient satisfaction than wait times.35 We removed 
all wall postings not pertinent to ED staff and patients, 
and all subsequent postings required departmental 
approval before being placed in a central location. 
We also redecorated the ED waiting room and patient 
examination rooms with framed photographs of coastal 
communities from the hospital’s rural catchment area.
5. Physician Initial Assessment “Door to Doctor” Focus: 
A number of studies have found a strong correlation 
between patient satisfaction and PIA; the shorter the 
PIA, the more satisfied the patient.36-38 To reduce the 
time to PIA we used the following strategies
a. ED staff briefly assessed patients even when formal 
assessment space was not immediately available.
b. EPs were provided with the option of triaging with 
nursing staff with the potential goal of patient discharge 
directly from the triage room without waiting.
c. Triage nurse-driven orders (eg, symptom management, 
laboratory testing, diagnostic imaging, etc.) were only 
applied on patients who would be waiting longer than 
one hour to see a physician. If the patient could have 
been seen by a physician within an hour, waiting for 
potentially unnecessary test results could delay the PIA.
d. If there were no available beds, EPs assessed patients 
arriving on ambulance stretchers in the hallway to 
initiate investigations instead of waiting for a bed to be 
free.
e. Staff attempted to offer short physician assessments 
prior to ordering diagnostic tests that could have 
potentially delayed discharge.
6. Performance Data and Patient Flow: Regular 
performance reporting enhances ED functioning and 
assists with improvement strategies.27,38 Previously, the 
Carbonear EPs, nurses, managers, and staff infrequently 
reviewed ED performance data; however, as part of 
SurgeCon, our team circulated and clearly posted data in 
a prominent area of the department on a monthly basis. 
Individual physicians were informed of their monthly 
PIA times compared to the ED average. 
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7. Action-based Surge Capacity Protocol: We created 
and implemented a unique frontline, action-based tool 
that helps ED staff (paramedics, nurses and physicians) 
manage their actions to actively reduce patient 
surges and wait times and increase patients’ access to 
emergency medical care. This tool uses algorithms to 
prompt the appropriate and timely use of volume-based 
staffing and management and overcapacity protocols, 
which may otherwise be overlooked by distracted 
frontline ED staff. When the ED is at overcapacity, 
ED staff require additional external support and 
resources, which are obtained by calling management. 
The prescribed actions included in the protocol when 
patient demand exceeds capacity in an optimal flow 
environment (eg, SurgeCon 4 & 5) are designed to find 
ways to remediate systemic issues that exist outside 
the ED and require managerial-level interventions that 
contribute to holistic operating conditions. This protocol 
converts key performance indicators into instructions for 
ED providers using a three-step process: 
i. An EP, nurse, or administrator enters counts of 
specific indicators every two hours (eg, number of 
beds available, number of admitted patients, number 
of patients not seen) onto a whiteboard as part of their 
regular workflow.
ii. As a result of step (i), the team gains awareness of 
workload that can be shared with key stakeholders both 
internal and external to the ED. External stakeholders 
could determine bed availability, extract patients 
from the ED to an assigned inpatient bed, temporarily 
increase nurse and physician staffing, contact admitting 
consultants, and contact primary care paramedics for 
assistance.
iii. Using the visual board, the team adds the scores to get 
a total. This total score falls in one of five graduated 
levels, each with a set of prescribed actions. For 
example, a total score of 40 or more is level 5, with 
associated actions such as “Send all lower acuity 
patients to the waiting room.” This scoring algorithm 
provides clarity for frontline staff in real time (Appendix 
II). Moving stable patients or visitors from clinical 
assessment spaces back to a primary or alternate waiting 
room is in line with our objective of creating a patient-
centered environment as this allows for more non-
assessed patients to become the center of care.39,40 
Outcome Measures
The ED team (EP, nurses, and nursing management) 
manually collected data for PIA, LOSDep, and LWBS from 
Carbonear’s hospital records, and reviewed it monthly from 
July 1, 2013–March 31, 2017. In May 2017, we retrospectively 
reviewed PIA, LOSDep, and LWBS in each study period and 
compiled the data for analysis.
An ED team (clinical manager, site clinical physician chief, 
nurse practitioner, nursing-appointed chairperson, and various 
other frontline staff) identified the following as outcome measures 
before the intervention began:
•	 PIA: mean time (in minutes) from patient triage to 
first assessment by a physician or their delegate (nurse 
practitioner, trainee, etc.). PIA is also referred to as 
“arrival to provider” or “door to doctor.”1,41,43
•	 LWBS: percentage of patients who leave the ED without 
an assessment by a physician or their delegate. LWBS is 
also referred to as “left before being seen.”1,43,44
•	 LOSDep: mean time interval (in minutes) between 
patient being triaged and discharged from the ED (in 
minutes). LOSDep is also referred to as “ED length of 
stay for discharged patient.”1,43 
Senior ED management send out scorecards with PIA, 
LOSDep, and LWBS data to local ED management for their 
review. To get PIA and LOSDep times, they take the earliest of 
three time stamps (arrival time, triage time, or registration time) 
and use that as the patient’s time of arrival.
Data Analysis
Interrupted time series (ITS) analysis is an effective statistical 
approach to assess the impact of an intervention in a quasi-
experimental research design.45 To design a robust ITS analysis, we 
used guidelines introduced by Bernal, Cummins, and Gasparrini,46 
and selected a single-group, segmented time-series regression 
model. Time series analyses calculate the change in an outcome 
over time before an intervention is introduced, and then assess the 
immediate (month after introduction) and long-term (change in 
trend over time) effects of the intervention after adjusting for this 
pre-intervention trend. Thus, an immediate effect is significant if 
there is a statistically significant change in outcome in the month 
after program introduction from what would have been expected 
if the pre-intervention trend had continued. The long-term effect of 
the intervention is assessed by determining if there is a difference 
between the rates of change in outcome over time (slope) from the 
pre- to post-intervention periods. 
For the purpose of this study, we initially conducted a 
segmented time-series regression model with two segments 
(pre-intervention and post-intervention) to identify whether there 
was any significant change in outcomes after implementation of 
the intervention. Then, we graphed the data and visualized two 
breakpoints occurring after the intervention. Therefore, we used a 
three-segment ITS model to more accurately represent our data. 
To identify the optimum breakpoints, we visually estimated that 
the breakpoints would be somewhere between months 15 and 30 
of our 45-month study period. We looked for any sign changes 
and big swings in the values of the estimated coefficients as well 
as the model fitness criterion. 
The analyses suggested that the estimates of the early 
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intervention become significant after six months of 
the intervention and remained so until 15 months of 
intervention with no variation in the magnitude or direction 
of the estimated coefficients. The analyses also suggested 
that the estimates of the late intervention become significant 
after 15 months. Increasing the duration of the late 
intervention period did not show any significant change 
in model fitness, magnitude and direction of the estimated 
coefficients of the late intervention until 30 months after 
initiation of the intervention. For this reason, the three-
segmented linear regression model with segments including 
before intervention (July 1, 2013 to September 30, 2014, 
inclusive), early intervention (October 1, 2014 to December 
31, 2015, inclusive), and late intervention (January 1, 2016 
to March 31, 2017, inclusive) have been fitted to the data. 
Finally, we added the number of visits per month as a 
covariate in the model to reassess the model fitness and any 
statistically significant changes in the estimated coefficients. 
We also conducted seasonality analysis to see whether the 
data experienced regular and predictable changes, and found 
no periodic fluctuations in all calendar seasons. Details 
about the parameters in the model are available in Appendix 
I. We used Stata version 14.2 (StataCorp, College Station, 
Texas) for statistical analyses.
RESULTS
Over the entire study period, there were 80,709 patient 
visits to the Carbonear ED. Table 1 shows the characteristics 
of ED visits.
Overall, in this 45-month study PIA decreased from a 
mean of 104.3 minutes (±9.9 standard deviations) to 42.2 
(±8.1) minutes, LOSDep decreased from 199.4 (±16.8) 
minutes to 134.4(±14.5) minutes, and LWBS decreased from 
12.1% (±2.2) to 4.6% (±1.7). The results of a segmented 
time series analysis are as follows:
Physician Initial Assessment
As described in Table 2, the ITS regression with two 
segments shows an immediate effect (level change) of -19.8 
minutes (p<0.01; 95% confidence interval [CI], -33.68 to 
-5.89] ) drop in PIA and a long-term effect (slope change) 
of -2.72 (p< 0.001; 95% CI, -3.97 to -1.48) after the 
intervention.
Using the three-segment model, the level change shows 
a reduction in both early and late intervention by -5.59 
(p=0.186; 95% CI, -13.99 to -2.81) and -13.99 (p<0.004; 
95% CI, -23.35 to -4.63), respectively. The change in PIA 
slope was mainly due to changes in the early intervention 
period where the PIA significantly decreased every month 
by -4.45 minutes on average (p<0.001; 95% CI, -5.59 
to -3.32). A monthly increase of 5.12 minutes (slope 
change) in PIA can be seen during the late-intervention 
period (p<0.001; 95% CI, 4.19 to 6.05) compared to 
early intervention. However, considering the linear trend 
of -3.80 (p< 0.001; 95% CI, -4.45 to -3.15) in the early 
intervention vs l.3 (p< 0.001; 95% CI, 0.60 to 2.05) in the 
late intervention and the level change of 13.99 (p<0.004; 
95% CI, -23.35 to -4.63) in the late intervention, there was 
an overall decline over the entire post-intervention period. 
This can be verified upon visual inspection of Figure 1.
Pre-intervention Post-intervention
Early-intervention Late-intervention
Total number of patients 23898 26780 30031
Total number of months 15 15 15
Total number of days 457 457 456
Mean PIA, minutes (SD) 104.3 (9.9) 77.3 (18.3) 42.2 (8.1)
Mean LOSDep, minutes (SD) 199.4 (16.8) 170.6 (25.4) 134.4 (14.5)
Mean LWBS, % (SD) 12.1 (2.2) 8.2 (3.2) 4.6 (1.7)
CTAS 1, n (%) 83 (0.3%) 56 (0.2%) 44 (0.1%)
CTAS 2, n (%) 1212 (5.1%) 1063 (4.0%) 1157 (3.9%)
CTAS 3, n (%) 7148 (29.9%) 9590 (35.8%) 8981 (29.9%)
CTAS 4, n (%) 10459 (43.8%) 13201 (49.3%) 16820 (56.0%)
CTAS 5, n (%) 1315 (5.5%) 1756 (6.6%) 1660 (5.5%)
Unspecified CTAS 3688 (15.4%) 1069 (4.0%) 1236 (4.1%)
Table 1. Characteristics of patient visits to the Carbonear emergency department.
PIA, time until physician initial assessment; SD, standard deviation; LOSDep, length of stay for departed patients; LWBS, patients who left 
without being seen; CTAS, the Canadian Triage and Acuity Scale.
*Note that patient numbers reported by CTAS level will not match patient numbers reported by patient visits to the Carbonear emergency 
department (ED). This discrepancy is the result of a combination of an oversight in Eastern Health’s internal reporting system, patients who 
visit the ED for reasons not requiring a CTAS score (e.g., intravenous specialist assessment), and omissions in paper charts.
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Length of Stay Until Departure from Emergency 
Department 
According to the two-segment model, the immediate 
effect of the intervention was a 17.5-minute decrease in LOS 
for departed patients, but this difference is not statistically 
significant (p<0.150). The long-term effect (slope change) 
on LOSDep is statistically significant (p<0.002) with a 
reduction of three minutes per month after implementation of 
the intervention.
The three-segment model reports a statistically non-
significant level change in both early intervention (1.93, 
p=0.82) and the late intervention period (0.43, p=0.97) (Table 
3). It also reveals a significant decrease of 5.7 minutes in 
LOSDep (slope change) during the early period (p<0.001) 
and 5.7 minutes increase (slope change) in the late period 
(p<0.001). By looking at the linear trend results for the early 
intervention period (-5.1, p<0.001, 95% CI, -6.64 to -3.59) and 
late intervention period (0.6, p=0.43, 95% CI, -0.92 to 2.12), 
the overall diminishing trend seems to be preserved during the 
post-intervention period (-3, p<0.002; 95% CI,  
-4.87 to -1.14). This also can be verified upon visual 
inspection of Figure 2.
Left Without Being Seen
Applying a two-segment model shows an immediate 
effect of 3.8% decrease (p<0.02; 95% CI, -6.87 to -0.75) and 
the long-term effect of decrease by 0.4 % (p<0.004; 95% 
CI, -0.73 to -0.15) on LWBS after the implementation of the 
intervention. Using the three-segment model, a statistically 
non-significant level change of -1.42% (p=0.340) in the early 
period and 0.41% (p=0.718) in the late period is seen (Table 3). 
This model also shows a drop in the long-term effect of 0.78% 
(p<0.001; 95% CI, -1.14 to – 0.43) and then an increase of 
0.68% during the late intervention (p<0.001; 95% CI, 0.41 to 
0.95). The linear trend in the early intervention period shows a 
significant decrease by 0.58 (p<0.001; 95% CI, -077 to -0.40) 
and a non-significant trend of 0.09 (p=0.38). Since the overall 
slope change is declining (Table 2), the slope of linear trend in 
the early-intervention period is decreasing by 0.58 (p<0.001) 
and the positive slope of linear trend is not statistically 
significant (0.09, P=0.38), the overall long-term effect (trend) is 
diminishing over the post-intervention period (Figure 3).
To control for the effect of patient volume, we adjusted 
the model by adding number of visits per month (“Visits”) 
Emergency department efficiency indicator Coefficient 95% confidence interval
Lower band, Upper band
P value
Average physician initial assessment
Baseline slope 0.66 -0.35, 1.66 0.20
Level change -19.80 -33.68, -5.89  0.01*
Slope change -2.72 -3.97, -1.48 0.001*
Average length of stay until departure from emergency department
Baseline slope 0.63 -0.96, 2.22 0.43
Level change -17.52 -41.63, 6.59 0.15
Slope change -3.00 -4.87, -1.14 0.001*
Percent of patients left without being seen
Baseline slope 0.20 -0.06, 0.46 0.13
Level change -3.81 -6.87, -0.75 0.02*
Slope change -0.44 -0.73, -0.15 0.0014*
Table 2. Interrupted time-series analyses showing effects of intervention on time to physician initial assessment, patient length of stay 
and left without being seen rates. 
* P value < 0.05.
Figure 1. Physician Initial Assessmen (PIA).
Visual depiction of the overall declining trend in time to physician 
initial assessment over entire post-intervention period.
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Emergency department efficiency indicator Coefficient 95% confidence interval
Lower band, Upper band
P value
Average physician initial assessment
Baseline slope 0.66 -0.30, 1.61 0.17
EI: Level change -5.59 -13.99, 2.81 0.19
EI: Slope change -4.45 -5.59, -3.32 0.001*
LI: Level change -13.99 -23.35, -4.63 0.001*
LI: Slope change 5.12 4.19, 6.06 0.001*
EI: Linear trend -3.80 -4.45, -3.15 0.001*
LI: Linear trend 1.32 0.60, 2.05 0.001*
Average length of stay until departure from emergency department
Baseline slope 0.63 -0.58, 1.84 0.30
EI: Level change 1.93 -15.35, 19.20 0.82
EI: Slope change -5.74 -7.69, -3.79 0.001*
LI: Level change 0.43 -19.60, 20.45 0.97
LI: Slope change 5.71 3.48, 7.95 0.001*
EI: Linear trend -5.11 -6.64, -3.58 0.001*
LI: Linear trend 0.60 -0.92, 2.12 0.43
Percent of patients left without being seen
Baseline slope 0.20 -0.09, 0.49 0.17
EI: Level change -1.42 -4.22, 1.37 0.31
EI: Slope change -0.78 -1.14, -0.43 0.001*
LI: Level change 0.41 -2.23, 3.04 0.76
LI: Slope change 0.68 0.41, 0.95 0.001*
EI: Linear trend -0.58 -0.77, -0.40 0.001*
LI: Linear trend 0.09 -0.12, 0.31 0.38
Table 3. Three-segment statistical model showing a statistically non-significant level change in both early intervention and late interventions.
EI, early intervention (October 1, 2014 to December 31, 2015); LI, late intervention (January 1, 2016 to March 31, 2017).
* P value < 0.05.
Figure 2. Length of stay for departed patients (LOSDep).
Visual depiction of the overall diminishing trend during the entire 
post-intervention period.
Figure 3. Patients left without being seen (LWBS).
Visual depiction showing overall long-term trend diminshing over 
the post-intervention period.
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to the three-segment model. The results (Table 4) show visits to 
be associated with PIA (0.02, 95% CI, 0.00 to 0.04; p<0.05) and 
LWBS (0.01, 95% CI, 0.00 to 0.01; p<0.04).
Overall, the adjusted model (Table 4) is consistent with 
the primary model (Table 3). No abnormal changes in the 
direction/sign of coefficients were seen, except the magnitude of 
coefficients, which have partially changed between the early- and 
late-intervention periods. Comparing the primary and adjusted 
models, the only difference is that the baseline slopes become 
statistically significant in PIA ([0.66, p=0.17] vs ([0.76, p<0.03]) 
and LWBS ([0.20, p=017] vs. [0.23, p<0.03]), respectively.
DISCUSSION
Before implementing SurgeCon, there was anecdotal 
evidence that the Carbonear ED was not achieving national 
Emergency department efficiency indicator Coefficient 95% confidence interval
Lower band, Upper band
P value
Average physician initial assessment
Visits 0.02 0.00, 0.04 0.05*
Baseline slope 0.76 0.07, 1.46 0.03*
EI: Level change -6.16 -13.39, 1.07 0.09
EI: Slope change -5.19 -6.60, -3.78 0.001*
LI: Level change -11.69 -22.85, -0.52 0.04*
LI: Slope change 5.48 4.30, 6.65 0.001*
EI: Linear trend -4.43 -5.55, -3.30 0.001*
LI: Linear trend 1.05 0.18, 1.93 0.02*
Average length of stay until departure from emergency department
Visits 0.00 -0.04, 0.04 0.96
Baseline slope 0.64 -0.62, 1.89 0.31
EI: Level change 1.90 -15.56, 19.36 0.83
EI: Slope change -5.77 -8.42, -3.12 0.001*
LI: Level change 0.53 -22.67, 23.72 0.96
LI: Slope change 5.73 3.46, 8.00 0.001*
EI: Linear trend -5.14 -7.25, -3.03 0.001*
LI: Linear trend 0.59 -1.22, 2.40 0.51
Percent of patients left without being seen
Visits 0.01 0.00, 0.01 0.04*
Baseline slope 0.23 0.02, 0.44 0.03*
EI: Level change -1.57 -3.93, 0.80 0.19
EI: Slope change -0.97 -1.37, -0.57 0.001*
LI: Level change 1.00 -2.16, 4.16 0.53
LI: Slope change 0.77 0.44, 1.09 0.001*
EI: Linear trend -0.74 -1.05, -0.43 0.001*
LI: Linear trend 0.03 -0.23, 0.28 0.84
Table 4. Number of visits per month and time to physician initial assessment and left without being seen rates.
EI, early intervention (October 1, 2014 to December 31, 2015); LI, late intervention (January 1, 2016 to March 31, 2017). 
* P Value < 0.05.
benchmarks and had the highest LWBS rate relative to 
similar-sized EDs in NL.8 This study provides evidence that 
EDs can be adapted to efficiently provide urgent and non-
urgent care in rural communities. All of our analyses showed 
an upward trend (ie, worsening) in outcomes over time in 
the pre-intervention period. After the implementation of 
the SurgeCon platform at the Carbonear ED, all outcomes 
showed a significant improvement. While the trend change 
was reversed in the late-intervention period, the rate of change 
was either non-significant or slower compared to immediate 
and long-term effects of the intervention in the early 
intervention period. The worsening trend from the early- to 
late-intervention period is likely a combination of an increase 
in ED volume and sustaining the gains long term. A refresher 
session may improve the results after the first 15 months. 
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Sensitivity analyses did not show any significant change in 
the model’s fitness or estimated coefficients where we applied 
the three-segment models to different subsets of the data. 
Moreover, repeating these processes by adding the variable 
number of visits per month did not show any significant 
change in the model’s fitness or estimated coefficients. 
It is worth highlighting that the dramatic improvements 
in outcomes demonstrated here occurred despite a 25.7% 
increase in patient visits from the pre- to the late-intervention 
periods. Moreover, no additional staff were hired during the 
study period. The increased volume were predominantly 
patients who were categorized as Canadian Triage and 
Acuity Scale (CTAS) 4 or non-urgent visits, which are often 
considered to be those that are amenable to treatment in 
primary care. The ability to provide care to a larger volume 
of patients without increasing wait times may be due in part 
to improved team awareness. The mechanisms that lead to 
improved “team awareness” in the context of the SurgeCon 
platform are a result of the tasks and goals set by the protocol. 
The protocol addresses issues related to harmful assumptions, 
establishes a common decision-making process, improves 
communication, and sets expectations for everyone on the 
ED team through role assignment. This is achieved via the 
protocol by defining the problem, the strategies to overcome 
them, and the overall goals of the department depending on 
the level of demand at any given time. 
Our study does not suggest EDs can replace traditional 
means of accessing primary care; however, they can be relied 
upon as a secondary alternative approach to providing primary 
care in communities where access to a family physician may 
be challenging. In the community surrounding the Carbonear 
Hospital there has been a large loss of primary care physicians 
who retired in recent years. Recent studies have found 
evidence that rural patients are more likely to use EDs for non-
urgent reasons when compared to their urban counterparts.47,48 
Geographic proximity to EDs and the likelihood of being 
seen by a regular family physician were found to be important 
factors influencing this discrepancy.48-50 
In recent years many studies have evaluated Lean 
initiatives,51-53 fast-track areas in the ED,54-6, physicians 
in triage,57 and full capacity protocols,58 although the vast 
majority of these studies took place in urban centers. 
Furthermore, most studies examine just one initiative 
while our study included a large initiative with seven parts. 
The biggest strength to this study is that the initiatives 
were developed and implemented by a team of frontline 
practitioners (physicians and registered nurses) who have 
experienced firsthand the inefficiencies of the ED.
LIMITATIONS
There are a few limitations that should be taken into 
consideration when interpreting the findings from this study. 
First, the generalizability of our results is limited given that 
implementation occurred at a single site. That said, the nature 
of a proof-of-concept initiative is to test a novel process on a 
small scale for feasibility and impact. The scoring system as 
shown in Appendix II also has limited generalizability because 
it is not normalized against ED size, and gives exact numbers 
(e.g., number of occupied beds) instead of proportions of beds 
that are full. Another limitation encountered during the study 
is particular to the hospital setting, where we could only call 
the inpatient unit for the immediate extraction from the ED 
during SurgeCon 5, instead of proactively calling. This was 
due to a negotiation between busy units, when ideally the unit 
would be called prior to this level of overcapacity. 
Second, once patients had been seen by ED staff they 
were sorted using the CTAS. This triaging was not considered 
in our analysis because for this QI initiative, we used data 
aggregated on a monthly basis. We did not have data at the 
individual level to assess the associations with CTAS. Visits 
based on CTAS shows slight fluctuations in CTAS I and 
II during the study period and increasing number of visits 
with CTAS III and IV. The percentage of unclassified CTAS 
patients was also higher in the pre-intervention period than 
in the post-intervention period. Third, we did not measure 
72-hour return to ED rate; however, a 2016 study by Cheng 
et al.59 found that this often-cited measure is not reliably 
indicative of ED quality. Another potential limitation is that 
we only used 45 time points and it is known that power in ITS 
analyses increases with a larger number of time points.46 The 
decision to use mean instead of median might be viewed as a 
limitation within the context of this study. Although median 
may perform better for a skewed distribution such as length 
of stay in hospital and wherever the goal is to represent a 
typical length of stay, mean is more sensitive to magnitude 
and is a more representative statistic from the point of view of 
assessing health system costs and efficiency.60-62 
One may question the decision to use segmented 
regression instead of autoregressive integrated moving 
average (ARIMA).63 Although ARIMA models inherently 
account for autocorrelation, non-stationarity and seasonality, 
they require a sufficient number of data points and 
observations in the pre- and post-intervention periods (a 
minimum of nine data points and over 100 observations).64 
Segmented regression on the other hand is one of the most 
common interrupted time series methods used in health 
sciences research.64 It is similar to linear regression and is 
suggested for functions that cut segments of time particularly 
for studies such as the one described here where the points of 
switching segments are known. They are also more flexible for 
multivariate analysis.46,65 To ensure elements covered through 
ARIMA models were included in our analysis, we checked 
for autocorrelation, non-stationarity, and seasonality before 
running the model (Appendix). With this in mind, due to the 
flexibility and applicability in the context of a proof of concept 
study we conducted a segmented regression analysis.66 
As there is a trend toward increasing PIA, LOSDep, and 
LWBS between the early- and late- intervention stages, it 
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is possible some of the measures may have returned to pre-
intervention levels if the study had continued for longer. It is 
possible that a “refresher” training session may be needed to 
combat this. It is also possible that a decrease in LWBS will 
result in a slight increase in the number of patients leaving 
before treatment is completed as some patients will not want 
to wait for test results regardless of how quickly the doctor 
sees them. Unfortunately, the routinely collected data used 
in this study did not include the number of patients who left 
before completing treatment. Another possible limitation of 
this study is the Hawthorne effect in which individuals behave 
differently when they know they are being observed. This 
may have led to ED staff modifying their behavior over the 
course of this study. Finally, physicians and nurse practitioners 
manually entered PIA, which may have impacted data quality. 
CONCLUSION
Our team recognized the necessity of a hospital-wide 
response from the outset, and designed and implemented 
SurgeCon accordingly. We took careful stock of existing 
resources in the ED and developed the comprehensive 
SurgeCon strategy around them. This was achieved by aligning 
the ED team around performance gains and approaching other 
key stakeholders in the system to help with output issues. This 
study provides evidence that interventions such as SurgeCon 
can result in significant gains with regard to key wait-time 
metrics in a rural community hospital with limited resources.
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Introduction: Emergency department (ED) patient care often hinges on the result of a diagnostic test. 
Frequently there is a lag time between a test result becoming available for review and physician decision-
making or disposition based on that result. We implemented a system that electronically alerts ED 
providers when test results are available for review via a smartphone- and smartwatch- push notification. 
We hypothesized this would reduce the time from result to clinical decision-making. 
Methods: We retrospectively assessed the impact of the implementation of a push notification system 
at three EDs on time-to-disposition or time-to-follow-up order in six clinical scenarios of interest: 
chest radiograph (CXR) to disposition, basic metabolic panel (BMP) to disposition, urinalysis (UA) to 
disposition, respiratory pathogen panel (RPP) to disposition, hemoglobin (Hb) to blood transfusion order, 
and abnormal D-dimer to computed tomography pulmonary angiography (CTPA) order. All ED patients 
during a one-year period of push-notification availability were included in the study. The primary outcome 
was median time in each scenario from result availability to either disposition order or defined follow-
up order. The secondary outcome was the overall usage rate of the opt-in push notification system by 
providers.
Results: During the study period there were 6115 push notifications from 4183 ED encounters (2.7% of 
all encounters). Of the six clinical scenarios examined in this study, five were associated with a decrease 
in median time from test result availability to patient disposition or follow-up order when push notifications 
were employed: CXR to disposition, 80 minutes (interquartile range [IQR] 32-162 minutes) vs 56 minutes 
(IQR 18-141 minutes), difference 24 minutes (p<0.01); BMP to disposition, 128 minutes (IQR 62-225 
minutes) vs 116 minutes (IQR 33-226 minutes), difference 12 minutes (p<0.01); UA to disposition, 105 
minutes (IQR 43-200 minutes) vs 55 minutes (IQR 16-144 minutes), difference 50 minutes (p<0.01); 
RPP to disposition, 80 minutes (IQR 28-181 minutes) vs 37 minutes (IQR 10-116 minutes), difference 
43 minutes (p<0.01); and D-dimer to CTPA, 14 minutes (IQR 6-30 minutes) vs 6 minutes (IQR 2.5-
17.5 minutes), difference 8 minutes (p<0.01). The sixth scenario, Hb to blood transfusion (difference 19 
minutes, p=0.73), did not meet statistical significance. 
Conclusion: Implementation of a push notification system for test result availability in the ED was 
associated with a decrease in lag time between test result and physician decision-making in the 
examined clinical scenarios. Push notifications were used in only a minority of ED patient encounters. 
[West J Emerg Med. 2019;20(4)666-671.]
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What do we already know about this issue?
Electronic health records can push notification of 
results to smartphones; this strategy has been shown 
to reduce time to disposition in chest pain patients.
What was the research question?
Does a push notification system decrease lag time 
to decision-making in several clinical scenarios of 
interest?
What was the major finding of the study?
Use of result push notifications was associated 
with decreased time to decision-making in several 
clinical scenarios.
How does this improve population health?
Push notifications are a strategy that busy 
emergency departments may consider to help 
address issues of crowding and improve throughput.
INTRODUCTION
Decreasing emergency department (ED) length of stay 
and wait times is an ongoing effort in emergency medicine.1-3 
ED crowding is a challenge, and increasing throughput is an 
objective for many institutions. Improvements in ED flow 
and crowding are associated with higher quality of care.4,5 
Crowding is associated with higher stress levels among 
healthcare providers, longer wait times, increased boarding 
of admitted patients, and a higher rate of adverse events and 
poor outcomes.6,7 While many factors are associated with ED 
crowding, ED patients are often awaiting test results to affect 
a clinical disposition. This is an element of ED throughput that 
may be a target for quality improvement.8 
Emergency physicians typically manage several patients 
simultaneously and make clinical decisions based on 
information that becomes serially available as tests result. 
Tracking the timing of resulting patient studies while caring 
for multiple patients is difficult and managed idiosyncratically 
by most physicians. Delays in responding to newly resulted 
test information (due to task-switching, interruptions, and 
other challenges of the ED clinical environment) likely impact 
patient throughput.9,10 Electronic systems that wirelessly alert 
providers about timed events have been shown to improve 
throughput in ED patients evaluated for chest pain.11,12 These 
alerts also increase the likelihood of the result reaching the 
provider and help avoid potential errors in communication of 
test results.13 
At our institution we implemented the ability for 
providers to receive an electronic alert when the result of 
any selected test has been entered in the system. Providers 
are able to indicate their choice to receive such an alert at the 
point of order entry in the electronic health record (EHR). 
This alert is sent in the form of a push notification to handheld 
devices (smartphones and smartwatches) that have the mobile 
version of the EHR installed. The notification signals to the 
provider that a test result is available for viewing on either the 
smartphone or computer. 
We chose to examine four commonly ordered tests in 
the ED to evaluate whether a push notification about the 
availability of these results reduced the time to a disposition 
decision being made about patients (discharge vs admission). 
Additionally, we examined two clinical scenarios to evaluate 
whether the time to ordering a follow-up intervention was 
reduced by the new alerting mechanism. The first scenario 
evaluated the time from a critically low hemoglobin result 
(<7 grams per deciliter) was entered into the system and a 
blood transfusion was ordered; the second scenario was the 
time from an abnormal D-dimer result to the time when a 
computed tomography pulmonary angiogram (CTPA) was 
ordered. These scenarios were chosen a priori by the study 
investigators as clinical decisions most clearly related to the 
result of a single preceding test result. Our hypothesis was that 
the new alerting system would reduce the lag time between 
result availability and physician decision-making.
METHODS
Study Setting and Population
New York University (NYU) Langone Health is an 
integrated health network in New York City with three EDs 
that collectively evaluate 150,000 patients per year. NYU 
Tisch Hospital is a tertiary care academic medical center with 
approximately 75,000 visits per year, NYU Cobble Hill is a free-
standing ED with approximately 24,000 visits per year, and NYU 
Brooklyn Hospital is a Level 1 trauma center with approximately 
52,000 visits per year. We collected data on patients from 
July 1, 2017, when the push notification functionality was 
made available, through June 30, 2018. In that time period, 
78 ED providers subscribed to at least one push notification 
(37 attending physicians, 24 resident physicians in emergency 
medicine, and 17 physician assistants).
Study Design
This was a retrospective, multicenter study to evaluate 
a quality improvement initiative. ED providers were free to 
subscribe to push notifications on whatever studies they chose 
and on whichever patients they chose. Providers were notified 
of this new functionality via departmental email update. Any 
order not yet resulted after being placed could be selected for a 
result push notification. This included orders placed by nursing 
or any other provider. Providers were not blinded as blinding in 
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this setting would have been infeasible. Providers were never 
prevented from accessing result data via the traditional log-
in, computer-based EHR (Epic Systems Corporation, Verona, 
Wisconsin), even if they were using push notifications. EHR 
data was queried from the Epic Systems Clarity database with 
the use of Oracle SQL Developer (Oracle Corporation, Redwood 
City, California) and exported for data analysis; the queried data 
included encounter ID, notification type, notification time, order 
time, order-resulted time, and disposition time (defined as order 
to either admit or discharge the patient from the ED). The study 
was approved by the institutional review board of the NYU 
School of Medicine.
Outcomes
The outcomes of interest in this study included the following: 
time from the result of a chest radiograph (CXR) being made 
available to the time of disposition; time from basic metabolic 
panel (BMP) result available to disposition; time from urinalysis 
(UA) result available to disposition; time from respiratory 
pathogen panel (RPP) result available to disposition; time from 
hemoglobin (Hb) result available to time blood transfusion 
was ordered; and time from D-dimer result available to time of 
CTPA order. Point-of-care laboratory tests (eg, troponin, lactate) 
– the results of which are communicated directly from the test 
performer (the nurse) to the test orderer (physician or physician 
assistant) – were excluded from analysis because the results of 
these tests are available prior to being entered in the EHR. We 
also excluded  advanced imaging studies from analysis because 
providers are frequently informed of critical results by radiology 
telephone call prior to their being entered into the EHR. 
Data Analysis
Median time with interquartile ranges (IQR) is reported in 
each scenario, and we used the Mann Whitney (Wilcoxon) test 
for unpaired data to assess whether the difference in medians 
between the two groups was statistically significant, defined as 
two-tailed p‐values < 0.05 (R Statistics, version 3.3.3). For each 
of the measured scenarios we constructed a clustered boxplot 
comparing the median times with IQRs in the push notification 
and no push notification groups; minimum/maximum value 
whiskers were not displayed for visual scaling purposes (Excel, 
Microsoft Corporation, Redmond, Washington).
RESULTS
During the study period there were 152,574 ED encounters: 
148,391 ED encounters without a push notification (no 
notifications cohort), and 4183 ED encounters with a push 
notification (notifications cohort). There were 6115 push 
notifications generated from the notifications cohort, comprised 
of 4102 distinct patients. The median age, admission rate, average 
Emergency Severity Index, and gender percentages for the two 
patient cohorts are presented in Table 1. Overall, 32% (78/241) 
of ED providers subscribed to at least one notification during the 
study period: 28% (37/136) of attending physicians, 38% (17/45) 
of physician assistants, and 53% (24/45) of resident physicians. 
Fifteen of the 78 providers (19.2%) accounted for 79.7% of 
the notifications. Providers received result notifications about 
320 unique lab/imaging studies. Of the 320 studies, 37 (11.6%) 
accounted for 79.8% of the total. There were four lab or imaging 
tests on average ordered per encounter in the push notification 
cohort. Push notifications were employed in 2.7% of all ED 
encounters during the study period. The overall rate of push 
notification subscriptions rose slightly over the study period, from 
2911 push notifications during the first six months to 3204 push 
notifications in the second six months.
Of the six diagnostic tests we examined in this study, 
five were associated with a decrease in median time from test 
result availability to provider decision-making (Figure 1); the 
sixth scenario did not meet statistical significance. The largest 
improvements in median time from result to disposition were 
seen with the UA and RPP result notifications (50 and 43 
minutes, respectively), whereas the improvement in time from 
result to disposition for the CXR and BMP results was more 
modest (24 and 12 minutes, respectively) (Table 2). In the follow-
up order scenarios, the time from abnormal D-dimer to CTPA 
order was eight minutes faster in the push notification group; the 
time from critically low Hb result to blood transfusion was 19 
minutes faster, but this finding was not statistically significant.
DISCUSSION
This study’s findings demonstrate a correlation between 
employment of test-result push notifications to smart devices 
and improved patient care efficiency. Of the six diagnostic test 
types examined, all were associated with a decrease in lag time 
from result availability to the next clinical step –  either patient 
disposition, or defined follow-up order. A larger magnitude 
of effect was observed for UA and RPP results than for CXR 
and BMP results. Both UA and RPP require specific collection 
(urine sample or nasopharyngeal swab), which commonly leads 
to delays, and both tests typically take longer to result than 
blood tests; result notifications may be more efficacious in the 
setting of tests that are slow to result. The improved time from 
D-dimer result to CTPA order was modest (eight minutes). In 
the setting of cascading delays in ED patients who first wait for 
Characteristcs
No Notifications 
Cohort,  
n = 148,391
Notifications 
Cohort, n = 4,183
Age, median 41 51
Women (%) 50.6% 51.8%
Admission rate (%) 17.2% 21.9%
ESI* 3.87 3.35
Table 1. Characteristics of the no push notification and push 
notification cohorts. 
ESI, Emergency Severity Index (lower values signify higher patient 
acuity). 
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blood test results and then imaging study results, even this small 
improvement in lag time may be relevant. Similarly, for the 
time from Hb result to blood transfusion, an improvement of 19 
minutes would also be clinically meaningful, even though due 
to the small sample size of push notifications in this scenario (18 
notifications) this finding did not meet statistical significance. 
The result push-notification functionality described is 
inherent to the EHR used at our institution, and therefore any 
institution using this EHR can potentially use this functionality. 
At this time, however, there is no ability to default result 
push notifications for all providers, or for a given provider 
conditionally for a specific test (for example, to always push 
CXR result notifications). The requirement to manually opt-
in each time a test is ordered may have limited the magnitude 
of effect and depressed the usage rate of the push notification 
functionality in our study. While the overall rate of push 
notification usage did rise slightly during the study period, and 
a large number of physicians and physician assistants used the 
push notification system at least once, there was a low overall 
percentage of patient encounters in which push notifications 
were employed by the provider (2.7% during the study period). A 
notably larger percentage of resident physicians opted to use the 
push notifications than attending physicians, which may be due to 
role-related workflows (residents primarily managing the patient 
flow) as well as age-related factors (younger resident physicians 
may be more likely to adopt smart device technology).14 
System improvements for ease-of-use and customizability 
might increase provider use and limit the potential for user 
frustration or overuse; too many notifications would likely 
prove counterproductive to ED flow.
The overall magnitude of improvements observed in 
our study is similar to a trial of smartphone, troponin- result 
push notifications, in which Verma et al. found a 26-minute 
improvement in lag time from troponin result to patient 
disposition.11 Our institution almost exclusively uses a point-
of-care troponin test in the ED and thus we could not study 
the specific clinical scenario of troponin to disposition in our 
study. A study of radiologic critical test results reported via text 
message to physicians similarly showed improved response 
time in ED patients.15 
Our study specifically examined clinical scenarios in which 
the authors felt knowledge of a test result would most clearly 
lead to either a disposition decision or an additional test order, 
and hence a measurable effect. These specific clinical situations 
represent only a small proportion of the total ED volume and 
clinical caseload during the study period. While prolonged length 
of stay and ED crowding are multifactorial in etiology and the lag 
time between result availability and physician action is a small 
contributor,8 these results suggest that push notifications were 
potentially effective in modestly decreasing time to decision-
making for providers opting-in for push notifications. This is 
also likely true in more complex clinical situations that were not 
0            50          100          150         200          250         300          350         400         450
Time (minutes)
Push Notification
No Push Notification
CXR to disposition
BMP to disposition
UA to disposition
RPP to disposition
D-dimer to CTPA
Hb to blood transufustion
Figure 1. Boxplot of median minutes and interquartile ranges for time to disposition or time to follow-up order in each clinical scenario studied. 
CXR, chest radiograph; BMP, basic metabolic panel; UA, urinalysis; RPP, respiratory pathogen; CTPA, computed tomography pulmonary 
angiography; Hb, hemoglobin. 
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studied. Further investigation is needed to identify and measure 
the impact of push notifications more broadly in the ED.
LIMITATIONS
There are multiple limitations to this study. Our 
retrospective study was only able to show a correlation between 
result push notifications and improved time to decision-making. 
In addition, because each provider independently made the 
decision on whether or not to subscribe to a given test push 
notification, there may have been a potential selection bias: it is 
possible that providers who were motivated to subscribe to such 
alerts may also be those who are more efficient in general. It’s 
also possible providers subscribed to push notifications more 
often in situations in which they could quickly disposition a 
patient pending that single result. 
The admission rate for the notification cohort was slightly 
higher than that for the encounters without a push notification. 
It is possible that slight differences in patient characteristics 
between the two groups may explain part of the difference 
in efficiency. We attempted to limit this shortcoming by also 
studying two scenarios in which patient factors would not affect 
efficiency (time to CTPA and time to transfusion).
The study only examined six different test results and 
clinical scenarios. It is possible that we chose scenarios 
that showed an improvement, whereas tests not studied (eg, 
extremity radiograph results) may not have demonstrated an 
effect. The finding of decreased lag time in every scenario 
studied suggests that the efficiency observed is likely 
generalizable to other types of studies.
CONCLUSION
Implementation of a push notification system for test 
result availability in the ED was associated with a decrease in 
lag time between test result and provider decision-making in 
several clinical scenarios. However, push notifications were 
used in only a minority of all ED patient encounters during the 
study period. The use of push notifications may play a role in 
improving the timeliness of care delivered in the ED.
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Introduction: Patients discharged from the emergency department (ED) may encounter difficulty 
finding transportation home, increasing length of stay and ED crowding. We sought to determine the 
preferences of patients discharged from the ED with regard to their transportation home, and their 
awareness and past use of ridesharing services such as Lyft and Uber.
Methods: We performed a prospective, survey-based study during a five-month period at a university-
associated ED and Level I trauma center serving an urban area. Subjects were adult patients who were 
about to be discharged from the ED. We excluded patients requiring ambulance transport home.
Results: Of 500 surveys distributed, 480 (96%) were completed. Average age was 47 ± 19 years, and 
61% were female. There were 33,871 ED visits during the study period, and 67% were discharged 
home. The highest number of subjects arrived by ambulance (27%) followed by being dropped off 
(25%). Of the 408 (85%) subjects aware of ridesharing services, only eight (2%) came to the ED 
by this manner; however, 22 (5%) planned to use these services post-discharge. The survey also 
indicated that 377 (79%) owned smartphones, and 220 (46%) used ridesharing services. The most 
common plan to get home was with family/friend (35%), which was also the most preferred (29%). 
Regarding awareness and past use of ridesharing services, we were unable to detect any gender 
and/or racial differences from univariate analysis. However, we did detect age, education and income 
differences regarding awareness, but only age and education differences for past use. Logistic 
regression showed awareness and past use decreased with increasing patient age, but correlated 
positively with increasing education and income. Half the subjects felt their medical insurance should 
pay for their transportation, whereas roughly one-third felt ED staff should pay for it.
Conclusion: Patients most commonly prefer to be driven home by a family member or friend after 
discharge from the ED. There is awareness of ridesharing services, but only 5% of patients planned 
to use these services post-discharge from the ED. Patients who are older, have limited income, and 
are less educated are less likely to be aware of or have previously used ridesharing services. ED 
staff may assist these patients by hailing ridesharing services for them at time of discharge. [West J 
Emerg Med. 2019;20(4)672-680.]
INTRODUCTION
Emergency department (ED) visits continue to grow 
steadily each year, with roughly 137 million per year based 
on the most recent data from the National Center for Health 
Statistics.1 ED crowding remains a serious problem despite 
University of California, Davis Medical Center, Department of Emergency Medicine, 
Sacramento, California
progressive measures aimed at improving patient flow, 
especially with regard to inpatient admissions.2 One factor 
that has received less recognition as a potential variable for 
ED crowding is time spent arranging transportation home 
for patients discharged from the ED, which adds to overall 
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Population Health Research Capsule
What do we already know about this issue?
 Patients discharged from the emergency 
department (ED) may encounter difficulty 
obtaining a ride home, especially the elderly 
and disabled.
What was the research question?
What are patients’ preferences regarding 
transportation home, and what is their 
awareness and use of ridesharing services?
What was the major finding of the study?
Transportation home with family or friend is 
preferred. Awareness and use of ridesharing 
services is limited.
How does this improve population health?
 Ridesharing services are underutilized, 
and ED staff may arrange rides for patients 
without smartphones. This may improve 
time to discharge, patient satisfaction, and 
ED crowding.
length of stay.3 Discharged patients may experience difficulty 
finding family or friends to pick them up from the ED, may 
not be able to use public transportation, or may have physical 
or mental limitations on their ability to get home on their 
own. Patients who have driven themselves to the ED may 
have received sedating medications and be unsafe to drive. 
The onus of finding appropriate transportation home for 
discharged patients frequently falls on ED staff, who may be 
overextended during periods of crowding.
The advent and rapid growth of ridesharing services, such 
as Lyft and Uber, represents a potential solution for timely 
patient discharges from the ED.4 Once available only to those 
with smartphone or internet access, ridesharing services may 
now be arranged by telephone and arrive expeditiously and 
reliably via real-time global positioning system tracking via an 
application (app) or webpage. These services are usually paid 
for by patients but may be covered by medical insurance or 
individual EDs contracting with ridesharing companies. As this 
technology is relatively new, the impact of ridesharing services 
on patient transportation to and from the ED is not yet known. 
To determine how much patients know about and use 
ridesharing services, we conducted a survey study in the ED. 
We also queried ED patient demographics, their preferences 
regarding transportation home, and their opinion of how it 
should be paid for. Our findings may be of interest to hospital 
and ED leadership, administration, and nursing. As ridesharing 
services expand and become more accessible to those without 
smartphone access, we believe ED patients may prefer this 
mode of transportation to and from the ED, especially if the 
hospital and/or their medical insurance cover its cost.
METHODS
We performed a prospective, survey-based study during the 
five-month period September 1, 2017–  January 31, 2018, at a 
university-associated ED and Level 1 trauma center serving an 
urban population of two million in central California. The study 
coincided with the advent of a hospital policy of arranging and 
paying for ridesharing service to certain patients discharged 
from the ED with financial or social hardships; the service 
was provided at the discretion and sanction of the ED charge 
nurse. This new policy was not publicized, did not apply to taxi 
services, and was granted on a case-by-case basis upon patient 
request. Subjects were a convenience sample of randomly-
chosen adult patients 18 years of age or older, or adult parents 
of patients under 18, who were about to be discharged from the 
ED. The survey questions (Supplement 1) were only provided 
in the English language, requiring subjects to be able to read 
English or have their accompanying family and/or friends 
translate for them. Exclusion criteria were patients requiring 
ambulance transport home.
The survey was voluntary and anonymous, and potential 
subjects could decline participating in the study prior to 
receiving the survey instrument. Surveys were distributed 
to subjects in paper form and collected immediately after 
completion by collaborators from our Emergency Medicine 
Research Associate Program (EMRAP). The EMRAP 
collaborators clarified any questions subjects may have 
had regarding the survey and also checked the surveys for 
completeness. If any surveys were incomplete or had multiple 
responses checked, the EMRAP collaborators worked with the 
subject to resolve any discrepancies at the time of collection. 
The time period of distribution in the ED was from 5 AM to 
midnight, seven days a week. This study was approved by our 
institutional review board as an exemption, and patient consent 
was waived. We performed univariate and multiple logistic 
regression analyses using MedCalc™ version 18.11.3 (Ostend, 
Belgium). Statistical significance was assumed at P ≤ 0.05.
RESULTS
A total of 500 surveys were distributed; 480 (96%) 
subjects completed the survey and 20 subjects (4%) declined 
to participate after receiving the survey. The average age 
of the study subjects was 46.4 ± 18.7 years, and 291 (61%) 
were female. In contrast, the overall ED population during 
the study period had an average age of 40.0 ± 23.8 years, and 
16,553 (49%) were female. Further demographics, including 
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race, education, income, and smartphone/internet usage are 
displayed in table 1. 
planned to use such a service post-discharge. There were 377 
(79%) who indicated they possessed a smartphone, and 220 
(46%) had previously used these ridesharing services. The 
highest number of subjects planned to get home with a family 
member or friend (n = 167, 35%), which was also the most 
preferred method (n = 141, 29%) (Table 2). Regarding the 
awareness of ridesharing services, we found significant age, 
education, and income differences from univariate analysis 
(Table 3). For prior use of ridesharing services, significant 
differences were found for only age and education (Table 4).
Logistic regression analysis of ridesharing awareness 
and use also revealed differences by age, education, and 
income, but not gender or race (Table 5). In general, 
both awareness and use decreased with age (Odds ratio 
(OR) less than one) and increased with rising education 
and income levels (OR greater than one). The model 
for predictors of ridesharing awareness was statistically 
significant (P < 0.0001, χ2 = 58.48, df = 17, Nagelkerke R2 
= 0.20, and area under the receiver operating characteristic 
(ROC) curve 0.77 (95% confidence interval (CI), 0.72 to 
0.80). Awareness predictor variables reaching statistical 
significance were age (OR = 0.96, P < 0.0001) education 
level up to 8th grade (OR = 0.33, P = 0.03), income less 
than $20,000 per year (OR = 0.52, P = 0.02), and income 
$50,000 - $100,000 per year (OR =3.7, P = 0.01). The 
regression model for predictors of ridesharing use was also 
significant (P < 0.0001, χ2=86.11, df = 17, Nagelkerke 
R2 = 0.22, and area under the ROC curve 0.73 (95% CI, 
0.69 to 0.77). Ridesharing use predictor variables reaching 
significance were age (OR = 0.95, P < 0.0001), high school 
or general educational development (GED) education 
level (OR = 2.05, P = 0.03), and college (OR = 2.77, P = 
0.002). Income greater than $100,000 per year approached 
significance (OR = 2.09, P = 0.06). 
Half the subjects (n = 241, 50%) felt their medical 
insurance should pay for their transportation home, whereas 
148 (31%) felt the ED staff should arrange and pay for it. The 
average estimated distance home was 16.4 ± 22.0 miles, with 
most being less than 10 miles from the ED. There were 589 
(2.6%) ridesharing transports arranged by ED staff and paid for 
by the hospital during the study period for a total cost of $8,731. 
Average cost and distance per ride was $15.70 ± 14.10 and 9.1 
± 10.1 miles, respectively. The majority were hailed during the 
day (7 AM - 7 PM) (n = 339, 57.6%) and 250 (42.4%) were 
hailed overnight (7 PM - 7 AM).
DISCUSSION
Transportation to and discharge home from the ED 
is an essential need, especially for elderly, disabled, and 
economically disadvantaged patients. It is estimated roughly 
four million individuals fail to receive medical care annually 
due to transportation barriers.5 Delays in the diagnosis and 
treatment of patients with chronic diseases often results in 
Age (years) 46.4 ± 18.7
Gender
Female 291 (60.6%)
Male 186 (38.8%)
Undisclosed 3 (0.6%)
Race
White 214 (44.6%)
Black 91 (19.0%)
Hispanic 80 (16.7%)
Asian 48 (10%)
Other 40 (8.3%)
Prefer not to disclose 7 (1.4%)
Education
College 207 (43.1%)
High school or GED 172 (35.8%)
Graduate 47 (9.8%)
Vocational school 25 (5.2%)
Up to Grade 8 18 (3.7%)
Prefer not to disclose 11 (2.4%)
Income
Less than $20,000 191 (39.7%)
$20,001 to $50,000 98 (20.4%)
$50,001 to $100,000 69 (14.4%)
Prefer not to disclose 85 (17.8%)
greater than $100,000 37 (7.7%)
Internet
Own smartphone 377 (78.5%)
Text messages per day 21.9 ± 35.7
Emails sent per day 8.3 ± 20.1
Aware of rideshare apps? 408 (85%)
Used rideshare apps? 220 (45.8%)
Table 1. Demographics of  respondents to a survey of transportation 
preferences post discharge from the emergency department.
GED, general educational development.
Of the 33,871 ED visits during the study period, 22,833 
(67%) were discharged home. The most frequent mode of 
transportation to the ED was by ambulance (n = 127, 27%) 
followed by being dropped off by a family member or friend (n 
= 119, 25%) (Table 2).
Although 408 (85%) were aware of ridesharing services, 
only eight (2%) came to the ED by this manner, but 22 (5%) 
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How did you come to the emergency 
department?
Ambulance 127 (26.5%)
Dropped off by family member or friend 119 (24.8%)
Your personal vehicle driven by someone 
else
101 (21.0%)
Your personal vehicle alone 93 (19.4%)
Walk 16 (3.3%)
Public transportation (Bus/Light Rail) 12 (2.5%)
App-based rideshare service (Uber/Lyft) 8 (1.7%)
Taxi 3 (0.6%)
Bike 1 (0.2%)
How do you plan to get home?
Pick-up by family or friend 167 (34.8%)
Your personal vehicle driven by someone else 119 (24.8%)
Your personal vehicle alone 89 (18.6%)
Not sure yet 28 (5.8%)
App-based rideshare services (Uber/Lyft) 22 (4.6%)
Walk 17 (3.5%)
Public transportation (Bus/Light Rail) 15 (3.1%)
Ambulance transport 11 (2.3%)
Taxi 8 (1.7%)
Other 3 (0.6%)
Bike 1 (0.2%)
Ideally, what is your top preference of 
transportation home?
Pick-up by family or friend 141 (29.3%)
Your personal vehicle alone 140 (29.1%)
Your personal vehicle driven by someone else 105 (21.9%)
App-based rideshare services (Uber/Lyft) 26 (5.4%)
Public transportation (Bus/Light Rail) 19 (4.0%)
Taxi 13 (2.7%)
Free, hospital-provided shuttle 10 (2.1%)
Ambulance transport 8 (1.7%)
Other 8 (1.7%)
Walk 7 (1.5%)
Bike 3 (0.6%)
Table 2. Transportation to the emergency department, and plans/
preferences for discharge transportation.
destabilization and progression of those diseases, ED crowding, 
excessive use of inpatient resources, and poor outcomes.6-8 
According to a 2016 report of the United States Government 
Accountability Office, the cost of medical transportation for 
Medicare and Medicaid patients exceeded $2.7 billion, with 
the Medicaid segment rising significantly in the past decade.9 
This does not include estimates on the cost of missed and/or 
unused clinic appointments and negative downstream health 
effects, which is estimated at $150 billion.10 
For the next several decades, the number and percentage of 
older adults are expected to increase, particularly the “oldest-old” 
(those 85 years and older). This subgroup will number roughly 
seven million (2% of the population) in 2020 but will grow to 18 
million (4.5%) by 2050.11 Coupled with this aging population and 
rising Medicaid enrollment, government spending on medical 
transportation will continue to increase. Thus, the need for more 
cost-efficient ways to provide transportation for patients has 
become an important issue in healthcare and consumer spending. 
Prior to the ridesharing app era, patients discharged 
from the ED who had no family/friends/self to drive them 
had to rely on taxis or private medical shuttle companies. 
At present, ridesharing companies such as Lyft and Uber 
have begun to offer programs that address this need at a 
lower cost than traditional taxi services, which have been 
shown to be more expensive in all major cities except New 
York.12 According to the Lyft business website, 80% of 
patients prefer Lyft for transportation, with a cost reduction 
of 32%.13 The chief business officer of Lyft wrote that the 
company’s goal is to reduce the healthcare transportation 
gap by 50% by 2020.10 Of 30,000 Lyft riders surveyed, 29% 
reported they have used the ridesharing app for healthcare 
transportation, according to the company’s 2019 economic 
impact report.14 Lyft has recently partnered with nine health 
systems and 10 medical transportation firms to provide 
patients with more extensive transportation options.15
Uber, the other major ridesharing app provider, 
launched Uber Health in 2015 for medical 
transportation.16,17 Uber Health, so far available only in 
the U.S., allows ED staff to book rides for discharged 
patients who do not have a smartphone. It has been used 
by more than 100 health facilities, many of which pay for 
the service to avoid the downstream health and personnel 
costs of delayed discharges and missed appointments. One 
issue that has arisen from the use of ridesharing apps for 
post-discharge transportation is that elderly and/or disabled 
patients may have unique needs and preferences, such as 
help getting into and out of the vehicle or a slower ride. 
Uber has responded to this need with Uber Assist, in which 
drivers are specifically trained to assist seniors and those 
with disabilities.18 Lyft has partnered with CareMore to 
provide similar services, and preliminary survey data from 
this program showed decreased transportation wait time 
and cost and increased patient satisfaction.18,19 Other novel 
programs aimed at reducing the transportation burden of 
older and disabled patients discharged from the ED include 
GoGoGrandparent, ITNAmerica, and Liberty Mobility Now.20
Despite the obvious cost and access advantages to the 
use of ridesharing services for medical transportation, the 
authors of one study found the impact of these services on 
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Aware Not aware P
Age (years) 44.8 ± 18.1 55.7 ± 19.2 < 0.0001*
Gender
Female 253 (86.9%) 38 (13.1%)
Male 153 (82.3%) 33 (17.7%) 0.2
Race
Asian 36 (75.0%) 12 (25.0%)
Black 80 (87.9%) 11 (12.1%)
Hispanic 63 (78.7%) 17 (21.3%)
White 186 (86.9%) 28 (13.1%)
Other 37 (92.5%) 3 (7.5%) 0.06
Education
Up to Grade 8 11 (61.1%) 7 (38.9%)
High School or GED 144 (83.7%) 28 (16.3%)
Vocational School 19 (76.0%) 6 (24.0%)
College 183 (88.4%) 24 (11.6%)
Graduate 43 (91.4%) 4 (8.6%) 0.009
Income/year
Less than $20,000 155 (81.1%) 36 (18.9%)
$20,001 to $50,000 86 (87.7%) 12 (12.3%)
$50,001 to $100,000 65 (94.2%) 4 (5.8%)
Greater than $100,000 34 (91.8%) 3 (8.2%) 0.03
Table 3. Patient awareness of ridesharing services.
* Student’s t-test; otherwise Χ2.
GED, general educational development.
medical appointment attendance may be minimal, even when 
offered for free. In their prospective clinical trial, Chaiyachati 
and colleagues offered gratis Lyft rides to 786 patients 
to and from their clinic appointments. The rate of missed 
appointments was 36.5% compared to 36.7% for study 
participants not offered free transportation.21 More than 
half of patients contacted with offers of a free ridesharing 
service responded they weren’t interested. Some theories 
on this finding were that those most in need of ridesharing, 
such as elderly and/or low-income patients, were the 
least technology-savvy and unlikely to own smartphones. 
Skepticism of ridesharing services and concern over 
privacy issues were also cited.
The findings of our survey with regard to age, income, 
and education parallel other studies conducted in non-
healthcare settings. According to the Pew Research Center, 
33% of adults in the U. S. have never heard of ridesharing 
services, and only 15% have ever used them.22 From the 
same survey, ridesharing users tended to be younger and 
college-educated, with higher than average incomes. 
Vivoda et al. surveyed older Americans and found 74% 
reported no knowledge of ridesharing services, and only 
1.7% had used them.20 Younger age, male gender, and 
higher education were all independently associated with 
greater knowledge of ridesharing services in their study. 
In the past, Lyft and Uber required the use of a 
smartphone and/or internet to hail a ride. It is estimated 
only 42% of older adults own a smartphone, and only 64% 
use the internet.23 Further survey findings have shown those 
with higher educations and incomes are likely to have more 
disposable income to spend on smartphones and internet 
access.24 In our study we did not ascertain differences 
between gender and race with regard to ridesharing service 
awareness and use. However, the authors of previously 
published studies have highlighted gender differences. 
Men, particularly in older adulthood, have been shown 
to take more trips per day than women and to have more 
favorable attitudes toward technology than women.25-27 
Women may be less inclined to use ridesharing services, as 
it involves taking a ride with a stranger in an environment 
perceived as less regulated than a taxi.28
The use of immediately-available ridesharing services 
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Used before Never used P
Age (years) 40.2 ± 17.4 51.6 ± 18.2 < 0.0001*
Gender
Female 140 (48.1%) 151 (51.9%)
Male 79 (42.7%) 106 (57.3%) 0.3
Race
Asian 27 (56.3%) 21 (43.7%)
Black 42 (46.1%) 49 (53.9%)
Hispanic 32 (40.0%) 48 (60.0%)
White 93 (43.4%) 121 (56.6%)
Other 22 (55.0%) 18 (45.0%) 0.2
Education
Up to Grade 8 4 (22.2%) 14 (77.8%)
High School or GED 72 (41.8%) 100 (58.2%)
Vocational School 6 (24.0%) 19 (76.0%)
College 102 (49.3%) 105 (50.7%)
Graduate 32 (68.1%) 15 (31.9%) 0.0004
Income/year
Less than $20,000 79 (41.3%) 112 (58.7%)
$20,001 to $50,000 49 (50.0%) 49 (50.0%)
$50,001 to $100,000 35 (50.7%) 34 (49.3%)
Greater than $100,000 22 (59.4%) 15 (40.6%) 0.1
Table 4. Prior use of ridesharing services by emergency department patients.
*Student’s t-test; otherwise Χ2. 
GED, general educational development.
for transportation to and from the ED has several benefits. 
The first is eliminating the need for arranging a ride, 
driving to the ED, negotiating traffic, and finding parking. 
These actions add additional stressors upon the patient 
and their accompanying family and friends. Patients often 
receive sedating medications during their ED stay, such as 
antihistamines, antiemetics, benzodiazepines, and opioids. 
Ridesharing services may mitigate the risk associated with 
patients driving themselves home, especially the elderly, 
and these services have been shown to decrease substance-
impaired driving after socialization.29,30 ED crowding may 
be favorably affected, as patient discharges from the ED no 
longer rely on finding a ride, which can take hours based on the 
availability of acquaintances or public transportation schedules. 
When ridesharing services are hailed by the ED staff 
for a patient, as in our ED, there is no longer a need for 
patient ownership of a smartphone. Reduction of pollution, 
traffic congestion, and fuel use are further benefits. 
The transportation sector is the largest source (29%) of 
greenhouse gas emissions in the U.S., leading to serious 
air pollution and negative health effects, with cars alone 
accounting for the largest share (41.6%).31 Furthermore, 
over three-quarters of Americans drive alone to work, while 
9.0% use ridesharing services and 5.1% use public transit.32 
In heavily congested and polluted cities, such as Beijing, 
China, ridesharing has been shown to improve greenhouse 
gas emissions and energy savings.33
LIMITATIONS
There are some limitations to this study that must be 
acknowledged. It is a survey study that relied on voluntary 
responses from subjects, although a high percentage (96%) 
completed the survey. Surveys were not distributed during 
the hours of midnight to 5 AM, and some differences in 
subject response may have been missed, especially during 
a time period of limited public and private transportation 
options. Recall bias may have been a factor, especially 
in the elderly subgroup. Some subjects may have been 
in discomfort or upset at ED crowding conditions while 
taking the survey, which may have affected their responses. 
Regarding the survey instrument (Supplement 1), response 
options were not alphabetized, which may have led some 
subjects to preferentially choose the first one or two 
options. There was overlap of income range on the fifth 
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B SE Wald OR 95% CI P
Awareness
Age -0.04 0.01 23.5 0.96 0.94 to 0.97 <0.0001
Education
Up to Grade 8 -1.1 0.53 4.28 0.33 0.11 to 0.94 0.03
Vocational school -0.56 0.97 0.33 1.18 0.23 to 5.96 0.83
High School/GED -0.23 0.84 0.07 1.92 0.48 to 7.72 0.35
College 0.11 0.85 0.01 2.85 0.70 to 11.52 0.13
Graduate school 0.51 1 0.25 4.03 0.75 to 21.55 0.1
Income/year
< $20,000 -0.64 0.27 5.4 0.52 0.30 to 0.90 0.02
$20,001 - $50,000 0.29 0.45 0.4 1.34 0.54 to 3.28 0.15
$50,001 - $100,000 1.31 0.62 4.42 3.7 1.09 to 12.51 0.01
> $100,000 1.08 0.72 2.25 2.95 0.71 to 12.16 0.11
Constant 3.26 1.42 5.22 0.02
Use
Age -0.04 0.01 45.64 0.95 0.94 to 0.97 <0.0001
Education
Up to Grade 8 -1.03 0.93 1.24 0.35 0.05 to 2.19 0.26
Vocational school -1.02 0.87 1.38 0.35 0.06 to 1.97 0.23
High School or GED 0.72 0.34 4.32 2.05 1.04 to 4.06 0.03
College 1.02 0.34 9 2.77 1.42 to 5.40 0.002
Graduate school 1.8 0.44 16.81 6.09 2.56 to 14.46 <0.0001
Income/year
< $20,000 0.01 0.26 0.001 1.01 0.59 to 1.69 0.97
$20,001 - $50,000 0.35 0.29 1.42 1.42 0.79 to 2.56 0.23
$50,001 - $100,000 0.38 0.32 1.39 1.47 0.77 to 2.78 0.23
> $100,000 0.73 0.4 3.4 2.09 0.95 to 4.59 0.06
Constant 2.12 1.17 3.25 0.07
Table 5. Multiple logistic regression analysis of ridesharing service awareness and use.
B, coefficient; CI, confidence interval; GED, general educational development; SE, standard error; OR, odds ratio.
question, and the last question may have been misinterpreted 
by those subjects without medical insurance. Our ED serves an 
urban geographic area serving a population of over two million, 
and this may not reflect other urban or rural settings with different 
racial and ethnic proportions. 
Another limitation is that our study subjects differed 
from the overall ED population with regard to gender and 
age, which may affect the generalizability of our findings. 
The proportion of females responding to the survey was 
significantly different from the overall ED population (60% 
vs 49%, X2 = 17.9, P < 0.0001). One potential explanation 
for this gender difference is that females are more likely 
than males to complete surveys.34 The average age of the 
study population was higher than the overall ED population 
(46.4 ± 18.7 versus 40.0 ± 23.8 years, P < 0.0001, unpaired 
t-test), which likely reflects that patients less than 18 
years of age were excluded. Finally, this study was only 
able to determine demographics, preferences, and rates of 
knowledge and/or use of ridesharing services; it did not 
assess underlying socioeconomic or medical reasons for 
any observed differences.
CONCLUSION
Patients prefer to be driven home by a family member or 
friend after discharge from the ED. There is ample awareness of 
ridesharing services, but only 5% use these services to get home 
after discharge from the ED. Patients who are older, have less 
income, and have less education are less likely to be aware of or 
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have previously used ridesharing services. ED staff may suggest 
or even contact a ridesharing service for patients at time of 
discharge to assist in their transportation home. The on-demand 
and expeditious nature of ridesharing services may have a 
positive impact on patient satisfaction and ED crowding. Further 
studies are needed to assess these variables as the prevalence and 
success of ridesharing services continues to grow.
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Introduction: The emergency department (ED) serves as the primary access point to the healthcare 
system. ED throughput efficiency is critical. The percentage of patients who leave before treatment 
completion (LBTC) is an important marker of department efficiency. Our study aimed to assess the 
impact of an ED phlebotomist, dedicated to obtaining blood specimen collection on waiting patients, on 
LBTC rates. 
Methods: This study was conducted as a retrospective observational analysis over approximately 18 
months (October 5, 2015-March 31, 2017) for patients evaluated by a triage provider with a door-to-room 
(DtR) time of > 20 minutes (min). LBTC rates were compared in 10-min DtR increments for when the ED 
phlebotomist collected the patient’s specimen vs not.
Results: Of 71,942 patient encounters occurring during the study period, 17,349 (24.1%) met study 
inclusion criteria. Of these, 1842 (10.6%) had blood specimen collection performed by ED phlebotomy. 
The overall LBTC rate for encounters included in the analysis was 5.26% (95% confidence interval [CI], 
4.94%-5.60%). Weighting the LBTC rates for each 10-min DtR interval using the fixed effects model led 
to an overall LBTC rate of 2.74% (95% CI, 2.09%-3.59%) for patient encounters with ED phlebotomist 
collection vs 5.31% (95% CI, 4.97%-5.67%) in those which did not, yielding a relative reduction of 48% 
(95% CI, 34%-63%). The effect of the phlebotomist on LBTC rates increased as DtR times increased. 
The difference in the rate of the rise of LBTC percentages, per 10-min interval, was 0.50% (95% CI, 
0.19%-0.81%) higher for non-ED phlebotomist encounters vs phlebotomist encounters. 
Conclusion: ED phlebotomy demonstrated a significant reduction in ED LBTC rates. Further, as DtR 
times increased, the impact of ED phlebotomy became increasingly significant. Adult EDs with increased 
rates of LBTC patient encounters may want to consider the implementation of ED phlebotomy. [West J 
Emerg Med. 2019;20(4)681-687.] 
INTRODUCTION
The emergency department (ED) serves as the primary 
access point to the healthcare system for more than 117 million 
patient encounters in the United States (U.S.) annually.1 
Prolonged wait times, extended lengths of stay (LOS), and 
crowding negatively impact the patient experience and quality of 
University of Arizona College of Medicine-Phoenix, Department of Emergency Medicine, 
Phoenix, Arizona 
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care.2,3 To meet patient and community healthcare needs, efficient 
ED throughput and patient flow is critical. Patients who leave 
the ED prior to completing assessment, treatment, and formal 
disposition by an ED provider have been identified as a potential 
marker of systemwide inefficiency.4 
Patients who leave the ED before treatment completion 
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Population Health Research Capsule
What do we already know about this issue?
Increased emergency department (ED) wait times, 
lengths of stay, and patients who leave prior to 
completing treatment (LBTC) are a potential marker 
of systemwide inefficiency.
What was the research question?
Do dedicated ED phlebotomists decrease LBTC 
rates on patients waiting to being roomed as door-to-
room (DtR) times increase?
What was the major finding of the study?
The LBTC rate for encounters with ED phlebotomy 
was 2.74% vs 5.31% in those without. The effect 
increased as DtR times increased.
How does this improve population health?
ED phlebotomy reduced LBTC rates as DtR times 
increased. EDs should consider the implementation 
of ED phlebotomy to reduce LBTC rates.
(LBTC) represent the total number of patients who leave early.5 
Overall, approximately 0.36%–15% of all patients presenting to 
an ED in the U.S. LBTC.5-8 Of these, approximately two-thirds 
leave before being seen (LBBS) by a physician or physician 
extender, with the remaining one-third leaving subsequent to 
being seen (LSBS).6 LBTC encounters increase ED recidivism, 
potentially damage the reputation and trust of the healthcare 
institution with the community, and result in lost revenue.6,9,10-13 
These encounters are considered “missed opportunities” for 
the healthcare system.9,14 Accordingly, the proportion of LBBS 
encounters is used by the Centers for Medicare & Medicaid 
Services (CMS) as a hospital quality indicator, with previous 
investigators estimating the desirable LBBS goal at <2%.4,15
Excessive wait time, due to crowding and fluctuating 
patient volumes beyond ED capacity, is the most powerful 
LBTC predictor.9,10,12,15-18 The mean time a patient spends in the 
ED before they leave without being seen is between 102.4–171 
minutes (min).9,19 Initiatives aimed at reducing ED LBTC rates 
commonly target the patient arrival process in order to reduce the 
time from patient arrival to room and formal evaluation.12 A target 
wait time of fewer than 45 mins, for patients who do not require 
the most immediate intervention or evaluation as characterized 
by an Emergency Severity Index (ESI) 3, and 60 mins for ESI 
4 patients, has been demonstrated to result in an overall LBBS 
rate of < 2%.15 Further, a door-to-room (DtR) time of <20 mins 
increases the likelihood of obtaining a LBBS rates of <1%.20
We predict early patient engagement in a meaningful and 
tangible way increases the patient’s investment in the encounter 
and will therefore make them less likely to leave early. Our 
study aimed to describe the impact of blood specimen collection 
performed by a dedicated ED phlebotomist on patients waiting to 
be roomed, on LBTC rates as DtR times increase.
METHODS
The study protocol was reviewed and approved by the 
Maricopa Integrated Health System institutional review 
board. The study did not involve human subjects. 
Study Setting and Population
The study ED is a large, urban, single-center, adult Level 
1 trauma center at a primary academic training institution 
and is part of a safety net healthcare system. The annual ED 
census includes approximately 50,000 patient encounters, with 
a 14% admission rate and approximately 2000 hours of ED 
boarding of admitted patients per month. The ED is staffed 
by emergency medicine (EM)-boarded physicians, advanced 
practice providers (APPs), and EM residents in a postgraduate 
year (PGY) 1-3 program. 
Upon arrival, patients are triaged by a registered nursing 
provider before moving to a bedded location in fast track (five 
beds), the main ED (32 beds), or a designated critical care area 
(five beds). Patients arriving via emergency medical services 
(EMS) are offloaded to a hallway bed before being moved to a 
room. For 12 hours a day, the triage encounter also includes a 
brief physician-in-triage screening assessment. Stable patients, 
unable to be roomed immediately due to ED saturation, wait 
in the ED external waiting room after triage is completed. The 
ED employs a single ED technician as a phlebotomist eight 
hours per day (1 PM-9 PM), four days a week (Monday, Tuesday, 
Thursday, Friday), in overlap with the physician-in-triage. The 
ED phlebotomist is tasked with blood specimen collection on 
orders placed during the triage process for patients waiting in 
the external waiting room prior to being roomed. For encounters 
occurring when ED phlebotomy is not available, a nurse collects 
a blood specimen collection after the patient has been roomed.
Study Protocol 
This study was conducted as a retrospective observational 
analysis over approximately 18 months (October 5, 2015-May 
31, 2017). We extracted the following from the ED electronic 
health record for all patient encounters that occurred during the 
study window: 1) patient demographics, including gender, age 
and ESI; 2) whether blood specimen collection was ordered 
and performed by ED phlebotomy or nursing; 3) encounter 
throughput metrics, including arrival time to triage, room, blood 
specimen collection, provider and disposition; and 4) whether the 
patient completed treatment. Data extraction was performed by 
a blinded programmer and then reviewed by study authors who 
were not blinded to the study hypothesis.
LBTC rates for patient encounters when the ED phlebotomist 
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collected the patient’s blood specimen were compared to 
encounters with nursing collection after the patient was roomed 
or when the patient did not require collection. We included for 
analysis only patient encounters with a screening evaluation 
by a triage physician and a DtR time of >20 mins for analysis. 
Encounters with undocumented or DtR time of <20 mins were 
excluded as previous studies have demonstrated very few patients 
roomed within 20 mins of arrival leave early.20 We also excluded 
encounters without a physician-in-triage screening encounter as 
ED phlebotomy was only available when the physician-in-triage 
was present, and it has previously been shown that a physician-
in-triage screening encounter increases the number of patients 
who are willing to complete treatment.21 For analysis, encounters 
were stratified into 10-min DtR time increments (starting with 
DtR of >20-≤30 mins). Patient encounters with DtR times 
beyond six hours were grouped into a single stratum for analysis. 
Patient encounters without blood specimen collection orders 
were included, as the patient was unlikely to be aware of whether 
collection orders were placed when deciding to leave early. 
Data Analysis 
Proportions are described with confidence intervals (CI) 
using Wilson method with continuity correction. To determine 
the overall percentage change in LBTC rates, we used a fixed 
effects model and calculated CIs using the law of propagation 
of uncertainty (and confirmed them using Monte Carlo 
simulation of the binomial distribution). Linear regression was 
performed to evaluate and compare the rate of LBTC increase 
as DtR times rose. We evaluated significance of the rate 
increase trend using Cochrane Armitage test. Statistical analysis 
was performed in Microsoft Excel (Microsoft Corp., Redmond, 
WA) and R version 3.5.1.
RESULTS
A total of 71,942 patient encounters occurred during the 
study period, of which 17,349 (24.1%) met study inclusion 
criteria (Figure 1). Additionally, one encounter was removed prior 
to analysis due to incomplete data. Of these, 1842 (10.6%) had 
blood specimen collection performed by ED phlebotomy prior to 
being roomed. Patient encounter demographics and throughput 
characteristics are described in Table 1. Encounters with ED 
phlebotomist collection were found to have a similar ESI (ESI 
3), with an overall lower rate of admission (10.7%) as compared 
to those without (14.1%). The ED phlebotomist encounter group 
was found to have similar door to triage (17.98 mins vs. 18.48 
mins), shorter door to blood specimen collection (66.16 mins 
v. 152.26 mins), and longer DtR (122.71 mins vs 74.12 mins), 
primary physician evaluation (207.10 mins vs 149.21 mins), and 
disposition times (343.76 mins vs 286.76 mins) as compared to 
the non-ED phlebotomist encounter group.
The overall LBTC rate for encounters included in the 
analysis was 5.26% (95% CI, 4.94%-5.60%). Weighting the 
LBTC rates for each ten-min DtR interval using the fixed 
effects model demonstrated an overall LBTC rate of 2.74% 
(95% CI, 2.09%-3.59%) for patient encounters with ED 
phlebotomist collection vs 5.31% (95% CI, 4.97%-5.67%) in 
those that did not, yielding a relative reduction of 48% (95% 
CI, 34%-63%). For encounters with DtR of <20 mins, which 
were excluded from the primary analysis, we found a significant 
difference in the LBTC rate for encounters with blood specimen 
collection performed by ED phlebotomy, as compared to ED 
nursing collection (1.68% vs. 2.57%, p < .001). 
Figure 2 demonstrates the LBTC rate at each 10-min interval 
between patients who had ED phlebotomist-collected specimens 
as compared to those who did not between DtR times of 20 mins 
to 240 mins. The effect of the phlebotomist on the LBTC rate 
increased as DtR times increased. (Cochrane Armitage test for 
trend was p < 0.01.) The difference in the rate of the rise of the 
LBTC percentage, per ten-min interval, was 0.50% (95% CI, 
0.19%-0.81%) higher for non-ED phlebotomist encounters vs 
phlebotomist encounters. For encounters with DtR of >240 mins, 
which were excluded from the primary analysis, the LBTC rate 
for encounters with blood specimen collection performed by ED 
phlebotomy was found to be 15.8% (95% CI, 10.4%-23.1%), and 
36.2% (95% CI, 31.0%-41.7%) for collections performed by ED 
nursing. Due to smaller sample sizes, larger LBTC rate variability 
was noted in the phlebotomy group as the DtR time increased.
Figure 1. Study population inclusion for comparison of throughput 
with and without ED phlebotomy.
Total patient 
encounters 
71,942 Exclusion for 
undocumented, or 
door to room time of
 <20 minutes 
37,179 (51.7%)Patient encounters 
with documented 
door to room time of 
>20 minutes 
34,763 (48.3%)
Patient encounters 
with 
physician-in-triage 
evaulation 
17,349 (49.9%)
Patient encounters
without 
physician-in-triage 
evaluation 
17,414 (50.1%)
Encounters with 
emergency department 
phlebotomist collection 
1,842 (10.6%)
Encounters without 
emergency department 
phlebotomist collection 
15,507 (89.4%)
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DISCUSSION
In addition to prolonged wait times, patient-specific 
and departmental factors have been shown to predict 
LBTC rates. Patients of younger age, male gender, a lower 
socioeconomic status group (including being uninsured 
or covered by Medicaid), non-English speaking or from 
a minority group, and with lower acuity presentations 
are at a higher risk of incomplete visits.6,11,12,17,18,22-26 
Additionally, department specific- predictors include visits 
in a metropolitan or urban area, encounters at a teaching 
institution, and a lack of department management by an 
EM-trained physician.12,15,22,23 While ED providers have 
little control over patient-specific or institution-location 
predictors, at the departmental level changes can be 
implemented to identify and retain patients at higher risk 
for leaving early. 
Initiatives aimed at reducing ED LBTC rates 
often target the “bottleneck” effect created during 
the patient arrival process.12 A variety of approaches 
directed at disrupting the arrival bottleneck, through 
increased operational efficiency and reduction in the 
time from patient arrival to provider evaluation, have 
been successfully demonstrated in the literature.12,27-29 
Approaches include the implementation of an ED fast track 
for lower acuity patients, a “team” approach to patient 
triage including a physician-in-triage screening evaluation, 
the initiation of patient treatments during the triage 
process, and dedicated ED technicians performing minor 
procedures on waiting patients.21,30-32 Such approaches have 
demonstrated significant reduction in patient wait times, 
door to physician evaluation, and total LOS.21,32-42 Further, 
such approaches have been demonstrated to reduce LBTC 
rates.21,32,36,38,39,42,43,46 Unfortunately, deployment of extensive 
changes to the ED arrival process and triage system may 
not be feasible due to significant development time, effort, 
and expense. 
To our knowledge, the impact of an ED phlebotomist 
encounter on premature departure rates has not been 
previously evaluated. In the study population, the ED 
phlebotomist group demonstrated a significant reduction in 
LBTC rates as compared to encounters when ED phlebotomy 
was not involved in the patient care process. This reduction 
in LBTC occurred despite an overall longer time from DtR, 
physician assessment, and disposition for encounters that 
included ED phlebotomy. Further, the impact on LBTC rates 
increased by half a percent for every 10-min increase in DtR, 
representing a population of encounters increasingly difficult 
to maintain in the ED. While the reason for the reduction in 
LBTC rates is unclear, it is reasonable to infer that patients 
who perceive their care has begun or is ongoing may be 
more inclined to wait longer to completion. Departments 
with limited ability to significantly change the patient 
arrival process may want to consider deployment of an ED 
phlebotomist in triage to reduce LBTC rates. 
Dedicated ED phlebotomists offer additional 
advantages to patient care. Prior studies have demonstrated 
an increase in the rate of effective phlebotomy, 
improved patient satisfaction, a reduction in hemolysis, 
contamination, and specimen-misidentification rates. 
Further, phlebotomy utilization has been shown to result 
in a reduction in cost to the patient and hospital system, 
decreased needle-stick injury rates among providers, 
and a potential reduction in ED LOS.44-50 In addition 
to the reduction in ED LBTC rates, institutions should 
Demographics and throughput 
characteristics 
Encounters with ED phlebotomist 
collection
Encounters without ED phlebotomist 
collection 
Total encounters 1842 15507
Age (median) 42.03 42.29
Female (%) 1288 (69.92%) 8243 (53.16%)
Admissions (%) 91 (4.94%) 1158 (7.47%)
Emergency Severity Index (ESI) (Median) 3.0 (IQR 3-4) 3.0 (IQR 3-4)
Median door to (minutes):   
Triage 17.98 18.48
Room 122.71 74.12
Blood draw 66.16 152.26
Primary physician evaluation* 207.10 149.21
Disposition 343.76 286.76
Table 1. Patient demographic and throughput characteristics.
IQR, interquartile range; ED, emergency department.  
*Primary physician evaluation subsequent to physician-in-triage screening.
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consider these additional advantages when considering the 
implementation of ED phlebotomists. 
LIMITATIONS
During study development and implementation, we 
identified several potential limitations. During the study 
window, a dedicated ED fast track was implemented, which 
altered patient flow. However, the lack of a formal ED fast 
track would likely have amplified study findings, as most 
ED fast track patients are of lower acuity, do not get blood 
drawn, and therefore are more likely to leave sooner.12 
This study was conducted retrospectively in a single, 
adult ED that uses a provider-in-triage, fast track, and ED 
technicians. Generalizability to dissimilar departments may 
be limited. 
While ESI (ESI 3) and patient age (42.03 vs. 42.29) 
were similar, additional patient demographics, including 
chief complaint, were not obtained and may limit 
comparison of the study groups. There was a predominance 
of female patients in the group that received ED 
phlebotomy collection. Previous studies have demonstrated 
a lower LBTC rate among female patients, which may have 
impacted the study results. Additionally, patients without 
blood specimen-collection orders after a physician-in-triage 
evaluation, by definition, were grouped with the patients 
without phlebotomy. This may have confounded the study 
results, as these patients were potentially lower risk, and as 
a result, more likely to LBTC. However, the distribution of 
patients by ESI in both study groups was similar. 
Median DtR, primary physician encounter, and 
disposition was prolonged in the ED phlebotomy group. 
We believe that this was the result of ED crowding during 
the ED phlebotomist shift timeframe rather than a negative 
effect of ED phlebotomy. Patient disposition, including 
LBTC designation, is assigned by nursing providers in real 
time. Nursing is trained to assign the correct disposition 
designation, but it is possible that the incorrect disposition 
type may have been applied at times, as it was not possible 
to review each chart for confirmation. When not performing 
blood specimen collections, the ED phlebotomist was tasked 
with assisting with other department tasks, including stocking 
and performing electrocardiograms. While the impact of 
the performance of these tasks was not quantifiable as part 
of this study, it is possible that utilization of dedicated ED 
phlebotomists would also increase the impact on LBTC rates.
 
CONCLUSION
 The utilization of ED phlebotomy in waiting patients 
resulted in a significant reduction in ED LBTC rates. Further, 
as DtR times increased, the impact of ED phlebotomy 
became increasingly significant. Adult EDs with increased 
LBTC rates may want to consider the implementation of ED 
phlebotomy. 
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Abstract
Introduction: Agitation in children and adolescents in the emergency department (ED) can be dangerous 
and distressing for patients, family and staff. We present consensus guidelines for management of 
agitation among pediatric patients in the ED, including non-pharmacologic methods and the use of 
immediate and as-needed medications.
Methods: Using the Delphi method of consensus, a workgroup comprised of 17 experts in emergency 
child and adolescent psychiatry and psychopharmacology from the the American Association for 
Emergency Psychiatry and the American Academy of Child and Adolescent Psychiatry Emergency Child 
Psychiatry Committee sought to create consensus guidelines for the management of acute agitation in 
children and adolescents in the ED.
 
Results: Consensus found that there should be a multimodal approach to managing agitation in the 
ED, and that etiology of agitation should drive choice of treatment. We describe general and specific 
recommendations for medication use.
Conclusion: These guidelines describing child and adolescent psychiatry expert consensus for the 
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